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Abstract 
 
The development of government policy to respond to the use and impact of illicit drugs is 
marked by controversy and the contestation of ideas.  The aim of this thesis is to understand 
why some policy ideas succeed and others fail by exploring the challenges of replicating drug 
consumption room policy.  Drug consumption rooms are government-sanctioned facilities 
that allow drug users to legally consume illicit substances under supervision to reduce the 
harms associated with drug use.  Formal evaluations attested to their success as public health 
interventions, yet the body of evidence supporting their effectiveness has not resulted in the 
interventions becoming mainstream policy.  The focus of this thesis is the challenges and 
barriers to the replication of policy both nationally and sub-nationally in Australia and 
Canada.  The research applies a multiple case study methodology which combines 
documentary analysis and thematic analysis of semi-structured interviews with key 
informants, focused on four cities in the two countries. 
Through the theoretical lens of policy transfer, this thesis identifies the different sources of 
policy change which have constrained or facilitated the replication of policy.  Comparative 
analysis undertaken of successful and failed policy diffusion in the case study sites 
demonstrates the interactions between the structures of the state, ideas and agents.  The 
thesis finds there is a tendency towards conservatism within institutional structures which 
constrains policy learning.  The dominant ideology of drug prohibition and other ideational 
factors such as stigma serve to inhibit change.  Crisis and civil disobedience are the two 
factors found to be significant where change has occurred.  The actions of civil society 
challenge institutional power from the bottom up; a factor inadequately captured by the 
policy transfer framework with its focus on top down change.  Following an appraisal of the 
framework, a modification is suggested to include civil society as a fifth source of policy 
change. 
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1.1 Introduction 
"At first people refuse to believe that a strange new thing can be done, then they begin 
to hope it can be done, then they see it can be done – then it is done and all the world 
wonders why it was not done centuries ago." (Hodgson Burnett, 2012 p.281) 
 
For some ‘strange new things’, acceptance comes via the linear pathway described above as 
an idea, at first rejected, gains support and then is normalised through demonstration of its 
effectiveness. This thesis is concerned with ideas, evidence and normalisation in the sphere 
of public policy, and specifically, policy governing illicit drugs. It is concerned primarily with 
understanding how to account for ideas that travel on non-linear pathways: ideas that can 
be demonstrated as being ostensibly successful but fail to gain acceptance, where policy 
stalls rather than flourishes. Frances Hodgson Burnett’s epigraph speaks to a world of 
rationality that proponents of evidence-based policy would recognise. But what happens 
when evidence is not persuasive? What contexts, what structures, what agents can account 
for whether an idea triumphs or fails? To explore these concerns, this research focuses on 
the contested policy of drug consumption rooms: a public health intervention where, in a 
specific physical space, the state sanctions the otherwise illegal activity of illicit drug 
consumption in the interests of reducing harms. Specifically, the research seeks to 
understand why replicating drug consumption room policy has proved so challenging in 
Australia and Canada. 
In 2001 the first supervised injecting facility outside of Europe opened in Australia on a trial 
basis. The Medically Supervised Injecting Centre (MSIC) in Kings Cross, Sydney, is a 
government sanctioned and funded service that provides a safe, clean environment where 
injecting drug users can consume illicit drugs under medical supervision. By 2016, one million 
visits had been made to the service and over 6000 overdoses had been managed. Despite 
the risk posed by drug overdose, no one has ever died at the facility (Uniting Church, 2018; 
personal communication, A. Salmon, Research Manager, MSIC, 29 January 2018). A statutory 
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review in the same year recommended ongoing support for the service on the grounds that 
there was continuing need and the facility was exceeding its targets (NSW Government, 
2016).  
In 2003, the city of Vancouver in Canada followed suit with the establishment of Insite, a 
stand-alone supervised injecting facility in the Downtown Eastside offering 12 injecting 
booths and onsite medically trained staff. Insite was sponsored by the Vancouver City Council 
and received the approval of both the federal government which ensured its legal status, and 
the provincial government which provided C$3.2 million for its initial capital and operational 
costs (Read, 2003). As a three-year pilot project, Insite was externally evaluated, and over 
thirty studies were published in its first five years of operation (Harati, 2015).  
Today, MSIC and Insite continue to operate in their initial sites, demonstrating the technical 
and legal feasibility of such services in their current settings. They have both been subject to 
extensive evaluation and research which, as will be discussed below, has found the services 
to be effective. This is consistent with the international literature on drug consumption 
rooms. For example, an international review conducted by the European Monitoring Centre 
for Drugs and Drug Addiction (EMCDDA) concluded: 
“Taken in sum, the available evidence does not support the main concerns raised 
about this kind of intervention and points to generally positive impacts in terms of 
increasing drug users’ access to health and social care, and reducing public drug use 
and associated nuisance.” (Hedrich et al., 2010 p.305) 
The combination of the evidence of effectiveness and the significant public investment might 
lead to an expectation that these two facilities would serve as exemplars in their respective 
countries, resulting in a scaling up of such interventions where commensurate need was 
established. This did not occur in Australia; in Canada, where scaling up has very recently 
occurred, it was only after a significant hiatus where the policy remained stalled. The initial 
concern of this thesis was to understand the challenges and barriers to the replication of drug 
consumption room policy. Developments in Canada during the course of the research have 
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broadened the scope of the thesis, providing an opportunity to identify not just the 
challenges and barriers, but those factors that have facilitated policy diffusion.  
Drug policy and the contested role of evidence 
Drug policy is an intersectoral government undertaking engaging a number of portfolios 
concerned with justice, law enforcement, health and education. This thesis focuses on drug 
policy that relates to the health outcomes associated with illicit drug use. It recognises 
however that these policies are not developed in isolation and are strongly influenced by the 
broader policy environment; in particular, the dominant prohibitionist architecture that 
divides the world of psychoactive substances into the licit and the illicit. Enforcement of these 
laws takes the lion’s share of public spending on drug policy, estimated at 64 per cent of 
government drug policy expenditure in Australia and 70 per cent of federal government 
spending in Canada (Ritter et al., 2013; Office of the Auditor General of Canada, 2001). The 
remaining funding is directed towards prevention, treatment and harm reduction. This is a 
contested policy domain where debate is subject to visceral reactions. The UK Drug Policy 
Commission (UKDPC), an independent body, spent six years examining the evidence 
associated with the development of drug policy in the UK, only to conclude “there is little 
political space for informed debate about policy options” (UKDPC, 2012 p.134). This concern 
with the lack of objectivity in policy making has led to strong arguments for the development 
of a better evidence base to inform drug policy. 
The evidence-based policy (EBP) paradigm emerged in the 1990s, initially in the UK before 
being more widely adopted. With its origins in evidence-based medicine, EPB represents an 
attempt to make more effective use of research in social policy. In the UK, Solesbury (2001) 
argues, the turn to EPB was deliberately anti-ideological, calling for new ideas and new ways 
of doing things, rather than a reliance on past practice that was embedded in political 
preference not pragmatism. Science was presented as the antidote to the politicisation of 
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policies developed to respond to complex social problems. Research and evidence, it was 
intended, would work not only to guide new approaches, but also to provide the means by 
which interventions would be evaluated to establish their validity and effectiveness, and 
consequently, their replicability. 
The harm reduction movement, approaching drug use and its consequences from a public 
health perspective, has embraced evidence as a fundamental element of drug policy (Rhodes 
and Hedrich, 2010). The close links between the public health and drug policy communities 
were forged as the emerging threat of HIV drew attention to the critical role that injecting 
drug users could play in combating the epidemic. As a result, the practices of public health, 
with its focus on predominantly quantitative research and ‘gold standard’ evidence, have 
been readily adopted by the alcohol and other drugs field (Olsen et al., 2015). The call for 
evidence has also become a part of the political rhetoric of the harm reduction movement. 
This was demonstrated by the Vienna Declaration of 2010, a statement urging drug law 
reform on the grounds of the gap between evidence and public policy, released to coincide 
with the 18th International AIDS conference (Wood et al., 2010).  
As will be discussed in Chapter Two, multiple problems have beset EBP, including the inability 
to form a consensus as to what constitutes evidence. Moreover, the methodologies that have 
driven evidence-based medicine do not lend themselves to the more complex array of social 
issues that require public policy responses. As Smith (2013) demonstrates, even in areas such 
as public health where there is a degree of consensus as to its aims and approaches, studies 
are not finding that policies are evidence-based. Drug policies, when subjected to the same 
scrutiny, also fall short, with empirical evidence demonstrating the gap between policy and 
a scientific evidence base (Nutt et al., 2007; Stevens, 2007; Bennett and Holloway, 2010). Of 
equal concern is the challenging assumption, underpinning EBP, that policy making can or 
should be ‘free’ of politics, values and beliefs (Nutley et al., 2007).  
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In response to the problems that have beset evidence-based policy approaches, a critical 
stream of drug policy scholarship has emerged that focuses on the policy making process 
itself in order to understand change. These post-evidence-based approaches are concerned 
with exploring the roles of multiple stakeholders, politics, ideas and narratives based on 
ideational and social constructionist approaches to researching policy making (Gstrein, 
2018). If we accept that evidence is a contested and problematic concept (Lancaster, 2014), 
it becomes critical to further our understanding of how ideas and knowledge have impacts 
on drug policy making. Why might ‘good’ ideas fail to be diffused or effective interventions 
fail to be scaled up? This thesis contends that by focusing on the issue through a policy 
transfer lens, new light can be shed on policy replication and policy learning. The argument 
presented to support this choice of theoretical framework is its capacity to appreciate not 
only the ideational elements of policy making, but the structures or contexts in which that 
deliberative process occurs. Policy transfer, in short, offers a heuristic that encompasses 
multiple sources of policy change, including multiple levels of governance and multiple 
agents operating and interacting within this environment. Through case studies and the 
insights provided from interviews with key stakeholders engaged in the policy making 
process in both Australia and Canada, this thesis contributes to our understanding of the 
challenges, barriers and facilitating factors that impact the diffusion of policy in a contested 
domain.  
1.2 Research aims and objectives 
The aim of this thesis is to understand why the replication or diffusion of drug consumption 
room policy has been problematic in Australia and Canada. The research seeks to identify 
factors that have either constrained or facilitated policy transfer at both the national and 
sub-national levels, in order to increase our understanding of the challenges of achieving 
policy change in relation to how we respond to illicit drugs and their social consequences. 
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The adoption of a policy transfer lens will enrich our understanding of the policy making 
process through its accommodation of the interaction of both structural and agency factors. 
Policy transfer theory also encompasses the exploration of ideational factors in order to 
understand the impact of ideas and knowledge in the process of policy development. This is 
an important area to address, given the challenges inherent in understanding the role of 
evidence in public debate and deliberation, as reflected in the divergent approaches to this 
issue in the literature. Through the construction of case studies and comparative analysis of 
empirical findings from field work in the case study sites, this thesis will make both empirical 
and theoretical contributions to drug policy literature. The opioid overdose crisis currently 
underway in Canada demonstrates the need for informed and innovative solutions in a 
dynamic environment. The findings of this thesis, and its reflections on the policy change 
process over a two-decade period, aim to contribute to our capacity to debate, develop and 
realise better policy in response to illicit drug use. Table 1.1 presents the specific objectives 
that the research will fulfil in order to achieve these aims. 
Table 1.1 Research objectives and key research questions 
Objectives Key research questions 
1. To critically review i) the literature on 
the use of evidence in drug policy, 
and ii) the literature on ideational 
and social constructionist approaches 
to drug policy 
How has evidence been contested in drug 
policy scholarship? 
How have ideational and social 
constructionist approaches been applied to 
drug policy problems? How have they been 
used to understand policy change and the 
use of evidence in policy making? 
What gaps exist in the literature? 
2. To develop a conceptual framework 
to analyse the challenges of 
replicating drug consumption room 
policy 
How can the policy transfer framework 
contribute to our understanding of the 
challenges of policy replication? 
3. To identify factors which constrain 
and facilitate the replication of policy 
in the case of drug consumption 
rooms, with a focus on four case 
studies in Australia and Canada 
What factors can be identified which 
constrain or facilitate the transfer of policy? 
Which sources of policy change are 
significant in the policy making process? 
4. To further interrogate those factors 
through the thematic analysis of 
stakeholder interview data 
Why is the policy contested? How are 
debates on DCRs framed? How is evidence 
used in the policy making process?  
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5. To test out the policy transfer 
framework  
Is the policy transfer framework an 
appropriate heuristic for improving our 
understanding of drug policy making? Are 
there factors that sit outside the framework 
that are significant? 
Can any modifications to the framework be 
suggested? 
6. To draw conclusions about the 
factors affecting the diffusion of 
policy and the scaling up of drug 
consumption rooms 
What structural and agency factors have 
affected policy development in this 
domain? 
What conclusions can we draw about the 
impact of ideas on the policy making 
process? 
1.3 Drug consumption rooms: background and literature 
This section has two aims. The first is to contextualise the thesis by introducing drug 
consumption rooms and the harm reduction philosophy under which they operate. The 
second is to provide an overview of the approaches that have been taken to understanding 
DCRs. This review of the literature demonstrates the limited extent to which the issue of 
replication of DCR policy has been explored, justifying the thesis’ focus on the policy making 
process to address this knowledge gap about the stalled diffusion of policy in Australia and 
Canada.  
1.3.1 Drug consumption rooms in context 
Drug use is pervasive in human societies. For complex historical and political reasons, drugs 
have broadly been divided into two categories: those which are legal to use but regulated, 
and those which are prohibited and therefore illegal to use (Berridge, 2013). The global scale 
of illicit drug use is vast. The United Nations Office of Drugs and Crime estimates 275 million 
people, or 5.6 per cent of the population aged between 15 and 64 years, used an illicit drug 
in 2016. Not all drug use is problematic, but according to the same report, some 31 million 
people would be considered problem drug users, who were drug dependent or suffering 
from drug use disorders. It is estimated 11 million people injected drugs in 2016, and over 12 
per cent of those people are thought to be living with HIV. The annual number of deaths that 
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can be directly attributed to drugs is increasing, up 60 per cent to 168,000 in 2015 compared 
to 105,000 deaths in 2000 (United Nations Office of Drugs and Crime, 2018). The opioid 
overdose crisis in North America will see global figures climb higher, with the United States 
alone recording 70,237 drug overdose deaths in 2017 (Centers for Disease Control and 
Prevention, 2019). 
As these figures demonstrate, the prohibition of drugs has not resulted in their decline or 
eradication despite a massive effort, led by the United States, to achieve this goal under the 
so-called ‘war on drugs’. A European Commission study into global illicit drug markets 
concluded that during the decade from 1998 to 2007, there was no evidence that the global 
drug problem had been reduced despite the dominance of prohibitionist policies. It found 
instead substantial unintended harms that could be attributed to the enforcement of drug 
prohibition (Reuter and Trautmann, 2009). This finding is shared by the United Nations Office 
on Drugs and Crime’s evaluation of a century of international drug control efforts (1909-
2009), which acknowledges the violent consequences of the illicit drug industry (United 
Nations Office of Drugs and Crime, 2009). 
The emergence of the HIV virus provided the impetus for the development of more 
diversified approaches to drug issues over recent decades. Injecting drug use is a major mode 
of transmission for HIV and other blood-borne viruses, and explosive epidemics among 
injecting drug users have occurred in diverse countries including the United States, Scotland, 
China and Kazakhstan (Ball, 2007). Harm reduction was first explicitly adopted in a national 
drug strategy in Australia in the mid-1980s. Other countries in both the developed and the 
developing world followed in the next two decades, often in the context of national HIV 
strategies or health sector plans (Ball, 2007). According to the International Harm Reduction 
Association, 97 countries and territories have adopted harm reduction approaches 
(Stoicescu, 2012 p.13). Rhodes and Hedrich (2010) define harm reduction as “…interventions, 
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programmes and policies that seek to reduce the health, social and economic harms of drug 
use to individuals, communities and societies” (p.19). Such policies include the adoption of 
measures such as needle syringe programmes (NSPs), opioid substitution therapy and ‘low 
threshold’ services, being those that provide support to drug users without requiring 
abstinence from drug use in order to receive services.  
Drug consumption rooms are an example of a harm reduction intervention, seeking to tackle 
both the private harms that affect people who use drugs, such as the risks of overdose and 
the transmission of blood borne virus, and the public harms that accrue through public 
injecting and street-based drug scenes, such as public nuisance and the littering of drug 
paraphernalia (Hunt and Lloyd, 2008). Drug consumption rooms are also known as 
supervised injecting facilities or supervised consumption sites (SCSs). The term drug 
consumption room is generally used in this thesis as it encompasses different forms of 
consumption, including injecting, smoking, inhaling and snorting. Supervised injecting facility 
is used where it is important to delineate those centres which are only sanctioned to 
supervised injecting drug use and not other forms. The first official drug consumption room 
opened in Berne, Switzerland in 1986 (Hedrich, 2004). The number of countries now offering 
official drug consumption services stands at ten. Table 1.2 shows the distribution and number 
of DCRs operating in 2018. Planning is underway to open DCRs in three further countries: 
Ireland, Portugal and Belgium (EMCDDA, 2018). 
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Table 1.2 Countries with official drug consumption rooms, 2018 
Country Number of DCRs 
Australia 2 
Canada (includes approved sites where 
opening is pending) 
28 
Denmark 5 
France 2 
Germany 24 
Luxembourg 1 
The Netherlands 31 
Norway 2 
Spain 13 
Switzerland 12 
TOTAL 120 
Sources: EMCDDA, 2018; Health Canada, 2019. 
Drug consumption rooms are targeted interventions with two primary aims: to reduce public 
and high-risk drug use, and to improve public amenity where it has been affected by street-
based drug markets (Hedrich et al., 2010). According to the EMCDDA, the target population 
of DCRs are: 
“those who inject in the streets, who are characterised by extreme vulnerability as a 
result of social exclusion, poor health and homelessness, and who often lack, in 
addition to health care, food, hygienic facilities for drug consumption and access to 
drug services.” (Hedrich, 2004 p.9). 
Four models of DCRs can be identified: i) stand-alone or specialised; ii) integrated, where the 
capacity to supervise drug consumption is incorporated into existing health facilities; iii) 
mobile; and, iv) overdose prevention sites (OPSs) where drug consumption takes place under 
observation but not necessarily medical supervision and may or may not have legal sanction 
(Hedrich, 2004; Wallace et al., 2019). Regulations differ, but it would be common for users 
to register with the centre and exclusions often apply, preventing access for anyone under 
18 years of age, pregnant women and first-time injectors (Belackova et al., 2017). Facilities 
are supervised by staff trained in resuscitation, who can administer oxygen in the case of 
overdose, and, in some jurisdictions, naloxone, a drug which blocks or reverses the effects of 
opioids. Clean injecting equipment is provided, and whilst staff do not help with the injecting 
itself, they will provide education regarding safer drug consumption techniques (Kelly and 
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Conigrave, 2002). A range of additional services is generally available, including primary 
health care assistance, counselling, referral to drug treatment and in some cases, housing.  
Opponents of drug consumption rooms have composed values-based arguments, as well as 
critiques of the aims and effectiveness of DCRs. Such services are seen to ‘send the wrong 
message’ and condone drug use. Concerns have also been raised they will attract drug users 
to the area where they are established and therefore increase drug dealing and drug-related 
crime in the locality. DCRs, it has been argued, maintain addiction and therefore divert 
people from drug treatment (Elliot et al., 2002; Kimber et al., 2003; Hall and Kimber, 2005; 
Hedrich et al., 2010). Through the formal evaluations of both MSIC in Sydney and Insite in 
Vancouver, and through other studies, these questions have been subject to rigorous 
scrutiny as discussed below.  
1.3.2 An overview of drug consumption room literature 
Evidence of effectiveness 
Drug consumption rooms have been in operation for over thirty years and have been subject 
to considerable quantitative and qualitative research. While earlier European facilities did 
not consistently apply rigorous evaluation methods, the establishment of the pilot 
interventions in Sydney and Vancouver in the early 2000s added substantially to the evidence 
base concerning the effectiveness of DCRs. Belackova and Salmon’s (2017) overview of the 
international DCR literature identifies 75 studies addressing aspects of effectiveness. Studies 
have focused on three broad areas: the feasibility of DCRs, including their ability to reach 
target populations; the impact on health, including risk behaviours, overdose and 
transmission of blood borne viruses; and the impact on communities, including public order 
and crime outcomes (Hedrich et al., 2010; Hunt and Lloyd, 2008). A number of reviews of the 
evidence have been undertaken to appraise international findings (Kimber et al., 2003; 
Hedrich, 2004; Kerr et al., 2007; Hedrich et al., 2010; Potier et al., 2014). In addition to this 
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scientific literature, there are reports which assess the evidence base with a view to making 
recommendations as to the appropriateness of services for specific jurisdictions (Parliament 
of New South Wales, 1998; Drug Expert Policy Committee, 2000; Independent Working 
Group, 2006; The Coroners Court of Victoria, 2017; Parliament of Victoria, 2017). 
Potier et al.’s (2014) systematic review of findings considers evidence related to both the 
benefits and harms of DCRs. Seventy-five studies met the inclusion criteria for this review, 85 
per cent of which concerned Vancouver and Sydney. The exclusion of non-English studies 
suggests a bias towards these sites. An earlier review by Hedrich (2004) was inclusive of non-
English studies. Potier et al. are unequivocal in their conclusions on the question of DCR 
effectiveness: 
“All studies converged to find that SISs [supervised injecting services] were efficacious 
in attracting the most marginalised PWID [people who inject drugs], promoting safer 
injecting conditions, enhancing access to primary health care, and reducing overdose 
frequency. SISs were not found to increase drug injecting, drug trafficking or crime in 
the surrounding environments. SISs were found to be associated with reduced levels 
of public drug injections and dropped syringes.” (Potier et al., 2014 p.48) 
This conclusion is also supported by Belackova and Salmon’s (2017) more recent review of 
the international literature. In addition, their report notes that DCRs can be associated with 
increasing access to treatment, preventing blood borne viruses and yielding cost savings in 
relation to averted HIV and Hepatitis C infections.  
While the literature points to a convergence around findings of effectiveness, there are some 
important limitations that need to be acknowledged. It is not possible, due to ethical issues 
and the question of equipoise, to conduct a randomised controlled trial (RTC) to measure the 
efficacy of DCRs – RTCs being considered the ‘gold standard’ in the hierarchy of evidence 
(Maher and Salmon, 2007). Observational study designs have, however, been adopted (Kerr 
et al., 2005). As Maher and Salmon (2007) argue, given the limitations in relation to research 
design, it is necessary to have realistic expectations about what evidence is able to be 
produced and what can be concluded from it. A major limitation, for example, is that people 
14 
 
who use drugs may only use the facilities irregularly, making it difficult to distinguish the 
impact of the DCR from other interventions or factors (Fischer et al., 2002; Kelly and 
Conigrave, 2002). This is a particularly difficult factor in attempting to assess the impact of 
SIFs on the transmission of blood borne viruses and is compounded by the lack of coverage 
of SIFs (for example in Sydney, where there is only one), raising questions as to the 
expectation that DCRs can have a population-level impact (Hall and Kimber, 2005). These 
methodological issues, in casting doubt about the certainty with which claims of 
effectiveness can be made, illustrate the contested nature of evidence in this complex area.  
Feasibility of DCRs 
In addition to research focused on effectiveness and impact, studies have explored different 
aspects of the feasibility of drug consumption rooms. Legal and regulatory issues have been 
at the forefront of concerns, due to the challenge posed by the criminalisation of drugs and 
drug use. Given the specificity of local legal requirements, studies in this area have generally 
been country-based, although international law is relevant because of the drug control 
treaties administered by the International Narcotics Control Board (Williams, 2016; Burris et 
al., 2009; Fortson, 2006; Malkin et al., 2003; Elliot et al., 2002; Malkin, 2001). In general, this 
literature is concerned with legal issues that relate to establishing drug consumption rooms. 
As this thesis is primarily concerned with replication rather than establishment, its concerns 
fall outside the scope of this literature, the exception being the legal challenges that were 
mounted against the service in Vancouver, which are addressed in detail in Chapter Six. 
Other studies of feasibility have considered the potential of DCRs in specific sites. This has 
included assessments of need and viability in particular locations; for example, Melbourne 
(Dwyer et al., 2016); Toronto (Jozaghi and Reid, 2015); Semaan et al’s (2011) assessment of 
the potential of SIFs to reduce BBV transmission and overdose mortality in the United States; 
and Lloyd and Hunt’s (2007) commentary on the potential to pilot drug consumption rooms 
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in the United Kingdom. Another important aspect of feasibility has been assessments of the 
attitudes of injecting drug users to the introduction of services (O’Shea, 2007; Kerr et al., 
2003; Fry, 2002; Fry et al., 1999) and to other stakeholders such as police (Watson et al., 
2012), local community (Strike et al., 2015; Strike et al., 2016), and policy makers (O’Shea, 
2007). 
Policy development 
The process by which drug consumption rooms have come to be established or, in some 
cases, have failed to be established, has garnered the interest of researchers. Such research 
seeks to understand the factors beyond evidence that have influenced the policy process, 
such as the roles of public opinion, public discourse and stakeholders (Jauffret-Roustide and 
Cailbault, 2018; Hallam, 2006; Small et al., 2006; Gunaratnam, 2005; Mendes, 2002). Policy 
change itself, through the lens of multiple streams analysis, is the subject of Houborg and 
Frank’s (2014) study of the factors that led to the establishment of Denmark’s drug 
consumption facilities. A relatively small body of comparative work is also emerging that 
compares the experience of developing, or attempting to develop, DCR policy. This includes 
Skretting’s (2006) consideration of the different approaches taken in the Nordic countries; 
Zampini’s comparative study of governance and government in England and Australia; 
Hayle’s (2015) study of Canada, England and Wales; and most recently, Lloyd et al.’s (2017) 
research comparing responses to drug consumption rooms in the UK and Germany. The latter 
study identifies four key points of difference between the experience of the two countries: 
the impact of the level of focus on the issue (national versus local); the nature of the problem; 
the role of ‘direct action’; and, the presence of stigma in media reporting. In addition to 
comparative studies at the national level, just three studies have been identified that 
undertake comparative analysis at the sub-national level: Gunaratnam’s (2005) comparison 
of the policy debate on supervised injecting in three jurisdictions in Australia; Fitzgerald’s 
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(2013) study focusing on the role of policy narratives in two Australian cities; and Hayle’s 
(2017) comparison of the policy making process in Vancouver and Toronto, utilising Lenton’s 
policy change framework.  
The issue of greatest pertinence to this study, the question of replication of policy, has seen 
little engagement by scholars. There have been commentaries calling for the scaling up of 
initiatives, but these have been argued largely from within the evidence-based paradigm, for 
example, Kerr et al.’s commentary in The Lancet, calling for the global scaling up of supervised 
injecting facilities, in which they argue: 
“Ongoing harms among injection drug users, such as HIV infection warrant innovative 
and swift action that is based on the best available scientific evidence. More than 25 
years of experience with supervised injection facilities has shown that the time for the 
global scale-up of these programmes has come. Such scale-up, however, can only 
occur if political leaders are willing to take the courageous step of putting scientific 
evidence and public-health interests ahead of ideology.” (Kerr et al., 2008 p.355) 
Questions around scaling up services have been largely focused on Canada. Commentaries 
and articles have focused on questions of cost effectiveness, as well as general effectiveness 
(Kerr et al., 2017; Enns et al., 2016; Jozaghi et al., 2013; Andresen and Jozaghi, 2012). Further, 
Jozaghi and Andresen’s (2013) qualitative study into the impact of Insite on injecting drug 
users’ lives calls for scaling up based on the transformative role their study demonstrated. 
Hyshka et al.’s (2013) policy case study contributes useful insights into the prospects of 
scaling up of DCRs in Canada in light of the Supreme Court of Canada’s 2010 ruling on the 
constitutionality of supervised injecting. While identifying barriers and facilitating factors 
that might contribute to scaling it, it does not, however, analyse these through a theoretical 
lens. No studies addressing the issue of scaling up in Australia were identified and no 
comparative studies on the issue have been uncovered. On the different, but related issue of 
policy replication and policy transfer, a striking lacuna exists in the drug consumption room 
literature. McCann and Temenos’ (2015) study, reviewed in detail in Chapter Three, stands 
out for its direct application of concepts from the policy mobility literature as it traces the 
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mobilisation of the DCR model from Europe to Australia and Canada, and the policy learning 
that occurred in that process.  
This overview of the scholarly literature demonstrates the dominance of the focus on 
building the evidence base to address questions of the feasibility and effectiveness of this 
innovative public health intervention. The controversy that has accompanied policy debates, 
and the stalling of the scaling up of services, warrant further attention. The limitations of the 
existing literature addressing the issue as one of policy change have been presented above, 
providing an opportunity for this thesis to make an original contribution on the subject. This 
contribution will be situated within the broader drug policy literature which is the subject of 
the review presented in Chapter Two.  
1.4 Outline of the thesis 
This chapter has introduced what has been problematic about the stalled diffusion of policy 
in relation to drug consumption rooms in Australia and Canada, and outlined the objectives 
and rationale for this research. It has examined the existing literature exploring drug 
consumption rooms, and highlighted the strong focus on the generation of evidence of 
effectiveness. The focus of this research is to address gaps in relation to the policy making 
process and, in doing so, to provide a conceptual and theoretical basis for identifying barriers, 
challenges and facilitating factors that impact on the policy transfer process. 
Chapter Two situates the research by undertaking a broad review of drug policy literature. It 
establishes the relationship between drug policy scholarship and evidence-based policy, 
analysing the literature that has focused on improving the use of evidence, including 
understanding the barriers to the uptake and utilisation of evidence in drug policy making. 
The main body of the chapter, however, is focused on the alternative accounts that have 
arisen as a challenge to the dominance of the evidence-based policy paradigm. This literature 
rejects the privileging of evidence as the main driver of policy, and recognises multiple 
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influences including ideas and knowledge; political and non-political agents; networks; 
narratives; and problem construction. The chapter presents the findings of a scoping review 
of ideational and social constructionist approaches to understanding policy change and 
development in the field of drug policy. This review identifies several gaps in an otherwise 
rich field of literature, including an absence of theorising on replication and the scaling up of 
interventions; the limited application of comparative methodologies; and insufficient 
consideration of the impact of national policy on local jurisdictions and sub-national policy 
transfer.  
Chapter Three sets out the theoretical orientation of this thesis. Building on the findings of 
the literature review, a case is made for the adoption of concepts from the policy transfer 
literature to explore the issues affecting the stalling and diffusion of policy in the chosen case 
studies. Following an exploration of the debates within the policy transfer and policy 
mobilities literature, and their application to drug policy, arguments are presented as to the 
merits of adopting a policy transfer framework to address the research question concerning 
the replication of policy. These arguments include the capacity to appreciate the influence of 
multiple levels of government; to accommodate comparative analysis; and to consider the 
roles of policy transfer networks and policy-oriented learning. It is contended that the policy 
transfer framework provides a robust lens through which to analyse sources of policy change 
and stall at multiple levels, consistent with a critical realist ontology that acknowledges the 
dialectic relationship between structure and agency. Critically, this theoretical orientation 
accommodates both ideational and constructionist concepts.  
The purpose of Chapter Four is to lay out the ontological foundations of the research and to 
describe the methodological approach and the research design. The chosen theoretical 
framework for the thesis is underpinned by a critical realist ontology. Critical realism 
accommodates a dialectical understanding of the interaction between structure and agency, 
19 
 
supporting a central tenet of the policy transfer framework with its focus on multi-level and 
multiple agent analysis. These issues are explored alongside a discussion of the relationship 
between material and ideational structures. In this worldview, ideas are attributed with 
causal power that exists independently of material interests: a concept that is at the heart of 
understanding the role ideas play in achieving policy change in a contested policy domain. 
The research design of this thesis combines a multiple case study methodology with thematic 
analysis to address the research question. Case studies are developed from extensive 
documentary analysis and interview material. Thirty semi-structured interviews conducted 
at the four case study sites in Australia and Canada provided the data for undertaking 
thematic analysis to identify patterns of meaning that shed light on the research concern of 
policy replication. 
Having established the theoretical and methodological foundations of the research, three 
empirical chapters then follow. Chapters Five and Six present four case studies that explore 
the policy making process in the Australian cities of Sydney and Melbourne, and the Canadian 
cities of Vancouver and Toronto. Spanning a period of two decades from the late 1990s, the 
case studies provide an account of how the idea of drug consumption rooms came to be on 
the policy agenda, and the success or failure of that idea in the policy process over time. 
These case studies explore the political and policy contexts in which supervised injecting was 
debated and deliberated, seeking to understand the impact of different sources of policy 
change. In addition to focusing on formal policy settings and processes, consideration is given 
to the impact of civil disobedience in each case. Comparative analysis is undertaken to 
distinguish general and specific features of the cases. Instances of both policy stall and policy 
diffusion are in evidence, providing the foundations for analysis of the key factors which 
constrain and facilitate policy replication in a contested policy domain. 
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Chapter Seven presents findings from thematic analysis undertaken of interview data 
gathered from key stakeholders who have been engaged in the policy making process in the 
four case study sites. Relevant views on a range of challenges and opportunities for policy 
reform were collected through semi-structured interviews with informants, including former 
politicians, policy makers, researchers, law enforcement officers, advocates and 
practitioners. The analytical strategy involved a round of open coding, followed by two 
rounds to review and consolidate the themes. Six themes are presented in this chapter, 
addressing issues including: problem definition and the role of crisis; the effect of interactions 
between different levels of government; policy conflict; politics and political leadership; 
controversy, stigma and discrimination; and the role of evidence. This analysis provides 
significant insights into the policy making process, complementing the earlier case study 
findings. 
Chapter Eight returns to the theoretical concern of the thesis in order to understand what 
factors have been significant in constraining or facilitating policy transfer and, therefore, 
replication. Evans’ (2004) policy transfer framework identifies four sources of policy change. 
The chapter begins by mapping the empirical findings to this framework and assessing the 
significance of each component. The results of this analysis demonstrate the relative 
weakness of international sources of policy change when compared to the strong impact of 
state-centred sources and policy-oriented learning. The role played by civil disobedience in 
catalysing change is considered through this theoretical lens. It is demonstrated that the 
actions of communities challenged institutional power from the bottom up. It is then argued 
the policy transfer framework’s top-down orientation limits its ability to capture this 
significant source of policy change. A modification to the policy transfer framework is 
therefore proposed whereby a fifth source of policy change – civil society – is added to 
improve the heuristic.  
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Chapter Nine concludes the thesis by summarising its main findings and discussing its 
empirical and theoretical contributions. Two scenarios are compared, one of policy stall and 
one of policy diffusion, in order to demonstrate how structural, ideational and agency factors 
have combined to affect policy development and policy learning. Reflections on the 
contributions of the thesis are presented, including a discussion of how this research relates 
to the current body of drug policy literature exploring policy change through both ideational 
and social constructionist approaches. Limitations of the research are considered before 
future research directions are proposed. These focus on ideational, governance and 
participatory issues, and include a recommendation for further research that tests the utility 
of the proposed modification to the policy transfer framework beyond the drug policy field.  
 
 
 
 
 
 
 
 
 
 
Chapter two      
A review of the literature 
• • 
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2.1 Introduction 
“Once again, Australia is experiencing rapidly increasing drug overdose deaths. Why 
when the need for MSICs is so great and the evidence is so compelling has it had to be 
such an uphill battle to establish a network of such centres in drug hotspots across the 
country?” (Wodak, 2018) 
 
Alex Wodak, a long-time champion of drug law reform in Australia, is not alone in expressing 
frustration at the barriers to the adoption of drug consumption rooms in the face of the 
evidence of their effectiveness. It is a frustration felt across a range of drug policy issues, in 
a myriad of countries, and has led to calls, at the highest levels of national governments and 
international organisations, to look to evidence to formulate better and more effective policy 
in relation to illicit drugs (Wood et al., 2010; Editorial, 2016). The rise of evidence-based 
policy in the 1990s dovetailed with the growth of the harm reduction movement, which 
advocated for public health approaches to drug use issues, spurred on in part by the 
intersection of concerns about rising HIV risk among injecting drug users. The arguments for 
harm reduction are often formulated in the language of public health and reflect public 
health’s affinity with evidence-based policy approaches (Steward and Smith, 2015; Lancaster, 
2014). Despite an oft-cited commitment to the use of evidence in policy making, examination 
of policies and how they were derived shows evidence-based policy has been difficult to 
actualise. In Ray Pawson’s words, “Evidence-based policy is much like all trysts, in which hope 
springs eternal and often outweighs expectancy, and for which the future is uncertain as we 
wait to know whether the partnership will flower or pass as an infatuation” (Pawson, 2006 
p.1).  
In this chapter, I explore the literature in relation to evidence, drug policy and policy change 
with the objective of establishing the basis for the theoretical orientation of the thesis. 
Broadly, there are two main strands of drug policy scholarship which have attended to the 
question of evidence-based policy and the use of evidence in the development of drug policy. 
Section 2.2 introduces the literature which is concerned with achieving evidence-based 
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policy or improving the use of evidence in drug policy. It explores scholarship that seeks to 
establish an evidence-base for drug policy as well as research that exposes the 
ineffectiveness of many current policy approaches in order to argue for reform. Other 
relevant literature in this area has focused on addressing barriers to the uptake and 
utilisation of evidence to inform policy. 
The shortcomings of EBP have given rise to alternative accounts of drug policy development 
based on ideational and social constructionist approaches that challenge the orthodoxy of 
drug policy as an evidence-based policy endeavour. Section 2.3 presents the findings of a 
scoping review, capturing and summarising the breadth of scholarship in this field. This 
review, developed as part of this doctoral project, has appeared in the International Journal 
of Drug Policy and is largely reproduced here (Gstrein, 2018). The discussion in Section 2.4 
focuses on the unresolved issues that arise from the review and identifies specific gaps in the 
literature. Consideration is then given to the linkages between the findings of the review and 
the research concerns of the thesis, in order to provide a rationale for the adoption of the 
theoretical stance introduced in Chapter Three.  
2.2 Evidence-based policy and drug policy scholarship 
This section provides a foregrounding to the scoping review presented in Section 2.3. The 
first part examines the normative agenda promoted through research focused on 
establishing both evidence of effectiveness and evidence of ineffectiveness as a means of 
arguing for reform to prohibitionist and other drug policies. It also looks at arguments that 
are mounted in support of evidence as a path to rational policy development in a contested 
area. The second part of this section introduces the literature that has recognised the 
shortcomings of achieving evidence-based policy, and has pursued an agenda of 
understanding the barriers to EBP and improving the use of evidence in the drug policy field.  
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2.2.1 Evidence-based drug policy: a normative agenda 
Harm reduction-oriented drug policies gained ascendency in many jurisdictions as a direct 
result of the need to address the challenges posed by the HIV pandemic and the increased 
risk of HIV transmission for people who inject drugs. Many of the policies promoted to reduce 
the spread of HIV support interventions were devised as mainstream public health 
approaches and therefore fit comfortably in an evidence-based policy paradigm (valentine, 
2009). Concurrently, there has been a strong research base that has scrutinised the 
effectiveness of interventions and policies in the area of illicit drugs, disseminating the 
findings of the research as a normative agenda promoting ‘better practice’ and arguing for 
policy reform in relation to drug use (Ball et al., 2005; Ball, 2007; Rhodes and Hedrich, 2010; 
Strang et al., 2012). In this field, there has been a marked focus on quantitative research, 
compounding an association of ‘evidence’ with quantitative data. A 2015 review 
commissioned by the Drug and Alcohol Review found that qualitative research makes up a 
minority of outputs across drug and alcohol journals. Of the journal’s own papers published 
in 2014, only five out of 138 were qualitative research papers, representing four per cent of 
outputs – an issue the journal has been keen to address (Olsen et al., 2015 p.474).  
Much of the research has been technical in nature, with outputs collated and disseminated 
by organisations such as the World Health Organisation and UNAIDS through instruments 
like the ‘Evidence in Action’ series (2008) and the Centre for Harm Reduction’s Manual for 
reducing drug related harm in Asia (Costigan et al., 2003). The European Monitoring Centre 
for Drugs and Drug Addiction (EMCDDA) has also been heavily engaged in research, collating 
a database of evidence and producing policy and practice briefings. Rhodes and Hedrich’s 
(2010) important volume on the evidence, impacts and challenges of harm reduction was 
published by the EMCDDA and is an example of the literature in this field promoting the 
evidence base for new approaches to drug policy. Researchers have continued to be at the 
forefront of vocal and, ironically perhaps, highly political calls to apply evidence-based 
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approaches to challenge existing drug policy regimes internationally through actions such as 
the Vienna Declaration, the establishment of the Johns Hopkins-Lancet Commission on Drug 
Policy and Health, and engagement in the UN General Assembly Special Session on Drugs 
(UNGASS) in 2016 when global approaches to drug policy were debated (Wood et al., 2010; 
Editorial, 2016; Werb et al., 2016). 
The other side of the ‘evidence of effectiveness’ coin is the ‘evidence of ineffectiveness’, 
arguments which are used to challenge prohibitionist drug policies. For example, an 
assessment of the state of illicit drug policy in Canada notes the discordance between 
evidence and policy in this area, with the majority of resources going to drug use prevention 
and drug law enforcement activities that have been proven to be ineffective, while strategies 
that have been assessed as being effective, such as needle syringe programmes, supervised 
injecting facilities and opioid substitution therapy, remain underfunded (Wood et al., 2012 
p.e35). On the international stage, the Johns Hopkins-Lancet Commission on Drug Policy and 
Health has extensively examined the evidence in relation to the health impacts of drug policy 
based on prohibition (Csete et al., 2016). The conclusions of the Commission are that 
prohibitionist policies present a paradox, undermining the health status of the populations 
they are meant to be protecting. They argue that the evidence suggests prohibition has 
“contributed directly and indirectly to lethal violence, communicable-disease transmission, 
discrimination, forced displacement, unnecessary physical pain, and the undermining of 
people’s right to health” (Csete et al., 2016 p.1429). 
The third area for discussion in this section is the push for evidence-based policy as a remedy 
to the contested nature of drug policy. The use of evidence-based policy has been advocated 
as a means of ‘de-politicising’ drug policy by offering a ‘rational’ means by which to make 
decisions. Such work is exemplified by the attempt by Nutt et al. (2007) to develop a ‘rational 
scale’ to assess the harms associated with drugs. Nutt et al. argue that the classification 
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system used in the UK to divide drugs into categories of harm based on the purported danger 
they pose is not founded on scientific evidence, resulting in “ill-defined, opaque, and 
seemingly arbitrary” processes driving policy making in this area (Nutt et al., 2007 p. 1047). 
The authors instead propose a transparent methodology based on nine categories of harm 
which could be used to rank both currently legal and illicit drugs. The application of the 
assessment tool challenged the current classification system, producing, amongst other 
results, the outcome that alcohol, based on harms caused, could well sit with other class A 
drugs such as heroin and cocaine. As a ‘licit’ substance, it currently falls outside the UK Misuse 
of Drugs Act 1971, leading the authors to question why assessments of the dangers of drugs 
should be subject to prejudice and arbitrary decisions as to which drugs are deemed illicit 
and subject to control (Nutt et al., 2007). 
Aligned with these concerns to provide a rational or scientific basis for policy decisions, are 
the arguments in support of evidence-based policy as a countermeasure to the prejudices 
and stereotypes that appear to underlie drug policy (MacGregor, 2011). The use of 
stigmatising language and the misconceptions regarding drugs and addiction that have 
accompanied public debate and media reporting have been well researched (Elliot and 
Chapman, 2000; Bright et al., 2013; MacGregor, 2013; Chalmers et al., 2016). That scientific 
evidence could, however, divorce policy development from the political processes which 
mediates such public discourse is highly problematic and predicated on evidence and politics 
being framed as opposing forces (Smith, 2013). Such ideas are discussed at more length in 
Section 2.3 below. 
2.2.2 Closing the gap: better use of evidence 
The section above introduces EBP’s links to health-based drug policy. Looking beyond the 
normative stance – the desirability of evidence-based drug and public health policies – 
assessments generally conclude that there is little indication that policies are actually 
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evidence-based (Smith, 2013; Oliver et al., 2014). For example, Bennett and Holloway’s 
(2010) study of UK drug policies focused specifically on the question of the extent to which 
they were evidence-based. They found that while policies made reference to what they 
determined was good quality evidence, issues remained with the interpretation and 
reporting of research used, and the authors specifically noted biases in the selection of 
research used to support policy decisions. Bennett and Holloway acknowledge that policy is 
the result of multiple influences, but express concern that claims are made in policy 
documents that they are evidence-based: 
“Managing the conflict inherent in promoting on the one hand an ordered ideal and 
describing on the other a more chaotic reality has resulted in a somewhat distorted 
picture of the role of research in drug policy.” (Bennett and Holloway, 2010 p.416) 
This recognition of the limitations of the achievement of evidence-based drug policy is 
consistent with the findings of more general policy scholarship. There has been a 
longstanding interest in the better utilisation of research and the identification of barriers to 
the use of research and evidence (Weiss, 1979; Caplan, 1979; Nutley et al., 2007; Boaz et al., 
2008). There has also been a strong focus within drug policy literature on improving the 
accessibility of research and developing better collaborative relationships between policy 
makers and researchers. This is exemplified by the work of the Drug Policy Modelling 
Program, based at the University of New South Wales. This program has actively supported 
a research agenda that aims to provide more and better evidence to inform drug policy (in 
recognition of shortcomings in the evidence base), while also seeking to understand and 
thereby reduce the barriers that might prevent the uptake of evidence in the policy making 
process (Ritter et al., 2007; Ritter, 2009). While making a convincing case for the benefits of 
improving the availability and use of evidence, proponents of this work have also readily 
acknowledged that it would be ‘naïve’ to assume that evidence of effectiveness is the only 
criterion on which to base policy. They have instead recognised the complexity of the policy 
making process and its many inputs (Ritter et al., 2007; Ritter and Bammer, 2010). Duke’s 
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work has also made an important contribution in this regard, through her empirical 
investigation of the interplay of research, evidence and policy making in relation to drugs and 
prison policy. She concludes that researchers could have greater impact by being more 
proactive in the earlier stages of policy development to better shape the policy agenda and 
framing of the problems to be addressed (Duke, 2001). 
2.2.3 Beyond evidence-based policy? 
The literature on drugs, their uses and addiction has been dominated by scientific disciplines 
such as epidemiology, psychiatry and biomedicine (MacGregor, 2011). These disciplines have 
favoured the production of the gold standard evidence seen as the pinnacle of EBP. However, 
it is unsurprising that this wealth of scientific data has not produced rational, ‘value-free’ 
drug policy. Evidence-based policy has been subject to sustained critique as questions are 
raised about the barriers to its adoption, the legitimacy of privileging evidence in policy 
making, and the tendency to ignore the complexity of the policy making process itself by 
relying on a contested model of linear, rational policy making (Smith, 2013; Boaz et al., 2008; 
Clarence, 2002). These concerns from the broader policy literature apply equally to drug 
policy and have given rise to alternative explanations for the state of drug policy making, 
drawing in particular on social science disciplines such as political science, policy studies and 
sociology. Two significant strands of this literature, ideational and social constructionist 
approaches, are explored in depth below. 
2.3 Ideation, social construction and drug policy: a scoping 
review 
The logic of evidence-based policy posits a model of policy making that is both linear and 
rational. For many in the drug policy field, the achievement of a better evidence base should 
have resulted in reforms to drug policy that would reflect ‘what works’ to tackle complex 
drug problems. However, as Ritter and Bammer capture, researchers have been vexed by the 
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way research has been both utilised and underutilised in policy making. From this frustration, 
a rich field of research has emerged that explores the complexity and unpredictability of the 
policy making process by introducing and testing new concepts and models, particularly from 
political science (Ritter and Bammer, 2010). While some excellent studies exist that address 
specific drug issues or interventions, there is, as yet, surprisingly little work that reflects on 
this field of scholarship and its future directions. It was therefore timely to undertake a 
scoping review to capture and summarise the breadth of scholarship in this field. The findings 
of this review, presented below, appeared in the January 2018 edition of the International 
Journal of Drug Policy (Gstrein, 2018). As will be discussed in Section 2.4, the gaps identified 
in the field of research have helped develop the theoretical orientation of this thesis. 
The research question posed by this review is: how have ideation and social constructionism 
been used to analyse drug policy? These two broad theoretical approaches were chosen as 
two of three dominant narratives that are used to explore and challenge drug policy (Stevens 
and Ritter, 2013). The third, characterised as ‘authoritative choice’ by Stevens and Ritter, is 
a narrative in which policy constitutes a technical process of solving problems; this is 
captured by the discussion of evidence-based policy and research utilisation in Section 2.2 
above.  
Ideational theories have arisen as a challenge to interest-based approaches in politics, and 
seek to explain the role of ideas and beliefs in policy making. Ideation theorists contend ideas 
are a primary source of political behaviour, as they shape not only how we understand 
political problems, but how we subsequently develop and embrace (or reject) approaches to 
those problems. In ideation theory, the focus is on the processes of meaning, not choices. 
Interests matter, but they too are subject to the interpretative frameworks that are 
developed and guided by our ideas (Béland and Cox, 2011; Braun, 1999). Ideational 
approaches provide a way of accounting for a myriad of influences in politics, by including 
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actors whose roles had previously been marginalised in political analysis, such as non-political 
organisations and networks. Despite acknowledging the dynamic nature of ideas, coherence 
can emerge through shared beliefs and values. Hall’s notion of paradigms, for example, or 
Haas’ epistemic communities, describe how collective action can occur, not motivated by 
direct interests, but by shared ideas (Hall, 1993; Haas, 1992). Other key policy change 
theories that have made an impact on drug policy scholarship are the multiple stream 
heuristic (Kingdon, 2010) and the advocacy coalition framework (Sabatier, 1988). These two 
approaches provide a means of interrogating how certain policy problems and solutions 
come to prominence.  The ACF for example, is concerned with coalitions that coalesce around 
shared beliefs and compete with other coalitions to secure policy outcomes through the 
domination of their ideas.  The multiple streams theory is concerned with how particular 
ideas and policy solutions come to be adopted, positing that the idea must simultaneously 
be high on the agenda of three streams of policy action characterised as politics, problems 
and policies. 
Ideas are also at the heart of social constructionist approaches to exploring policy making. 
Social constructionism places a particular focus on problem construction; the impact of the 
construction of target populations; and frames and narratives. Rather than see policy making 
as a rational, linear process where solutions are produced in response to recognised and 
understood problems, social constructionists see the problems themselves as being 
constructed through the policy making process. Bacchi (2009) has been particularly influential 
in this regard, inspiring extensive use of her framework, which asks ‘what the problem is 
represented to be’, in order to challenge underlying assumptions about the policy problem that 
is being addressed.  
This literature review applies the Arksey and O’Malley (2005) methodological framework for 
scoping reviews. This method is outlined in Section 2.3.1. The stages of the review are 
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described in Section 2.3.2, followed by the presentation of results in Section 2.3.3. The results 
are analysed quantitatively, before a narrative synthesis is presented that summarises the 
key theoretical approaches and introduces significant contributions. The discussion in 2.3.4 
considers the implications of the review, and its findings and limitations. 
2.3.1 Method 
The Arksey and O’Malley (2005) framework for scoping reviews provides a means of 
summarising and capturing the breadth of literature in a particular field. It has similarities with 
the systematic review method, but where systematic reviews generally focus on narrow areas 
of inquiry with an emphasis on the quality of studies, scoping reviews are more concerned with 
the ‘extent, range and nature of research activity in a particular field’ (Brien et al., 2010). The 
framework provides an effective means of collating and categorising strands of scholarship. 
The findings are presented through a narrative synthesis that allows conclusions to be drawn 
from the existing literature regarding the overall state of research activity (Arksey and 
O’Malley, 2005).  
The Arksey and O’Malley (2005) framework has five distinct stages: 
1. Identifying the research question 
2. Identifying the relevant studies 
3. Study selection 
4. Charting the data  
5. Collating, summarising and reporting the results 
The first stage, identification of the research question, sets the parameters of the study and 
shapes the development of the search strategy. The second stage is focused on a 
comprehensive search of primary studies from a variety of sources, including electronic 
databases, key journals, networks, organisations and conferences. The third stage employs 
inclusion and exclusion criteria appropriate to the research question to determine the 
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relevance of studies, which are reviewed and, if necessary, eliminated: first by title, then 
abstract, and finally review of the full article. The fourth stage of ‘charting the data’ involves 
the extraction of key information through the application of a common analytical framework 
to all the studies. The fifth and final stage is two-fold: basic quantitative analysis is undertaken 
of the charted data to describe the scope of the body of literature, and, a narrative account is 
given of the existing literature based on a framework or thematic construction, reflective of the 
purpose of the research question that first guided the review (Arksey and O’Malley, 2005). 
2.3.2 Application of the framework 
Stage 1 – The research question 
A broad research question was established: how have ideational approaches and social 
constructionism been used to analyse drug policy? Drug policy was narrowly defined, focusing 
on government policy that addresses the issues arising from the use of illicit drugs, with a 
particular but not exclusive focus on health outcomes. Excluded from the area of inquiry (unless 
there is an explicit link to drug policy) is literature primarily concerned with drug addiction, 
drug treatment, drug supply and markets, and drug-related criminal justice and law and order 
concerns. As with any area of social policy, boundaries in academic literature are not neat, so 
where there was cross-over and connection between issues, an inclusive approach was used. 
Stage 2 – Identification of relevant studies 
My initial search, conducted in April 2016, accessed three databases, employing a combination 
of relevant search terms. No time or language restrictions were placed on the searches. Table 
2.1 shows the search terms employed, resulting in 1114 records identified.  
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Table 2.1 Search terms and records identified 
Database Search terms Records 
Scopus drug* AND policy AND ideation 72 
 drug* AND policy AND frames 254 
 drug* AND policy AND narrative* 242 
 drug* AND policy AND construction* 188 
 drug* AND "advocacy coalition framework" 4 
ProQuest drug* AND policy AND ideation NOT suicid* 7 
 drug* AND policy AND "advocacy coalition framework" 10 
 drug* AND policy AND "social construction*" 226 
 drug* AND policy AND narrative AND illicit 37 
 drug* AND policy AND frames AND illicit 27 
Medline drug* AND policy AND ideation NOT suicid* 3 
 drug* AND policy AND "social construction*" 24 
 drug* AND policy AND narrative AND illicit 18 
 drug* AND policy AND "advocacy coalition framework" 2 
  1114 
 
The initial search in Scopus using the term ‘ideation’ revealed a strong link to articles on suicide, 
so subsequent searches were modified by including the term ‘NOT suicid*’ to eliminate 
literature related to suicide and drug use from the search. The use of the term ‘illicit’ was also 
included after the initial Scopus searches to eliminate articles related to pharmaceutical drugs. 
This is a problematic distinction as harm from drugs does not a priori relate to whether drugs 
are licit or illicit, but government policies relating to problematic drug use do tend to be 
inclusive of illicit drug use, making this a useful term to narrow the inquiry. The search terms 
were derived from background reading of both drug policy and policy theory literature.  Table 
2.1 captures the initial searches that were undertaken in April 2016.  The search process was 
iterative, allowing for modification to the search terms.  The subsequent hand searching 
process based on a review of the initial included literature allowed further searches to be 
undertaken based on specific theories, theorist and fields of literature that were uncovered. 
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Stage 3 – Study selection 
The 1114 records were screened by title, and only 68 were thereby selected for inclusion. 
Despite modifications to the search terms to try to refine the results, many studies were 
focused on pharmaceutical drugs and policy, vaccinations, paediatrics and psychiatry, and were 
therefore excluded. Of the 68 studies selected, 15 were duplicates, reducing the number of 
articles to be screened by abstract to 53. At this stage, a further 20 were removed. Works were 
excluded if they were journalistic, historical narratives, or opinion pieces. Studies were also 
excluded if they did not primarily address the development of drug policies, as were studies 
related only to alcohol and tobacco. 33 articles from the initial list of 1114 then remained to be 
screened by full text. 
Ongoing hand searching was undertaken during the review period, as the included studies 
revealed relevant literature through citations and bibliographies. A methodical search was also 
undertaken of the following journals: International Journal for Drug Policy; Drugs Education, 
Prevention and Policy; Harm Reduction Journal; Addiction; Substance Use and Misuse; Addiction 
Research and Theory; and Drug and Alcohol Review. This process yielded an additional 19 
works, four of which were subsequently excluded as their approach did not meet the criterion 
of a focus on ideation or social construction. With 15 hand searched studies and the original 
33, the total number of studies included in the review came to 48 (see Figure 2.1). Consistent 
with Arksey and O’Malley’s emphasis on accessing a variety of literature sources, 69 per cent 
of studies were retrieved through the initial database search with the remaining 31 per cent 
being added through hand searching.  
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Figure 2.1: Flow chart of study selection 
 
 
Stage 4 – Charting the data 
Information on each study – including geographic coverage; theoretical approach; drug policy 
or issue; method; and data source – was extracted and recorded on an Excel spreadsheet, 
which forms the basis of Appendix 1. In categorising the literature, there was a risk that the 
studies’ approaches would be oversimplified in order to have them conform to set headings or 
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categories. Despite this risk or limitation, the process provided structure for the findings and 
allowed the literature to be critically analysed according to a thematic framework that built 
upon the type of theoretical approach applied in each study. This analysis is summarised in a 
narrative review, as reported under Stage 5, below. 
2.3.3 Results 
Stage 5 – Collating, summarising and reporting the results 
In keeping with Arksey and O’Malley’s (2005) framework, this final stage of the review presents 
the results in two parts. The first section reports the outcomes of applying quantitative analysis 
to the charted data to present a picture of the scope and distribution of the literature. The 
second part presents a narrative synthesis of the literature, which is organised thematically 
according to the dominant theoretical approaches that were first analysed through the initial 
charting of the data. 
5.1 Scope and distribution of the literature 
The charting of the data revealed the limited geographic coverage of the literature, with studies 
relating to only 14 countries, nine of which are in Europe. The most represented country is 
Australia, with 40 per cent of the studies (n=19) focused on its drug policies and issues, followed 
by the UK (n=8) and the US (n=7). The majority of the studies (n=40) focus on one country only, 
with just one study coming from Asia (Afghanistan) and no studies from Central and South 
America, Africa or the Middle East. Of the remaining eight studies, four are comparative, 
examining the approaches of two or more countries. A further two take an international 
perspective, while the remaining two relate more generally to the issues of social construction 
and drug policy, without being country-specific.  
Time restrictions were not placed on the search, but articles that met the criteria were 
published from 1996 to 2016. Up until 2011, there was a fairly steady flow of studies appearing, 
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after which there was a significant increase. Of the 48 studies, 22 appeared in the first 16 years 
(from 1996 to 2011), whilst the remaining 26 (54 per cent) appeared between 2013 and 2016. 
43 of the 48, or 90 per cent of the studies, were found in peer-reviewed journals. Of these 
articles, a third appeared in the International Journal of Drug Policy (n=14). The remaining 
studies comprised a PhD thesis (n=1), books (n=2), a book chapter (n=1) and a report (n=1).  
At the end of the charting process, five broad theoretical approaches or underpinnings of the 
studies could be identified: ideational policy theory (predominantly influenced by Kingdon 
(2010) and Sabatier (1998)) (n=14); problem construction (predominantly based on the work 
of Bacchi (2009)) (n=15); narratives and frames (n=15); construction of target populations 
(drawing on Schneider and Ingram’s (1993) work) (n=4); and, policy transfer and mobilities 
(influenced by the work of Dolowitz and Marsh (2000), Evans (2009) and Stone (1999, 2000)) 
(n=5). Five of the studies are identified as fitting into two categories; therefore, the count of 
studies exceeds the total of 48. As outlined above, the process of categorising work requires 
judgements to be made that may restrict how work is described. In general, however, these 
categories usefully capture the spread of studies across the broad theoretical approaches. The 
work is described in more detail below (see 5.2 Narrative synthesis). 
Reflecting the concern with ideation and social construction, all studies are qualitative and 
utilise an array of data sources, including policy documents, parliamentary records, media, 
interviews, surveys, ethnographic material, participant observations, grey literature and 
research texts. Table 2.2 captures the range of topics that emerge in the literature. Again, the 
count exceeds the number of studies as more than one topic is evident in many works. That 
the works addressed drug policy was a criterion for inclusion in the review; the use of a ‘drug 
policy’ category reflects that some studies specifically sought to address the subject in a more 
direct way than others. 
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Table 2.2 Topics covered by studies 
Topic Count 
Drug policy  19 
Evidence/research 13 
Specific drug programs 9 
Specific drugs 8 
Media 9 
Discourse 5 
Drug users 3 
Moral panic 3 
Law 2 
Networks 1 
 72 
 
5.2 Narrative synthesis 
This section is organised according to the key theoretical approaches that were initially 
identified during Stage 4. It seeks to directly address the question of how ideational and social 
constructionism are used to analyse drug policy. Studies are organised according to the main 
theoretical underpinnings or concerns that influenced their work. This section is followed by a 
discussion of the gaps in the literature and potential future directions for research. 
2.3.4 Ideational approaches to policy analysis 
Ideational approaches to drug policy have been used to critique evidence-based policy; test 
‘multiple streams’ approaches to policy making; and explore the transfer, translation and 
sharing of ideas. 
Evidence and drug policy 
Ideational theories have been used to provide a framework for critiquing evidence and its 
relationship with the political process of developing policy in a contested area. Critiques of EBP 
are concerned with what constitutes evidence and how effectively it is utilised, as well as 
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challenging the “naïve” assumption that policy making can be de-politicised by the judicious 
application of science to societal problems (Stevens and Ritter, 2013). 
One of the most influential scholars in this area is Stevens (2007), who explores bias in the use 
of evidence, claiming there is an underlying misunderstanding about the link between evidence 
and policy. He proposes a new theoretical approach to understanding that relationship, based 
on an evolutionary analogy. While he illustrates that evidence is used selectively to entrench 
the legitimacy of powerful groups, he does not suggest that evidence is irrelevant or that the 
idea of using evidence in policy should be abandoned. Rather, Stevens argues that evidence is 
only one of a number of determinants of policy, and that it is the narratives used to frame social 
problems that provide the key to whether evidence enters policy (Stevens, 2007). 
Monaghan (2011) challenges Stevens’ conceptualisation by focusing his inquiry on the nature 
of evidence itself. Monaghan questions the presented dichotomy of policy as either ‘evidence-
based’ or ‘evidence-free’, the latter being read as ideologically driven. Through his work on the 
UK drug classification system and the reclassification of cannabis, Monaghan identifies three 
perspectives, representing different views of evidence, and concludes that a plurality of 
evidence exists, casting into doubt the notion that a consensus on evidence-based policy is 
achievable. Monaghan’s stance is reflected in Roumeliotis’ (2014) study of Swedish drug policy 
(discussed below), which is premised on the argument that knowledge itself cannot be free 
from ideology.  
MacGregor (2013) asks the question: are politicians the problem in relation to the barriers that 
impact the use of evidence? While her work is discussed below in relation to frames and 
narratives, it is important to note that this vexed question of the relative influence and the 
nature of evidence itself continues to be a very active line of inquiry in drug policy scholarship 
(see also Ritter, 2009; Tieberghien, 2014; Lancaster, 2014; Lancaster and Ritter, 2014; Van 
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Toorn and Dowse, 2016; Fraser and Moore, 2011; Dwyer and Moore, 2013; Bright et al., 2013; 
and Everett, 1998). 
Policy change theories 
Policy making theories, drawn from political science, provide useful frameworks for exploring 
contested policies; in turn, drug policy scholarship provides valuable case studies to contribute 
to theory testing and development. For example, Lancaster et al.’s (2014) examination of the 
development of methamphetamine policy in Australia tests the extent to which Kingdon’s 
multiple stream heuristic is a useful tool for the analysis of drug policy issues. This 
comprehensive study draws on a range of source documents that are classified against each of 
the three streams (problem, policy and political). While finding strengths in Kingdon’s 
approach, the authors also provide an insightful critique, questioning the extent to which the 
streams operate independently, and whether policy windows are necessary for action. In 
addition, they identify in Kingdon’s approach a potential underestimation of the role the media 
plays in agenda setting.  
Kingdon’s framework is also employed in two papers exploring the introduction of drug 
consumption rooms in Australia and Denmark, respectively (Gunaratnam, 2005; Houborg and 
Frank, 2014). These papers are concerned with the debates conducted on introducing facilities, 
and the roles played by stakeholders and politicians. Despite the very different circumstances 
and locations, both studies draw similar conclusions, noting the critical role played by political 
actors in exercising their powers over legislation and resources allocation. Houborg and Frank’s 
work on policy change in Denmark can be understood in terms of a shift from ‘government’ to 
‘governance’; they conclude there is limited space for governance in drug policy, on account of 
the legal and prohibitive foundations of the policies (Houborg and Frank, 2014). This is an 
important reminder of the constraints placed on the engagement of civil society and other 
actors in the development of new approaches to drug policy, particularly when attempting to 
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understand the factors that may ultimately lead to policy change. Gunaratnam’s (2005) 
conditional endorsement of Kingdon’s approach, to explain why a trial proceeded in New South 
Wales but not in the other two jurisdictions also pursuing safe injecting facilities, is more 
problematic. While I would agree that Kingdon’s multiple streams can be used to describe the 
outcomes, Gunaratnam does not provide sufficient explanation for why politicians ultimately 
supported different outcomes in three jurisdictions. 
The Advocacy Coalition Framework (ACF) (Sabatier, 1988; Sabatier and Jenkins-Smith, 1999) 
promises to shed light on drug policy issues with its argument that policy outcomes are the 
result of competition between coalitions which hold different beliefs about policy problems. 
Studies that have utilised the framework focus on understanding how one set of ideas becomes 
ascendant over another within a policy sub-system (Hallam, 2006; Kübler, 2001; Monaghan, 
2011; Sobeck, 2003). Scholars such as Kübler (2001) and Hallam (2006) demonstrate the utility 
of the ACF when applied to drug policy issues, albeit with modifications to the framework in 
each case. Monaghan (2011) treats the ACF more as a springboard, replacing the notion of 
‘coalitions’ with ‘appreciative perspectives’ in his study of the UK drug classification system. 
The strengths of the ACF lie in its recognition of the role coalitions play in carrying ideas to 
policy outcomes, while acknowledging the crucial role played by the decision-making power 
that resides in government structures. An ongoing challenge for the application of the ACF lies 
in testing out whether the influence of coalitions is overstated: coalitions can be identified, but 
can it be demonstrated that the policy goals that were achieved were the outcome of collective 
action (Schlager, 1995)? 
In providing case studies for policy theories, drug policy scholarship has further challenged the 
underlying presumption of coherence in policy making. For example, Hughes et al.’s (2014) 
study of the drug trafficking legal threshold highlights the complexity of introducing policy in 
areas that affect multiple policy stakeholders. Drawing from both Kingdon and Sabatier’s 
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approaches, this study focuses on four key aspects of the policy process: the roles of formal 
policy actors; public opinion; the ‘problem’; and the available research that could inform the 
policy solutions. This framework is deftly applied and the authors draw the conclusion that the 
policy development process has been “arbitrary and messy”, raising concern about the extent 
to which policy development should proceed in the absence of evidence.  
Where the study on legal thresholds takes a relatively narrow aspect of policy, Hudebine’s 
(2005) paper looks at broader changes to drug policy over a longer period of time, focusing on 
the advent of harm reduction policies in the United Kingdom. He, too, concludes that consensus 
and coherence are the exception rather than the rule in drug policy. Like Houborg and Frank 
(2014), Hudebine identifies that the prohibitive elements of policy have a powerful effect; in 
this case, achieving the deviantisation of the drug using population. Attempts to ensure the 
social inclusion of this marginalised population (through harm reduction approaches) result in 
a duality, creating tension and ambiguity. The picture he paints is one of dynamic but not deep 
change, where drug policies are better understood as an exercise in ‘containment’: a political 
balancing act severely challenged by the emergence of HIV (Hudebine, 2005). 
Policy transfer and mobility 
The final area of literature with a focus on an ideational approach is that of policy transfer and 
mobility. A limited number of studies were identified that directly address the process by which 
policy makers from one jurisdiction borrow ideas or use knowledge about institutions or 
practices from another jurisdiction (McCann, 2008; McCann and Temenos, 2015; Temenos, 
2016; Bewley-Taylor, 2014; Butler, 2013). These works are illuminating as they seek to trace 
the circulation of ideas and consider the factors that affect the successful transplanting of 
policies from one place to another. Consideration of policy transfer sits comfortably with the 
study of the impact of evidence on drug policy; scholars explore a notion of ‘best practice’ and 
demonstrate the limitations of policy as ‘technical solutions’ when applied in new settings. 
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Both Butler (2013) and Bewley-Taylor (2014) present case studies that explore the explicit 
borrowing of policies by national bodies, Butler examining the Dublin pilot drug court in Ireland 
which sought to transplant the US model, and Bewley-Taylor reconstructing the events that led 
to the development of the Afghan National Drug Control Strategy. While Butler’s study employs 
a limited number of interviews with key informants, he is able to highlight some of the potential 
pitfalls of policy transfer, illustrating the scepticism with which this ‘outside’ idea was met, and 
the failure of the policy sponsors to embrace the underlying philosophy of therapeutic 
jurisprudence, which he argues is central to the American drug court practice. Butler succeeds 
in presenting a convincing picture of the complexity of policy transfer, stressing the tensions in 
this particular field between political aspirations, separation of powers functions and inter-
governmental cooperation (Butler, 2013). Bewley-Taylor’s study of Afghanistan considers the 
impact of local setting on this instance of policy transfer. He argues the inclusion of 
(progressive) harm reduction approaches in the strategies demonstrates evidence of the 
impact and influence of international policy networks in Afghanistan (Bewley-Taylor, 2014). 
Both Bewley-Taylor and Butler stress the power of the symbolism embodied in the adoption of 
the particular policies in their respective case studies – an outcome far removed from concerns 
of effectiveness or best practice that might more readily be associated with the motivation for 
adopting others’ policies. 
Finally, mobility is a central theme in the work of McCann (2008), McCann and Temenos (2015) 
and Temenos (2016). Mobility is explored not just in relation to policy, but in relation to people 
who carry ideas and have interactions in ‘real’ places. These articles promote broadening the 
focus of policy transfer from state actors to others engaged in sharing knowledge and 
experience, through case studies of the development of Vancouver’s Four Pillars drug policy 
(McCann, 2008); the global model of drug consumption rooms (McCann and Temenos, 2015); 
and the role of harm reduction conferences as sites where policy mobilisation occurs (Temenos, 
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2016). An extensive discussion of both the policy transfer and the policy mobilities literature, 
and their contributions to our understanding of drug policy, will follow in Chapter Three. 
2.3.5 Social construction 
The utilisation of social constructionist approaches to analyse drug policy has focused on four 
areas: problem construction; narratives and frames; drug users as a target population; and the 
construction of drugs themselves. 
Problem construction 
The literature in this field has been significantly influenced by Bacchi’s (2009) approach to 
problem construction and her ‘what’s the problem represented to be’ framework. A central 
tenet of Bacchi’s work is that problems are not solved by policies, but rather made by them. 
This is not to argue that the issues are not real, but that they are defined and ‘made’ by the 
policy that seeks to address them. Problem construction has proved to be a useful 
underpinning for work on drug policy in two ways. First, it provides a means of unpacking the 
underlying assumptions of drug policy, helping to shed light on limitations of current 
approaches and opening up the possibility of reform. Secondly, it provides a robust critique of 
the evidence-based policy paradigm by challenging the validity and authority of evidence in the 
policy making process. 
Lancaster and Ritter’s (2014) examination of Australian national drug strategy documents, and 
Lancaster et al.’s (2015) comparative study of the ‘recovery’ agenda in Australia and the UK, 
apply Bacchi’s concept of ‘problematisation’ to demonstrate how ideas of problems shape 
what is possible in terms of policy ‘solutions’. While Lancaster and Ritter (2014) find a 
connection between the construction of the problem of drugs in the Australian context and 
what is then proffered as an appropriate set of responses, the latter paper is able to show, 
through its comparative approach, that meanings (in this case in relation to the ‘recovery’ 
agenda) are not fixed and are subject to negotiation (Lancaster et al., 2015).  
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Fraser and Moore (2011), in a similar vein, apply Bacchi’s approach to explore meaning and the 
role of causation and evidence in the development of policy responses to amphetamine-type 
stimulants in Australia. By focusing on representations of the substances themselves in policy 
documents, Fraser and Moore seek to understand the extent to which drugs can be seen to be 
deterministic (i.e. to what degree they can be said to cause a particular effect). They conclude 
that despite an acknowledged paucity of evidence, causation (for harm) is still attributed, thus 
justifying the policy responses in the documents. In another paper, Moore and Fraser (2013) 
use problem construction to examine addiction treatment and practices, arguing that by 
conceiving of addiction as a bounded problem that can be treated in isolation, the system works 
to produce ‘addicts’ who are defined by the treatment regime (i.e. the policy solution). Moore 
and Fraser demonstrate the unintended consequences that flow from this approach, including 
the outcome that “As addiction comes to be produced by the very system designed to treat it, 
the scale of the problem appears to be growing rather than shrinking” (Moore and Fraser, 2013 
p. 916). 
The second stream of work to emerge under the banner of problem construction is a 
consideration of the role evidence plays in the formation of policy, and the way in which it is 
increasingly relied upon as a means of ‘knowing the problem’ in the context of national drug 
strategies (Roumeliotis, 2014; Lancaster and Ritter, 2014). Roumeliotis examines knowledge 
utilisation in the development of national drug policy in Sweden and concludes there has been 
a shift from seeing drugs as an issue of social exclusion to a problem of individual behaviour, 
the solution to which lies in the domain of experts, not politics. Van Toorn and Dowse (2016), 
using Bacchi’s framework to compare the use of evidence in two policy areas (drug policy and 
child protection), conclude the role of evidence is to construct a common frame through which 
meaning is applied and resolutions to problems sought, as opposed to being used to ‘solve’ 
policy problems.  
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Lancaster (2014) argues against evidence being treated as inherently valid and therefore 
privileged in the policy making process. Her commentary offers the possibility of pushing for 
reform by developing policy through a more inclusive process that breaks the monopoly of 
‘valid’ knowledge. If we understand policy as constructed, the possibility must exist to 
‘reconstruct’ it in a new form with new influences. However, questions remain as to how key 
interest groups participate and are heard in policy processes. Dingelstad et al.’s (1996) study 
concludes that debates about drugs are socially constructed and linked to the key interest 
groups that participate in those debates. The authors, however, offer no insights into what 
allowed those particular interest groups to dominate the debates, or into other questions 
about the operation of power or influence. Of all the works, Fraser and Moore’s is the most 
reflective, arguing that neither a material view or an entirely socially constructionist view is 
sufficient to understand the interactions that produce the ‘problem’ of drugs. They contribute 
the following useful insight: “We need, instead, to understand the problem as both factual and 
political, and policy as a site in which the politics and materiality of drugs are made” (Fraser 
and Moore, 2011 p. 500). 
Narratives and frames 
Stone’s (1989) work on causal stories resonates with drug policy scholars, providing a 
framework for accounting for the often repeated but relatively unfounded narratives that 
dominant representations of drugs. These narratives, in which drugs are framed in terms of 
criminality or as an issue of individual morality, curb the policy solutions that are offered. 
MacGregor delves into the question of the over-arching but rarely challenged narrative that 
‘drugs are dangerous’, which she sees as dominating public debate (MacGregor, 2013). Her 
comprehensive study of drug policy in Britain since 1979 comprises document and media 
analysis as well as participant observation and interviews. To MacGregor, the frames signal a 
set of interests and values that relate to politicians ‘playing the game’ of electoral survival, 
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constrained by a collective decision-making model. MacGregor’s work demonstrates how 
particular narratives prevail and remain remarkably unchanged despite the emergence of new 
evidence and knowledge. Moreover, MacGregor succeeds in situating her work squarely in the 
sphere of politics and political actions, while still demonstrating the value of a social 
constructionist perspective on the influence of ideas. 
Where MacGregor identifies continuity in the underlying narrative shaping British drug policy, 
it is change that is identified in a comparative study of the framing of drug consumption and 
gambling in Germany and the Netherlands (Euchner et al., 2013). Encompassing a sixty-year 
period, this study draws on parliamentary and government documents to identify dominant 
frames, concluding that morality framing, while present in the mid-twentieth century, lost its 
importance over time, and that close connections can be identified between ‘frame shifts’ and 
policy outputs. A further interesting application of the analysis of policy narratives comes from 
Fitzgerald’s work on two divergent attempts to introduce supervised injecting facilities in 
Australia. To better understand the cause for the failure of the Victorian initiative, Fitzgerald 
identifies a distinctly different narrative dominating the policy debates in relation to law 
enforcement in the two locations, concluding the lack of confidence in the police in New South 
Wales opened the way for more acceptance of alternative framing and solutions to the street-
based drug scene (Fitzgerald, 2013). 
Media 
A series of studies has sought to understand the role the media plays in framing debates on 
drug issues and drug policy, raising, amongst other issues, the question of how influential the 
media is in policy debates and political outcomes. Useful starting points to this literature are 
Lancaster et al. (2011) and Bright et al. (2008). The former article identifies four key functions 
played by the media: agenda setting; framing; shaping attitudes towards risk; and feeding into 
political debates and decision making. The latter employs a social constructionist approach, 
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identifying the dominant discourses that recur in Australian media and exploring how those 
discourses impact on how we conceive substance use, providing a rationalisation for the policy 
outcomes that are offered. Interestingly, the study identifies six dominant discourses, 
challenging more binary conceptualisations of debates hinging on proponents and opponents 
of particular policy positions (Bright et al., 2008, and for contrast, see Hallam, 2006). 
The media plays a readily identified role as a vehicle for creating ‘moral panic’, seen in the work 
of Everett (1998), Bright et al. (2013) and Alexandrescu (2014). Each study deals with the media 
reaction to the appearance and impact of a single drug (crack cocaine, Kronic and mephedrone 
respectively), and all make the case that the media played a significant role in drawing the 
public’s attention to these drugs and, in doing so, agenda setting through demanding a 
response from government. Each study raises the concern the narratives that recur through 
media reports are divorced from a scientific evidence base, and can carry the unintended 
consequence of increasing risk to the public as a result of media focus.  
Two studies stand out for presenting more nuanced and ambiguous findings about the role of 
the media (Tieberghien, 2014; Hughes et al., 2011). Tieberghien explores the representation of 
scientific knowledge in the Belgian media, in relation to drugs.  She concludes that while the 
media was found to support an ‘enlightenment’ role, incorporating scientific information in 
reporting on drugs, the presentation was often inaccurate or distorted, demonstrating a 
selective use of research (Tieberghien, 2014). Hughes et al.’s (2011) study of Australian print 
media, which aimed to understand how generalisable findings of media bias and 
sensationalism are, offers important insights into the debate on the role of media and moral 
panic. Their research found that, overall, there was a bias of reporting towards frames that 
depicted crime or deviance; however, most articles were reported in a neutral manner and 
crisis framing was absent, leading the authors to conclude that media reporting (in Australia) 
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“may be less overtly sensationalised, biased and narrowly framed than previously suggested” 
(Hughes et al., 2011 p. 285). 
While the above studies demonstrate that framing of drug issues occurs, linking that framing 
to political or policy outcomes is more problematic. Two studies that seek to achieve this are 
Elliott and Chapman (2000) and Lawrence et al. (2000), both of which examine media coverage 
during the attempt to introduce a heroin trial in the Australia Capital Territory during the 1990s. 
Where Elliott and Chapman focus on the representation of drug users, Lawrence et al. are 
concerned with the orientation of reporting on any aspect of heroin. Both studies conclude 
that the extensive negative coverage contributed to the failure of the trial. While the 
arguments are compelling, these two works (like other media analyses) are limited by only 
being able to suggest or imply a link between the outcomes and the reporting, as neither study 
demonstrates a direct impact that the reporting had on the political and policy decision making 
process, being limited methodologically to analysis of media.  
This limitation suggests that there is a need for further work exploring the impact of the agenda 
setting function played by the media. An approach to this is demonstrated in Everett’s (1998) 
study of the US federal sentencing guidelines for crack cocaine. Utilising a public arena 
framework, Everett depicts the media as challenging political elites’ ability to frame and define 
social problems. Complementing his media analysis, Everett explores the interactions between 
the Congress and the US Sentencing Commission when the laws were subject to review 
following exposure of the racial bias that accompanied the enactment of the sentencing 
guidelines. Given how divorced the sentencing laws were from evidence about the relative 
harms of crack cocaine versus powder cocaine, Everett makes a compelling case for the ability 
of the media to set an agenda that enabled legislators to pursue ideological positions in the 
face of contrary evidence (Everett, 1998). 
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Target populations 
The social construction of drug users as a target population arises in a number of studies from 
the US, UK and Australia (Amundson et al., 2015; Lybecker et al., 2015; Neill, 2014; MacGregor, 
2013; Stevens, 2011; Hudebine, 2005; Elliott and Chapman, 2000). Influenced by the works of 
Schneider and Ingram (1993) and notions of ‘deservedness’, these studies focus on the impact 
on policy of the negative construction of drug users as a deviant population. MacGregor (2013) 
and Stevens (2011) see British policy as having been strongly influenced by underlying 
assumptions and characterisations of drug users that have served to inextricably link drug users 
and criminality, oversimplifying the complexity of circumstances surrounding drug use. 
Evidence is also of concern here, as studies such as Amundson et al. (2015) conclude. In 
examining the public discourse of state legislators in the US during debates on welfare drug 
testing, this study finds proponents did “little to distinguish welfare recipients from drug 
abusers…Although empirical evidence does not support a connection between welfare receipt 
and drug use” (Amundson et al., 2015 p.458).  
Neill (2014) specifically applies Schneider and Ingram’s (1993) notion of social construction to 
two drug policy models (law and order, and public health). Neill finds the dominant model 
depends on how the drug population is perceived and concludes by advocating for a public 
health approach based on a ‘drug addiction as disease’ model. In doing so, Neill fails to take 
the social constructionist analysis through to its logical conclusion that the disease model is 
also a social construct, and itself subject to criticism for its underlying assumptions. Neill, in 
privileging ‘medical treatment’ above ‘politically based solutions’, fails to explore the 
complexity of the issue, placing herself at odds with other scholars, such as Roumeliotis (2014), 
who argues that in treating drug use as an issue of the individual, rather than society, 
opportunities are lost to see the wider social circumstances that make drug use problematic.  
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Construction or enactment of drugs 
The final area of literature to emerge from social constructionist approaches concerns the 
impact on policy of the construction of drugs themselves, or the way in which they are 
produced and reproduced in public discourse (Moore and Fraser, 2013; Dwyer and Moore, 
2013; Kolind et al., 2016). Moore and Fraser’s (2013) article using Bacchi’s approach is 
discussed above, but two additional relevant works were found that derive from a Science and 
Technology Studies approach. Dwyer and Moore (2013) critically examine the way 
methamphetamine is ‘produced and reproduced’ in public discourse. This study looks beyond 
public policy documents, searching webpages, health promotion, education and campaign 
materials, media accounts, grey literature and research texts. More innovatively, the authors 
compare their findings from this public discourse with consumers’ experiences of 
methamphetamine use, taken from an ethnographic study. They find that public discourse 
“enacts methamphetamine as an anterior, stable, singular and definite object routinely linked 
to the severe psychological ‘harm’ of psychosis” (Dwyer and Moore, 2013 p. 203). This is at 
odds with the findings of the ethnographic accounts (which indicate a range of experiences) 
and, for the authors, gives insufficient consideration to the social and cultural contexts in which 
the drug can be taken – a factor which is “well established as essential to any understanding of 
drug experiences and effects” (Dwyer and Moore, 2013 p. 206).  
Kolind et al.’s (2015) work complements Dwyer and Moore’s study in its examination of the 
way both legal and illegal drugs are enacted in Danish prisons. Following identification of three 
enactments of drugs in Danish prison settings, the authors conclude that drugs do not have a 
static meaning, but that meaning will depend on the particular situation. This work 
demonstrates social construction at play beyond the construction of the problem of drug use, 
to the very substances themselves, the meaning of which cannot be taken for granted in policy 
development. 
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2.3.6 Limitations of the scoping review 
This scoping review has a number of limitations which should be noted. The narrative synthesis 
of the results groups the findings by themes based on theoretical approach. There is a risk that 
the studies presented are ‘pigeon-holed’ to fit the thematic schema, and the breadth of their 
approach and findings may not be fully conveyed. However, the thematic groupings were easily 
found through the process of extracting data during Stage 4, suggesting that the included 
literature is representative of the work being undertaken in this field. 
A further limitation lies with the issue of the completeness of the review. While a reasonable 
attempt has been made to rigorously apply Arksey and O’Malley’s framework, there are still 
questions as to how many databases should be searched initially and how much hand searching 
should be undertaken. The use of Scopus, in particular, should give excellent coverage but 
defining and refining search terms is crucial to the process. The number of articles that were 
subsequently picked up through hand searching key journals was surprising but may reflect the 
key words used by authors. Despite no language restrictions being placed on the searches, no 
non-English language studies were returned. This is unexpected given relevant work being 
undertaken, particularly by European scholars. While English search terms were utilised, 
databases such as Scopus contain translations of materials (at least at the abstract level). This, 
and the issue of search term returns, warrant further investigation. 
Further, the process of establishing and applying inclusion and exclusion criteria will greatly 
affect the range and volume of literature subsequently reviewed and selected for inclusion. 
The decision as to which studies are selected can only be resolved by constant reference to the 
central research question. Studies focused on governance comprise one area of literature that 
was largely excluded as falling outside the immediate area of inquiry, but these studies 
contribute fruitfully to drug policy research and would be of interest to drug policy scholars. 
Finally, Arksey and O’Malley (2005) recommend an optional step of undertaking stakeholder 
54 
 
 
consultation to augment a review’s findings. This step was not undertaken due to time and 
resource constraints but could well have served to improve the completeness of the review. 
2.4 Discussion 
As the scoping review demonstrates, drug policy scholarship’s adoption of ideation and social 
constructionist approaches goes back only two decades. As a relatively young field, there is 
considerable scope for continuing to pursue these theoretical positions in more depth. This 
discussion presents selected gaps revealed by the review and draws together some key 
unresolved issues in the literature. These issues are:  
i) the continued problematisation of evidence;  
ii) opportunities to broaden the range of policy change theories being applied to drug 
policies;  
iii) the narrow geographic focus on the current literature; 
iv) the relationship between different levels of policy, particularly between national 
and local jurisdictions; and 
v) the absence of theorising on replication and the scaling up of interventions. 
The problem of evidence 
The starting point for this chapter’s review of the literature was the relationship between 
evidence-based policy and health-oriented drug policy. Concern with the problematic nature 
of EBP and the privileging of evidence in the policy process gave rise to alternative accounts of 
the influences on the policy process. The findings of the scoping review demonstrate the issue 
of evidence remains unresolved in the ideational and social constructionist drug policy 
literature, although there is consistency in the position that a ‘pure’ form of evidence-based 
policy is unachievable. What emerges is a spectrum of positions on how much evidence does 
and should matter. It is perhaps this question of how much evidence should matter that 
ensures the issue continues to be problematised, leaving room for ongoing exploration of what 
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constitutes evidence and ‘whose’ evidence we are referring to and consulting in the policy 
process. There appears to be a new normative agenda emerging, with a focus on broadening 
the scope of what we consider evidence to be as a means of legitimating participation in policy 
making. Scholars in this area are also exploring questions of broadening participation in policy 
making and the relationship between evidence, values and democracy (Lancaster, 2014; 
valentine, 2009; Lancaster et al., 2017; Ritter et al., 2018). There is a social constructionist cast 
to the current literature in this area, opening up potential to explore these same questions 
from a policy change and political science perspective. 
The application of policy change theories 
Emerging from the critique of evidence-based policy is the recognition that if evidence is 
demonstrably not the prevailing influence on policy outcomes, then other influences on policy 
must be accounted for. As the scoping review illustrates, drug policy has provided rich grounds 
for exploring the process of policy change and testing out policy change theories and 
frameworks which recognise the multiple influences on policy development, including ideas 
and knowledge, political and non-political actors, networks and coalitions, the media and 
crises. A theme identified in the review was the issue of the ‘coherence’ of drug policy, with 
studies describing policy as “arbitrary and messy” (Hughes et al., 2014) and characterised by 
“ambiguity and ambivalence” (Hudebine, 2005). These characteristics of drug policy potentially 
challenge more conventional applications of policy theory models, providing opportunities to 
test out the boundaries and applicability of familiar frameworks and approaches, such as the 
Advocacy Coalition Framework and Kingdon’s multiple stream approach. What is apparent 
from the scoping review is that some influential theoretical approaches remain less explored, 
such as Haas’ (1992) epistemic communities or Baumgartner and Jones’ (1993) punctuated 
equilibrium theory (for exceptions, see Ritter and Lancaster, 2013 and Rychert and Wilkins, 
2018). While there are studies that embark upon theory building (see Stevens, 2007 and 
Monaghan, 2010 as examples), of the 48 studies in the scoping review, only three articles were 
56 
 
 
primarily concerned with the state of theory in the body of drug policy research, presenting an 
opportunity for further consideration and debate of the field itself amongst drug policy scholars 
(Lancaster, 2014; Ritter and Bammer, 2010; and Stevens and Ritter, 2013). 
Geographic focus 
The review has revealed a narrow geographic focus in the body of literature. Work being 
undertaken in Australia dominates, ahead of the UK and the US, with the majority of the 
remaining studies focused on European countries. Given the significance of drug issues in South 
America, Asia and Africa, there is a remarkable gap in the literature in this regard. Bewley-
Taylor’s (2014) study of Afghanistan’s national policy stands out; while it could be a model for 
exploring policy transfer approaches in other countries, there is a more fundamental need to 
explore policy making in different political systems from domestic perspectives. Also revealing 
is the lack of comparative literature in this field, with only four studies captured by the scoping 
review examining the approaches taken in two or more countries. There is a significant 
opportunity to contribute to our understanding of policy development by undertaking 
comparative research.  
The relationship of national policy to local policy 
An insufficiently explored area in the literature is the relationship between different levels of 
policy and, in particular, the impact of national policy on local jurisdictions. The importance of 
this issue will vary from country to country and be dependent on the local context, but its 
exploration brings with it opportunities to interrogate the gap between policy and 
implementation, and issues of local interpretation and policy transfer issues sub-nationally. Of 
the works reviewed, Hudebine (2005) provides the best example of an attempt to understand 
the consequences of ambiguity in national policy, leading to alternative interpretations of 
policy implementation at the local level. Further work in this area is warranted and would frame 
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the exploration of questions such as the impact of national level discussion and narratives on 
the reality of implementing drug policy and services at the community level. 
Policy replication and scaling up of initiatives 
An area very under-researched, as revealed by the scoping review, is the scaling up of 
interventions and the replication of policy initiatives (whether at the national or sub-national 
level). These issues are of direct concern for this thesis and its exploration of drug consumption 
rooms. Arguably, the concern in many studies with the impact of evidence reflects a 
preoccupation with the evaluation of policy and questions of effectiveness, but there is still an 
identifiable gap in the literature in relation to replication, policy learning and scaling up, moving 
beyond the rhetoric of evidence-based policy. The policy transfer and mobilities literatures is 
the exception in this area, although as discussed in Section 2.3.4 above and more extensively 
in Chapter Three below, there has been very limited application of these approaches to drug 
policy issues. 
2.5 Conclusions 
This chapter has had three key purposes. It has demonstrated the strong relationship 
between health-based drug policy and the evidence-based policy paradigm. It has scoped the 
field of alternative accounts that challenge the centrality of evidence in the policy making 
process in relation to illicit drugs, introducing the breadth of literature that employs 
ideational and social constructionist lenses. Finally, it has identified some gaps and 
unresolved issues in the literature, enabling this thesis to genuinely pursue some original 
lines of inquiry in relation to its research concern with drug consumption rooms and policy 
replication. 
While drug consumption rooms provide the topic under exploration, this study’s primary 
concern is that of change in a contested policy area. As the literature review demonstrates, 
scholars have been drawing on theoretical frameworks from political science and policy 
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studies to better understand the barriers to and influences on policy development. The 
‘problem’ of drug consumption rooms offers a multitude of issues that can help us address 
critical areas in relation to drug policy more generally. The following chapter will make the 
case that, of the policy change theories explored above, it is the policy transfer framework 
that appears to be the most appropriate approach to provide insights into the process of 
policy change across the chosen case studies. The policy transfer framework also has the 
benefit of accommodating comparative research, which is an identified gap in this field, and 
of providing a framework in which the relationship between local and national policy 
development can be explored. Finally, the review of the literature demonstrated the valuable 
contribution that is being made to drug policy scholarship from a social constructionist 
perspective. Policy transfer, as will be argued in the following chapter and the discussion on 
ontology in Chapter Four, sits comfortably with a ‘thin’ constructivist approach that accepts 
the co-existence of both structural forces and social constructions (see Section 4.3.2 below). 
This is important, as it allows this thesis to be reflective of contributions from both an 
ideational and social constructionist perspective. 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter three      
Theoretical framework 
• • • 
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3.1 Introduction 
This thesis seeks to understand the barriers and challenges to replicating drug consumption 
rooms with reference to the policy processes in the case study countries. The literature 
review in Chapter Two demonstrates how two distinct approaches, ideational and social 
constructionist, have been applied to studying drug policy. These approaches recognise the 
complexity of the policy process and the role of multiple agents in influencing and developing 
policy outcomes. They also interrogate the role played by evidence and knowledge in the 
policy making process. The review demonstrated there are gaps in the literature in relation 
to comparative studies that address drug policy making, not only between states, but within 
countries at the sub-national level. In addition, the review identified that limited empirical 
and conceptual work had been undertaken in relation to utilising the concepts of policy 
transfer and policy mobility to interrogate questions of drug policy development. 
Policy transfer, depending on its interpretation and application, has straddled both ideational 
and constructionist spheres. The chapter outlines the debates within the literature that have 
shaped our current understanding of the movements of policy across national and sub-
national boundaries under the banner of policy transfer. It explores the alternative 
interpretations of policy transfer that have been developed, primarily by geographers 
exploring urban policy mobility, before demonstrating the limited ways in which these 
approaches have been applied to questions of drug policy. A case is then made for why a 
policy transfer lens is an appropriate theoretical framework for addressing the issue of stalled 
policy development in the case of the replication of drug consumption rooms, with particular 
reference to the need to investigate multiple levels of governance and undertake 
comparative analysis. The chapter presents a framework, based on the work of Evans and 
Davies (1999) and Evans (2004) which interrogates various levels of inquiry and the impact 
of policy-oriented learning and policy transfer networks. It reflects an appreciation of policy 
as a complex undertaking engaging multiple state and non-state actors and will form the 
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basis for interpreting the findings from the case studies in Chapters Five and Six, and the 
outcomes of the thematic analysis presented in Chapter Seven. 
3.2 Conceptual review 
3.2.1 From policy transfer to policy mobilities 
Policy transfer literature developed within political science and international studies as a 
response to the growing phenomenon of policy ideas and approaches from one political 
setting being drawn on or influencing the development of policy and institutions in another 
political setting. Building on earlier literature on policy learning, lesson drawing, diffusion and 
convergence, Dolowitz and Marsh developed a conceptual framework with a focus on the 
voluntary and coerced elements of policy transfer. They went on to further refine this 
framework, encouraging researchers to look beyond checklists concerning the process in 
order to provide greater explanatory value as to the motivations behind policy transfer and 
the relationship between policy transfer and policy success or failure (Dolowitz and Marsh, 
1996; Dolowitz and Marsh, 2000).  
A multitude of empirical studies across a range of disciplines has enquired into the extent to 
which, and the means by which, policy may have travelled between jurisdictions and what 
the consequences of that may be (Benson and Jordan, 2011). As this scholarship reveals, and 
as Dolowitz and Marsh (2000) have argued, there is an indisputable growth in evidence of 
transfer or borrowing as a result of new technologies and the rise of globalisation. This gives 
rise to the question: if this is no longer a novel phenomenon is there value in focusing on 
policy transfer rather than policy development or policy change in general? Even before the 
advent of much of this work, Evans and Davies (1999) were posing the question that if policy 
transfer were such an ‘every-day’ part of policy development, does policy transfer analysis 
continue to be a meaningful exercise? 
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The utility of a theory or theories of policy transfer has been much debated, as have the 
theoretical credentials of such approaches, with Dolowitz and Marsh (2012) maintaining that 
their framework is a heuristic rather than a theory. Critique of policy transfer has focused on 
the political science ‘shortcomings’, particularly of the earlier work, which was criticised for 
its focus on a rational and linear model of policy development. The limitations, according to 
Peck and Theodore (2010), include a presumption that policy makers will optimise outcomes 
by choosing the best policies from a market place where ideas are freely exchanged, allowing 
“good policies to drive out bad, in a process for optimizing diffusion” (Peck and Theodore, 
2010 p.169). Below it is argued that these valid criticisms have been addressed by newer 
approaches to policy transfer that are rooted in alternative political science approaches, but 
first I will introduce the response to orthodox policy transfer approaches from the 
interdisciplinary body of critical policy studies. 
Benson and Jordan (2011), in their review of the policy transfer literature, pose the question 
as to whether academics more or less know what should be known about policy transfer. 
They suggest a stasis may have been reached in its conceptual value and that there is minimal 
additional knowledge to be gained by further enquiry. In rebuttal, McCann and Ward (2012) 
argue that there is much to be learned about the global circulation of policies, which 
continues to be an active area of enquiry for many scholars working outside of traditional 
political science. Stepping away from the limitations implied by ‘policy transfer’, McCann and 
Ward detail an emerging field that they argue departs significantly from earlier 
conceptualisation with its focus on policy mobilities, mutations and assemblages. Working 
from a constructivist perspective, scholars critical of policy transfer have contested the 
narrow linear notion of a ‘neatly parcelled’ policy travelling from jurisdiction A to further 
jurisdictions. They argue instead that in the process of the journey they “are not simply 
traveling across the landscape – they are remaking this landscape, and they are contributing 
to the interpenetration of distant policy making sites” (Peck and Theodore, 2010 p.170). 
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Furthermore, in the process of travel, policies mutate as they engage with social, spatial and 
political factors and will have different effects in new locations (McCann and Ward, 2012).  
One of the key concepts utilised is ‘assemblages’, derived from the work of Deleuze (McCann, 
2011). Assemblages is used in the sense of ‘parts from elsewhere’ being brought together 
but not necessarily in a fixed way. 
“Assemblages are always coming apart as much as coming together, so their existence 
in particular configurations is something that must be continually worked 
at…Assemblages are always works in progress. They involve invention, labour, politics 
and struggle on the part of those involved.” (McCann, 2011 p.145, italics in original)  
Prince emphasises that the policy transfer process is both technical and political; it is in the 
making of an assemblage that a policy transfer is effected. The resultant policy then exists as 
an assemblage of “texts, actors, agencies, institutions, and networks” (Prince, 2010 p.173). 
The study of such assemblages therefore relies on detailed empiricism to capture multiple 
layers of actors and complexity, existing in a state of fluidity.  
While the work of critical scholars places a welcome emphasis on the multiplicity of 
influences on the policy process and makes a strong case for why the results of any policy 
transfer process will necessarily be shaped by local factors, critical questions remain. The 
concern for scholars of policy mobility appears to have shifted once more to the process of 
policy transfer (however that is conceived). The conceptual lens of ‘assemblage’ will render 
every case unique, and uncovering those cases will require detailed empirical study, raising 
questions about the generalisability of the findings. The claims of ‘constant flux’ leave few 
fixed points, with the exception of the spatial domain under investigation, although even 
territories, in the eyes of Deleuze, are “not fixed for all time, but are always being made or 
unmade” (Wise, 2005, quoted in McCann, 2011 p.144). 
The varying positions held on policy transfer are, as Dolowitz and Marsh (2012) contest, a 
reflection of the ontological and epistemological positions held by the scholar. I contend that, 
despite the valuable contribution being made to the literature on policy mobility by critical 
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policy scholars, there are still strong arguments to be made for adopting an approach to 
policy transfer that acknowledges the role of both agency and structure in the processes. The 
remaining parts of this chapter first discuss the limited application of policy transfer analysis 
to drug policy before addressing the question of the suitability of applying a policy transfer 
framework to the research question at hand, particularly in light of the critiques presented 
above. Finally, a proposed policy transfer framework is presented, incorporating a multi-level 
approach to policy transfer analysis (Evans, 2004). 
3.2.2 The limited application of policy transfer and mobility lenses to 
drug policy 
Despite the relatively rich body of work in drug policy scholarship that is concerned with 
policy change and the impact of evidence and ideas, the use of concepts from policy transfer 
and mobility literature has been limited, as illustrated by the introduction to the literature 
presented in Chapter Two. The purpose of this section is to explore that literature, illustrating 
how it has been utilised to capture aspects of drug policy development. Mirroring the more 
general literature, the application of policy transfer concepts to drug policy issues falls neatly 
between more classic studies based on the work of Dolowitz and Marsh and Evans (applied 
by Butler, 2013 and Bewley-Taylor, 2014), and the mobilities literature by McCann (2008), 
McCann and Temenos (2015), Temenos (2016; 2017) and Longhurst and McCann (2016).  
Butler (2013) and Bewley-Taylor’s (2014) studies are concerned with the transfer of policy 
from one national jurisdiction to another. Both refer to the works of Dolowitz and Marsh 
(2000), while Bewley-Taylor also draws on Evans (2009) and Stone (1989) to provide insights 
into this process. Butler (2013) examines the introduction of an American model of drug 
courts into Ireland; having established a ten-year history of poor outcomes, Butler seeks to 
understand why the ‘trial’ was allowed to continue and political support was maintained for 
the programme. While he does not use Dolowitz and Marsh’s (2000) terminology, he is 
clearly arguing this is a case of ‘inappropriate transfer’. His findings attribute the outcomes 
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to the transfer being treated as a ‘discrete technical process’ which ignored the 
incompatibility of the intervention with the underlying judicial philosophy in operation in the 
Irish court system. Butler’s conclusion is that, while there is strong evidence of a failure of 
implementation, the symbolism of the transfer has served a political purpose. In contributing 
to our understanding of drug policy and policy transfer, Butler’s study serves as confirmation 
that policy transfer without adaptation for local circumstances and context is unlikely to 
succeed. It contributes to the body of empirical studies that seek to explore unsuccessful 
transfer in line with Dolowitz and Marsh’s (2000) call to examine cases of both success and 
failure.  
Bewley-Taylor’s (2014) study of the development of the Afghan National Drug Control 
Strategy adopts a multi-level perspective that incorporates elements of both Dolowitz and 
Marsh (2000) and Evans’ (2009) frameworks. He is concerned with interrogating various 
levels of enquiry; capturing the roles played by multiple agents (within and outside 
government); and exploring the policy transfer network that operates across international, 
state and inter-organisational levels. Bewley-Taylor supplements this policy transfer 
framework with narrative policy analysis, which he uses to differentiate the motivations of 
the various agents at work within the policy network. He uses a process of historical 
reconstruction or process tracing to uncover the roles played by different policy actors. 
Unlike Butler, Bewley-Taylor is not concerned with an assessment of the success or failure of 
the transfer process, but rather what can be learned about the influence of the actors and 
their agendas, many of whom represented international organisations or foreign 
governments. Like Butler, Bewley-Taylor identifies “inappropriate content” which “left the 
Strategy in many ways divorced from the realities of some aspects of the drug market within 
the country” (Bewley-Taylor, 2014 p.1016). What he describes, however, is not a case of 
coercive policy transfer (Dolowitz and Marsh, 2000) but an instance of a ‘recipient’ 
government deliberately embracing a “predominantly exogenous document” as an entrée 
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back into the international community by embracing the “normative expectations of the 
international drug control regime” (Bewley-Taylor, 2014 p.1016). Bewley-Taylor’s analysis 
furthers our understanding of the importance of motivation in policy transfer scenarios. 
Using policy transfer as an ‘analogical model’ rather than a theory, the study demonstrates 
its usefulness in interrogating multiple levels of actors and influence. 
The work of McCann (2008), McCann and Temenos (2015), Temenos (2016; 2017) and 
Longhurst and McCann (2016) all shares an approach to policy mobility that has developed 
from urban geography and introduces spatiality into the analysis of policy movement. The 
main concerns of these scholars are the circulation of knowledge and the networks of policy 
actors and the spaces in which they interact. By tracing the movement of policy ideas through 
global circuits of knowledge, policy mobility scholars study the ‘assemblage’ of policy at local 
sites and the mutation or adaptation of those policies as the local context and local actors 
interact with ideas from ‘elsewhere’ and in turn contribute to the global ‘models’. This 
process of assembly is “a thoroughly political process” (Longhurst and McCann, 2016 p.111) 
and, as all these studies reflect, the use of a policy mobility lens is intended to shed light on 
the power and politics at the heart of policy making processes. McCann and Temenos (2015) 
describe the mobilisation of policy as “a complex, power-laden social process” and argue that 
“policy mobilities are always about power and politics” (pp.217-218). They state that 
knowledge exchange is inherently a political process, going so far as to argue knowledge 
exchange and politics are “two sides of the same coin” (p.221).  
The focus on a multitude of actors reflects an ontological belief that power lies with agents, 
not within institutions or structures, although Longhurst and McCann (2016) do acknowledge 
the effects of a constrained political-institutional environment in their study of the 
constrained mobility of harm reduction drug policy in Surrey, British Columbia. Temenos 
(2017) effectively dismisses formal political structures as being able to contribute to change, 
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due to their capture by neoliberal forces in what she argues is a ‘post-political condition’. The 
political action that she sees as important, as discussed below, focuses on actions outside 
state structures. This idea is challenged by the findings of this thesis, as will be discussed in 
later chapters. 
McCann has been at the forefront of the development of the policy mobilities approach, and 
some of his earliest work has focused on drug policy. His study of the development of 
Vancouver’s four pillar drug strategy is a thorough analysis which develops his earlier 
(McCann, 2008) concept of urban policy mobilities. It is concerned with the movement of 
ideas and policy from city to city through ‘global circuits of policy knowledge’. McCann is 
interested in the complex relations and interconnections of urban policy actors, of which he 
identifies a broad range, thus contributing to a focus on practices and actors that sit outside 
the formal state apparatus. McCann’s work, importantly, is concerned with the spatialities 
“where experts work, connections are made, and where truths are deployed, legitimized, 
questioned, and operationalized” (McCann, 2008 p. 16). For drug policy scholarship more 
generally, McCann’s work contributes an acknowledgement of the role of an epistemic 
community (although this is not a term used by McCann); one democratically conceived, 
where expertise may be from community activists and people who use drugs, not just 
academics and policy experts.  
Temenos’ (2016; 2017) two papers are concerned with drug policy activism and its influence 
on policy development. The first paper explores the role of conferences as ‘convergence 
spaces’ where policy mobilisation occurs. Temenos (2016) argues that her focus on micro-
spaces, as she terms them, sheds light on the role played by policy activism in the process by 
which policy is assembled. She highlights the role of transnational advocacy networks in 
knowledge exchange, as well as being interested in the political impact of a city’s role in 
hosting conferences in the context of local and national government relationships. 
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The second study describes the contestation over harm-reduction-driven public health 
activities in three diverse cities in Canada, Dominican Republic and Luxembourg. Temenos 
argues that harm reduction is a technical response, embedded in expert medical knowledge 
and aimed at risk reduction, yet it is also a radical social movement with roots in participatory 
democratic practice. She wishes to explore the political geographies of public health and drug 
policies and argues that a focus on policy mobilities can illuminate the relationship between 
policy and politics. Temenos sets this analysis in a context of the ‘post-political condition’, 
arguing that “exclusion of people from the state blocks debate over what should be governed 
in favour of discussion of techno-managerial questions regarding how best to order and 
police social lives” (p. 585, italics in original). She is therefore interested in the disruptive role 
played by activism, privileging, as she calls it, ‘everyday proper politics’ over more traditional 
politics, which she argues have been reduced to the management of technical issues and no 
longer provides a forum for debate over fundamental ideological differences. Her position 
therefore would seem to disregard the role of formal political institutions as a site for reform 
or change, given their ‘capture’; a claim challenged by this thesis by its continued focus on 
state-centred institutions. Temenos’ work demonstrates policy mobility scholarship’s 
concern with fluidity, flux and dispersed networks that act both globally and locally. 
Finally, reflecting their concern with spatiality, Longhurst and McCann (2016) contribute a 
concept of the ‘policy frontier’ where “mobile policies encounter resistance, barriers, and 
challenges as they are mobilised” (p. 111). In this conceptualisation, they argue that in 
‘frontier politics’ outcomes remain politically open but are sites of contestation and struggle 
over policy ideas and ideology. They use the case study of the attempts to introduce harm 
reduction policies in Surrey, British Columbia, a neighbouring city of Vancouver, identifying 
this as a case of constrained mobility where agents for change have met resistance and 
barriers. Once again, the focus of this work is on mutation, with Longhurst and McCann 
arguing that policy models will always be subject to adaptation; the policy frontiers are 
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viewed as “spaces in which alliances can be built, debate can occur, and experimentation can 
take place” (Longhurst and McCann, 2016 p. 120). 
3.2.3 The case for applying a policy transfer lens 
The application of a policy mobilities lens to questions of drug policy development has 
brought a focus on the role of multiple agents, and contributed to our understanding of how 
policies are shaped and interact at local, regional, national and global levels. I would contend, 
however, that despite this valuable contribution, there is existing scope within policy transfer 
literature to continue to offer utility without having to go down a constructivist path that 
privileges agency at the expense of structure. I argue instead that the adoption of a policy 
transfer framework offers a suitable lens for interrogating the question of the replication of 
drug consumption rooms by looking at different levels of governance and considering the 
relationship between agency and structure to be dialectic.  
The debate over the utility of the concept of policy transfer has, according to Newburn et al., 
largely focused on “the overly rationalistic, occasionally positivistic tendencies of much 
orthodox policy transfer scholarship” (Newburn et al., 2018 p.567). These shortcomings have, 
however, been addressed by Dolowitz and Marsh (2012) in response to the criticisms of 
McCann and Ward (2012), and by Evans and Davies (1999) in their discussion on the 
complexity of modern governance. Work within the field of policy change more generally, as 
discussed in Chapter Two, has also developed to respond to the increasing complexity 
affecting policy development, offering insight into the roles of multiple agents, ideas, 
narratives and discourse. I therefore maintain that policy transfer remains a useful concept, 
particularly when it is utilised from an appreciation of the complexity of policy change, such 
as through the framework developed by Evans and Davies (1999) and Evans (2004). 
As the review of the drug policy literature demonstrates, there have been very few attempts 
to apply policy transfer concepts in this field, although the policy mobilities literature is better 
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developed. The restricted volume of the literature is perhaps surprising, given that a 
fundamental concern of drug policy literature has been to interrogate the role played by 
evidence and evidence-based policy. Policy transfer is about ideas and the sharing and 
transfer of knowledge, and therefore highly relevant to how drug policy is developed. It also 
shares a concern with how ‘global’ ideas, such as those developed through a social 
movement like harm reduction and through epistemic communities, are accepted or adapted 
at the local level. Within drug policy scholarship, there has been a call that “Much more 
attention needs to be paid to issues of problem construction, politics, ideology, power and 
the messy complexity of the policy process” (Stevens and Ritter, 2013 p.169). The potential 
for policy transfer to contribute to our understanding of these issues has been underutilised 
to date, and it is the intention of this study to address this lacuna. 
While the policy mobility literature shares the concerns of knowledge exchange and 
circulation, I would argue its ontological underpinnings that privilege agency over structure 
blind it to the highly relevant role played by structure in the cases being explored; therefore, 
an approach that allows for the interaction between agency and structure will more fully 
shed light on the policy processes under examination. This decision has been made in 
recognition that while the debate and deliberation over drug consumption rooms has 
engaged many agents, the implications of the criminalisation of drugs are that there is a 
critical legislative and institutional element that comes into play in the policy process. This is 
not to restrict the research to the realm of formal politics, but the study recognises that 
institutional structures have served to constrain or shape policy development and the 
approach to the study needs to incorporate their role. A more detailed discussion of the 
ontological underpinnings for the study and the justification for adopting a critical realist 
perspective is undertaken in the following chapter. 
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Policy transfer or policy change? 
Before introducing the proposed policy transfer framework, it is necessary to address the 
issue raised by James and Lodge (2003) when they queried the explanatory value of policy 
transfer approaches, as distinct from other literature focused on policy change. Using 
Dolowitz and Marsh’s case study of the ‘failed’ transfer of the British Child Support Agency 
model, they argue that analysing the case from a policy transfer perspective does not result 
in an explanation for failure in terms of the process of transfer itself, but rather, other factors 
that were at play. This may well be a valid criticism of that particular case but I argue 
employing a framework developed around the concept of policy transfer provides some 
‘additionality’ to other policy change theories. I will develop three arguments to support 
using a policy transfer lens for this particular study. 
This study seeks to address the question of why drug consumption rooms were not replicated 
or were slow to be replicated in the case study countries, looking at the experience of four 
different cities where a case could be made for drug consumption rooms to address a specific 
identified need in relation to street-based drug use. My first argument is that it is indisputable 
that drug consumption rooms are an idea that has travelled from Europe to both Australia 
and Canada, as has been documented by McCann and Temenos (2015) and Dolan et al. 
(2000). For this thesis, the question then arises as to why there was such a significant lag time 
between the initial official sites in Sydney and Vancouver, and any subsequent adoption or 
replication of the policy, whether locally, regionally or nationally, particularly given the 
technical feasibility had been established by those pilots. By examining the question of the 
challenges or barriers to diffusion of the policy across sub-national jurisdictions, this study 
seeks to make a contribution to policy transfer literature, which has largely been concerned 
with the transfer of policy across rather than within national boundaries (Dolowitz and 
Marsh, 2012). 
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A second but related point is that the comparative nature of the study lends itself to a policy 
transfer framework. Each of the four case studies is concerned with the same policy initiative. 
Both Dolowitz and Marsh (2012) and McCann and Ward (2012) make the case for examining 
unsuccessful instances of policy transfer, so the literature in this field provides a relevant 
guide to interrogating the research question’s interest in replication and policy stall. A policy 
transfer framework should be sufficiently broad and multi-layered to interrogate a range of 
factors to see which are the most influential in each case and to analyse the findings for 
commonality and differences between the cases.  
There is a final aspect that makes the concept of policy transfer very relevant to the concern 
of this research, which relates to the question of ‘success’ or ‘failure’. It could be argued that 
earlier policy transfer studies were often concerned with technical aspects related to the 
process of policy transfer, in order to determine if the transfer had been fully achieved or 
partial or inappropriate (Dolowitz and Marsh, 2000). It is not the intention of this study to 
forensically examine the policy transfer process in order to make determinations about the 
process of transfer. As Marsh and McConnell (2010) argue, claims for the ‘success’ of a 
particular policy are commonplace but are rarely justified against systematic criteria. This 
prompted them to propose that policy success can be conceived in three dimensions: 
process, programmatic and political. This is a useful heuristic to apply to questions of policy 
transfer ‘success’ and seems highly relevant to the cases at hand, where, as will be discussed 
below, a wealth of ‘evidence’ points to programmatic success of the pilots yet subsequent 
policy development stalls. A policy transfer framework, focused on multiple sources of policy 
change, offers an opportunity to examine the conditions that impact on policy outcomes and 
replication. The concerns of this study therefore sit comfortably with two of Dolowitz and 
Marsh’s (2000) key questions, considered in the development of their policy transfer 
framework: what restricts or facilitates the policy transfer process? How is policy transfer 
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related to policy ‘success’ or policy ‘failure’? This final question leaves open the possibility 
for the study to conclude that policy transfer was not the primary driver in some or all cases. 
3.3 Theoretical framework 
3.3.1 A multi-level approach to policy transfer 
The research question is concerned with the policy process in each case study city site; 
however, the cases, which focus on the interface of public health and law enforcement 
policy, are not constrained by local governance boundaries but are enmeshed in regional, 
national and international contexts and settings. It is therefore necessary to apply a 
theoretical framework which incorporates a multi-level approach to analysis. The work of 
Evans and Davies (1999) and Evans (2004) provides such a focus. The following section 
outlines the key features of their policy transfer framework and explains how this framework 
will guide the analysis of the empirical findings of the four case studies. 
Evans and Davies (1999) approach to policy transfer analysis was developed out of a concern 
that political scientists from different subject areas were grappling with similar problems 
related to uncertainty and complexity, but were not benefiting from each other’s insights. 
Looking across the discipline, Evans and Davies sought to deliberately integrate five 
approaches that they felt could enlighten the study of policy transfer. Those approaches are 
“international structure and agency and the epistemic community approach, domestic 
structure and agency, policy network analysis and formal policy transfer analysis” (Evans and 
Davies, 1999 p.363). The result is a heuristic model of a multi-level approach to policy transfer 
based on three dimensions: global, transnational and international levels; the macro-state 
level; and the interorganisational level. The model is developed on a foundation of 
structuration theory that sees structure and agency in a dialectic relationship. At each level 
of analysis, the authors are concerned about the impact of structural processes on the 
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process of policy transfer, and also whether the actions of agents have had an impact on 
external structures. 
“We must assess whether structural processes external to the process of transfer we 
are looking at have an impact (directly or indirectly) upon the context, strategies, 
intentions and actions of the agents directly involved. Conversely we must also run the 
counterfactual and assess whether the strategies, intentions and actions of agents can 
constrain and/or enable structures.” (Evans and Davies, 1999 p.370) 
 
Table 3.1 Multi-level policy transfer analysis 
1 
Global, International and Transnational Structures 
Economic, technological, ideological and institutional structures constrain but 
do not determine the behaviour of state actors at levels 2 and 3 
2 
The State Project (e.g. the UK Competition State) 
The state has some autonomy from structural forces (economic, technological, 
ideological and institutional) at the level of strategic selectivity 
3 
Meso-Level: the Policy Transfer Network 
A network of indigenous and exogenous agents in resource-dependent 
relationships with some level of autonomy from structural forces at the level of 
options analysis and implementation in processes of policy transfer. Events at 
level 3 can often be explained by reference to the interactions of 1 & 2. 
(Source: Evans, 2004 p. 23.) 
Table 3.1 depicts the three levels of analysis based on Evans and Davies’ (1999) 
conceptualisation. At the macro level, analysis should focus on those structures identified at 
the global, international and transnational level that either enable or constrain action in 
relation to the attempted policy transfer. State-centred forces constitute a second macro-
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level of analysis. Evans describes state-centred explanations of policy change as “changes 
that emanate from systems change (electoral, institutional, ideological), historical legacies 
and the sharing of similar problems” (Evans, 2004 p.33). As Evans and Davies (1999) argue, 
for example, a policy idea that does not align with the strategic concerns of the state is 
unlikely to be adopted. At the meso-level of analysis, the focus is on policy transfer networks. 
Integrating ideas from policy networks and epistemic communities literature, Evans and 
Davies developed the concept of the policy transfer network, conceived as an ad hoc, action-
oriented policy making structure comprised of state and non-state actors. Their primary 
interest here was in developing a tool for analysing the acquisition and utilisation of 
knowledge by decision makers. Evans (2004) adds a fourth level of analysis, being the micro-
level processes of policy-oriented learning. He identifies four forms of policy-oriented 
learning: copying, emulation, hybridisation, and inspiration. Analysis at this level would seek 
to identify factors that constrain policy-oriented learning, which Evans groups into cognitive, 
environmental, and international and public opinion. 
3.3.2 Modifying and applying the framework 
I propose to use this framework (see Figure 3.1) to analyse sources of policy change or stall 
in order to better understand the issues affecting the replication of drug consumption rooms 
in the case study cities. The analysis will be based on the findings of the case studies (Chapters 
5 and 6) and the empirical findings from the thematic analysis of the qualitative interviews 
(Chapter 7). This analysis will be presented in the discussion section (Chapter 8). The use of 
this policy transfer framework will shed light on the policy process in each case study site 
while allowing for comparisons to be made across project sites. There will be an opportunity 
to test out the adequacy of the policy transfer framework to contribute to our understanding 
of drug policy development in these sites. Given the gap identified in the literature, this will 
serve as an important contribution to drug policy scholarship. In the process of mapping the 
findings to the framework, I will be attempting to identify factors that lie outside the 
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framework, which, if significant, may result in modifications being proposed and therefore a 
contribution also being made to the body of policy transfer literature. 
Figure 3.1 Sources of policy change and stall 
 
As a contested concept, policy transfer has been subject to debate and interpretation as 
discussed above. Dolowitz and Marsh (2000), in drawing together the various strands of 
scholarship, illustrate the breadth of concerns that are studied under the guise of being policy 
transfer problems. They also illustrate that these problems can be approached from a 
number of angles, depending upon whether the concern is embedded in process issues or a 
search for more explanatory factors that have influenced policy outcomes. In developing 
their initial framework, Evans and Davies (1999) purposively sought to integrate ideas that 
were circulating among political scientists, and argued that their approach to policy transfer 
was as a model of policy change. Their framework as it stands is an ideal analogical model to 
identify sources of policy change and stall that can help shed light on our understanding of 
the issues affecting the replication of drug consumption rooms.  
Global/international 
structures
Eg. Role of UN agencies and international drug 
treaties
State-centred forces
Eg. National/provincial/local levels of 
government and their interactions
Eg. Micro-level factors that constrain learning
Policy-oriented learning
Eg. Agents that facilitated policy transfer
Policy transfer networks
Sources of policy 
change/stall
(adapted from Evans, 
2004)
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3.4 Conclusions 
Drug policy scholarship has been increasingly engaging with literature from political science 
and policy studies in order to better understand the complexity of policy change in the 
contested area of illicit drug policy. There have been few attempts by drug policy scholars to 
engage with the concepts offered by policy transfer, despite a shared interest in the use of 
evidence and knowledge, policy learning and policy success and failure. As a comparative 
study seeking to understand barriers to policy replication and diffusion, the utilisation of a 
policy transfer lens offers an opportunity to analyse sources of policy change and stall at 
multiple levels while acknowledging the roles of both structure and agency in the process. 
The robustness of this framework will be considered through the analysis of the empirical 
findings from the four case studies and the thematic analysis of the study’s qualitative 
interviews and if necessary, modifications will be proposed in the discussion in Chapter 8. 
 
 
 
 
 
 
 
 
 
 
 
Chapter four      
Methodology 
• • • • 
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4.1 Introduction 
The previous chapter, in outlining the debate between scholars concerned with theorising 
policy movement and change, demonstrated the significance of the ontological and 
epistemological issues that underlie theory development. In large part, the differences 
between the schools of thought on policy transfer and policy mobility lie with a difference in 
worldview as to the nature of the reality being investigated and how we can gain knowledge 
of that reality. The purpose of this chapter is two-fold. First, to state the ontological position 
held by the researcher to justify and support the choice of theoretical approach. And second, 
to introduce the methodological approach best suited to explore and analyse the research 
question in light of that ontological position and the chosen policy transfer framework 
introduced in Chapter Three.  
The chapter is divided into six sections. The first, section 4.2, outlines the tenets of critical 
realism and examines the implications of critical realism for developing an understanding of 
the dialectic relationship between structure and agency, an issue problematised in the 
previous chapter. The role of the ideational is also explored, making the argument that ideas 
are critical due to their causal role which exists independently of material interests. That 
stance opens the way for critical realism to accept elements of interpretivism and sit within 
a spectrum of constructivism. Section 4.3 provides a bridge between the discussion on 
ontology and methodology by linking the ontological position with the theoretical approach 
and the broad research design. The chapter then addresses methodological issues in sections 
4.4 and 4.5, introducing the case study methodology, data sources and methods of collection. 
Section 4.6 discusses the methods of data analysis, including the construction of the case 
studies and the use of thematic analysis. Ethical issues are the focus of the final section (4.7). 
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4.2 A critical realist ontology 
Furlong and Marsh (2010) urge us to consider our ontological position as a ‘skin’ rather than 
a ‘sweater’, meaning it is something we always carry with us rather than something we ‘put 
on’ only when we address the philosophical issues underlying our research. This section will 
introduce the critical realist ontology that underpins this thesis and outline the links between 
this ontological position, its epistemological consequences and the theoretical stance 
introduced in the previous chapter.  
One of the fundamental tenets of realism is its assertion that the world exists independently 
of our knowledge of it (Furlong and Marsh, 2010). For realists, ‘events’ which are considered 
“observable and experienceable phenomena” are generated by underlying structures which 
are not directly observable (Willig, 1999). These structures include social structures, which 
through their ability to generate events are considered to have causal powers. As they are 
not directly observable, they must be ‘discovered’ by searching for their effects. This is not, 
however, a case of relying upon empirical evidence or what can be observed, for the 
structures can exist but produce no events, and events may occur whether observed or not 
(Marsden, 2005). As Furlong and Marsh argue, there are significant methodological 
implications of this: “It means that realists do not accept that what appears to be so, or, 
perhaps more significantly, what actors say is so, is necessarily so” (Furlong and Marsh, 2010 
p.204). The aim therefore of realist science is to explain observable phenomena by 
referencing the underlying structures and mechanisms (Blaike, 1993). The device through 
which this is done is theory (Hay, 2002).  
Modern critical realism, based on the work of Bhaskar (1975) and Archer (1998), maintains 
that there are three levels of reality, the domains of the ‘real’, the ‘actual’ and the ‘empirical’. 
The ‘real’ are generative mechanisms or structures or processes that generate events. The 
‘actual’ are the events, whether observed or not. The ‘empirical’ are the experiences of 
events. These levels of reality are, according to Marsden (2005), ‘interrelated, but distinct 
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and irreducible’. As stated above, structures are considered to have causal powers; however, 
for critical realists, causation “is an object’s capacity to act and is intrinsic to its internal 
structures and mechanisms” (Marsden, 2005 p.134). Empirical observation, therefore, does 
not provide an explanation for events. As Sayer explains: 
“What causes something to happen has nothing to do with the number of times we 
have observed it happening. Explanation depends instead on identifying causal 
mechanisms and how they work, and discovering if they have been activated and 
under what conditions” (Sayer, 2000 p.14).  
Importantly, this rejection of a positivist model of causation as successionist (from cause to 
effect), opens the possibility of viewing the social world as an ‘open system’ where the same 
causal power can produce different effects (Sayer, 2000). The acknowledgment that there 
are alternative possible futures (‘potentialities’) creates the opportunity to theorise about 
change and transformation (Willig, 1999).  
While arguments ensue as to whether structure and agency are considered ontologically 
separate under critical realism, it is agreed that there is interplay between the two, whether 
that is conceived as Archer’s ‘morphogenic’ approach or Jessop’s ‘strategic relational’ 
approach (Hay, 2002). I have adopted a dialectic interpretation of structure and agency that 
allows us to conceptualise structures as constraining, but also offering opportunity, and 
individuals as having the capacity to exercise agency in relation to these structures. As Archer 
articulates, “…there are properties and powers particular to people which include a 
reflexivity towards and creativity about any social context which they confront” (Archer, 1998 
p. 190). In this way, neither structure or agency is privileged. It is through an acceptance and 
examination of the interplay between the two that we might seek meaning.  
The acknowledgement of the role of structure sets critical realism apart from interpretivist 
or constructivist positions that reject the notion that the world exists independent of our 
knowledge of it. Rather, social constructivists conceive of the world as being purely 
discursively or socially constructed, where meaning does not exist independent of our 
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interpretation. These interpretations can only be understood through the discourses or 
traditions attached to the social phenomenon under investigation (Furlong and Marsh, 
2010). Whilst there is a fundamental difference in the ontological positions of critical realism 
and idealism, critical realism accommodates some of the tenets of interpretivism. Critical 
realists in their acceptance of an ‘unobservable’ reality, also accept there is a socially 
constructed element to that ‘reality’; agents act based on perception and a discursive 
construct. The implications of this are significant as agents’ actions, whether undertaken on 
the basis of reality or a perception of reality, have causal power. As Furlong and Marsh 
explain, “We need to identify and understand both the external ‘reality’ and the social 
construction of that ‘reality’ if we are to explain the relationship between social 
phenomenon” (Furlong and Marsh, 2010 p.205). 
Critical realism, therefore, accommodates the ideational, which is of fundamental 
importance to the theoretical underpinnings of this thesis. The critical realist position on the 
relationship between the ideational and the material, like that between structure and 
agency, is dialectical. Hay groups critical realists within a spectrum of constructivism, where 
ideas are attributed with an independent causal role that is not reducible to underlying 
material interests. His argument for this is that actors do not have perfect information with 
which they can negotiate the contexts (structures) in which they are required to operate; 
therefore, their interactions with that context must involve an element of interpretation. As 
he puts it, ‘Ideas provide the point of mediation between actors and their environment’ (Hay, 
2002 pp.209-210, italics in original). Elaborating on the dialectical nature of the relationship 
between agency and structure, Hay states: 
“Political outcomes are, in short, neither a simple reflection of actors’ intentions and 
understandings nor of the contexts which give rise to such intentions and 
understandings. Rather, they are a product of the impact of the strategies actors 
devise as a means to realise their intentions upon a context which favours certain 
strategies over others and does so irrespective of the intentions of the actors 
themselves.” (Hay, 2002 p. 208) 
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Within this spectrum of constructivism, Hay characterises the ‘thick’ constructivists as those 
who privilege the role of ideas but recognise material factors, whilst the ‘thin’ constructivists 
(including critical realists) emphasise the role of the material world in constraining discursive 
constructs.  
To summarise, the following points from the above discussion provide the basis on which we 
can devise an appropriate methodology to explore our concern with policy change in the 
context of the theoretical framework of policy transfer introduced in Chapter Three. 
1. Critical realism maintains there are three levels of reality: the ‘real’, the ‘actual’ and 
the empirical’. Explanation depends on identifying the underlying causal mechanism, 
not exclusively on empirical observation. 
2. Structure (context) and agency (conduct) are in a dialectic relationship, where 
structures can act as constraints, but individuals can exercise agency in relation to 
these structures. 
3. Critical realism accepts there is a socially constructed and interpreted element to 
‘reality’. We cannot observe the ‘real’; therefore, agents rely on interpretation of 
their contexts. Ideas therefore have an independent causal relationship which affect 
political outcomes. Both the material and the ideational matter and are in a 
dialectical relationship. Critical realism therefore accommodates a form of (thin) 
constructivism. 
4.3 Ontology, the theoretical framework and research design 
The critical realist ontology described above underpins this thesis’ exploration of policy 
change. Having established a position on what constitutes the nature of the reality being 
investigated, it is appropriate to introduce the proposed approach as to how we will gain 
knowledge of this reality and what research strategy will be employed. The purpose of this 
section is to provide a bridge between the discussion of ontology and the methodology of 
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the thesis by addressing the compatibility of the critical realist approach and the chosen 
theoretical approach of policy transfer, followed by a broad outline of the research design. 
4.3.1 Critical realism and the policy transfer framework 
Having established an ontological position, an epistemological question arises. How can 
knowledge of this reality be acquired? The assertion of critical realism – that reality exists at 
three levels (the real, the actual, the empirical) – creates a dilemma, as it rejects empiricism 
on the grounds that the ‘real’ consists of unobservable underlying structures and the events 
of the ‘actual’ may or may not be observed. It therefore falls to theory to map these real 
relationships (Marsden, 2005). In Hay’s words, theory is deployed “as a sensitising device to 
reveal structured reality beneath the surface” (Hay, 2002 p. 122). 
As described in Chapter Three, the policy transfer framework developed by Evans and Davies 
(1999) and Evans (2004) is based on multi-level policy analysis. In seeking to identify sources 
of policy change the framework’s authors have devised a model that is consistent with a 
critical realist ontology, acknowledging the roles of both structure and agency and attributing 
causal power to both. It is a dialectic model that sees elements of structure and agency 
working to enable or constrain attempts at policy transfer. Operating on multiple levels, the 
framework encourages the identification of sources of policy change from both international 
and state-centred structures. Further, the framework incorporates a concern with agency 
through its focus on the role of agents in Evans and Davies’ (1999) conception of ‘policy 
transfer networks’. The agents in these networks are understood to have causal power and 
operate with some level of autonomy from the structures with which they interact. A concern 
with ideas and the transfer and passage of knowledge sit at the heart of policy transfer. Here, 
the ideational can be expressed both through embodiment in structure, where ideas are 
embedded in institution structures (Béland and Cox, 1999), and through the impact of ideas 
on agents. The latter is captured through the concept of a policy transfer network where the 
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focus is on the passage of ideas and the acquisition and sharing of knowledge (Evans and 
Davies, 1999). 
4.3.2 Research design 
The ontology of critical realism does not provide a prescribed approach or research method 
(Marsden, 2005). The discussion above describes the compatibility of critical realism with a 
‘thin’ constructivist approach that espouses the co-existence of both structural forces and 
social constructions. In order to identify both structures and constructions that may act as 
enablers or constraints in relation to the research questions under investigation, it is 
proposed to combine a case study methodology largely based on documentary analysis and 
thematic analysis of interview data. The relationship between these elements is captured in 
Figure 4.1 below. 
Figure 4.1 Relationship between ontology, epistemology and research strategy 
 
 
Research strategy
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4.4 Case study methodology: selection and analysis 
A multiple case study methodology (Yin, 2014) has been chosen as the appropriate method 
to capture the specific cases of the drug consumption room policy development in two 
chosen countries, Australia and Canada. In both countries, there have been both successful 
and failed attempts to change drug policy to allow for the establishment of DCRs. Four cities 
have been selected as cases to explore in depth these attempts at policy change. The choice 
of cases is consistent with a theoretical sampling approach, where these cases have been 
selected on the basis of their relevance to my research questions and my theoretical position. 
As Mason explains: 
“Theoretical sampling is concerned with constructing a sample…which is meaningful 
theoretically, because it builds in certain characteristics or criteria which help to 
develop and test your theory or explanation.” (Mason, 1996 pp. 93-94)  
Case studies are well suited to qualitative research in the social sciences, where the purpose 
of theory is not to be predictive. Flyvbjerg, elaborating on this point, argues that what the 
social sciences can offer is “concrete, context dependent knowledge”, for which the case 
study is particularly suited (Flyvbjerg, 2006 p. 223). The generalisability of cases follows a 
theoretical logic, rather than generalisability to populations (Bryman, 1988 cited in 
Silverman, 2014). An equally important part of the multiple case study methodology is the 
use of comparison, as it allows for both in-case and cross-case analysis. By choosing two case 
study sites in each of the two countries, there is also opportunity to consider (consistent with 
the multi-levelled theoretical approach) the impact of national factors as well as those at the 
local level. 
Australia and Canada have been chosen for the study as, at present, they have the only 
official drug consumption rooms in the English-speaking world, as detailed in Chapter One. 
The remaining 90 drug consumption rooms worldwide are on the European mainland, spread 
across eight countries as detailed in Chapter One (see Table 1.2). Both the initial Australian 
facility (MSIC, established in 2001) and the Canadian facility (Insite, established in 2003) were 
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set up under legislation and run on a trial basis. In both of these cases, the evaluations of the 
pilot projects generated credible evidence that established the effectiveness of the centres 
against their objectives (KPMG, 2010; Wood et al., 2006). This thesis’ research question is 
concerned with the challenges of replicating these successful services, with a focus on the 
policy process. Four cities, two in each country, have been chosen as case study sites: Sydney, 
Melbourne, Vancouver and Toronto. The period of the study is approximately 20 years, from 
the late 1990s to the present day. The rational for this period is that it covers the time from 
when DCRs were first considered as a policy option, to recent, significant events in this policy 
domain. As the case studies will demonstrate, by considering the issue in each site over a 
two-decade period it is possible to analyse the process of policy development in depth 
without the potential risk of drawing conclusions from isolated events were the timeframe 
shorter. 
At the commencement of the research project in 2015, there were only the aforementioned 
two sanctioned centres in Sydney and Vancouver. As the case studies in Chapters Five and 
Six will demonstrate, this situation changed during the course of the research: new centres 
were opened across Canada (including in the selected case study cities) and a medically 
supervised injecting room was opened in Melbourne, Australia. These developments 
necessitated some flexibility as to the methodology of the thesis, as the initial premise of the 
selection of the cases was consistent with a replication logic based on a ‘change/no change’ 
criterion (Yin, 2014). Fortunately, the unanticipated developments did not invalidate the case 
selection but served to enhance the study by adding a richness to the processes being 
explored. 
As part of the research design process, consideration was given to including a country from 
Europe, where drug consumption rooms have been more prolific. This would have opened 
up interesting research questions with regards to policy transfer and replication. Given the 
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diversity of countries in Europe, the inclusion of a case study from that region would not have 
been grounds for generalising about a ‘European’ approach to drug policy. However, 
exploring the challenges to policy change under different political configurations and regimes 
would be a fruitful branch of future comparative research. The final choice to use case studies 
from Australia and Canada was made on three grounds. First, the shared political 
characteristics of Australia and Canada in terms of their federalism and Westminster-style 
parliamentary systems allows for cross-case analysis based on some similarities, 
strengthening the replication logic noted above (Yin, 2014). Secondly, despite a noted 
divergence in policy development paths during the course of the study from 2016 onwards, 
for much of the twenty-year period under examination, both countries followed a 
remarkably similar path in regard to non-replication of DCRs. Finally, on a practical level, 
given the importance of documentary analysis to the methodology of the project, working 
with material that was in a common language was deemed to more likely produce rigorous 
and comparable analysis. The same issue was also pertinent to the choice to conduct 
interviews only in English, without the aid of translators. Ultimately, given the resource 
constraints and the nature of collecting data as a single researcher and not as part of a multi-
researcher team, it made sense not to attempt to incorporate foreign language material. 
The multiple case study methodology encompasses both in-case and cross-case analysis. The 
in-case analysis allows for consideration of the factors specific to each site, including, but not 
limited to, patterns of drug use and their public health implications; the local drug policy 
context; local political considerations; the level of active campaigning; and funding issues. 
The second stage of analysis, cross-case analysis, considers those factors that the sites have 
in common and those factors that are specific to the local context. See Table 4.1 below for 
an illustration of the different levels of analysis.  
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Table 4.1 Multiple case study methodology analysis 
In-case analysis Cross-case analysis 
 
 
Australia 
C1  
Sydney 
 
 
National 
comparison 
 
 
 
Australia 
(C1 & C2) 
 
 
 
International 
comparison 
 
 
Australia  
and  
Canada 
C2 
Melbourne 
 
 
Canada 
C3 
Vancouver 
 
Canada 
(C3 & C4) 
C4  
Toronto 
4.5 Data sources and methods of collection 
The case study methodology was supported by the collection of qualitative data from 
documentary sources and semi-structured in-depth interviews. 
4.5.1 Documentary sources 
A systematic approach was taken to the collection of both primary and secondary 
documentary material. The process of collecting material was documented through research 
memos to ensure an audit trail was maintained. The initial search began with secondary 
material in the academic literature. Earlier background and literature review searches were 
augmented with keyword searches of relevant journals, such as the International Journal of 
Drug Policy and Drugs: Education, Prevention and Policy. References from journal articles 
were followed up, including the material contained in the systematic reviews of drug 
consumption rooms. A review was then conducted to source primary material for each case 
study site, including reports, policies, transcripts of parliamentary debates, legislation, court 
findings and evaluations (see Table 4.2 below). These documentary materials provided 
insight not only into processes, but also the nature of the debate and framing of the issues, 
capturing the complexity and contested nature of the subject. The documentary materials 
were a resource for identifying potential interview participants, but also provided reference 
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points for the interviews. Participants provided valuable insights from ‘behind the scenes’ 
into documentary materials; for example, through reflections on the presentation of issues 
or events in the media, and how and why official reports had portrayed issues or outcomes. 
Media materials were also an important data source for the case studies. The database Nexis 
was used to search for and access media reports from Australia and Canada using keyword 
searches. The data collection process was iterative, enabling the ongoing collection of 
material as it came to light through further reading and the interview process. A network of 
relevant contributors to debate and discussion on drug policy was established through 
Twitter, which was monitored regularly as a means of staying abreast of any new articles, 
events or developments that would have bearing on this thesis.  
Table 4.2 Key documentary source categories 
Key documentary source Examples 
Parliamentary reports Parliamentary Committee Reports and 
background research reports 
Parliamentary transcripts (Hansard) Debates to introduce legislation to allow for 
provision of drug consumption rooms 
Legislation Acts pertaining to supervised injecting 
Government reports Statutory review reports required under 
legislation 
Government policy papers Official drug strategy documents 
Public health documents Drug surveillance bulletins issued by Public Health 
departments 
Committee/Council Minutes Board of Health meeting minutes 
Submissions to Committees Responses to calls for submissions to public 
inquiries from organisations and individuals 
Evaluation documents Independent evaluations conducted on services 
Research documents Journal articles, academic literature 
Coroners’ reports Reports addressing overdose risk and supervised 
injecting 
Media Reporting on overdose, drug use and supervised 
injecting, including current and archived material 
Press releases Statements outlining positions of organisations or 
individuals in relation to supervised injecting 
Project proposals Feasibility studies for drug consumption rooms 
Websites Government and non-government agencies’ 
websites 
Social media sources Twitter feed 
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4.5.2 Interviews 
Interviews are considered one of the most important sources of evidence for case studies 
(Yin, 2014) and they were an integral part of the research design. Combined with 
documentary analysis, interview material can be used for methodological triangulation 
(Duke, 2002). Extensive preliminary background analysis was undertaken prior to entering 
the field, allowing for the focused selection of participants in order to use the interviews to 
corroborate key aspects of the case studies (Yin, 2014). In addition, the interviews were an 
opportunity to gather views and perceptions of participants, and to that end the selection of 
interviewees was purposely undertaken to achieve a broad representation of roles and 
occupation in relation to the policy process. 
Following the granting of ethical approval from Ulster University, a semi-structured interview 
guide was developed for each case study site, consisting of 14 questions (see Appendix 2). 
The four guides followed the same logical ordering but were tailored to reflect the 
circumstances of each site. The intention was to conduct a ‘topical’ interview, where my role 
was to guide participants in a focused way through areas of concern, rather than allowing for 
free-ranging discussion (Arthur and Nazroo, 2003). However, flexibility was employed in 
order to accommodate the different perspectives and roles played by participants, as well as 
to allow their specific concerns and areas of focus to be captured. In this sense, the interviews 
were undertaken in quite a conversational way, rather than rigidly following the guide. 
Sampling and recruitment 
Participants for the study were recruited based on their involvement and experience with 
the policy making process specifically in relation to drug consumption rooms and drug policy 
more broadly. The range of roles undertaken by participants included policy makers, 
politicians, researchers and academics, public health practitioners, law enforcement officers, 
lawyers, advocates and non-government organisation representatives. These categories are 
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condensed to four major roles: Policy Maker, Practitioner, Researcher and Advocate. 
Potential interviewees were identified through the initial documentary analysis, including 
through media reports in which they may have featured or been quoted. Report authors, 
members of committee and spokespeople for organisations were also approached. In 
addition, some suggestions were made to me through informal discussions with former 
colleagues. In all, 48 requests for interview were made by email: 32 of these were accepted. 
Two individuals indicated they were not available during the dates of my field visits and 14 
individuals did not respond to the initial email or a follow-up request for them to consider 
the invitation. 31 interviews were conducted in total; one potential participant was not 
interviewed due to her unavailability in the interview window (see Table 4.3). Table 4.4 
provides a breakdown of the participants by role. Further reflections on the response rate 
are discussed at the end of this section. 
Table 4.3 Recruitment of interview participants 
Site Requests Acceptance Unavailable No 
response 
Total 
interviews 
completed 
Sydney (C1) 
 
11 8 0 3 8 
Melbourne 
(C2) 
 
12 8 2 2 8 
Vancouver 
(C3) 
 
13 7 0 6 7 
Toronto (C4) 
 
12 9 0 3 8 
Total 
 
48 32 2 14 31 
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Table 4.4 Interview participants by category (role) and site 
Site Policy 
Maker 
Practitioner Advocate Researcher Total 
Sydney (C1) 
 
2 4 1 1 8 
Melbourne (C2) 
 
2 1 2 3 8 
Vancouver (C3) 
 
0 2 2 3 7 
Toronto (C4) 
 
3 1 2 2 8 
Total 
 
7 8 7 9 31 
 
Interviews were undertaken at the case study sites during two two-week field visits to 
Canada and Australia undertaken between April and June 2017, with the exception of one 
interview which was conducted by Skype. Participants were provided with an information 
sheet and all signed consent forms which acknowledged that their participation was 
voluntary and that they had the right to withdraw from the study at any time. Interviews took 
approximately one hour; with the permission of participants, all were recorded and then 
transcribed using an online software called Trint. Participants were asked if they would like 
to receive a copy of their transcript. Only two participants requested to see their transcript 
and one submitted changes to the information recorded, including the deletion of 
statements she had made. No names were recorded on the transcripts in the interests of 
maintaining the anonymity of the participants; codes were instead ascribed to the data. 
The response to the requests for interview was very positive, particularly given the logistics 
of conducting fieldwork in four locations in two countries in a tight timeframe with a limited 
budget. Two issues regarding recruitment should be noted. First, no policy makers were 
interviewed in Vancouver despite attempts to recruit there. I attribute this in part to the 
public health crisis that was underway in the city but also to a sense of fatigue. Vancouver 
has been heavily researched and responses to requests to participate in this research 
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reflected that. To counteract this potential gap, attention was paid to the policy making 
process through the use of primary documentation, such as committee meeting minutes and 
policy documents. While it would have been ideal to interview some policy makers, I do not 
believe it has compromised the outcomes of the research and the interviews that were 
undertaken reflected a strong knowledge of the policy making process, even if the 
participant’s primary designation was not ‘policy maker’. 
In addition, there was an issue with recruiting participants who had voiced strong opposition 
to drug consumption rooms. I approached four people who were on the public record 
opposing drug consumption rooms but did not receive any response to the original requests 
for interview, using the standard interview request email, or to a follow up email. While the 
sample I was able to recruit expressed a plurality of views, it was disappointing that I could 
not explore in more depth the strong opposition arguments that were uncovered in the 
documentary review process. For future research, more time would need to be spent 
developing a network that could assist in gaining access to ‘opponents’. In this instance, the 
task was made more difficult by undertaking the study at a distance from both project 
locations, minimising opportunities to probe and develop appropriate connections. This issue 
is discussed further under ‘Limitations’ in the concluding chapter of the thesis. 
A brief reflexive account of the interview process 
Conducting interviews in a contested policy domain can be fraught with challenges, including 
the negotiation of the relationship between the interviewer and the interviewee (Lancaster, 
2017).  The process of undertaking interviews for this research proved a rich experience 
which was made all the more interesting by the continuous development of events during 
the research period.  The following provides some brief reflections on my position as a 
researcher and the impact of real time policy developments. 
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I came to this research with familiarity of the fields of drug policy and harm reduction through 
my professional background in public health, and overseas aid and development.  While this 
gave me insights into the area and access to networks, I needed to exercise caution regarding 
any preconceptions that I may have.  My professional involvement also went back a period 
of time and I was conscious that I was not a current ‘expert’; a fact that perhaps allowed me 
to engage more openly and with curiosity with interviewees.  Having a background in the 
area did, however, allow me to gain trust of many of the participants, leading to rich 
interviews.  I was known to a number of participants by virtue of my previous roles.  Through 
the interview guide I was able to cover a broad range of areas and keep questions open.  
Where I felt in the interviews that presumptions were being made about my own knowledge 
in the area I would attempt to prompt people for their own critical perspectives and 
reflections on the topic under discussion.  I found that participants were largely very 
confident regarding their knowledge and keen to discuss their perspectives.  I encountered 
very little reticence from participants, with the only observation that those who held 
bureaucratic positions were the most likely to exercise caution as to their responses.  
Having lived and worked in Australia I was more familiar with the networks, context and 
politics.  However, there is richer literature on the experience of drug consumption rooms in 
Canada, so I entered the field having read extensively from both primary and secondary 
sources.  I conducted the Canadian interviews first and my time in the field coincided with 
the unfolding public health emergency presented by the opioid overdose epidemic.  The crisis 
was very tangible, from the presence in the streets of emergency services, notices on health 
clinics cautioning about dangerous batches of drugs and very regular local media reporting.  
Some participants became quite emotional during the interviews as a result of the impact of 
the crisis.  For example, a number of participants made a reference to the shock caused in 
policy circles by the death of a prominent activist on the eve of a national gathering to discuss 
responses to the epidemic.  It was important to give participants an opportunity to reflect on 
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current events and their impact, but I also endeavoured to probe events in the past to reflect 
my interest in the passage of this policy issue over a number of decades. 
While there was not a comparable sense of crisis in Australia, participants were still highly 
engaged in the interviews and passionate about the issues.  They often spoke of the 
circumstances in Australia in comparison to Canada and displayed a high level of knowledge 
and interest in developments in Canada.  These insights were particularly interesting from a 
policy transfer perspective, demonstrating the impact of the flow of information and 
knowledge across national boundaries and a keenness to reflect upon and learn from the 
experiences of others.  The prominent case of the epidemic in Canada also gave participants 
(mostly unprompted) a chance to place the experiences of Australia in an international 
perspective which was most interesting. 
4.6 Methods of data analysis 
This section outlines the analytical strategies used to develop the case studies and to 
undertake thematic analysis of the interview data. The results of the analysis are presented 
in Chapters Five to Seven. 
4.6.1 Construction of the case studies 
The development of the four case studies, presented in the following chapters, concentrated 
on providing the rich contextual information that would allow for meaningful analysis of the 
interview material, presented in Chapter Seven, and the subsequent discussion and 
theoretical reflection in Chapter Eight. The starting point for the construction of the cases 
was the development of a timeline which highlighted events and milestones in the policy 
development process. The decision on what constituted pertinent events was made on the 
basis of their relevance to the research question. The cases were then constructed in more 
detail, relying on both the documentary sources and information provided by interviewees. 
By utilising both documentary sources and interview data in a combined fashion, information 
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and ideas could be pursued and probed in depth, rather than relying on only one account or 
version of events. This was particularly useful as events that proved critical to the study were 
unfolding while the research was being conducted. 
The cases are presented as narratives, based on a common structure that reflected the key 
issues that were relevant to developing policy in this area. It is important to note that these 
narratives do not claim to be complete historical reconstructions or comprehensively detail 
all factors that might be critical to the policy making process. Rather, they are structured to 
best reflect the concerns of the specific research question. For example, a different framing 
of the research question may have required extensive presentation and analysis of 
epidemiological data. While public health concerns are obviously critical to the policy 
process, the purpose of the research is not to make a judgement of the ‘need’ from a public 
health perspective, but rather to identify issues that appeared to have influenced outcomes 
regardless of their scientific validity. The ‘descriptive-analytical’ approach adopted allows for 
similarities and differences between the cases to be identified, supporting comparative 
analysis (Hughes, 2006). This facilitates analysis at the national level, which is important to 
the chosen theoretical framework of policy transfer with its focus on multi-level analysis. 
4.6.2 Thematic analysis 
The method chosen to guide the analysis of the interviews is thematic analysis. It provides a 
means for “identifying, analysing, and interpreting patterns of meaning (‘themes’) within 
qualitative data…” with the aim being to “…identify, and interpret, key, but not necessarily 
all, features of the data, guided by the research question” (Braun and Clarke, 2016 p.1). The 
steps in the analytical strategy are captured in Table 4.5 below. NVivo 11 qualitative data 
analysis software was used to undertake coding and aid the analysis. Thematic mapping was 
undertaken in Excel. 
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Table 4.5 Phases and processes of thematic analysis 
Phases Process Purpose 
1. Familiarisation with the 
data 
 
Transcribing data; reading and 
re-reading data; importing 
data into NVivo. Noting initial 
ideas. 
Data management 
2. Generating initial codes 
 
Coding interesting features of 
the data systematically across 
the entire data set; collating 
data relevant to each code 
3. Searching for themes 
 
Collating codes into potential 
themes; collating all data 
relevant to each potential 
theme. 
Identifying emerging themes 
4. Reviewing themes Checking if the themes work in 
relation to the coded extracts 
(level 1) and the entire data 
set (level 2); generating a 
thematic map 
Refining, mapping and naming 
themes 
5. Defining and naming 
themes 
Ongoing analysis to refine the 
specifics of each theme and 
the overall story the analysis 
tells, generating clear 
definitions and names for each 
theme 
6. Producing the report The final opportunity for 
analysis. Selection of extracts; 
final analysis of extracts; link 
to analysis of research 
questions and literature. 
Write up. 
Explanatory account 
Source: Adapted from Braun and Clarke, 2006 p. 87 
Working case by case, an initial open round of coding was undertaken with 30 of the 
interviews. (One of the interviews was found to contain inconsistencies in the information 
provided and was therefore excluded in its entirety from the coding process on the grounds 
of its potential unreliability. The interviewee claimed credit for published work that when 
later checked was attributable to someone else.) The initial round of coding produced 67 
codes, which ranged in frequency from 94 references to ‘evidence and evidence-based 
policy’ to single references for ‘demonisation of drugs’, ‘personal or family experience of 
drugs’ and ‘gender’. These 67 codes and their references were then reviewed in order to be 
collated into themes. The initial themes were then reviewed, resulting in eight dominant 
99 
 
 
themes which are captured below in Table 4.6. The empirical findings presented in Chapter 
Seven do not mirror these themes exactly but are based on a further process of review and 
analysis to extract the themes which offered the best insights into the challenges facing the 
replication of drug consumption rooms. This is consistent with the key research concern of 
the thesis: to explore the issue of replication and policy change in the context of pursing a 
theoretically-driven explanation. 
Table 4.6 Final themes from thematic analysis 
Theme Sample codes contained within theme 
The ‘problem’ Amenity 
Visibility 
Need 
Crisis 
Proximity 
Controversy 
Drug markets and drug scenes 
Discourse and narrative Arguments in support 
Arguments in opposition 
Moral arguments 
Stigma and discrimination 
Effects of media 
Evidence Evidence-based policy 
Effectiveness 
Transferability 
Persuasiveness 
Problematic use of evidence 
Legality and law making Legal arguments 
Legislation 
Parliamentary processes 
Prohibition 
Crime and criminality 
Law enforcement Police as stakeholders 
Policy Making Policy making 
Policy change 
Policy transfer, mobility and learning 
Policy conflict (public health versus law enforcement) 
Activism and civil disobedience 
Advocacy and campaigning 
Community consultation and participation 
Politics Political leadership 
Electoral politics 
Interactions of different levels of government 
Models of DCRs Alternative models (linked to meeting need) 
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4.7 Ethical issues 
Ethical approval was granted by Ulster University to undertake this research prior to the 
commencement of the fieldwork. The project conformed to the University’s research 
governance standards for research on human subjects. Steps were undertaken to ensure all 
participants consented to their involvement, were fully informed as to the aims of the 
research and apprised of the processes for securing and maintaining the confidentiality of 
the data. Participants’ names were delinked from their interview transcripts and replaced by 
codes. They were not identified in the presentation of the findings, other than by their code 
and occupational group, maintaining their anonymity. Great care was taken throughout the 
transcribing process to ensure that interviews were accurately captured. 
The criterion for inclusion as a participant in the project was having played a role in some 
capacity in relation to policy development regarding drug consumption rooms. These roles 
included but were not limited to policy development, advocacy, practitioner or research, and 
could relate to attempts to establish drug consumption rooms or change policy, regardless 
of whether the outcome was successful or not. The purpose of the research was not to 
establish the acceptability or efficacy of services for potential or existing clients; therefore, 
no specific consideration was required with regards to the potential vulnerability of study 
participants. All potential participants who were identified were considered to have acted in 
a professional or occupational capacity, with most appearing at some point on the public 
record in relation to their views or actions. Interviews were however conducted with due 
regard to potential sensitivities given the range of views that drug use elicits across society. 
4.8 Conclusion 
Working to address the ontological issues posed by the chosen theoretical framework of 
policy transfer introduced in Chapter Three, this chapter provides a detailed explanation for 
the adoption of a critical realism. The discussion demonstrates how critical realism 
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accommodates a dialectical understanding of structure and agency which is key to exploring 
the multi-level analysis required for the policy transfer framework. Similarly, critical realism 
was shown to encompass both material and ideational structures in a dialectic relationship. 
Ideas are accepted as having independent causal power, which is a critical issue for exploring 
policy transfer, with its focus on the movement and sharing of ideas and knowledge in the 
policy sphere. 
Having established the compatibility between the critical realist approach and the theoretical 
stance of the thesis, the chapter then introduces the methodology and methods of the 
research. The multiple case study methodology and its ‘descriptive-analytical’ approach is 
demonstrated to provide the rich contextual information required to support comparative 
analysis both between cases and at the national and international level. In addition, the case 
studies provide critical insights into the nature of the debates and discourse concerning this 
contested policy area. An argument is then made for the use of thematic analysis to seek 
patterns of meaning in the interviews. The findings of the case studies are presented in 
Chapters Five (Australia) and Six (Canada) before the empirical findings from the thematic 
analysis are presented in Chapter Seven.  
 
 
 
 
 
 
 
 
 
 
 
Chapter five      
Australian case studies:  
Sydney and Melbourne 
• • • • • 
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5.1 Introduction 
The following two chapters present the four case studies that provide the “concrete, context 
dependent knowledge” (Flyvbjerg, 2006 p.223) upon which the policy transfer framework 
can be tested, in order to interrogate the question of what constrains and facilitates the 
replication of policy in the case of drug consumption rooms. As described in the previous 
chapter, this thesis’ research strategy combines both case studies and thematic analysis. The 
case studies presented here have been constructed using both primary and secondary 
documentary sources (see Table 4.2) and evidence collected through the interviews 
undertaken at the field sites. They are designed to provide an account of why and how drug 
consumption rooms came to be considered as a possible public health intervention in the 
case study sites and to probe pertinent questions in relation to opportunities for, or 
constraints on, the scaling up and transfer of policy. Comparative analysis is applied between 
the cases, facilitating the multiple levels of analysis – local, regional, national and 
international – that are relevant to the thesis’ concern with policy transfer. 
This chapter is focused on Australia and is divided into four main sections. Section 5.2 
introduces the case study of Sydney in the state of New South Wales. It traces the origins of 
supervised injecting from a Royal Commission into police corruption and an unprecedented 
five-day high-profile Drug Summit, to the establishment of the South Hemisphere’s first 
medically supervised injecting centre in 2001. Consideration is given to potential 
opportunities for the expansion of services beyond the original site. Section 5.3 focuses on 
events in Melbourne, Victoria. Although the state of Victoria appeared to be on track to 
approve five supervised injecting facilities in the late 1990s (responding to its multiple open 
street-based drug markets), its first and only centre did not open its doors until 2018. This 
section is concerned with the ebbs and flows of political and community debate and the 
impact of the changing landscape of Melbourne’s drug markets in that period. Section 5.4 
seeks to contextualise the Australian case studies by considering the political and policy 
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settings in which these events occurred. It focuses particularly on the different levels of 
government engaged in policy debate and the role of state level party and parliamentary 
politics. The impact of civil disobedience as a disruptive force on the more formal policy 
process is then considered. Finally, Section 5.5 draws together findings from the two case 
studies, noting the many similarities between the two sites in relation to issues that affect 
replication of the policy. 
5.2 Case study 1: Sydney, Australia 
In May 2018, in the course of a coronial inquest into the deaths of six opiate users in New 
South Wales, Deputy State Coroner Harriet Grahame stated: “We have one medically 
supervised injecting centre in the whole of NSW…by now I would’ve thought we would have 
more” (Thompson, 2018). Sydney’s Medically Supervised Injecting Centre (MSIC) opened in 
the inner-city area of Kings Cross in 2001. It was the first facility of its kind to be established 
outside of Europe and, until July 2018, it remained the only facility to offer medically 
supervised drug consumption in Australia. This case study examines the establishment of 
MSIC, tracing the key events and actions that brought the idea of supervised injecting into 
the public domain and political debate. Through the use of documentary evidence and the 
contributions of study interviewees, the opportunities for, and constraints on, the expansion 
of services in Sydney are also explored. 
5.2.1 The emerging issues 
By the late 1990s, both drug use and drug overdose deaths were high on the public agenda 
in Australia. The number of heroin-related overdose deaths had increased three-fold, up 
from 302 in 1989 for the 15-44 year age group, to 960 in 1999 (Warner-Smith et al., 2001a 
p.1113). Fifty per cent of those deaths occurred in NSW, host to two prominent street-based 
drug markets: Kings Cross, a renowned inner-city red light district, and suburban Cabramatta, 
in south-western Sydney. Twenty per cent of heroin-related overdose deaths occurred within 
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two kilometres of Kings Cross, while Cabramatta recorded 15 per cent of the cases (Warner-
Smith et al., 2011b viii, p.19; Parliament of NSW, 1998).  
The idea of supervised injecting sites as a response to issues associated with overdose and 
injecting in public began circulating in the early 1990s. During this time, illegal ‘shooting 
galleries’, linked to the sex industry, had begun operating in Kings Cross. Hotels offered 
rooms for a short period of time, specifically to inject drugs, and also sold injecting 
equipment. Ingrid van Beek, MSIC’s first Medical Director, recalls discussions as early as 1990 
with the local police commander about legal supervised injecting as a response to managing 
the multiple risks posed by shooting galleries (van Beek, 2004). Between 1995 and 1997, 
Justice Wood presided over a Royal Commission into the New South Wales Police Service, 
called to address concerns about systematic and entrenched corruption in the force. The 
Commission found that some of the shooting galleries were tolerated by the Kings Cross 
Police, and corrupt payments had been received from the proprietors (Wood, 1997 p.98). In 
his Final Report, Commissioner Justice Wood recommended that the NSW Government trial 
supervised injecting rooms, arguing: 
“At present, publicly funded programs operate to provide syringes and needles to 
injecting drug users with the clear understanding they will be used to administer 
prohibited drugs. In these circumstances, to shrink from the provision of safe, sanitary 
premises where users can safely inject is somewhat short-sighted. The health and 
public safety benefits outweigh the policy considerations against condoning otherwise 
unlawful behaviour.” (Wood, 1997 p.222) 
 
The Commission then recommended: 
“Consideration be given to the establishment of safe, sanitary injecting rooms under 
the licence or supervision of the Department of Health, and to amendment of the Drug 
Misuse and Trafficking Act 1985 accordingly.” (Wood, 1997 p.229) 
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5.2.2 Phases of the response  
Policy debate and legislative development (1997-1999) 
The Royal Commission’s findings led to a new phase of activity in the consideration of 
supervised injecting facilities. The NSW State Government, led by Australian Labor Party 
(ALP) Premier Bob Carr, referred the recommendation to a Joint Select Committee of 
Parliament which reported in early 1998. The Committee’s report ran for over 300 pages and 
extensively detailed arguments both for and against supervised injecting facilities, 
considering health, social, legal and economic perspectives. Substantial public interest was 
shown in the inquiry; the Committee took evidence from 89 witnesses and received 103 
submissions. Contributions came from individuals, residents’ groups, interest groups, 
religious organisations, user groups, and non-government organisations. In addition, many 
professionals engaged in the process, including from the Ambulance Service, prisons, the 
police force, and public health and medical research bodies. Members of the Committee 
toured DCRs in the Netherlands, Switzerland and Germany, and met key stakeholders 
including politicians, bureaucrats and non-government and church-based service providers. 
The report reflected this concern with overseas experience by documenting what had been 
learned. In addition, visits were conducted of potential local sites, including Kings Cross and 
Cabramatta. The Chair of the Committee provided a dissenting report but a majority of the 
Committee recommended against proceeding with a trial of supervised injecting rooms. They 
cited safety concerns, the impact on the local community, the potential for an increase in 
crime, that it sent the ‘wrong message’ about drug use and that resources could be better 
deployed to treatment (Parliament of New South Wales, 1998). As a result, no legislation was 
brought to the House at that time.  
In 1999, supervised injecting returned to the political agenda. In January, the Sun Herald 
newspaper published a photograph on its front page, purportedly of a teenage boy injecting 
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heroin, prompting Premier Carr to promise to hold a summit on drugs should he be re-elected 
(Fitzgerald, 2013). The following month, a welfare agency, Open Family, announced plans to 
establish supervised injecting rooms in the suburbs of Cabramatta in Sydney and Footscray 
in Melbourne (AAP Newsfeed, 1999). The Premier responded to the national press coverage 
by labelling the proposal “irresponsible, dangerous and illegal” (Swain, 1999 p.3). Carr was 
returned to government the next month and the Drug Summit was announced for May 1999. 
Fearful that supervised injecting was to be excluded from the Summit agenda, a group of 
‘concerned citizens’ opened an unsanctioned injecting room at the Wayside Chapel in Kings 
Cross in May 1999. The service opened on five occasions before closing after a clergyman 
and three clients of the service were arrested following police raids. The charges were later 
dropped (Wodak et al., 2003). See Section 5.4.2 below for further discussion of these actions. 
The Drug Summit was held over five days and participants included 135 NSW 
Parliamentarians, two Federal Members of Parliament, 80 invited delegates and 45 associate 
delegates (Swain, 1999). Non-parliamentary delegates represented a cross-section of 
interest groups, government departments, non-government organisations, local government 
representatives and academics. There was considerable debate over a proposal to trial 
injecting rooms, but a recommendation was passed with a very clear majority of support. 
Resolution 3.15 of the 172 Summit resolutions read: 
“The Government should not veto proposals from non-government organisations for 
a tightly controlled trial of medically supervised injecting rooms in defined areas where 
there is a high prevalence of street dealing in illicit drugs, where those proposals 
incorporate options for primary health care, counselling and referral for treatment, 
providing there is support for this at the community and local government level. Any 
such proposal should be contained in a local Community Drug Action Plan developed 
by local agencies, non-government organisations, volunteers and community 
organisations. These should be submitted to full public and community consultation 
processes (such as those used in urban planning law) and preferably a local poll. They 
must be part of a comprehensive strategy for local law enforcement, health, 
community and preventative education initiatives.” (Swain, 1999, Appendix 3, 
Resolution 3.15) 
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As a result of the Summit, the Drug Misuse and Trafficking Act 1985 was amended in 1999 to 
allow for the possession and self-administration of illicit drugs in specifically licenced 
premises. The Opposition opposed the Bill, although a number of its members crossed the 
floor to vote with the Government (Gunaratnam, 2005). The legislation allowed for the 
granting of “one licence in respect of only one premises” (Drug Misuse and Trafficking Act 
1985). This restricted NSW to having only a single supervised injecting facility in the whole 
state unless the legislation was amended by the Parliament. This issue is further discussed in 
Section 5.2.3 below. 
Establishment and evaluation (2000-2016) 
Although not without challenges, Australia’s first Medically Supervised Injecting Centre 
opened in Kings Cross in May 2001 on an 18-month trial basis. Initially the Government 
approached the Catholic organisation Sisters of Charity Health Service to develop the service, 
but the direct intervention of the Vatican forced their withdrawal. The Uniting Church then 
stepped in to take up the licence (van Beek, 2004). The centre was further delayed by a legal 
challenge from the local Kings Cross Chamber of Commerce, which objected to the proposed 
location of the facility. They argued in the Supreme Court that there had been inadequate 
consultation with local businesses and residents. The Court did not uphold this claim, 
allowing the Uniting Church to proceed (Gunaratnam, 2005). Surveys conducted prior to the 
establishment of MSIC and in subsequent years demonstrate a majority of both local 
residents and business operators supported the establishment of MSIC. 
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Table 5.1 Support for the operation of MSIC in Kings Cross 
  Survey years  
 2000 
% 
2002 
% 
2005 
% 
Residents    (Agree) 68 78 73 
Business operators 
(Agree) 
58 63 68 
    
Source: Salmon, 2008 p.82 
MSIC’s initial 18-month trial was extended through legislative amendment on three 
occasions, in 2002, 2003 and 2007. The first extension bridged a gap between the finalisation 
of the independent evaluation committee’s report and the first trial period. That report, 
published in July 2003, assessed the feasibility and impact of the service, producing overall 
positive results, including a finding that “the majority of the community accepted the MSIC 
initiative” (MSIC Evaluation Committee, 2003 p.207). A second set of evaluation reports was 
published with further positive results in 2006-2007, resulting in a four-year extension to the 
‘trial’ being granted in 2007 (Ralston, 2007).  
The continuous cycle of evaluation created uncertainty and raised questions about the 
purpose of maintaining a trial status. Each extension required legislative amendments to be 
debated in the Parliament. Evidence featured heavily in the parliamentary speeches. For 
example, the Government, introducing the amendment in 2003, said the decision to continue 
was based on the outcomes of the evaluation report and advice from the NSW expert 
advisory group on drugs, and framed the approach as being “in line with this Government’s 
evidence-based approach to drug policy” (Parliament of NSW Hansard, 2003). Liberal MP 
Catherine Cusack, however, challenged the Government to justify the ongoing trial status: 
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“A real trial has a beginning, a middle and an end. If it's successful, it is replicated into 
general policy; if it is unsuccessful, it is concluded. In all seriousness, I ask the 
Government to tell us what is the trial seeking to accomplish and when and how will 
we know when it has been accomplished.” (Hanna, 2003) 
The independent evaluators for the first two rounds of evaluation declined to be involved in 
the final round, saying: 
“It seemed to us that to continue looking at it as a trial was not ideal from a public 
health point of view, to keep looking for an answer to the question of ‘Is this working?’. 
The case seems to have been made in general terms.” (Nicholls, 2010 p. 3) 
In 2010, legislation was passed that removed MSIC’s trial status, granting it permanency. This 
followed the publication of a further evaluation report by KPMG which was commissioned 
by the NSW Health Department to assess the performance and effectiveness of MSIC. The 
report confirmed, once again, that MSIC was delivering on its objectives (KPMG, 2010). 
5.2.3 Opportunities for expansion or replication 
The introduction to this case study noted the NSW Deputy State Coroner’s remarks that she 
would have expected NSW to have more medically supervised injecting centres in 2018 
(Thompson, 2018). The purpose of this section is to review the evidence, obtained from the 
case study, that demonstrates concerns with supervised injecting beyond the Kings Cross 
centre.  
As described above, the initial legislation was deliberately restrictive, supporting the 
establishment of the specific facility in Kings Cross rather than endorsing the general principle 
of supervised injecting. During the parliamentary debate, Liberal Party Member Kevin Rozzoli 
attempted but failed to move an amendment to lift the restriction of one licence. Rozzoli 
argued that it made no sense to only provide the service in one location: 
“I propose the establishment of four injecting centres on two bases. First, it provides 
flexibility to have four centres in the city – possibly two in the Kings Cross area and two 
in the Darlinghurst area, or we may widen the experiment by having, say, two centres 
in the Kings Cross area and two centres in Cabramatta.” (Parliament of NSW, 
Legislative Assembly Hansard, 1999) 
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Three factors can be identified that influenced the restricted nature of the legislation: 
political risk; a perception of community fear; and value-led political decision making. On the 
issue of the risk inherent in pursuing the controversial intervention, one interview participant 
recalled the response of the then-Premier of NSW Bob Carr in 1998, when she had suggested 
that there would be a need for four or five centres in NSW, including Cabramatta, and 
Redfern in the inner city of Sydney. 
“And he looked at me like I’d grown another head…[and] he said, “if it ever happens it 
will be one and it will be a trial, okay”. He said to think about three or four or five would 
be complete political suicide.” (Practitioner 7, Sydney) 
A Policy Maker who was interviewed argued the legislation provided reassurance for 
Parliamentarians in the face of questions and fear from their communities, noting in 
particular South Western Sydney where Cabramatta was located. 
“And I think that in many ways it was to assuage the concerns of… Labor MPs with the 
South Western Sydney seats who were concerned that they were the next cab off the 
rank. And I think it … allowed the Government to argue very clearly it was a trial. It was 
contained. You know, it said in the legislation is was only going to be in Kings Cross. It 
meant that people couldn't run the scare campaign [that] a medically supervised 
injection centre is coming to your suburb soon. I think it was a very deliberate political 
containment strategy, and an important one.” (Policy Maker 6, Sydney) 
Finally, Premier Carr, whose leadership was instrumental in this process, brought the power 
of his personal convictions to bear on the issue of drugs and drug taking, demonstrating the 
importance of the exercise of agency in the policy process. The Premier’s brother had died 
of a heroin overdose and he readily admitted that the evidence and testimony presented at 
the Drug Summit had persuaded him to revise some of his own views (Humphries and Totaro, 
1999). He is attributed with exercising great influence over the outcomes of the Summit, 
including the resolution in support of the supervised injecting trial. As one Policy Maker 
participating in the study observed: “…if Bob Carr wanted to stop it, he could have. 
Absolutely. Absolutely” (Policy Maker 6, Sydney). Instead, Carr urged others to support the 
proposal, arguing for new approaches while also maintaining his personal abhorrence of drug 
use (Morris, 1999a). He continued to frame the Government’s position in a way that made 
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clear that support for supervised injecting did not equate with condoning drug use, stating, 
“I will not accept the normalisation of heroin in our society…I say to people who live in hope 
that the stigma related to heroin use will be removed that we cannot do that” (Morris, 
1999b). 
The case study uncovered evidence that consideration was given to sites other than Kings 
Cross, with both Cabramatta and Redfern featuring in debate. Cabramatta had been closely 
investigated in the course of the Joint Select Committee in 1997 due to its high-profile street-
based drug market and the incidence of public injecting and overdose. Unlike Kings Cross, 
where a majority of local people had expressed support for a service (Salmon, 2008), there 
was strong opposition to the idea in Cabramatta and politicians were firm in their opposition 
on behalf of their communities. Labor MP Reba Meagher, who sat on the Joint Select 
Committee, argued:  
“The local area would be turned into a drug ghetto, there would be an increased crime 
risk and drug dealers would congregate nearby…There’s also the safety issue, how can 
you maintain a safe injecting room where people are using an uncontrolled and illegal 
substance.” (Sands, 1998) 
Cabramatta had very different characteristics to inner city Kings Cross. In evidence to the 
Joint Select Committee in 1998, researcher Dr Lisa Maher expressed reservations about 
proceeding with a trial in Cabramatta. 
“My personal opinion is that Cabramatta is perhaps not the best place to trial the safe 
injecting facility, given that there are very complex issues to do with the ethnic 
communities there. There is already, I think, a high degree of perhaps hostility and 
opposition that we have seen in relation to the needle and syringe issues in that 
community.” (Parliament of NSW, 1998, p.105) 
The Mayor of Fairfield, the council area in which Cabramatta sat, was adamant in his 
opposition, saying, “We won’t be approving any in Fairfield” (Clennell, 1999). According to 
Wodak et al. (2003), a proposal for a trial in the southwest was put to the NSW Cabinet in 
1999, but was dropped because of Meagher’s “relentless opposition”. 
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Redfern, an inner city area in Sydney, was raised in the parliamentary debate in 1999. 
Legislative Assembly MP Clover Moore, on noting the support of her constituents for 
supervised injecting in the vicinity of Kings Cross, said: 
“At the other end of my electorate, in Redfern-Darlington, there is also strong support 
for a supervised injecting facility and frustration that so far only one trial has been 
approved. While the legislation could be amended in future to allow other trials to take 
place, I seek a strong commitment from government on behalf of my constituents to 
allow further trials.” (Parliament of NSW, Legislative Assembly Hansard, 1999) 
The issue was raised again at the Standing Committee on Social Issues inquiry into Redfern 
and Waterloo in 2004, when Moore (then Lord Mayor of Sydney) again urged consideration 
be given to establishing a SIF in Redfern to “take injecting off the streets, getting people into 
treatment and saving lives from overdosing” (Parliament of NSW Legislative Council, 2004 
p.131). Other witnesses to the inquiry spoke against such a proposal. For example, Clive 
Smith said that the service “would send the message that the Government accepts that 
Redfern will continue to have flagrant and open drug markets, supported mostly by ‘visitors’ 
to the area” (Parliament of NSW Legislative Council, 2004 p.131). Premier Carr did not rule 
out the possibility but said it would only be considered if there was support from local 
Aboriginal leaders, the police and other stakeholders (Parliament of NSW Legislative Council, 
2004 p.132). The Committee did not support the proposal.  
In 2016, a Statutory Review of MSIC was conducted by the Departments of Health and Justice 
(NSW Government, 2016). Overall, the review found MSIC continued to meet its objectives 
under the Act and was economically viable despite a reduction in visit numbers. This review 
specifically addressed the issue of removing the Act’s restriction on NSW only having one 
supervised injecting centre. Twelve submissions were received (out of 25 in total) that 
recommended lifting the current restriction. Two findings were made on this question. First, 
that “the evidence suggests that there is significant need at the current location, compared 
to other areas” (p.9), leading to the recommendation that no change be made to the current 
location. Secondly, the review stated: 
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“According to the data currently available regarding unplanned emergency 
department admissions relating to opioids, incidents of use/possession of narcotics 
and the number of ambulance callouts to heroin overdoses already prevented, there 
does not appear to be a clear need for another supervised injecting facility elsewhere 
in NSW at this time.” (NSW Government, 2016 p.11) 
The general view of interviewees in the case study was that Sydney’s open drug scenes of 
the 1990s no longer exist on account of gentrification, civic developments and changing 
patterns and visibility of drug dealing (Practitioner 7; Policy Maker 5; Policy Maker 6, 
Researcher 6, Advocate 4 all Sydney). The argument was made that the conditions that gave 
rise to the establishment of MSIC were no longer present: 
“Well I mean it arose as a specific kind of policy problem in a particular context that 
doesn't exist anymore, you know, substantial street base injecting, huge volumes of 
public needle discards, and a sense of crisis.” (Advocate 4, Sydney) 
As one Policy Maker said in relation to the Statutory Review’s finding not to support further 
centres: “Look there's probably a fair point about injecting rooms. I'm not sure where you 
would set one up to be honest.” (Policy Maker 5, Sydney) In addition, the trend was noted 
that there had been a shift away from heroin-related overdoses to overdoses related to 
pharmaceutical opioid misuse, reducing the focus on injecting (Advocate 4, Sydney).  
These changes to Sydney’s drug markets over time have impacted on the process of policy 
transfer, particularly the appropriateness of the model of SIF that was adopted in 2001. The 
potential for a new centre in South Western Sydney was noted by a Researcher, but her 
comments were couched in terms of the need to look carefully at the model of service, 
speaking of “mobile” services or “micro-sites” (Researcher 6, Sydney). This was an issue also 
taken up by another interviewee, who spoke of the need for a “much more mature debate 
about what the model of service delivery can be” (Practitioner 4, Sydney). One group to 
advocate for an alternative model of supervised service is the Noffs’ Foundation, which 
began a campaign in 2015 for the introduction of drug consumption rooms in Sydney that 
would offer supervised inhalation for crystal methamphetamine (‘ice’) users (Noffs, 2016). 
Liverpool in South Western Sydney was proposed as a possible location. There is little 
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evidence that this campaign has gained any traction in NSW, and the proposal was rejected 
by the then-Assistant Minister for Health Pru Goward and the local Liverpool Chamber of 
Commerce (Park, 2016). The reception from local businesses and residents at the first 
community meeting on the proposal was reported in the national media to be “cool” 
(Metherell, 2016).  
5.2.4 Current status  
New South Wales’ only Medically Supervised Injecting Centre continues to operate from its 
original site in Kings Cross, Sydney. In 2016, MSIC marked its millionth visit to the service 
(Uniting Church, 2018). Numbers of average daily visits have declined since the early 2000s, 
reflecting the changing nature of the drug scene in Kings Cross and surrounding areas. At the 
highest point, the facility supervised an average of 220 injections per day in 2003, but it now 
supports an average of 130 injections per day (Salmon and Jauncey, 2015; Researcher 6, 
Sydney). The Statutory Review undertaken in 2016 found that MSIC exceeded quarterly 
targets for referral to treatment, counselling and clinical services (NSW Government, 2016). 
It has managed over 6000 overdoses without any fatalities since 2001 (personal 
communication, A. Salmon, Research Manager, MSIC, 29 January 2018).  
5.3 Case study 2: Melbourne, Australia 
Proposals for supervised injecting facilities in response to open street-based drug markets 
circulated in the state of Victoria in the 1990s, at the same time as the issue was being 
considered in New South Wales. There have been both similarities and differences in the 
paths that these two states have travelled as policy ideas circulated and political and 
community debate took place. This case study explores two distinct phases of engagement: 
the first in the late 1990s and early 2000s, and a second phase from around 2010 onwards. 
During these two decades, considerable changes took place to Melbourne’s drug markets; 
these have influenced the patterns of need and the visibility of the issue of street-based drug 
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use. This case study is characterised by deep engagement of the institution of parliament; a 
significant investment in research and evidence gathering through formal inquiries; and 
extensive community consultation and debate. The prospects for the scaling up of drug 
consumption services in Melbourne are considered in the context of Victoria’s first medically 
supervised injecting room opening only in July 2018. 
5.3.1 The emerging issues 
The development of proposals exploring the introduction of supervised injecting facilities in 
Melbourne, Victoria, came at a time of increasing concern with public drug use. In the 1990s, 
there were a number of distinct and dispersed street-based drug scenes across the city of 
Melbourne. The problems were multi-faceted, affecting the community through the harms 
such as overdose and the spread of blood-borne viruses, and also in terms of amenity and 
safety in local neighbourhoods. In 1996, the Premier’s Drug Advisory Council raised a concern 
with the increased availability of high-purity heroin in Victoria and the risk this posed for 
young users (Premiers Drug Advisory Council, 1996). Between 1996 and 1999, the state 
government allocated A$100 million to its Turning the Tide strategy, aimed at supporting a 
multi-sectoral response to illicit drugs and their impact on the Victorian community 
(Department of Premier and Cabinet, 2000 p.1). Despite this investment, drug-related 
overdose deaths from heroin continued to rise, and by 1999 there were 359 recorded, up 
from 49 in 1991 (Drug Policy Expert Committee, 2000 p.vi). This ‘toll’ was in the public domain 
through a daily report published in the local paper, the Herald Sun, alongside the annual toll 
of road-related deaths (Hughes, 2013 p.7).  
The open street-based drug scenes brought with them a decrease in amenity, evidence of 
drug litter and increasing public nuisance (Micallef, 1998). Across the city, five ‘hot spots’ 
were identified in local municipal areas, and local councils developed their own action plans 
to address drug related harms. Those municipalities were Greater Dandenong, Maribyrnong, 
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Melbourne, Port Phillip and Yarra (Drug Policy Expert Committee, 2000). A local politician 
from one of the hot spot areas in Greater Dandenong wrote of the community’s “wide and 
strongly felt” concern and a “growing sense of anxiety” (Micallef, 1998 p.2). One study 
participant recalled the community’s frustration with what was perceived as a lack of 
government action to deal with the levels of “mayhem” that had come with the emerging 
street-based drug scenes.  
“What the community wanted was an end to injecting in their face, they wanted an 
end to their kids standing on used needles, or the fear of their kids standing on used 
needles…And they wanted less violence…” (Practitioner 8, Melbourne) 
5.3.2 Phases of the response 
Policy learning, community debate and legislative development (1997-2000) 
As in New South Wales, the process of policy development in Victoria was led by the 
institution of the state parliament, although local governments engaged actively with the 
issues. There is also strong evidence in Victoria of policy learning occurring through the 
utilisation of research from the NSW experience and from overseas, as discussed below. The 
first reference to the possibility of supervised injecting came in a Council report on ‘safety 
clinics’ prepared for the City of Greater Dandenong in September 1997 (Micallef, 1998). The 
issue was also considered by the Drugs and Crime Prevention Committee of the Victorian 
Parliament in the course of its inquiry into the Turning the Tide strategy the same year. The 
Committee expressed the view: 
“that there is some merit in the idea of suitably regulated and controlled safe houses. 
The committee urges that there be greater public debate concerning the possibility 
of safe houses, and that that debate be guided by appropriate evidence.” (Parliament 
of Victoria, Drugs and Crime Prevention Committee, 1997 p.155, emphasis in original) 
Continuing to promote the idea, Committee member Eddie Micallef (1998) wrote a 
discussion paper for colleagues on the question of whether Victoria should have a supervised 
injecting trial. This was followed by a formal Occasional Paper, produced under the auspices 
of the Committee considering the justification and viability of SIFs in the Victorian setting. 
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This paper drew heavily on the work conducted by the NSW Joint Select Committee and its 
inquiry report released in 1998, as well as utilising both local and overseas academic 
research. The findings of this paper encouraged further exploration of the issue and stated, 
“There are few interventions other than Safe Injecting Facilities that are specifically suited to 
comprehensively deal with the range of harms arising from public street injecting” 
(Parliament of Victoria, Drugs and Crime Prevention Committee, 1998 p.i, emphasis in 
original). 
By 1999, supervised injecting facilities had become an electoral issue (see more detail in 
Section 5.4.2 below). The incumbent Liberal Government of Jeff Kennett officially opposed 
any proposals, while the Australian Labor Party, under the leadership of Steve Bracks, 
campaigned on a platform supporting five supervised injecting centres. Following the ALP’s 
unexpected electoral victory, Professor David Penington was appointed to head a Drug Policy 
Expert Committee (DPEC), charged with investigating and recommending to the Government 
a course of action on supervised injecting (Dolan et al., 2000). Penington’s inquiry was 
extensive and involved an assessment of the current local context of drug issues, but also 
sought guidance internationally and included visits to Sweden, the Netherlands and 
Germany, demonstrating a clear interest in learning from the policy approaches elsewhere.  
Stage One of the Committee’s terms of reference focused on the development of a local drug 
strategy for municipalities with high levels of drug use, and addressing the issue of the 
implementation of a trial of supervised injecting. The Committee received 130 public 
submissions, held local community meetings and consulted with key stakeholders. It also 
conducted a community survey specifically on the issue of supervised injecting which found 
“nearly two-thirds of respondents in the five municipalities nominated for injecting facilities 
support the trial, providing a suitable location can be identified” (Drug Policy Expert 
Committee, 2000 viii). The Committee recommended to the Government that a trial should 
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be implemented where there was local municipal support. The Report’s recommendation for 
the trial was embedded in the development of local drug strategies and the engagement of 
key stakeholders. With the Government pledging that centres would not be established in 
communities without local Council approval, legislation was introduced in the Victorian 
Parliament in May 2000, only to be defeated in the Upper House that November (Mendes, 
2002). Despite the electoral mandate and the extensive consultative work of the DPEC, the 
Government did not seek to re-introduce the legislation following its defeat. 
Ongoing advocacy, political consideration and establishment (2010 – 2018) 
While the issue died down in terms of high-profile public debate, the idea of supervised 
injecting facilities continued to circulate in policy and research networks (Fitzgerald, 2013). 
This occurred in the context of shifting patterns of drug use in Melbourne and a decrease in 
overdose rates (Fry, 2011). While some drug markets retracted, North Richmond and 
adjacent Abbotsford continued to host an active street-based drug scene. A local community 
group, the Yarra Drug and Health Forum, advocated for a SIF to address community concerns 
over drug use (Papanastasiou et al., 2009). In 2011, the City of Yarra Council voted 6:1 in 
support of a proposal to establish a SIF, but failed to gain the necessary support of the state 
government, then under the leadership of Liberal Ted Ballieu (Gregoire, 2016). 
By 2016, annual heroin-related deaths in Melbourne had risen once more to 190 (Wahlquist, 
2017) and a broader coalition of support for a supervised injecting facility in Richmond had 
coalesced and won the support of Sex Party politician Fiona Patten who introduced a private 
member’s bill to the State Parliament in February 2017 (Preiss, 2017). In the same month, 
Coroner Hawkins of the Coroners Court of Victoria released her findings of the inquest into a 
heroin-related death in Richmond. In exercising the role of the Court in relation to preventing 
future deaths, the Coroner called on expert witnesses (including the Medical Director of MSIC 
in Sydney) and received written submissions. She also called on two Australian experts to 
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review and report the evidence of the efficacy of SIFs. Coroner Hawkins’ first 
recommendation, directed to Martin Foley, the Minister for Mental Health, was to establish 
a supervised injecting centre trial in North Richmond (The Coroners Court of Victoria, 2017). 
The Coroner’s report noted the Department of Health and Human Services’ submission did 
not address the issue of SIFs, concluding that they were bound by current government policy. 
This provides an interesting contrast to the proactive role played by the public health 
agencies in Canada, which is explored in the following chapter.  
The Government, through Minister Foley, did not commit to the trial but referred the matter 
to the Parliamentary Committee’s Inquiry into Drug Law Reform that was due to report in 
March 2018. The stated position at this time was that the Government had an established 
policy against trialling a supervised injecting room (Carey, 2017). In parallel to the Drug Law 
Reform inquiry, the Legislative Council (Upper House) referred the bill to its Legal and Social 
Issues Committee. The Committee, in addition to calling for public submissions and being 
addressed by stakeholders, considered evidence concerning both MSIC in Sydney and the 
EMCDDA’s review of DCRs (EMCDDA, 2018). The Committee also made a site visit to the MSIC 
facility. The report concluded that medically supervised injecting facilities “improve the 
health of injecting drug users and reduce signs of drug use in surrounding streets” 
(Parliament of Victoria, 2017 p.xv). In addition, the Committee found that “drug use in North 
Richmond has reached crisis level” (p.xv). However, no recommendation was made to 
proceed. This was despite 46 of 49 submissions to the Committee supporting a trial (p.xv). 
The critical issue on which the decision seemed to pivot was that of community support, as 
explained in the Chair’s Foreword: 
“The Committee believes that the views of the community, all stakeholders and local 
government must be considered when deciding matters relating to a supervised 
injecting centre. The Committee was not set the task of confirming the level of local 
support and had practical restrictions on its capacity to do so definitively. One of the 
most contentious issues for the Committee was reaching a shared understanding of 
the level of support for a supervised injecting centre in North Richmond; the list of 
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submissions confirms that while most were in favour of a trial, these were from 
organisations from outside North Richmond.” (Parliament of Victoria, 2017 p.xii) 
In October 2017, the Victorian Government, in a surprising reversal of policy, approved a 
two-year trial of a supervised injecting facility in North Richmond, with Premier Andrews 
announcing: “This is a change in policy, there’s no doubt about that, but it’s a change that’s 
needed. We have the highest heroin death toll since 2000” (Wahlquist, 2017). This decision 
to reverse stated Government policy came as the Labor Government was faced with a by-
election in the inner-city electorate of Northcote in November 2017. A rally of around 600 
people had come out in support of the proposed SIF in the lead-up to the election, 
demonstrating the salience of the issue and the degree of public support (Houston and Preiss, 
2017). The ALP faced a strong challenge from the Greens Party, which supported the 
proposal. It has been suggested that the Government was attempting to appeal to potential 
Greens voters through a series of policy announcements around health and housing. The 
Government lost the by-election in a 11 per cent swing to the Greens but proceeded to put 
the supervised injecting legislation to the Parliament (Raue, 2017). The legislation 
successfully passed through both houses and the amended Drugs, Poisons and Controlled 
Substances Act was assented to in December 2017 (Drugs, Poisons and Controlled Substances 
Amendment (Medically Supervised Injecting Centre) Act 2017). 
5.3.3 Current status and opportunities for expansion 
The Victorian legislation endorses a two-year trial of a medically supervised injecting room 
(MSIR). Like the New South Wales Act, Victoria’s legislation specifies provision of a single 
licence for a single site. However, it goes further, naming the location as the North Richmond 
Community Heath (NRCH) centre, which is registered as both a company limited by 
guarantee and a charity (North Richmond Community Health, 2015). NRCH has been a 
methadone service provider and needle and syringe outlet since the 1990s. The trial is 
designed to offer an integrated service, rather than a stand-alone service, as in Sydney 
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(Wahlquist, 2017). The service is restricted to those 18 years and over (Drugs, Poisons and 
Controlled Substances Amendment (Medically Supervised Injecting Centre) Act 2017). An 
Expert Advisory Panel has been appointed to assist in establishing the service and, 
additionally, a review panel will be convened to evaluate the MSIR’s effectiveness 
(Department of Health and Human Services, 2018). The trial commenced in July 2018 and the 
centre received 8000 visits in its first two months of operation (Preiss, 2018). 
Post-dating the passing of the legislation, the Government’s Inquiry into Drug Law Reform 
reported in March 2018. The report acknowledged the Government’s decision to proceed 
with the trial; the parallel Legislative Council inquiry concerned itself with the key finding 
from the evidence it had collected. That evidence was informed in part by an overseas study 
tour that had included visits to supervised injecting sites in Spain, Switzerland, Germany and 
Canada. The Committee noted the issue of the potential benefit of multiple sites and mobile 
supervised injecting services. It also acknowledged the strong arguments that had been made 
in relation to the need for a supervised injecting centre in North Richmond, noting that with 
the exception of the Australian Christian Lobby and Drug Free Australia, all other inquiry 
stakeholders had supported the intervention (Parliament of Victoria, 2018 pp.482-483). The 
report made no general recommendation, on account of the recently passed legislation, but 
made two specific recommendations in view of the evidence it had collected, including that 
from the overseas study tour. It recommended allowing various illicit substances to be 
consumed in the North Richmond site, including amphetamine-type substances. It further 
recommended that the centre operate on a low threshold model to encourage accessibility; 
for example, not insisting that identification be produced as a condition of entry (p.484). 
Finally, it considered the potential future threat that might arise from the arrival of fentanyl 
or an equivalent synthetic opioid into the local drug market (such as has been experienced 
in Canada). The Committee recommended that consideration be given to possible temporary 
medically supervised injecting facilities in areas of high concentration of injecting drug users 
123 
 
 
and overdose. This recommendation was specifically influenced by the Committee’s visits to 
Vancouver’s ‘pop-up’ overdose prevention sites, which arose in response to the opioid 
overdose crisis (p.488 and see Section 6.2.3 below). 
In terms of replication or expansion of facilities in Victoria, it appears unlikely that services 
will be expanded beyond North Richmond at this time. In addition to the legislation in Victoria 
mirroring the ‘single licence, single premises’ model of NSW, there is recognition that the 
street-based drug markets which have prompted calls for supervised injecting services have 
retracted in Victoria. This was acknowledged in the Parliamentary Committee Inquiry into 
Drug Law Reform which heard evidence that North Richmond was identified as “the last open 
street-based drug market in Victoria” (Victorian Parliament, 2018 p.482). The Committee did, 
however, in reflecting on the unfolding situation in Canada in relation to the arrival in the 
market of the synthetic opioid fentanyl, give consideration to the fact that significant changes 
to the drug market could give rise to new need (p.488). 
In a postscript, Victoria went to the polls in November 2018 with the Liberal opposition 
campaigning to close the MSIR should they be re-elected. The Liberals suffered a 6 per cent 
swing against them, assuring an ALP victory and the continuation of the service in North 
Richmond (ABC News, 2018). 
5.4 Contextualising the Australian case studies 
The case studies have provided a detailed, chronological account of key events and influences 
on the policy making process in relation to supervised injecting in the two Australian 
locations. The purpose of the following section is to contextualise those case studies by 
examining the political and policy settings in which these events occurred. The case studies 
are notionally city-based due to the nature of the street-based drug scenes that supervised 
injecting facilities have the potential to address. However, as has been demonstrated, the 
policy setting is much broader, encompassing international institutions, and federal, state 
124 
 
 
and local levels of government. Guided by the sources of policy change and stall identified by 
Evans (2004) in his policy transfer framework, this section explores both structural and 
agency factors that have impacted policy development. In addition to contextualising the 
formal political setting in which the policy debates occurred, a comparative consideration is 
given to the role of civil disobedience in the two sites, providing critical analysis that will 
inform the application of the theoretical framework of policy transfer in Chapter Eight. 
5.4.1 Political setting 
International sources of policy change  
Evans (2004) notes that policy transfer can be constrained by international institutional 
structures that affect the behaviour of state actors. Australia’s position as a signatory to 
international drug control treaties created the potential for the Federal Government to 
exercise power in relation to states’ decision making on drug issues. The treaties are 
administered by the International Narcotics Control Board (INCB), an independent expert 
body consisting of 13 members elected by the UN Economic and Social Council (International 
Narcotics Control Board, 2018). The INCB reacted swiftly to the debate in Australia, stating in 
its annual report in 1999: 
“The Board urges the Government of Australia not to permit the establishment and 
operation of drug injection rooms, or so-called “shooting galleries”. In the view of the 
Board, such establishments would provide an outlet for illicit drug abuse and facilitate 
or encourage illicit drug trafficking, which, under the international drug control 
treaties, Governments are obliged to combat in all its forms.” (International Narcotics 
Control Board, 2000 p.62) 
Prime Minister Howard, in turn, wrote to all Premiers and Chief Ministers (the Heads of 
Government of the two Australian Territories) calling on them to abandon any plans for SIFs 
(Coorey, 1999). The claim that Australia would contravene the treaties was contested on the 
grounds that any initiative would have trial status and therefore was permissible within the 
terms of the treaties. The NSW Parliamentary Inquiry in 1998 had considered this issue and 
concluded that any proposed centre would not cause a treaty breach (Parliament of NSW, 
125 
 
 
1998). Ultimately the Federal Government, despite its threats, did not move to enact its 
external affairs powers. Howard was under political pressure at this time for paying little 
heed to international treaty obligations on the human rights front (Mendes, 2001), and by 
mid-2000 it was apparent that the Federal Government would not intervene (Chappell, 
2000). The INCB itself was not able to provide definitive evidence that its treaties were 
breached, despite its rhetoric, which did not help the Federal Government prosecute a case 
(Totaro, 2000). 
There have been no further signs of possible federal intervention in the issue. Any impetus 
for the Federal Government to intervene on the grounds of treaty breaches has been 
removed by the INCB taking a new stance on drug consumption rooms after many years of 
public condemnation of countries which operate DCRs. The INCB’s 2016 annual report noted: 
“the ultimate objective of these measures is to reduce the adverse consequences of 
drug abuse through treatment, rehabilitation and reintegration measures, without 
condoning or increasing drug abuse or encouraging drug trafficking. “Drug 
consumption rooms” must be operated within a framework that offers treatment and 
rehabilitation services as well as social reintegration measures”. (International 
Narcotics Control Board, 2017 p.91) 
In Australia, the current Liberal-National Party coalition Federal Government did not engage 
in the issue as Victoria developed its plans for a supervised injecting facility. Prime Minister 
Malcolm Turnbull, who held the office at the time the Victorian legislation passed, 
represented the NSW electorate in which MSIC is based. When asked, early in 2017, about 
his position on the facility, he expressed support, saying on balance it “had been more 
successful than not” (AAP Newsfeed, 2017).  
National drug policy in Australia 
Australia’s national drug policy and the institutional arrangements that support it have the 
potential to facilitate policy transfer with their focus on evidence-based policy and 
cooperative institutional structures. A national drug strategy framework has been in place 
since the mid-1980s. The current National Drug Strategy 2017-2026 aims to minimise the 
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harms of alcohol, tobacco and other drugs through the three pillars of demand reduction, 
supply reduction and harm reduction. Drug consumption rooms are recognised in this 
current strategy as an example of evidence-based and practice-informed approaches to harm 
minimisation (Commonwealth of Australia, 2017 p.51). Given the controversy that has 
surrounded them, this is perhaps surprising, but it is indicative of the overall acceptance of 
the ideology and practice of harm reduction in Australian drug policy. As such it is an 
ideational factor with potential to facilitate policy transfer.  
The national strategies are built on the principles of partnership and coordination, 
recognising the impact of Australia’s constitutional arrangements and division of powers 
between governments. They also explicitly recognise the need to work in partnership with 
community, industry and professional groups, including researchers (Fitzgerald and Seward, 
2002). This approach is supported by institutional structures that bring together relevant 
State, Territory and Federal Ministers from health, justice and law enforcement portfolios in 
a Ministerial Drug and Alcohol Forum. Its work is supported by the National Drug Strategy 
Committee, made up of senior bureaucrats (Commonwealth of Australia, 2017). Until 2014, 
the Prime Minister had convened an advisory body, the National Council on Drugs, which 
contained a cross-section of representatives with expertise and experience of drugs and 
alcohol; the Council facilitated policy sharing and learning across jurisdictions (Australian 
National Council on Drugs, 2014).  
State-centred sources of change: federal, state and local government politics 
The capacity for engagement in the development of drug policy by three levels of 
governments, across multiple policy portfolios, has complicated policy transfer in relation to 
drug consumption rooms in Australia. Consistent with Evans’ (2004) conjecture, the case 
studies demonstrate that structural forces have been significant, as we see through the 
strong focus on the role of political institutions such as parliament in the policy process. Also 
127 
 
 
consistent with Evans’ conceptualisation is the autonomy that is exercised by forces such as 
political parties through strategic selection of their support or opposition to the idea of 
supervised injecting at various junctures. That strategic selection has been influenced 
strongly by political leadership being exercised at critical points of the policy process, a factor 
which demonstrates the dialectical interaction of structure and agency. These issues are 
explored below, beginning with the role played by the Federal Government. 
Under Australia’s federal system of government, the states retain powers over criminal law 
and the provision of health care, but the federal government’s capacity to raise taxes sees it 
influencing national agendas and resourcing of initiatives in areas such as health and drug 
policy. The federal government has been a major funder of drug policy initiatives, allowing it 
to set policy directions and exert structural power (Ritter et al., 2011). John Howard, a 
conservative Liberal Prime Minister, launched the multimillion-dollar federal initiative ‘Tough 
on Drugs’ in 1997. As debates on drug consumption rooms got underway in three 
jurisdictions in the late 1990s (NSW, Victoria and the Australian Capital Territory), the Federal 
Government announced a $220m plan to tackle illicit drugs, focusing on treatment and 
diversion programs (Rollins and Hannan, 1999). Howard was staunchly opposed to 
supervised injecting facilities, arguing there was insufficient evidence from overseas of their 
effectiveness, and that SIFs sent the wrong signal to the community about illegal drugs 
(Mendes, 2001). In this way, he used his position as a powerful agent to influence the debate, 
asserting his own ideas, embedded in his conservatism, to challenge evidence and lay moral 
claim to the arguments that opposed SIFs. Moreover, the significant funding controlled by 
the federal government influenced the type of programmes which could be implemented by 
the states. 
At the state level of government, institutional factors proved significant in the development 
of drug consumption room policy in Australia. States not only have the residual powers under 
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the federal system to develop new drug policy, legislatively, but are also accountable to local 
communities and electors to deliver policy solutions to the problems presented by drug 
markets and public injecting. In both case studies, parliaments were central to the 
development and consideration of policy through multiple inquiries and committee reports. 
Bureaucratic bodies have been less prominent. Other significant fora included the NSW Drug 
Summit (which all NSW parliamentarians attended) and, in Victoria, the convening by the 
Bracks Government of the Drug Policy Expert Committee under Professor Penington. 
Throughout the policy making process, evidence gathering has been central through study 
tours, contributions from expert witnesses, public submissions and commissioned reports. 
These institutions also actively sought input from the community and facilitated debate 
through public meetings. 
Despite robust and consultative processes, politically the decision on whether to proceed or 
not with supervised injecting facilities continued to be a difficult one for governments to 
make. This conflict for governments represents a process of strategic selection which can be 
explored by examining the various positions that political parties took in both government 
and opposition. It illustrates the conflicting agendas that governments faced, which 
challenged the salience of the idea of supervised injecting at varying points of electoral 
cycles. Significantly, a closer examination of the standing of political parties demonstrates 
the significance of the role of political leadership – a key act of agency in the policy change 
process. 
In Victoria, Labor Governments introduced both the initial bill in 2000 (which failed) and the 
successful bill in 2017. Yet for many years in between, the ALP did not actively pursue or 
support a supervised injecting room. For example, the Bracks ALP Government won a 
landslide election only two years after their failure to secure Upper House support for their 
legislation, but never returned the proposal for supervised injecting facilities to its party 
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platform. Daniel Andrews’ Government, too, spent many months resisting calls to address 
North Richmond’s escalating drug crisis with the introduction of supervised injection. 
Andrews’ reversal of party policy on the issue only came with mounting pressure from Fiona 
Patten’s private members bill, the Coroner’s report and a strong community campaign. More 
significantly, electoral pressure from the Greens Party and the threat of losing the by-election 
contributed to the Government’s changed stance. 
The Liberal Party’s record of support for supervised injection in Victoria has been mixed. 
Whilst in power, leader Jeff Kennett demonstrated that he was open to the idea, making 
public statements to that effect when Open Family announced their plans to establish rooms 
in both Victoria and NSW in early 1999 (AAP Newsfeed, 1999). Whilst Mendes (2002) is 
correct in pointing out that Kennett ruled out support for a SIF during the 1999 election, three 
key informants I interviewed were of the view that Kennett intended to proceed with a 
facility following the election that he was expected to easily win (Practitioner 8, Policy Maker 
7, Researcher 8, all Melbourne). Section 5.4.2 below provides more details. However, 
following the Liberal’s electoral defeat, newly installed Liberal leader Denis Napthine 
opposed the legislation when it was introduced by the Bracks Government in 2000. The 
Opposition Leader argued that the proposal sent the “wrong message” and was not reflective 
of community wishes (AAP Newsfeed, 2000). With sufficient numbers in the Upper House 
and the failure to permit a conscience vote, the Victorian Liberals’ position ensured the 
defeat of the legislation.  
The Labor Party also successfully passed the bill supporting MSIC in NSW. Initial proposals 
were blocked by the parliamentary scrutiny of the Joint Select Committee. Support only came 
after the five-day NSW Drug Summit, where the issue was subject to intense scrutiny. 
Without the leadership of Bob Carr, who was convinced by the evidence presented to the 
Summit, it is difficult to see how enough support would have been rallied among Labor ranks. 
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There was strong opposition from ALP members, such as Reba Meagher, who argued a 
proposal for supervised injecting facilities was at odds with the needs of the community she 
served in Cabramatta (Sands, 1998). In any case, the Labor Party in NSW has remained 
committed to the argument that this is an exceptional measure for exceptional 
circumstances, and have sought to reassure their voter base that they do not condone drug 
use. John Della Bosca, Special Minister for State, in his second reading speech on the 
introduction of the legislation in 1999, emphasised this point: 
“In all instances the Government remains committed to the view that self-injection of 
addictive substances cannot be normalised, and must be rejected as a behaviour on 
social, health and moral grounds…This is a centre for rehabilitation, a centre for 
treatment, a centre for counselling and referral – it offers a gateway to treatment.” 
(Parliament of NSW, Legislative Assembly Hansard, 21 October 1999) 
The Liberal Party of NSW has, in general, opposed the Government of the day on supervised 
injecting, but members have crossed the floor to vote with the Government (Gunaratnam, 
2005). The Liberal Party of NSW opposed the 1999 bill, with leader Kerry Chikarovski arguing 
that the bill “conveys the wrong message” and that “this process merely entrenches and 
expands a culture that says illegal drugs, such as heroin, are acceptable within our 
community” (Parliament of NSW, Legislative Assembly Hansard, 11 November 1999). By 
2010, with the introduction of the bill to end the trial status of the MSIC, Liberal MPs were 
granted a conscience vote by Opposition Leader Barry O’Farrell and once again members 
crossed the floor. The parliamentary debate reveals the conflict for parliamentarians in 
supporting the idea of supervised injecting, lest being seen to condone drug use. This conflict 
is captured by the speech given by Deputy Leader of the Opposition, Jillian Skinner: 
“As I said during the 2007 debate, I have struggled with the concept of the injecting 
centre and I could go either way in voting on the bill. The message the centre sends 
that people can take drugs safely is not right. We should never allow people to think 
we condone drug taking and that people can inject drugs safely… However, it all comes 
down to those who use the centre. Their average age is 34, most are male, many are 
on some form of government income benefit and many have been in prison. They are 
chronic users and have underlying health problems, such as HIV and hepatitis C, and 
other medical problems. … So despite my personal discomfort, as an aspiring Minister 
for Health with an abiding determination to put patients first as a guiding principle and 
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being firmly of the view that the medically supervised injecting centre helps people 
stay alive and improves their health and wellbeing, I will be supporting this legislation.” 
(Parliament of NSW, Legislative Assembly Hansard, 20 October 2010, p.26395). 
 
Local government responses 
An examination of the role of local government reveals the critical role played by both 
ideational and structural forces in the policy transfer process. Local governments grapple 
directly with the contesting of the idea of supervised injecting by their communities as they 
come to terms with the reality of the concept. In addition, tensions are generated by a local 
problem that requires a state-level solution. In terms of successful policy transfer, this latter 
tension is a potential constraint. DCRs are generally a response to a geographically-bound 
problem through their association with specific street-based drug scenes. Whilst the capacity 
to deliver the required legislative frameworks sit at a higher governmental level, local 
Councils have a responsibility to their communities for safety and amenity. A significant 
tension arises between the desire of local Councils to determine a local response and the 
necessity for the debate to be taken to a much broader audience, which is not necessarily in 
touch with the day-to-day experiences of the affected communities.  
Councils have taken strong stances both for and against proposed injecting sites. In New 
South Wales, the strongest push for SIFs came through the deliberative process of the Drug 
Summit, but its recommendation to trial supervised injecting was not met with support from 
local Councils such as Fairfield, the administrative area in which Cabramatta sits. There was 
a strong fear that local Councils would have injecting rooms ‘forced’ on them by the State 
Government. To counter the State Government, 46 Councils agreed to form an Australian 
wing of a grouping called the European Cities Against Drugs in order to work together to 
resist any such imposition from the State Government (Penberty, 1999). Other Council areas 
such as South Sydney, which included the inner-city area of Kings Cross, came out in support 
of the proposal (Clennell, 1999). That Council recognised, however, that it could not go it 
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alone without the State Government, citing legal and resourcing issues (Sands, 1998). 
Ultimately, the narrow scope of the bill, specifying the trial of only one injecting facility, 
eliminated the concern that centres would be ‘forced’ on unwilling local councils. The 
corollary of this position was that it also removed the possibility for other local Councils to 
pursue a centre in the absence of a legislative amendment.  
In Victoria, Councils were split in their support as the Bracks Government pursued its agenda 
of five injecting sites in the ‘hot spots’. At the time of consideration of the legislation in 2000, 
three municipalities were supportive, but two, the Cities of Greater Dandenong and 
Melbourne, had cast local votes within their Councils to reject any proposals (Mendes, 2002). 
The appointed Drug Policy Expert Committee under Professor Penington had developed a 
number of community and consultation processes but the debate stirred up considerable 
anxiety and concern (Dolan et al., 2000). Community groups mobilised both for and against 
the proposals and actively made their voices heard (Gunaratnam, 2005). According to one 
interview participant, at times public meetings on the issue descended into “shouting 
matches” (Researcher 8, Melbourne). The Government appeared to respond to this pressure 
by having a ‘bet both ways’. While arguing that sites would only proceed if they had the 
support of the local municipalities, in an effort to garner support on the floor of Parliament, 
the Government committed to adding a condition to the bill that Parliament would have the 
authority to approve (or disapprove) the service agreements (Gunaratnam, 2005). Should the 
bill have passed, this could have opened the way for State Parliament to overrule local 
decision making on the issue. 
Moving forward to 2010 in Melbourne, the marked changes to local drug markets meant that 
there was arguably only one street drug scene that would appear to meet the criteria for 
benefiting from a supervised injecting facility (Dwyer, Power and Dietze, 2013). North 
Richmond and Abbotsford experienced a thriving street-based drug market, and the public 
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nuisance and amenity issue that accompanied that. The local Council, the City of Yarra, had 
supported a number of proposals over the years for a trial of a supervised injecting facility, 
including passing a vote 6:1 in favour in 2011 (Gregoire, 2016). This vote did not generate the 
required support from the State Government, so the proposal did not progress. In their 
submission to the 2017 Legislative Council Committee inquiry into Patten’s bill, the Council 
outlined the limitations of its position: 
“Whilst Council is committed to improving the amenity of Victoria Street, it has limited 
powers and responsibilities in other aspects including the measures recommended by 
Coroner Hawkins…Yarra City Council urges the Victorian Government to act on the 
extensive evidence available that supports the establishment of as SIF as a means of 
reducing drug-related harm in our community, and calls on the Victorian Government 
to implement the recent recommendation made by the Coroner Hawkins and to 
amend legislation to allow this to occur”. (Yarra City Council, 2017) 
That inquiry, as discussed above, did not make a recommendation to support the trial. In her 
foreword to the report, the Chair emphasised the importance of taking into account the 
views of the community and local government. She went on to say that the Committee, 
however, was not “set the task of confirming the level of local support” (Parliament of 
Victoria, 2017 p.xii). The implication of this statement is that without some definitive 
measure, the inquiry was not justified in recommending for the trial to proceed, even with 
46 of the 49 submissions in favour, including an unequivocal recommendation from the local 
Council. This demonstrates the problematic issue of interpreting ‘community’ views in the 
policy making process, but also the potential for ‘buck passing’ to occur between the 
different levels of government: an issue of relevance in the Canadian case studies.  
5.4.2 Civil disobedience 
Both case studies in Australia captured acts of civil disobedience via the provision of an 
‘illegal’ supervised injecting service prior to legislation sanctioning services. This section 
explores the contexts and impact of such actions in each case. A different pattern of activity 
is discernible between the two cases, with Sydney’s very visible Tolerance Room serving a 
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highly successful agenda setting function, while Melbourne experienced a more ‘behind the 
scenes’ approach as Wesley Central Mission tried to move forward with developing a 
functional service in tandem with political developments. 
The opening of the unsanctioned injecting room at the Wayside Chapel in May 1999 in the 
lead up to the NSW Drug Summit was, at the admission of its instigators, intended to be 
symbolic and deliberatively timed to put pressure on the Carr Government (Wodak et al., 
2003). The organisers actively engaged with the media and the drama of the arrest of 
clergyman Reverend Ray Richmond following police raids was well-covered in the national 
press (Harris and Jackson, 1999; Trimingham, 1999; Carlton, 1999). While there appears to 
be a consensus that this act of civil disobedience can be credited with supervised injecting 
being placed on the Drug Summit agenda (van Beek, 2003), it is of note that one member of 
the group was a former member of the NSW Parliament and continued to effectively use her 
influence amongst her parliamentary network through “discreet contact”, in contrast to the 
highly visible act of civil disobedience (Wodak et al., 2003 p.615). 
In Melbourne, civil disobedience has not been a prominent feature of campaigns to establish 
drug consumption rooms. In May 1999, the Community Coalition for Heroin Reform and the 
Militant Socialist Organisation set up a temporary safe site in Collingwood (Mendes, 2002). 
With the debate having entered the political domain and become an electoral issue, there is 
some question as to what a civil disobedience campaign would have achieved, particularly 
once the ALP had pledged A$4.5m of funding for the five sites (Dolan et al., 2000).  
A factor that may have undercut a push for civil disobedience was the effort of local 
Melbourne Church group Wesley Central Mission to develop a supervised injecting room in 
the central business district (CBD) in 1999, prior to the political or legislative resolution of the 
issue. These efforts were subject to a fierce community debate involving Wesley and a local 
group, Residents 3000. The Health Minister John Thwaites entered the debate and said 
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assurances had been received from Wesley that they were not in breach of the law and that 
any evidence of facilities would be referred to the police (Martin, 2000). No action was taken, 
but Melbourne City Council voted against support for the facility in June 2000 (Finlay, 2000). 
Interview participants in this study indicated that Premier Jeff Kennett was well aware of 
Wesley’s plans in 1999 and was secretly supportive of them. According to one source, 
Kennett had provided “tacit agreement” to an injecting facility being established in the CBD 
(Policy Maker 7, Melbourne). Another participant said: 
“Anyway, they [the Government] knew about it. But they tried to keep it secret. I 
believe what Wesley were being told was, ‘We can’t come out and support this…but 
wait until after the election.’ So they kept developing it.” (Researcher 8, Melbourne) 
Further, a Practitioner recalled, “But I mean I think they built the room; they were ready to 
go. And really, if Jeff Kennett had have got elected, re-elected, maybe it would actually have 
happened” (Practitioner 8, Melbourne). 
While civil disobedience was a factor in Sydney, it does not appear to have been a tipping 
point in the debate, given the number of other influences, including growing public concern 
with drug issues and prominent media coverage. In Melbourne, pressure was brought to bear 
in a more formal way with Wesley Central Mission openly developing a service in advance of 
government approval, but without threatening to provide service in the absence of 
appropriate frameworks. It is noteworthy that in both cases, change was being pushed 
strongly from Church-based organisations, being the Wayside Chapel, a parish of the Uniting 
Church in Sydney and Wesley Central Mission in Melbourne. Ultimately, in both Sydney and 
Melbourne, change was still required to be delivered through formal government processes 
to ensure the delivery of credible services. 
5.5 Findings and conclusions 
The case studies above are detailed by their nature as an exercise in reconstructing key 
events and influences as supervised injecting policy has been debated by both the 
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community and in formal political institutions. Spanning two decades, the case studies of 
Sydney and Melbourne may appear on the surface to have been quite different. However, it 
is striking, in comparing the two cases, how many similarities there are in terms of  the main 
findings that can be drawn in relation to the replication of policy. This section presents those 
key findings, focusing first on the similarities of the cases and then any differences that are 
of note, before drawing some general conclusions. The findings presented here will be drawn 
on in Chapter Eight to apply the policy transfer framework to understand what influenced 
the success or failure of policy transfer in the Australian and Canadian case studies.  
While all three levels of government in Australia have been involved in the process of 
developing policy on the issue of supervised injecting, it is clear from both cases that the 
state level of government has dominated. Parliaments in both New South Wales and Victoria 
controlled the policy process through the decision to pursue a legislative response (as 
opposed to an administrative or discretionary response). With the exception of the failed 
legislation in Victoria in 2000, the other two, successful pieces of legislation have been 
deliberately crafted to limit the provision of service to single sites. This has sent the strong 
message that supervised injecting is an extreme measure supported in very specific 
circumstances. It should not be viewed as a service that Governments embrace, other than 
when there is a ‘crisis’ of a magnitude that can justify such a measure. In both cases, the 
Governments have been able to make the argument that they support supervised injecting 
in these specific instances, while attempting to persuade the community that they have 
nothing to fear as the measure is strictly contained (both geographically and temporally). The 
narrowness of the legislation in both sites is not an encouragement for policy learning, 
despite the framing of the interventions as trials and the focus on evaluation and the 
development of an evidence-base. 
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Another means by which state governments have sought to assuage communities is through 
extensive consultation, yet the case studies demonstrate a tension between community 
‘opinion’ and political support for supervised injecting. In both Sydney and Melbourne, there 
was evidence that more people in the community supported trials of supervised injecting 
than did not, but it remained a difficult issue politically for elected representatives (Drug 
Policy Expert Committee, 2000; Salmon, 2008). Politicians appear to be conflicted in their 
role as representatives as to whether they take a moral stand, reflect community opinion or 
calculate for potential electoral backlash. This is issue is taken up in Chapter Seven. In both 
states, decisive political leadership was a prerequisite for the passage of legislation but not 
necessarily a sufficient condition, as the Bracks Government’s failure in 2000 indicates.  
In terms of the other levels of government, a degree of coordination has been required which 
adds to the complexity of policy change in this area. The Federal Government, while having 
the potential to act through its external powers in relation to international treaties, 
ultimately chose not to challenge the states’ positions on the issue. Local governments, 
through the Council structure, have been actively engaged through their concern with 
amenity, health and safety issues in their local areas, but have been unable to act alone to 
provide services. They have, in some cases, attempted to assert the right not to accept 
services (for example, Fairfield Council in NSW and City of Melbourne in Victoria), although 
there has never been any test of whether a state government would choose to override a 
local authority and insist on service provision.  
The Australian case studies provide evidence that the introduction of supervised injection 
was influenced by experience from overseas; policy development in both jurisdictions 
therefore contained elements of policy transfer. Both Victoria and New South Wales policy 
makers embarked on study tours, and evidence from overseas was tabled in Parliamentary 
reports and inquiries (Parliament of New South Wales, 1998; Drug Policy Expert Committee, 
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2000; Victorian Parliament, 2018). Australia’s national policy has been broadly supportive 
through its recognition of harm reduction as a pillar of drug policy. However, despite this 
potential for policy learning to occur through the partnership approach that underlies 
Australia’s national drug policy and its institutional structures, policy has not been scaled up 
nationally. It can be concluded that despite exposure, for example, of Victorian politicians to 
the experience of MSIC in Sydney, including a site visit (Victorian Parliament, 2018), sub-
national policy transfer has had a limited impact. Victoria’s comparatively late establishment 
of their MSIR, seventeen years after Sydney’s MSIC, did not occur without a thorough 
reconsideration of the evidence and questioning as to the appropriateness of the service for 
‘local’ conditions, as demonstrated by the extensive work of two Parliamentary inquiries in 
2017-2018 (Parliament of Victoria, 2017; Parliament of Victoria, 2018). The 2017 inquiry, for 
example, despite finding that medically supervised injecting facilities were effective, did not 
recommend one for North Richmond (Parliament of Victoria, 2017). It can be concluded that 
there is not, in the Australian cases, evidence of a straightforward adoption of policy from 
one jurisdiction to another: an issue given further consideration in Chapters Seven and Eight. 
A final similarity of note between the two cases is the shared experience of changes to each 
cities’ street-based drug markets. The evidence points to a contraction of open drug markets, 
which appears to have been influenced by a number of factors, including gentrification; 
changes to drug dealing that have been brought about by the widespread uptake of mobile 
phones; and shifts in methods of consumption and types of drugs being consumed. These 
changes have influenced perceptions of the policy problem and the magnitude of the ‘crisis’ 
that needs to be addressed in Australian cities in relation to street-based drug use. It also has 
implications for the model of drug consumption that may be appropriate in a more dynamic 
market, suggesting that consideration must be given to temporal factors in the process of 
policy transfer. 
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In terms of differences in the findings of the cases, only two of significance are noted. The 
first relates to the role played by civil disobedience. Whilst the case studies revealed acts of 
civil disobedience in both sites, Sydney’s Tolerance Room appears to have had the greatest 
impact in terms of agenda setting. However, in neither site has there been any act of civil 
disobedience which pushed for further services after 1999, limiting the impact that civil 
disobedience has had on policy development in both sites. This point is relevant in terms of 
later discussion of the cases in Canada.  
The other significant difference relates to the original strategy that was pursued in 
Melbourne to support five potential supervised injecting sites compared to a more limited 
focus in Sydney. Bracks’ strategy did not succeed as the legislation was rejected by the Upper 
House. One participant was earlier quoted as saying that NSW Premier Carr had called her 
suggestion that they would require four or five centres in Sydney “political suicide” 
(Practitioner 7, Sydney). It was certainly the case that there was vocal opposition expressed 
in Melbourne within communities, as well as two of the Council’s formally passing motions 
to express their opposition to supervised injecting facilities being established in their 
jurisdictions. However, given that the State Government proceeded to take their legislation 
to the Parliament, it is not possible to say whether the strategy of pursuing five rather than 
one centre at that time had any bearing on the legislation’s defeat in the Upper House. 
In conclusion, the case studies of Sydney and Melbourne’s experiences in relation to 
developing policy on drug consumption rooms show that while supervised injecting was 
supported in both locations following extensive community and political debate and scrutiny 
of evidence, including from overseas, the scope of the interventions was deliberately 
constrained. The legislation put in place limited the political risks associated with the 
controversial measure by specifying, in both cases, that only one licence for one premises 
would be granted. While further amendments to this legislation are possible, the likelihood 
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for the scaling up of services seems very remote at this time – despite the acknowledged 
success of MSIC in meeting its objectives. This is due to a number of factors, including the 
contraction of street-based drug markets and the changing perception of the problems 
associated with public drug taking. The limited prospects for the policy of supervised injecting 
becoming more mainstream as a public health intervention reflect an underlying 
conservatism within the Australian political landscape in relation to illicit drugs. Following the 
case studies from Canada which are presented in Chapter Six, further consideration will be 
given, in Chapters Seven and Eight, to the factors that have constrained and facilitated policy 
change in this area. 
 
 
 
 
 
 
 
 
 
 
Chapter six      
Canadian case studies:  
Vancouver and Toronto 
• • • • • • 
  
142 
 
 
6.1 Introduction 
This chapter builds on the foundations laid in Chapter Five by presenting the two further case 
studies of the Canadian cities of Vancouver and Toronto. The Australian case studies 
demonstrated how policy replication and sub-national transfer were affected by the control 
exercised over policy by state governments, and the changing nature of street-based drug 
use in the cities of Sydney and Melbourne. The Canadian cases present a complex picture 
that spans three levels of government. The distribution of powers under federalism and the 
multi-sectoral nature of drug policy engages a number of institutions and a significant level 
of coordination to achieve policy change. The idea of supervised injecting in the Canadian 
context has been politically and ideologically contested. From its origins in activism and civil 
disobedience, innovative policy emerged in Vancouver, borrowing directly from European 
ideas and experiences. Policy replication stalled, however, despite a strong evidence base of 
the effectiveness of Canada’s first official supervised injecting facility, Insite. Supervised 
injecting became an issue of national concern that was contested through the institutions of 
parliament and the judicial system. However, the current escalating epidemic of opioid 
overdose deaths has challenged governments in Canada to respond, resulting in the scaling 
up of drug consumption services after a period of policy stall. These two case studies are 
constructed utilising the same methodology as the Australian cases (Yin, 2014), using 
extensive primary and secondary documentary sources and drawing on data collected from 
interviews undertaken at the field sites. 
Following the format of the previous chapter, the Canadian case studies are presented in 
four main parts. Section 6.2 is concerned with the city of Vancouver in British Columbia. 
Vancouver has led SIF policy development in Canada, engaging a range of stakeholders across 
multiple agencies and levels of government to address the public health crises facing the city 
in the last twenty years. Factors constraining the scaling up of policy in the city and the 
province are analysed. Section 6.3 introduces the case study of Toronto in Ontario where 
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supervised injecting policy has developed in the context of a very different drug use 
environment than Vancouver. This case study is characterised by the leading role played by 
the bureaucracy, as proposals to address street-based drug use were subject to extensive 
community consultation and a lengthy needs and feasibility assessment. Section 6.4 places 
events in Vancouver and Toronto in the political and policy context of the Canadian federal 
system, as both structural and agency sources of policy change are identified. Comparative 
analysis is undertaken of the impact of these factors at each site. The role and impact of civil 
disobedience on the scaling up of supervised injecting services is considered. Finally, Section 
6.5 summarises the key findings of the case studies. 
6.2 Case study 3: Vancouver, Canada 
Vancouver’s supervised injecting facility Insite is commonly introduced as the first facility of 
its kind in North America, having been established in 2003. Less frequently mentioned are 
the number of unsanctioned sites that pre-dated Insite, including the Dr Peter Centre, which 
operated with the knowledge of local authorities for fourteen years before gaining legal 
status. This case study of drug consumption services in Vancouver traces the development 
of these multiple sites, considering the role played by local government, policy makers and 
community activists. Evidence of the effectiveness of Insite in meeting its objectives did not 
prevent ongoing contestation of the idea of supervised injecting as an appropriate policy 
response to problematic drug use. Engagement of the federal level of government and the 
Supreme Court elevated events in Vancouver into the national political sphere, resulting in 
implications for the transfer of policy sub-regionally within Canada. The impact of successive 
public health crises and pressure on the state through acts of civil disobedience are explored 
in order to better understand the complex factors that contributed to the stop-start 
expansion of supervised drug consumption in Vancouver. 
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6.2.1 The emerging issues 
As a port city, Vancouver was particularly vulnerable to the increasingly fluid international 
drug market and experienced an influx of illicit drugs in the 1980s and 1990s (MacPherson, 
2000). Drug use was spread across Vancouver, but was concentrated in an area called the 
Downtown Eastside (DTES), the “epicentre of Vancouver’s illicit drug and sex trade 
economies” (Kerr et al., 2008a p.110). Some 5000 injecting drug users were estimated to live 
in a ten-block area and the Downtown Eastside accounted for 80 per cent of the city’s drug 
arrests (Kerr et al., 2003a p.579; Roe, 2009 p.86). 
In the early 1990s, the Chief Coroner and former Royal Canadian Mounted Police (RCMP) 
superintendent, John Cain, launched an investigation into heroin-related deaths in British 
Columbia. Annual drug overdose deaths in the province had increased from 39 in 1988 to 
357 in 1993 (Armstrong, 1998). Cain urged the Government to consider the impact of the so-
called ‘war on drugs’, which he termed an expensive failure, and to instead approach 
addiction and drug use as health and social issues. He argued for more innovative harm 
reduction approaches that would facilitate the safer use of illicit drugs. More radically, he 
urged consideration of a degree of legalisation and decriminalisation of illicit drugs (Cain, 
1994). According to Campbell et al. (2009), there were no tangible results to come from Cain’s 
report; they quote one source as attributing this to a lack of courage in all levels of 
government (Campbell, 2009 p.59). Overdose deaths continued to rise. By 2001, over 2000 
overdose deaths had been recorded in Vancouver over the previous decade, and drug 
overdose deaths had become the leading cause of death among people aged 30-49 (Elliot et 
al., 2002). 
Concomitant with rising overdose deaths, Vancouver experienced an increase in HIV 
infection rates. Prevalence of HIV among Vancouver’s injecting drug users (IDUs) rose from 
4 per cent in 1992-93 to 23 per cent in 1996-97 (Canadian HIV/AIDS Legal Network, 1999 p.9), 
in what has been described as “one of the fastest spreading HIV epidemics ever documented 
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in the developed world” (Urban Health Research Initiative, 2009 p. 7). The increasing 
availability of inexpensive cocaine and the practise of injecting cocaine at high rates of 
frequency (up to twenty times a day compared to two to three times for heroin) was linked 
to an escalation in risk behaviour (Kerr, 2000 p.14). In addition to the disease burden of HIV, 
88 per cent of IDUs in Vancouver had contracted Hepatitis C by 1998 (Kerr, 2000 p.14). 
Concern with these issues at a national level led to the 1997 declaration by the National Task 
Force on HIV/AIDS and Injecting Drug Use that Canada was in the midst of a public health 
crisis (National Task Force on HIV/AIDS, 1997). 
6.2.2 Phases of the response  
The potential of supervised injection as a means of ameliorating the risks faced by injecting 
drug users in Vancouver surfaced in the mid-1990s, and is a story of unlawful and lawful 
activity. Three distinct phases are discernible: a period of establishment of unsanctioned sites 
and then an officially sanctioned service, Insite (1995-2003); a period of contestation, and 
political and legal battle over supervised injecting (2006-2015); and currently, a period of 
expansion as Vancouver, and Canada more generally, grapples with an unprecedented opioid 
overdose epidemic (2016-2018). Throughout these phases, both structural and agency 
factors interact as ideas are contested and the replication of policy is challenged through the 
engagement of multiple levels of government and the courts. 
Establishment (1995 – 2003) 
The journey from the promotion of the initial concept to the establishment of Canada’s first 
government-approved drug consumption room was the culmination of the work of a range 
of agents: activists, bureaucrats, and politicians. Three strands of activity interwove and 
intersected: activism, which included advocacy, protest and civil disobedience through the 
direct provision of unsanctioned supervised injecting; policy study and debate, including 
drawing from international experience; and, finally, political contestation and resolution. 
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Activism 
Growing official concern with this burgeoning public health crisis had been preceded by a 
wave of community activism and advocacy, at the heart of which was the user-run 
organisation known as the Vancouver Area Network of Drug Users (VANDU). VANDU, along 
with community organisations such as the Portland Hotel Society (PHS) and advocacy group 
the Harm Reduction Action Society (HRAS), became instrumental in advocating for, and 
demonstrating, the benefits of harm reduction and people-centred approaches to tackle drug 
problems (Osborn and Small, 2006; Small, Palepu and Tyndall, 2006; Harati, 2015). They also 
worked in alliance with a family support group, From Grief to Action (FGTA), which was 
effective politically in re-framing drug use as an issue that could affect anybody (McCann, 
2008). Activists were key agents for change through acts of civil disobedience that 
demonstrated service delivery; equally importantly, they contributed to the development 
and circulation of policy ideas. 
The first unsanctioned supervised injecting site opened in the DTES in 1995. A group of drug 
users and activists known as IV Feed, developed the ‘Back Alley Drop-In’ which operated for 
nearly a year, seeing around 100 users a night, before being closed by the police (Folz et al., 
1999; Kerr et al., 2003b). According to Lawrence (2017), while no further organised sites 
operated for a number of years, members of VANDU offered their own rooms in the DTES as 
a safe place to inject. The idea of supervised injection, and the experience from overseas, 
was brought to the Downtown Eastside in 1998 when a group brought speakers from Europe 
and the United States to address over 700 people at a one-day conference called ‘Out of 
Harm’s Way’. This led to the establishment of the Harm Reduction Action Society, whose 
mission was the promotion of a SIF in Vancouver (Kerr et al., 2008a). HRAS developed a 
proposal for an 18-month pilot of two supervised injecting facilities (Kerr, 2000). It also ran 
two ‘mock’ SIFs at a local DTES church to dispel myths about supervised injection, attracting 
public interest and media attention (Kerr et al., 2008a). 
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Between 2000 and the opening of Insite in 2003, three more unsanctioned SIFs operated in 
Vancouver. Two were run by activist Ann Livingston, a key instigator of the Back Alley, in 2000 
and 2003. The latter operated for five months until the official opening of Insite, despite the 
threat of closure from police (Small et al., 2006). The third site was the Dr Peter Centre, a 
private HIV/AIDS care clinic which began an unsanctioned site in 2002 at their premises in 
Vancouver’s Downtown area. The case of the Dr Peter Centre is discussed below. 
Policy development and political resolve 
Following the declaration of the public health crisis in 1997, supervised injecting gained 
support in policy circles at different levels of government across Canada. With support from 
Health Canada, a series of important reports emerged that sought to address the issues of 
HIV and Hepatitis C among injecting drug users. Amongst their findings (echoing Cain) was 
the conclusion that the legal status of drugs in Canada was contributing to difficulties in 
tackling HIV/AIDS among injecting drug users (Canadian HIV/AIDS Legal Network, 1999). The 
potential for supervised injecting to address the risks posed by HIV and Hepatitis C was raised 
in a Consultant’s report put to the Vancouver/Richmond Regional Health Board in 1997. This 
proposal was immediately rejected by Provincial Health Minister Joy MacPhail prior to the 
Board’s own deliberations on the matter (Matas, 1997). The Board, however, convened a 
panel to consider supervised injecting, under the chairmanship of Bud Osborne, a key VANDU 
activist and health board member. In 1998, the panel recommended the establishment of 
four supervised injecting sites in the DTES (McMartin and Bains, 1998). The response to this 
report from key stakeholders was largely negative, but the idea continued to circulate with 
the production in 1999 of a policy options paper for pursuing supervised injecting rooms (Folz 
et al., 1999).  
A critical development came with the launch of the City of Vancouver’s Four Pillars drug 
strategy in November of 2000, which focused on the four pillars of prevention, treatment, 
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enforcement and harm reduction (MacPherson, 2000). This policy explicitly drew on the 
experience and evidence of effective models of care from outside Canada and has been 
described as “an assemblage of expertise and resource from close-by and far afield” (McCann 
and Temenos, 2015 p.219). The policy called for a feasibility study of supervised injecting 
facilities in British Columbia. Bureaucrats have been key members of the policy transfer 
network that continued to promote the option of supervised injecting. This role is 
acknowledged by Small et al, who wrote: 
“These bureaucrats were in numerous departments of the municipal, provincial and 
federal governments including the Vancouver Coastal Health Authority and Health 
Canada. They deserve recognition for their advocacy as without them a state endorsed 
and funded SIF would simply not have been implemented.” (Small et al., 2006 p.75) 
The strands of activism and policy development required political leadership to advance the 
policy idea. That resolve came in the form of a conversion from opponent to proponent by 
Vancouver Mayor Philip Owen, followed by an electoral victory fought on the issue of drugs 
by his successor and ally Larry Campbell. Owen was Mayor of Vancouver from 1993 to 2002, 
representing local municipal party, the Non-Partisan Association (NPA). Owen’s position on 
supervised injecting sites in the late 1990s was unequivocal: “I’m totally and violently 
opposed to this at this point. It’s absolutely wrong” (Armstrong, 1998). It was a position he 
reversed by 2001 to steer the Four Pillars policy through a hostile Council, including the 
recommendation for piloting supervised injecting. Owen’s championing of a new and 
alternative approach has been attributed to a genuine effort to understand the problems at 
the level of the street, coalition building and a capacity to draw in expertise and experience 
from other cities, particularly in Europe (Campbell et al., 2009). However, Owen’s outspoken 
support of drug policy reform cost him the endorsement of his party; the NPA nominated an 
alternative candidate for the mayoral election in 2002 (Vancouver Sun, 2002).  
The city’s drug policy and the Downtown Eastside were contested issue in the election. The 
Committee of Progressive Electors (COPE) fielded Larry Campbell, a former coroner and 
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police drug squad officer, who campaigned on a platform of opening a supervised injecting 
centre (McCann, 2008). Family advocacy group From Grief to Action held a mayoral debate 
in the lead-up to the election where, as Campbell et al. describe, no one spoke out against 
supervised injecting sites and “candidates were grilled on how they would ensure that at 
least one such site would open in Vancouver” (Campbell et al., 2009 p.170). Campbell won 
by a landslide and pledged to open a facility (Boyd, 2013).  
While the issue was being resolved politically in Vancouver, the Federal Government was 
providing the necessary legal cover for SIFs to begin operation in Canada. The Controlled 
Drugs and Substances Act 1996 (CDSA) made the possession of certain drugs illegal in Canada, 
but also contained the provision under Section 56 of the Act for the Minister of Health to 
exempt individuals and or/illegal substances from the application of the Act, provided that 
“…in the opinion of the Minister, the exemption is necessary for a medical, or scientific 
purpose or is otherwise in the public interest” (Controlled Drugs and Substances Act 1996). 
In December 2002, Health Canada issued draft guidelines stipulating that proposals for SIFs 
could be made to the Minister seeking such an exemption, but such sites would be required 
to be operated as scientific research projects (Bula, 2002). Following an application from local 
health authority, Vancouver Coastal Health, an exemption was granted by the Liberal Federal 
Government of Jean Chretien, enabling a sanctioned supervised injecting centre to be 
established.  
The establishment of Insite and evidence of effectiveness 
Insite opened its doors in Vancouver’s Downtown Eastside in September 2003 as a three-
year pilot project under a partnership between the Portland Hotel Community Services 
Society and Vancouver Coastal Health. The Provincial Health Ministry contributed C$2 million 
for operational costs and a further C$1.2 million towards renovation costs (Read, 2003). The 
site offered twelve injecting booths, a nursing station and a ‘chill out’ space. Insite has since 
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expanded to offer on-site detoxification and a recovery program (Harati, 2015). The service 
would typically have between 700-800 visits a day, but numbers can reach 1100 (Street 
Roots, 2010). 
Insite was licenced for scientific purposes only (consistent with a Section 56 exemption) and 
Health Canada developed new Federal Guidelines to govern the monitoring of the site 
(Christie et al., 2004). Evaluation of the pilot was undertaken by the B.C. Centre for Excellence 
in HIV/AIDS and over 30 studies were published in the first five years of operation (Harati, 
2015). According to the most recent systematic review of the benefits and harms of safe 
injecting site published in 2014 by Potier et al., 68 per cent of the literature came from studies 
of the Vancouver site (n=51). Studies addressed the acceptance of the SIF to the local drug 
using community; public order issues; safe injecting education and practices; HIV risk 
behaviour; referral for addiction treatment; overdoses; and community impact. Consistent 
with other international literature (Potier et al., 2014; Hedrich et al., 2010) the peer-reviewed 
evaluations of Insite have been overwhelming positive in their findings, documenting “a large 
number of health and community benefits, and…no indications of community or health-
related harms” (Wood et al., 2006 p.1403). (See Chapter 1 for further discussion.) 
Dr Peter Centre 
While Insite has dominated the story of supervised drug consumption in Canada, one 
organisation provided supervised injection services without government sanction for 
fourteen years before finally being granted an exemption in 2016. The Dr Peter Centre is a 
private HIV/AIDS care facility located near the St Paul’s Hospital in Vancouver’s Downtown 
area. In 2002, following two episodes of overdose, the Dr Peter Centre began offering a 
dedicated space and supervision by nurses for its clients who were injecting drug users 
(Davis, 2007). The Executive Director of the Centre, Maxine Davis, went public about the 
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practice at a press conference in April 2002 (Bohn, 2002a). The Vancouver Police, when asked 
to comment on the potential illegality of their actions, responded by saying: 
“Nurses are not injecting these individuals with the drug…They’re teaching them about 
proper usage of intravenous needles. There’s no criminal connection, so we wouldn’t 
be seeking any action.” (Bohn, 2002b) 
As detailed above, an exemption from the Controlled Drugs and Substances Act 1996 (CDSA) 
gave both users and providers of a supervised injection service legal protection from 
prosecution on possession, trafficking or aiding and abetting charges. The Dr Peter Centre, 
however, effectively turned the question of lawfulness on its head by arguing that for nurses 
in their employ to not provide such a service might place them in breach of their own 
professional standards as per the province’s Nurses (Registered) Act RSBC 1996 (Davis, 2007). 
The Association of Registered Nurses of British Columbia, when consulted by the Dr Peter 
Centre, agreed that “providing clients with evidence-based information to more safely give 
themselves intravenous injections is within the scope of registered nursing practice” (Wood 
R. et al., 2003). Health Canada, when approached about the issue, referred it back to the 
province, arguing medical practices lie within provincial jurisdiction (Bohn, 2003b). The Dr 
Peter Centre provided its service without interference from health or law enforcement 
authorities, even as the political environment at the federal level became increasingly hostile 
towards supervised injection. 
Contestation (2006-2015) 
In 2006, the deadline of the expiration of the three-year trial period of Insite coincided with 
a change of federal government. Steven Harper’s Conservative Party formed a minority 
government, after 13 years of Liberal Party rule. Harper made his opposition to supervised 
injecting sites known during the election campaign, stating, “We as a government will not 
use taxpayers’ money to fund drug use” (Boyd, 2013 p.236). The Federal Health Minister, 
Tony Clement, however, issued a 15-month extension to Insite’s exemption in September 
2006. He argued further time was needed to determine the outcomes of the pilot. No funding 
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was provided for continued evaluation, but the Government convened an advisory panel. 
Clement’s position was that the existing research was not conclusive and therefore the 
Government could not support new applications. His press release stated: 
“Initial research has raised new questions that must be answered before Canada’s new 
government can make an informed decision about the future of Vancouver’s drug 
injection site or consider request for any new injection site…“…Right now the only 
thing the research to date has proven conclusively is drug addicts need more help to 
get off drugs,” Minister Clement says. “Given the need for more facts, I am unable to 
approve the current request to extend the Vancouver site for another three and a half 
years.”…Health Canada will not entertain any applications for the establishment of 
additional injections sites in other parts of Canada until the new NDS [National Drug 
Strategy] is in place, and the Vancouver review is completed.” (Personal 
communication, Health Canada, 17 March 2017) 
The advisory panel commissioned a study which endorsed the B.C. Centre for Excellence on 
HIV/AIDS’ findings that Insite had not had a negative effect on public order and that it was 
viewed by local residents and business owners as having a positive impact on the 
neighbourhood (Boyd, 2013). Clement continued to contest the evidence which led to an 
investigation by the Pivot Legal Society. Through a series of Freedom of Information requests, 
they exposed the ‘research’ to which Clement referred was produced for the Royal Canadian 
Mounted Police. The RCMP commissioned four pieces of work. The first two commissioned 
reports were found to be largely favourable of Insite. Two further articles questioning the 
methodology and integrity of the evaluation process were published in a non-peer reviewed 
online Journal of Global Drug Policy and Practice, including one by the Director of Research 
at the Drug Prevention Network, Colin Mangham. These articles were used as justification by 
the Minister to question the effectiveness of supervised injecting and prevent the expansion 
of services beyond the Vancouver site (Paulsen, 2008; Boyd, 2013).  
The court challenges 
Facing uncertainty, the Portland Hotel Society and two injecting drug users challenged the 
federal government in court in August 2007. The case was argued around two key 
constitutional points: the first was that the federal government was overstepping its rights 
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in relation to the province by enforcing provisions in the CDSA; the second, that the federal 
government’s prohibition of a controlled substance (which thus prevented access to Insite) 
violated the right to life and security that was within the Charter of the Constitution of 
Canada (Voell, 2012).  
The case was heard first in the BC Supreme Court by Justice Pitfield, who found in favour of 
the plaintiffs in May 2008. Justice Pitfield dismissed the first argument, but accepted the 
arguments that addiction was an illness and that, given that the risks associated with the 
injection of drugs could be ameliorated by doing so in the presence of a health care 
professional, to deny access to such health care was a violation of the right under Section 7 
of the Charter to life, liberty and security of the person (Voell, 2012). Evidence of the 
outcomes of the Insite pilot played a crucial role during the case, with the judge’s decision 
resting on determinations about the effect of the intervention, as well as consideration of 
where risk most lay for drug users. The judge concluded that the risk was not inherent in the 
drugs themselves, but rather in the contexts in which drugs were consumed (Small, 2012). 
Justice Pitfield ruled that, despite the capacity for an exemption to be granted under Section 
56 of the CDSA, the process was too arbitrary resting in the hands of the Minister of Health, 
and therefore granted Insite a constitutional exemption from the CDSA, allowing it to 
continue to operate outside the ‘intrusion’ of criminal law (Boyd, 2013). 
The federal government appealed the decision in the Court of Appeal in January 2010, but 
the appeal was upheld in a 2:1 finding. The government’s subsequent appeal to the Supreme 
Court of Canada (SCC) was also lost, in September 2011. While the SCC dismissed the 
argument of interjurisdictional immunity (which was the basis of the majority finding of the 
Court of Appeal), it did find that the Minister of Health’s decision not to grant an exemption 
under Section 56 of the CDSA was unconstitutional and ordered such an exemption be 
granted. The Supreme Court upheld Justice Pitfield’s finding that the denial of access to 
154 
 
 
health services violated Charter rights, recognising that the risks associated with addiction 
and injecting could be ameliorated by being supervised by health professionals (Voell, 2012). 
As Boyd describes, the Supreme Court’s decision did not provide a blanket endorsement of 
supervised injecting services, but rested specifically on the evidence that Insite was effective 
and its operations did not run contrary to other criminal law objectives of the federal 
government (Boyd, 2013).  
Respect for Communities Act 2015 
The Federal Government responded by using its capacity to legislate to set new requirements 
for exemptions under Section 56 of the CDSA. The Respect for Communities Act, enacted May 
2015, established 26 criteria that an application would be required to address in order to 
make the case for a supervised injecting facility. The Government argued that the bill ensured 
a better balance could be achieved between public health and public safety concerns (The 
Canadian Press, 2015). In many ways, the requirements mirrored the considerations outlined 
in the Supreme Court ruling of 2011 instructing the Minister as to what to consider when 
granting an exemption (Canada (Attorney General) v. PHS Community Services Society, 2011 
paragraphs 152-153). The argument was made, however, that the bills were ideologically 
driven and privileged the voices of opponents of harm reduction (The Canadian Press, 2015; 
Zlotorzynska et al., 2013). Concerns were raised that the legislation both had implications for 
Insite’s ability to renew its exemption, and set unreasonable hurdles for the establishment 
of any further supervised injection sites in Canada (Hayle, 2015). 
The capacity of the Act to stall or block supervised injecting was never fully tested before the 
Harper Government was defeated by Liberal leader Justin Trudeau’s landslide victory in 
October 2015 (Murphy and Woolf, 2015). The Trudeau Government signalled its willingness 
to approve further drug consumption rooms and subsequently, the Dr Peter Centre 
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successfully applied for a licence which was granted in January 2016, allowing it to shift its 
long running unsanctioned service onto a more stable legal footing (Hayle, 2017).  
6.2.3 Current status and expansion of services (2016-2018) 
Away from politics, a major public health crisis was unfolding in British Columbia with the 
introduction into the illicit drug market of a powerful synthetic opiate called fentanyl. This 
prescription painkiller can be up to a hundred times more potent than morphine. It was first 
detected as a cause of overdose by the Coroner’s Office in 2012 (Hunter, 2016). Illicit drug 
overdose and overdose death rates have reached unprecedented levels, according to public 
surveillance reports, and a public health emergency was declared by the British Columbia 
Medical Officer in April 2016. The B.C. Coroners Service recorded 993 illicit drug overdose 
deaths in 2016. This rose by 50 per cent in 2017 to 1486 (B.C. Coroners Service, 2018a p.5). 
It is estimated that fentanyl will be detected in 85 per cent of illicit drug overdose deaths in 
2018, up from 4 per cent in 2012 (B.C. Coroners Service, 2018b p.2) 
Despite the change of federal government, the Respect for Communities Act still stood in 
2016, presenting a major obstacle for any organisation or local government wishing to open 
a new supervised injecting facility. In defiance of the law, a group in Vancouver established 
the Overdose Prevention Society. From a tent in the Downtown Eastside, they offered a place 
for people to both inject and inhale, and access to the drug naloxone which successfully 
reverses opiate overdoses (Lupick, 2016a). With pressure mounting, and an average of four 
people dying from overdose every day across the province, the British Columbia Health 
Minister, Terry Lake, issued a Ministerial Order in December 2016, allowing overdose 
prevention sites to open. The province thus provided a means for services to be offered 
without the burden of the federal requirements by arguing these services only monitored 
drug consumption, but did not medically supervise injecting or offer the ancillary services 
that a facility such as Insite did. By March 2017, 20 overdose prevention sites had opened 
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across British Columbia and had monitored 67,000 visits (Shore, 2017). (For further 
discussion see Section 6.4.2 below.) 
In parallel to the opening of the overdose prevention sites, proposals for two further 
supervised injecting facilities in Vancouver were submitted to Health Canada. Vancouver’s 
third site, known as Powell Street Getaway, opened its doors in July 2017 (Vancouver Coastal 
Health, 2017). The proposal for a facility at the Heatley Integrated Care Centre had not been 
approved as of December 2018 (Health Canada, 2018). 
Significantly, federal legislation was passed in May 2017, replacing the Respect for 
Communities Act. The new Act removes barriers to application for new supervised 
consumption sites by reducing the number of criteria from 26 to five broader conditions that 
reflect the concerns of the Supreme Court decision (Controlled Drugs and Substances Act 
2017). Applicants must show: “proof of need; community consultations; evidence about the 
site’s effect on crime; that there is an administrative structure in place; and that there are 
adequate resources to maintain the site” (Woo, 2017). Table 6.1 shows the number of 
approvals for exemptions by province that have been issued by the Minister through Health 
Canada as of December 2018, and the number of centres which are operational (the 
remainder are undergoing renovation). This table does not include data on the overdose 
prevention sites. 
Table 6.1 Approved drug consumption rooms by province, December 2018 
Province Exemptions Number of operational centres 
Alberta 
 
6 6 
British Columbia 
 
9 9 
Ontario 
 
11 9 
Quebec 
 
4 4 
Total 30 28 
Source: Health Canada (2019) 
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6.3 Case study 4: Toronto, Canada 
Although more than double the population size of Vancouver, Toronto has not faced the 
same scale of problematic drug use, overdose death rates or HIV and Hepatitis C prevalence. 
However, since the mid-2000s, the City of Toronto has recognised the need to develop 
effective responses to both licit and illicit drug use through coordinated intersectoral policy 
and programme action. A proposal for consideration of supervised injecting services was 
raised in 2004-2005; over twelve years lapsed before that idea translated to the first service 
opening its door in August 2017. This case study of Toronto begins with a brief exploration 
of the specific nature of the drug issues facing the city, followed by a description of the 
different phases of activity, some of which can only be characterised as ‘stalled action’. The 
importance of the burgeoning opioid crisis to hit Canada from 2016 onwards becomes 
apparent as the very slow journey of policy change moves more rapidly to policy 
implementation. This case study of Toronto demonstrates the persistence of the policy idea 
of supervised injecting in the face of an unreceptive political and community response. The 
key role of the local public health bureaucracy in continuing to develop policy options shows 
the critical role played by institutions and policy networks in this case. Once again, political 
leadership has also been decisive, as has the role of crisis framing, on the prospects for the 
replication and translation of policy. 
6.3.1 The emerging issues 
Visible public drug use in Toronto manifested later than in Vancouver but was prevalent in 
the city by the early 2000s, with the primary drugs of concern being alcohol and crack cocaine 
(Toronto Drug Strategy Advisory Committee, 2005). Toronto’s drug scene has been 
characterised as dispersed rather than concentrated, a factor acknowledged in the City’s first 
drug strategy through comparison to other cities across the world: 
“Toronto does not have large, concentrated, open drug scenes like the Downtown 
Eastside of Vancouver or the infamous “needle parks” of Zurich or Frankfurt. In 
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Toronto, substance use is spread throughout the city, often hidden from view. Hidden 
use can be risky as it is harder to reach people who may need help.” (Toronto Drug 
Strategy Advisory Committee, 2005 p. 2) 
Toronto did not experience the same patterns of disease outbreak among its drug-using 
population as British Columbia, with HIV rates estimated to be around 5 per cent in 2004 and 
Hepatitis C around 54 per cent (Toronto Drug Strategy Advisory Committee, 2005 p.3). The 
factors that contributed to this include both the prevalent types of drugs and the modes of 
consumption. The risk of transmission of infection is particularly heightened by injecting 
rather than other forms of consumption. Fischer et al. (2005) noted, in their comparative 
study of illicit opioid use in five cities in Canada, that participants from Toronto primarily 
employed non-injection routes of administration, and while crack cocaine can be injected it 
is more commonly smoked (Santibanez et al., 2005). Toronto was also the first city in Canada 
to offer a needle syringe program, with an unofficial program commencing in 1987, followed 
by an official one in 1989 (Canadian Centre on Substance Abuse, 2004).  
6.3.2 Phases of the response 
Toronto’s path to the establishment of supervised injecting facilities has been largely 
bureaucratically- and task force-driven, in contrast to the strong role played by activism and 
acts of civil disobedience in Vancouver. There have been distinct phases of activity, from the 
initial period of strategy development (2004-2005) to the lengthy period of the needs and 
feasibility study (2006-2012) that produced the TOSCA Report and its recommendation of 
the viability of three supervised injecting sites for Toronto. The final phase (2013-2018) has 
witnessed both initial political inaction and then change as the public health crisis and rising 
overdose deaths increased the pressure on local, provincial and national authorities. 
Strategy development (2004-2005) 
In 2004, the City of Toronto produced a comprehensive drug strategy aimed at coordinating 
and integrating the city’s responses to both licit and illicit drug use (Toronto Drug Strategy 
Advisory Committee, 2005). Fourteen public consultations (focus groups and town halls) 
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were conducted to gauge responses to the strategy. Following debate in the Council, the 
policy was passed with a vote of 24:15 in December 2005 (Spears, 2005b). Its four pillars 
approach, focused on prevention, treatment, enforcement and harm reduction, was 
modelled on successful international examples and Vancouver’s pioneering drug strategy. 
Included in its recommendations was a proposed needs and feasibility study for supervised 
consumption (injection and/or inhalation) services in Toronto.  
The recommendation attracted considerable controversy in the media and during Council 
debate over the strategy (Spears, 2005b). A key issue was whether supervised consumption 
was appropriate for Toronto. The recommendation for the feasibility study had the support 
of the city’s Medical Officer for Health, Dr David McKeown; however, members of Council 
were sceptical about the fit between supervised consumption and Toronto’s specific drug 
use patterns and issues. Councillor Kyle Rae, who headed up the Drug Strategy committee, 
while arguing for the benefits of supervised consumption sites in general, expressed concern 
that supervised injection might not be the right solution for Toronto, where crack cocaine 
was more predominant than heroin (Porter, 2005). He did, however, stress that the option 
should be explored: "Everything should be on the table…You get to say no if you don't think 
it's the right thing to do, but at least you've considered it" (Spears, 2005a). Despite concerns, 
the Drug Strategy and all its recommendations were passed by the Council. Recommendation 
65 for the needs and feasibility assessment of supervised consumption sites was passed with 
amendment to ensure the study considered, amongst other things, the effects of drug use 
on neighbourhoods, businesses, crime patterns and property values, and that residential 
groups be consulted (Toronto Drug Strategy Advisory Committee, 2005 p.86). 
Needs and feasibility study (2006-2012) 
While the mandate from Council was apparently clear, progress on the issue hit a major 
stumbling block as no specific funds were earmarked to support the study. This lack of 
160 
 
 
funding changed both the nature and the timeframe in which this critical piece of work could 
be delivered. With no direct resources to call on from the public purse, independent 
researchers from the university sector were approached to undertake the study and to secure 
the funding. Having to operate within the competitive research funding environment 
impacted the objectives, structure and duration of the project, as was confirmed by a 
participant interviewed for this thesis (Researcher 4, Toronto). The resultant study was 
undertaken as a collaboration between the University of Toronto and St Michael’s Hospital, 
and encompassed both Toronto and Ottawa, thus becoming the Toronto and Ottawa 
Substance Consumption Assessment Study, or TOSCA Report (Bayoumi et al., 2012).  
The TOSCA report was released in 2012, nearly seven years after the recommendation for 
the study was adopted. It is a remarkably comprehensive study, assessing the need for 
consumption services; modelling the potential economic impact, in particular on Hepatitis C 
prevalence; and addressing issues of community support and acceptance. The key 
recommendations to emerge from the TOSCA Report were that Toronto would benefit from 
three, fixed site supervised injection facilities, that should not be standalone, but integrated 
into existing services. The report also found that there was “insufficient evidence to support 
a supervised smoking facility” (Bayoumi et al., 2012 p.15). An important issue highlighted in 
the report was that the location of the proposed centres was a major concern for 
Torontonians:  
“Even residents and business owners supportive of supervised consumption facility 
implementation did not necessarily want to see a facility in their own residential 
neighbourhoods or near their businesses” (Bayoumi et al., 2012 p.10). 
Resistance, crisis and action (2013-2017) 
It was the local bureaucracy, through Toronto Public Health, that pressed forward with the 
recommendations, under the leadership of the Medical Officer of Health, David McKeown, 
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who reported to the Board of Health (BoH)1. This contrasts to the other three case studies 
where political institutions have tended to play a leading role. In June 2013, Dr McKeown 
recommended the BoH seek the support of the provincial government to fund integrated 
supervised injection services on a pilot basis (Toronto Public Health, 2013). Following public 
submissions and presentations to the Board, this recommendation was adopted (Board of 
Health, 2013). It failed, however, to gain the required political support to progress at either 
the local or provincial level. Toronto Mayor Rob Ford declared it the “worst thing that could 
happen to the city” (Editorial, 2013). Nor was support forthcoming from the provincial 
government under the premiership of Liberal Kathleen Wynne. A spokeswoman for the 
Health Minister cited a lack of support from the federal government: 
“Given that the federal government’s approval would be a prerequisite, at this point 
we have no plans to move forward with supervised injection sites.” (Dale, 2013) 
Public Health Toronto continued to keep the idea in circulation in policy circles and in the 
community during 2013-2015. It undertook public consultations and produced a ‘Supervised 
injection services toolkit’ which provided information for those considering establishing 
supervised injection sites, including guidance on meeting the criteria set out by the 2011 
Supreme Court ruling (Toronto Drug Strategy, 2013). In 2014, a local not-for-profit group, St. 
Christopher House, formed a Residents’ Reference Panel on Supervised Injection Services, 
randomly choosing 36 members from letters sent to 7,500 households. The purpose of the 
panel was to seek input on how local residents should be consulted and their concerns 
addressed, through the development of guiding principles for community consultation. As a 
result of this consultation, a report was produced containing recommendations and a 
roadmap on how such a service might best proceed (St. Christopher House, 2014). 
                                                          
1 The Board of Health is a City of Toronto board which oversees the work of Toronto Public Health 
and comprises 13 members, including six Council member, six citizen members and one educational 
representative.  
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While the issue of supervised injection did not appear to be gaining much political traction in 
Toronto at this time, the impact of drug use was getting worse, creating an opportunity for 
change to come about in the context of a new public health crisis. Overdose deaths increased 
by 41 per cent between 2004 and 2013 from 146 to 206 (Toronto Public Health, 2015 p.1). 
Deaths attributed to opioids increased from in 44 to 126 over the same period: an increase 
of 186 per cent (Toronto Public Health, 2015 p.7). Between 2006 and 2013 in Ontario, there 
were nearly 20,000 visits to emergency departments to treat forms of opioid toxicity and 
these resulted in over 10,000 hospital admissions (Miller, 2017). As in Vancouver, fentanyl 
was beginning to pose an overdose threat to drug users, as were prescription opioids such as 
oxycodone. In Ontario, deaths attributed to fentanyl (from licit and illicit sources) increased 
from 63 in 2009 to 111 in 2013 (Toronto Public Health, 2015 p.3).  
In 2016, the issue of supervised injection sites was brought twice before the Board of Health 
by the Medical Officer of Health. In March, Dr McKeown announced to the Board that three 
local health services were planning to introduce supervised injecting as part of existing 
services: Toronto Public Health (The Works), Queen West-Central Toronto Community 
Health Centre, and South Riverdale Community Health Centre. He sought and received 
unanimous approval to participate in community consultations in those areas in order to 
meet federal government requirements for the exemption process (Toronto Public Health, 
2016; Board of Health, 2016a). In July 2016, the Board of Health approved support for the 
three proposed services, and to the initiation of an exemption application to Health Canada 
and a request to the provincial government to support the full costs of implementation 
(Board of Health, 2016b). Previously absent political support materialised and the decision 
was endorsed by the City of Toronto Council in a 36:3 vote in favour, with support from the 
Mayor John Tory and Toronto Police Chief, Mark Saunders (CBC News, 2016). An application 
for federal exemption was submitted symbolically on World AIDS Day, 1 December 2016, but 
it was another month until the provincial government pledged its support. Its delay was 
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criticised by Ontario New Democratic Party Leader, Andrea Howarth, who in an open letter 
to the Premier, Kathleen Wynne, argued: 
“It should not take six months, in the face of a national overdose crisis, for the 
provincial government to approve funding and issue letters of support for the City of 
Toronto’s supervised-injection sites.” (Miller, 2017) 
Despite the new Trudeau Government’s support for supervised injecting, the timing of the 
exemption applications (late 2016) meant that the 26 criteria in the Respect for Communities 
Act 2015 were still to be addressed. These applications were approved by Health Canada, 
and Ministerial exemptions to the Controlled Drugs and Substances Act 1996 were issued for 
the three sites in Toronto in June 2017 – some twelve years after the initial recommendation 
for consideration was made in the Toronto Drug Strategy.  
Activism and civil disobedience 
Toronto has not had the extent of activism that is apparent in the case study of Vancouver. 
Since 2017, however, activists influenced by events in Vancouver in response to the opioid 
crisis have engaged in acts of civil disobedience to provide drug consumption services in 
response to what they felt were delays to the development of sanctioned services. The 
opening of ‘pop-up’ supervised sites has occurred in parallel to efforts to develop more 
permanent services. The first site to open was in Moss Park in downtown Toronto in August 
2017. Run by volunteers from the Toronto Overdose Prevention Society and the Toronto 
Harm Reduction Alliance, this service provided supervision for both injection and inhalation, 
initially from three tents. No action was taken by the City to shut down the illegal site and 
the Ontario provincial government donated equipment to the service (Arnone, 2017). 
Councillor Joe Cressy, Chair of the Toronto Drug Strategy Implementation Panel, captured 
the frustration of the local government with the delay in opening the newly sanctioned sites, 
reacting to the pop-up service: 
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“We wish our sites were open yesterday, and frankly they would have been if it didn't 
take nine months for the provincial and federal government to give us the funding to 
do it.… The City of Toronto cannot open a site which is illegal, I certainly cannot as a 
city councillor and as a harm reduction advocate, cannot condemn it." (Nassar, 2017) 
This act of civil disobedience in Toronto, and others across Canada, led directly to a change 
of policy. The federal government intervened in November 2017, by providing provinces with 
a CDSA exemption that would allow them to sanction overdose prevention sites on a three- 
to six-month basis as a crisis response. Approvals for five OPSs were granted by the Ontario 
government for sites in Toronto (de Villa, 2018). While the policy pathway to support OPSs 
was established, political support at the provincial level was withdrawn with the election of 
a new provincial government in June 2018. The Progressive Conservatives, under Premier 
Doug Ford, placed a freeze on new overdose prevention sites and called for a review of 
evidence, including of their links to rehabilitation services (Bueckert, 2018). The provincial 
government also demonstrated its capacity to be a key influence on policy in this area by 
suspending funding for any new sites. In response, activists opened an unsanctioned site in 
Parkdale in a further act of civil disobedience, opening the way for potential conflict between 
local government authorities and the provincial government (Jones, 2018). For further 
discussion on civil disobedience, see Section 6.4.2 below. 
6.3.3 Current status 
Opioid overdose deaths continue to rise steadily in Toronto. There were 303 deaths in 2017, 
up by 63 per cent on the 2016 figure and 121 per cent on the 2015 figure (de Villa, 2018 p.2). 
As of December 2018, there were four sanctioned supervised consumption sites operating in 
Toronto: The Works, South Riverdale Community Health Centre, Parkdale Queen West 
Community Health Centre, and the Fred Victor Centre. All sites offer supervised injection, 
and in addition, South Riverdale and Parkdale Queen West supervise intranasal and oral 
consumption (Health Canada, 2018). The Fred Victor Centre was the latest site to be 
approved. It is located opposite Moss Park and was intended to cater to the clients who used 
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the temporary Moss Park pop-up site (CBC News, 2018). Following the provincial 
government’s review of overdose prevention sites, new guidelines were issued in October 
2018. OPSs may continue to operate, but now must meet the federal requirements for 
supervised injecting sites in addition to further conditions, including proximity guidelines in 
relation to schools and parks. These requirements have not been welcomed by the Chair of 
the Toronto drug strategy implementation panel, Councillor Cressy, who described the 
guidelines as overly restrictive and said: 
“In the midst of the most significant health crisis in a century, we should not be 
restricting our ability to save lives, we should be scaling up our ability to provide life-
saving health care.”  (Pagliario, 2018)  
6.4 Contextualising the Canadian case studies 
The purpose of this section is to set the two individual case studies in the broader political 
and policy context of the Canadian federal system, in order to identify relevant sources of 
policy change and stall through the lens of Evans’ (2004) policy transfer framework. Particular 
attention is paid to state-based sources of policy change, given the complexity of the 
interactions of different levels of government in relation to drug policy generally and 
supervised injecting in particular. Following an examination of federal, provincial and local 
government roles, consideration is given to the impact of civil disobedience in both 
Vancouver and Toronto. 
6.4.1 Political setting  
International sources of policy change 
Consistent with the cases in Australia, there is little evidence that international institutions 
such as the International Narcotics Control Board exercised a constraining effect in relation 
to policy transfer in Canada. The INCB did, however, attempt to put pressure on the federal 
government, stating in its annual report in 2003 in relation to the approval of Insite: 
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 “The Board reiterates its view that such sites are contrary to the fundamental 
provisions of the international drug control treaties, which oblige States parties to 
ensure that drugs are used only for medical or scientific purposes.” (International 
Narcotics Control Board, 2004 p.49) 
The Board raised the issue again in its 2006 and 2007 annual reports (International Narcotics 
Control Board, 2008; International Narcotics Control Board, 2007). There is evidence that the 
federal government considered the risk of continuing to support supervised injecting in the 
mid-2000s. The Vancouver Sun reported that it had seen internal federal government 
documents that weighed concern with offending the international community as more 
serious than the repercussions of shutting down Insite against the wishes of the government 
of British Columbia (O’Neil, 2007). New Democratic Party Federal MP, Libby Davies voiced 
the fear that Health Minister Tony Clements would use the INCB’s criticism to continue to 
attack Insite (Edward, 2007). The Harper Government was forthright in its opposition to 
supervised injecting; there is, however, no evidence that the actions of the INCB contributed 
significantly to their policy agenda. 
State-centred sources of policy change 
The different distribution of powers within the Canadian federal system when compared to 
Australia affects the degree of engagement and the capacity to act at different levels of 
government. Despite the importance of these structural relationships between the levels of 
government, autonomy is exercised through the impact of ideational factors such as political 
parties’ ideological stances on drug use, and agency factors, such as the role of political 
leadership. The combination of these factors has influenced the degree to which drug 
consumption policy has been replicated. 
National drug policy in Canada 
Canada’s first national drug strategy was launched in 1987 under the Progressive 
Conservative Government of Brian Mulroney. Health Canada has been the lead agency, 
reflecting the underlying principle that drug misuse is primarily a health issue. The first four 
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phases of the strategy to 2007 increasingly adopted harm reduction measures, although 
demand and supply reduction dominated. While all levels of government are engaged in 
activities that address substance use issues, at the federal level, funding has been directed 
largely towards supply reduction through enforcement and interdiction activities (Office of 
the Auditor General of Canada, 2001). Successive federal governments have adapted the 
strategy to reflect their ideological positions on drug use. In terms of policy transfer, these 
differing ideological stances have acted as key constraining and facilitating factors in the push 
to develop drug consumption rooms. 
In 2007, the Harper Government re-badged the national strategy with the launch of the 
‘National Anti-Drug Strategy’ (NADS), reflecting its ‘tough on crime’ position. While the 
strategy included prevention and treatment as priority areas, law enforcement continued to 
receive 70 per cent of drug strategy funding (de Beck et al., 2009 p.188). The NADS strategy 
was criticised for excluding federal support for harm reduction activities (Carter and 
MacPherson, 2013). Under the current Trudeau Liberal Government, the NADS has been 
replaced by a new ‘Canadian Drugs and Substances Strategy’ launched in 2016. The strategy 
deliberately restores the harm reduction pillar, alongside prevention, treatment and 
enforcement, and according to the Government, reflects its commitment to “a 
comprehensive, collaborative, compassionate and evidence-based approach to drug policy” 
based on public health principles (Government of Canada, 2016).  
While Canada has ‘national drug policy’ in place, it has been contended that ‘federal drug 
policy’ would more accurately describe the approach, due to the lack of collaboration with 
provincial and territorial governments in the development and implementation of policy 
(Carter and MacPherson, 2013). This represents a difference to Australia, where drug policy 
appears to be better integrated across levels of government. In Canada, the provinces and 
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territories demonstrate considerable autonomy in relation to drug policy. As the 2008 
Evaluation of the NADS noted:  
“The provinces and territories have different objectives and priorities: they focus on 
substance abuse in general rather than abuse of illicit drugs, support harm reduction, 
and take a more holistic approach to substance use issues (for example, many 
provinces have integrated or are integrating mental health and addictions).” 
(Evaluation Division Office of Strategic Planning and Performance Measurement, 2010 
p.11) 
Fischer et al. (2016) argue that the divergence of policy goals and approaches between these 
levels of government has resulted in a bifurcation of drug policy between the two paradigms 
of public health and law enforcement approaches to drugs, and that the lack of 
‘harmonisation’ is undermining policy outcomes. The new Canadian Drugs and Substances 
Strategy would seem to swing the federal pendulum back in favour of public health 
approaches, more in keeping with policy approaches employed in the provinces (although 
arguably not uniformly). 
In terms of national policy in relation to supervised injecting, Health Canada was engaged in 
developing recommendations in the late 1990s in relation to HIV and Hepatitis C risk. 
Following a national consensus conference on the prevention and control of Hepatitis C, 
feasibility studies for “community safe injection sites” were proposed (Health Canada, 1999 
recommendation 4.2.1). In 2001, the Canadian Conference of Deputy Ministers of Health 
tasked a Federal/Provincial/Territory Committee with investigating drug use in Canada. The 
Committee’s report, in endorsing harm reduction, recognised the successful experience of 
other countries and set as an abiding principle that “Injecting drug use should be regarded 
first and foremost as a health and social issue” (Federal/Provincial/Territory Committee, 
2001). Within its framework for action was the recommendation that a feasibility study be 
conducted of establishing a scientific, medical research project regarding a supervised 
injection site in Canada. A working group was subsequently formed with approval from the 
Ministers (Elliott et al., 2002). The issue was taken up by a House of Commons committee on 
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the non-medical use of drugs which reported in 2002. The committee’s recommendation that 
the government remove any legislative barriers to the implementation of scientific trials and 
pilot projects was not adopted (Canada. House of Commons, 2002 p.89). 
Federal government 
National governments in Canada have influenced the ability of cities to host drug 
consumption rooms by their power to legislate in relation to possession of illicit drugs. This 
structural factor has been influenced by the ideational position of the Government of the 
day, as reflected in the varied legislative and political approaches in relation to supervised 
drug consumption. It is the federal government’s constitutional authority in relation to 
criminal law that allows it to regulate drugs – licit and illicit. The Controlled Drugs and 
Substances Act 1996 forbids “the unauthorised possession, manufacture, cultivation, 
trafficking, export and import of specified substances” and this prohibition extends to 
anything containing illegal substances, such as a used syringe (Elliott et al., 2002 p.36). To 
provide legal protection for both clients and staff of supervised injecting services, Health 
Canada developed guidelines for applications for an exemption under Section 56 of the Act 
which allows supervised injecting sites to be run for scientific purposes and thus be exempt 
from the application of the law (Bula, 2002). Through this process the federal government in 
2003 was able to support the establishment of Insite. In Australia, by contrast, the equivalent 
legislative power is held at the state/provincial level and there has never been any federal 
legislation that provided an avenue to sanctioning SIFs; states have each had to create new 
laws. 
Despite the existing legal provision, the change of Government in 2006 reduced certainty as 
to ongoing support for supervised injecting, with serious effects for the potential for scaling 
up of the policy. As one Advocate interviewed for this thesis noted: 
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“…with the change of Federal Government to a Conservative Government the future 
of Insite looked increasingly dodgy given their stated antipathy towards harm 
reduction in general, but especially supervised consumption services, including the 
Health Minister of the day declaring [Insite] an abomination.” (Advocate 3, Toronto) 
Under the CDSA, provision to make an exemption lies at the discretion of the Minister of 
Health. It was the arbitrary nature of this process that Justice Pitfield criticised when 
upholding the right for Insite to continue to operate under the Charter (Boyd, 2013). The 
Federal Government, however, on the loss of the case, used its legislative powers to control 
the licencing process in relation to supervised injecting facilities through the introduction of 
the Respect for Communities Act 2015 which established 26 criteria that applicants would 
need to address in seeking an exemption. As one interview participant described, even 
though there were doubts as to the constitutionality of the regime, “it had a chilling effect” 
(Advocate 3, Toronto), sending a message that new applications would not be considered 
favourably. 
As the case studies illustrate, the surge of new applications for exemptions in 2017 after years 
of such limited provision of service came about prior to the new Trudeau Government 
repealing the Respect for Communities Act. This demonstrates that the legislation alone, as 
a structural factor, did not constrain the scaling up of supervised injection services. It was the 
political and ideological position held by Governments that signalled to communities and to 
Health Canada as the bureaucratic agency acting for the Government, what would be 
acceptable and therefore whether applications would be facilitated or blocked. 
The provincial governments 
With the formation of the federation in Canada, provinces retained categories of rights while 
ceding other powers to the centre. Health has largely fallen to the provinces to manage, 
although the revenue raising capacity of the federal government gives it the ability to engage 
both in terms of policy and funding allocations. The criminalisation of specific drugs 
necessarily involves the federal government in policy making (through their powers over 
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criminal law), despite ongoing efforts to re-orientate responses to drugs as a health issue. 
Provinces have had no legislative power to support the development of supervised injecting 
facilities, as the states have done in Australia, as they cannot override the issue of the 
criminality of possession of illicit substances. The provinces have, however, been able to lend 
support to those municipalities seeking to establish SIFs, politically as well as financially. The 
record on both fronts has been mixed. In the period from the establishment of Insite in 2003 
until the present, there is little evidence that provincial governments actively supported 
efforts to replicate supervised injecting services, until the recent opioid overdose crisis.  
Both British Columbia and Ontario have been almost exclusively governed by Liberal 
provincial governments since 2003. Change only came about for British Columbia with the 
New Democratic Party coming to power in 2017. Ontario remained under Liberal rule until 
the election of the Progressive Conservatives in 2018. The Premier of B.C. in 2003 was Gordon 
Campbell, a former Mayor of Vancouver and supporter of that city’s first needle exchange 
program. He put his support behind the push for Insite, as then Mayor, Larry Campbell recalls: 
“I never felt a sense of hesitation on Gordon Campbell’s part. He could have easily said 
it was a federal issue, but he didn’t. He saw it as a health issue.” (Campbell et al., 2009 
p.176). 
The B.C. government continued to support Insite throughout the turbulent years of the 
Harper Government, but (with the exception of the Dr Peter Centre) provincial level support 
for supervised injection did not translate into further services on the ground in other 
municipalities, despite proposals for services in other B.C. cities, such as Victoria and Prince 
George (Fischer and Allard, 2007; Fong, 2006).  
For Toronto, on its slow journey towards its first supervised injecting centres, provincial 
support was never assured. On the release of the TOSCA report in 2012, with its 
recommendation for three sites in Toronto and two in Ottawa, the provincial government 
declined to support the proposals. Ontario Minister for Health, Deb Matthews is quoted as 
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saying that the government “was happy to receive good advice and that ‘we make our 
decisions based on evidence’”, while claiming, “Experts continue to be divided on the value 
of the sites” (Stinson, 2012). The following year, the new provincial government under 
Premier Kathleen Wynne maintained the stance, arguing the federal government’s position 
would rule out the necessary approval being obtained and therefore the provincial 
government would not be moving ahead (Dale, 2013). As one interview participant said: 
“It was clear the environment was not supportive politically of moving any of this 
forward, either here, in Vancouver, in Ottawa, in Thunder Bay or London. No it wasn’t. 
We had a Liberal provincial government but they were not particularly strong when 
we came out or when the TOSCA study came out; frankly they were a bit lukewarm to 
unhelpful.” (Policy Maker 3, Toronto) 
The tendency to defer to both the federal government and the municipalities belied the 
important role played by the provinces through their control of health budgets. One of the 
conditions that had to be met to receive an exemption was proof of sustainable financial 
support for the proposed project. The City of Toronto, in developing its application to Health 
Canada, was constrained by the slow commitment from the Ontario government, and in the 
end submitted their application in advance of the province pledging funds (Miller, 2017). In 
the view of another participant, the provincial governments were guilty of ‘buck passing’ 
between the municipalities and the federal government. See Theme 2 in Chapter Seven for 
further discussion of this issue. 
The provincial governments’ reluctance to engage in the issue of supervised injecting 
changed dramatically in both British Columbia and Ontario, as the extent and implications of 
the opioid crisis became apparent from late 2016 onwards. In British Columbia, the provincial 
government found an override for the arduous federal government process by differentiating 
between supervised injection services and overdose prevention. One Advocate explained the 
Minister of Health’s actions:  
“… these illegal tents that came up in Vancouver last year showed the government, 
again, how easy it can be. And then, when our provincial Minister of Health issued a 
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ministerial order on December 8th 2016, he actually said, "You know, I woke up in the 
middle of the night last night thinking about Sarah Blyth's tent". And then he passed 
the ministerial order, essentially making what she was doing, which was illegal, making 
it legal. He did that by calling it an overdose prevention site, instead of an injection 
site. Safe injection sites still require federal approval, overdose prevention sites do not. 
It was genius. And then within like five days we had 20 of them open across the 
province.” (Advocate 1, Vancouver) 
The province’s actions proved to be politically effective in pushing the federal government 
to address the inadequacies of the legislative regime: 
“And it was really throwing down the gauntlet a bit to the feds at that point saying 
we'll just call it something different but we're going to go ahead and do it and what 
are you going to do about it? Of course this Government - supportive of harm 
reduction - was not going to pick a fight with the provincial government in the middle 
of an overdose crisis in order to defend bad law that they’d inherited from the 
Conservative Government. So I think it just helped add to the momentum for 
legislative reform and the need to actually streamline this process for these things. But 
it was a good move by the B.C. Government, for sure.” (Advocate 3, Toronto) 
In addition to repealing the Respect for Communities Act 2015, the federal government also 
provided the provinces with further legal protection in November 2017 by issuing a new 
category of exemption under the CDSA, which allowed the provinces to issue temporary 
licences for OPSs (as discussed above).  
Again, legal protection alone has not been enough to allow services to operate; they remain 
dependent on ongoing political support, as the situation in Toronto has illustrated. The 
Ontario government of Kathleen Wynne reversed its initial ambivalence to supervised 
injecting, and announced in August 2017 that it would invest C$222 million in harm reduction 
and treatment measures, including C$23 million to expand the number of drug consumption 
sites across Ontario (Howlett and Giovannetti, 2017). However, a change of provincial 
government in July 2018 under the premiership of Doug Ford, as discussed above, has once 
again introduced uncertainty as to the ability of OPSs to continue to respond to the ongoing 
opioid crisis. In this way, the provinces remain key players in the development of supervised 
injecting policy, demonstrating the capacity to both constrain and facilitate the scaling of 
policy through the exercise of strategic selectivity of political preferences. 
174 
 
 
Local government responses 
There have been similarities and differences in the roles played by local governments in 
Canada compared to Australia. Like in Australia, Canadian local governments have a close 
proximity to the issues confronting their communities concerning amenity and safety. Also 
like in Australia, they are dependent on support from other levels of government to create 
an enabling legislative and political environment to support supervised injecting. One striking 
difference between the four case study cities is the scale of the jurisdictions in Canada, where 
both Vancouver and Toronto have their own police forces and public health agencies. In 
Melbourne and Sydney, those agencies are under state government jurisdiction. This 
changes the level of engagement and the levers at the disposal of local governments in 
Canada to constrain or facilitate supervised injection.  
The two Canadian case studies are marked by the different approaches they have taken, with 
drug issues in Vancouver being high on the political agenda while the City of Toronto has 
experienced a more bureaucratically- and research-led process. Arguably, the 
bureaucratically-driven process in Toronto reflects a lack of political saliency of the issue 
locally. In terms of agenda setting, it is apparent that there was a political concern with 
substance misuse in Toronto. The relative absence of injecting due to the dominant drugs of 
concern (alcohol and crack cocaine), however, may have reduced the impetus to consider 
SIFs as a policy solution. The dispersed nature of the street drug scenes may also have created 
a challenge for debating SIFs, where Insite was the primary example of a model. As a fixed 
site service, it was geographically bound and associated with the Downtown Eastside, for 
which there was no comparable scene in Toronto. It is not surprising that the TOSCA Report, 
reflecting the depth of the research underpinning it, specifically recommends a new 
integrated and dispersed model of services for Toronto (Bayoumi et al., 2012). 
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Agency factors at the level of local government have been apparent in both cases through 
the intervention of leaders in driving forward the issue (or attempting to block it). The 
leadership of mayors such as Philip Owen, Larry Campbell and Rob Ford has been crucial in 
determining the success or otherwise of policy proposals. Similarly, the leadership 
demonstrated by Toronto’s Medical Officer of Health, David McKeown, demonstrates the 
role that can be played by agents in promoting ideas with the aim of embedding them in 
institutional structures in order to achieve change. Ultimately, local governments, while 
driving the ideational basis of the policy through the development of locally specific policy 
documents such as Vancouver’s Four Pillars policy and Toronto’s Drug Strategy, have 
remained dependent on the structural capacity of other levels of government to fully deliver 
supervised drug consumption services (MacPherson, 2000; Toronto Drug Strategy Advisory 
Committee, 2005).  
6.4.2 Civil disobedience 
Civil disobedience features in both Canadian case studies, although over considerably 
different periods of time and with different impacts on the process of policy development. 
The case study of Vancouver details the unsanctioned sites that were established by activists 
prior to the opening of Insite (Folz, 1999). They included the Dr Peter Centre’s injecting room 
that operated within its private HIV/AIDS care clinic with the knowledge of authorities for 
fourteen years before it successfully applied to the federal government for an exemption 
(Hayle, 2017). In 2016, the Overdose Prevention Society established an unsanctioned drug 
consumption site in the Downtown Eastside in response to the rising death toll from fentanyl 
overdoses. This inspired twenty more sites to open across British Columbia, all of which 
initially operated outside the federal government’s exemption regime, but with the support 
of the local and provincial governments (Shore, 2017). In comparison, Toronto’s experience 
with civil disobedience was restricted to the establishment of ‘pop-up’ sites, inspired by the 
actions of the OPS in Vancouver (Arnone, 2017). The impact of civil disobedience on the 
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scaling up of services is further analysed in Chapter Eight (Section 8.3). The purpose of this 
discussion is to contextualise the experiences of Vancouver and Toronto in relation to civil 
disobedience by considering the ‘top-down/bottom-up’ nature of policy making in the two 
sites, and, the role of law enforcement. 
In Chapter Five, the role of civil disobedience in Australia is assessed as having a relatively 
low impact in relation to the achievement of policy change in the two case study sites. In 
Vancouver in particular, civil disobedience has been more critical, serving the role of having 
a ‘bottom-up’ effect on policy change through not only the direct demonstration of services, 
but more importantly, the discursive process by which the concept of supervised injecting 
has been deliberated. In addition to civil disobedience, activists have been part of the policy 
transfer networks developing and circulating ideas; for example, VANDU members have held 
positions on the Board of Health. Toronto, in contrast, has illustrated a more ‘top-down’ 
process. Such a process is described by Schmidt (2011) in her discussion on discursive 
institutionalism: policy elites are seen to construct the ideas that are then communicated to 
the public by political elites. In discursive institutionalism, whether the change is top-down 
or bottom-up, the role of agents is key in the generation of ideas and to persuade policy 
makers, politicians and the public that ‘new’ ideas are necessary and appropriate. 
In contrast to the focus on agency, law enforcement represents a potential structural barrier 
to the enactment of civil disobedience. Both Vancouver and Toronto have municipal police 
forces. The cooperation of local law enforcement has been a fundamental requirement for 
the effective operation of supervised injecting services, whether sanctioned or unsanctioned. 
As the discussion above of unsanctioned services in Vancouver has shown, there has been a 
significant degree of tolerance demonstrated by the police in relation to supervised injecting 
sites. One interview participant described the progressive approach taken by the Vancouver 
Police Department to drug use in general. She attributed this to a recognition by senior 
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management that they weren’t going to arrest their way out of the problems associated with 
drug use, particularly because of changes made by judicial institutions: 
“And part of this impetus was the criminal justice system that decided that we weren’t 
going to give significant sentences for drug possession any more. The criminal justice 
system, the judicial system seemed to recognise this as being more a health issue 
before we did. And so they started the conversation.” (Practitioner 2, Vancouver) 
The same participant was engaged with discussions with other forces across Canada and had 
encountered strong resistance to the ideas and institutional practices that have become 
dominant in the Vancouver force. 
In Toronto, the team undertaking the TOSCA study researched the perceptions of the local 
police force towards supervised injection services. According to Watson et al. (2012), police 
in the study did not support supervised injecting services: they rejected claims that SIFs are 
effective and “made claims that appeared to filter evidence and privilege anecdotal reports 
which suggest that negative outcomes will result from SCS [supervised consumption site] 
implementation” (p.367). The lack of support from local police was confirmed through 
interviews undertaken for this thesis. One participant described the difficulty of gaining 
access to police and engaging with them (Researcher 4, Toronto), while another discussed 
his contact with the then-Police Chief, who was adamantly opposed to supervised injecting 
(Policy Maker 2, Toronto). This was confirmed by Policy Maker 3 who said, “The police chief 
at the time felt that we didn’t have the same conditions as Vancouver and didn’t warrant it 
[supervised injecting]”. Given the strong stance taken by the police in Toronto prior to the 
opioid crisis, it is likely that civil disobedience would not have been tolerated in Toronto in 
the same way the unsanctioned sites were in Vancouver. In addition, it was argued of 
Toronto: “We’ve had very little of that kind of activism here” (Advocate 4, Toronto).  
6.5 Findings and conclusions 
The case studies of Vancouver and Toronto contribute key findings to this thesis’ concern 
with what constrains and facilitates policy transfer in relation to the replication of drug 
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consumption rooms in Canada. While spanning a comparable period of time to the case 
studies of Sydney and Melbourne, the outcome of the scaling up of DCRs in Canada has been 
starkly different, although both countries have experienced comparable periods of stalled 
policy replication. Four major findings of the Canadian case studies are presented in this 
section. They are concerned with observations about the role of state-centred sources of 
policy change; the limits of policy-oriented learning and sub-national policy transfer; the role 
of crisis; and the significance of civil disobedience. Along with the findings of Chapters Five 
and Seven, these factors will be considered through the lens of the policy transfer framework 
in the later discussion on what has facilitated or constrained policy transfer.  
As in the Australian cases, state-centred sources of policy change have proved to be very 
significant in the Canadian context. While the case studies have been city-based, multiple 
levels of government have played important roles in the policy development process, 
providing a strong argument for focusing on institutions and the formal processes and 
powers of government. Local governments, in particular, have been constrained by their 
dependence on provinces for funding and political support, and by the federal government 
for its ability to control the exemption process and thus the legality of the supervised 
injecting services. The need for coordination and alignment of goals has proved to be a 
significant constraining factor. The cases have also demonstrated the opportunity afforded 
by systems change, such as the election of new governments, for embarking on a new phase 
of policy development. Ideational factors have, however, shaped and influenced the 
workings and application of these structural forces. The ideological position of Governments 
in relation to drug issues has influenced the exercise of strategic selection in relation to the 
pursuit or otherwise of drug consumption services. Significantly, the case studies 
demonstrate the importance of a Government’s framing of issues in shaping outcomes and 
facilitating change in the face of apparent structural constraints. The constraint posed by the 
Respect for Communities Act 2015 on the scaling up of services under the Harper Government 
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significantly diminished with the change to the Trudeau Government in 2017. New services 
began receiving exemptions under the old legislation, illustrating that change was made 
possible through the interaction of ideational and institutional forces.  
There was a thirteen-year period between the establishment of the first sanctioned 
supervised injecting facility and a second SIF exemption being issued under the CDSA in 2016. 
It was another year until a city other than Vancouver established supervised injecting 
services. The development of Insite in Vancouver was clearly influenced by experiences from 
overseas, demonstrating policy transfer occurred on an international-sub-regional pathway. 
Vancouver’s experiences in turn had a national impact on policy development through the 
engagement of successive federal governments and the court rulings. In particular, the 
Harper Government’s antipathy towards Insite curtailed the development of proposals and 
policies in other jurisdictions. Policy makers in Toronto looked to Vancouver, but also to 
experiences overseas in places such as Frankfurt. The constraints on policy transfer at the 
sub-regional level are explored in more depth in Chapter Eight, but two points specific to 
Canada are relevant to note here. Sub-national policy transfer was significantly limited by 
national factors. This was not the case in Australia where the federal government’s 
involvement was restricted by the states having power over criminal matters.  
National factors included the engagement of the courts in making determinations about the 
constitutionality of the federal government’s policy approach in this area. The court cases 
amplified the evidence of the effectiveness of Insite, contributing to the public debate on 
supervised injecting. Despite this amplification, however, evidence continued to be 
contested in potential new locations, such as Toronto, where both politicians and 
stakeholders such as the police contested the scientific evidence that was in the public 
domain. This issue is addressed in more detail in the following chapters. It should be noted 
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here that the controversy associated with supervised injecting was a factor that curtailed 
opportunities for policy learning at the sub-regional level, inhibiting policy transfer. 
Vancouver and Toronto experienced different degrees and forms of problematic drug use. In 
both sites, however, the increase in opioid related overdose deaths as a result of the 
increased availability of fentanyl created crisis conditions, placing pressure on all levels of 
government to respond. Crisis has been a critical factor in the rapid scaling up of services 
across Canada and is demonstrably a factor in both case study cities, where the increasing 
focus on opioid deaths has served an agenda setting function. These marked changes in 
Canadian illicit drug markets and the resultant levels of death contrast to the current 
situation in Australia, where street drug scenes have contracted (see Chapter Five). 
Interestingly, the nature of the risks associated with fentanyl, including the contamination of 
a wide range of illicit drugs in the market, has widened the focus of concern from street 
scenes such as the Downtown Eastside to recreational and ‘hidden’ users in suburban 
locations. While the risks associated with illicit drugs are often associated with public or 
street-based drug use, evidence, such as first responder call-outs for overdose, are showing 
that high risk drug use is geographically widespread (B.C. Centre for Disease Control, 2017.) 
Finally, the case studies demonstrate that civil disobedience has been a significant facilitating 
factor in the scaling up of services. Arguably, civil disobedience has had greatest impact in 
Vancouver, as the acts of civil disobedience in Toronto occurred in parallel with attempts to 
develop services through official channels. However, the acts in Vancouver have had impact 
nationally, pushing the federal government to consider its approach. Policy changes at the 
federal level (for example, the issuing of CDSA exemptions to provinces to allow support for 
overdose preventions sites) have flowed to all provinces. The impact of civil disobedience on 
the process of policy change is considered in more depth in Chapter Eight. 
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In conclusion, although the chapter has focused on two city-based case study sites, the cases 
provided insight into the engagement in policy development of local authorities and 
stakeholders, as well as provincial and federal levels of government. The chapter has 
confirmed the importance of approaching the question of policy replication from multiple 
levels of analysis. It has demonstrated the impact on the policy transfer process of both 
structural factors, such as the distribution of powers in the Canadian federal system, and 
ideational factors, like the ideological stance on drug use held by different Governments. Two 
key additional factors have been prominent to understanding policy stall and change: the 
roles of crisis; and civil disobedience. These two factors have been crucial to catalysing policy 
change and serve as a significant point of contrast to the Australian case studies, as will be 
further explored in Chapter Eight. 
Moving away from this chapter’s descriptive-analytical approach, based largely on 
documentary sources, the following chapter employs thematic analysis of the interviews 
undertaken during the field visits to interrogate and identify patterns of meaning in order to 
further shed light on this thesis’ concern with policy replication.  
 
 
 
 
 
 
 
 
 
 
 
 
Chapter seven      
The challenges of replication: 
empirical findings 
• • • • • • • 
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7.1 Introduction 
The two previous chapters present the experiences of the four case study sites over 
approximately a twenty-year period. They explore each city’s attempts to respond to 
emerging problematic drug use, as well as the broader state or provincial and national 
contexts in which policy issues surrounding supervised injection have been debated and 
deliberated. The chapters address the structural, ideational and agency factors that have 
affected policy development, and focus on identifying the factors that either constrain or 
facilitate the replication of policy. The purpose of this chapter is to deepen our understanding 
of these issues by presenting findings from thematic analysis undertaken on interview data 
gathered from key stakeholders engaged in the policy process. The insights of participants 
into the challenges of replicating policy provide important data for developing an 
understanding of the significance of different sources of policy change. These findings are 
critical to the theoretical analysis undertaken in Chapter Eight. 
Six main themes and their various sub-themes are presented, addressing a range of issues 
from the role of crisis; the proximity of political debate from the specific geographic locus of 
the problem; the ongoing effect of stigma and discrimination on public debate; and the 
contested role of evidence in the policy making process. In addition to exploring insights into 
ideational aspects of policy change, participants also provide views on the role played by 
institutions, and structural issues such as the interactions of different levels of government 
and the legislative process. Interview material from all four sites is presented together to 
explore the commonalities and differences that emerge in the different case studies.  
7.2 Method 
The analysis in this chapter draws on data from 30 semi-structured in-depth interviews 
conducted during field visits to Australia and Canada undertaken between April and June 
2017. Following the granting of ethical approval and the development of city-specific 
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interview guides (see Appendix 2), invitations to participate were sent to key stakeholders. 
Potential interviewees were identified through the documentary analysis undertaken as part 
of the case studies and through consultation with informants known through existing 
networks. Participants included former politicians, policy makers, public health practitioners, 
law enforcement officers, researchers, lawyers and advocates. Interviews were recorded 
with the permission of participants and transcribed before NVivo Software was used to aid 
data analysis. The interviews were anonymised and are attributed below to broad 
occupational categories which best reflect the primary role played in the policy process by 
the participant, including Advocate, Researcher, Policy Maker and Practitioner. A list of 
participants by case study location can be found in Table 4.4 above.  
The analytical strategy applied to this project is derived from Braun and Clarke’s (2006) 
approach to thematic analysis, as discussed in Chapter 4 (Methodology). The first round of 
open coding produced 67 codes. These codes were then reviewed and consolidated into 
eight themes (Table 4.6). Through a third round of analysis, six themes were then identified 
that provided the most relevant insights into the research question’s central concern 
regarding replication. It is these themes that are described below.  
7.3 Thematic analysis findings 
Table 7.1 provides a summary of the key findings from the thematic analysis before each 
theme and its sub-themes are presented. 
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Table 7.1 Themes and sub-themes arising from stakeholder interviews in Australia and 
Canada of the challenges of replicating drug consumption rooms 
Theme Challenges 
1. Problem 
definition and crisis 
• Matching the ‘problem’ of street-based drug use to the 
‘solution’ of drug consumption rooms 
• Crisis framing may be required for support to emerge 
• The differing roles of HIV and overdose as drivers (public 
risk versus individual risk) 
• Dynamic drug markets and changing needs over time 
2. Interactions 
between different 
levels of 
government 
• Engagement of federal, state/provincial, and local 
government in facilitating services due to division of 
powers 
• Alignment of all levels of government is crucial but 
challenging 
• Proximity to the problem. DCRs are a niche intervention 
providing services in a limited geographic area: the 
agendas of different levels of government reflect their 
proximity to the problem 
3. Policy conflict 
between public 
health and law 
enforcement 
approaches to drugs 
• Contradictory policy positions: governments need to 
exempt their own laws on drug prohibition to sanction 
services 
• The prioritisation of the politics of law and order weakens 
support for public health approaches 
• Relies upon a shift within law enforcement to recognise 
health implications and change policing strategies 
accordingly 
• The authority of public health approaches is partially 
undermined by the requirement for community approval 
for services 
4. Politics and 
political leadership 
• Site of interpretation and mediation of community 
concerns 
• The influence of electoral politics and political cycles on 
political parties’ actions 
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• Political leadership is an influential factor, often affected 
by the personal experience of the leader 
5. Controversy and 
debate 
• Strongly held attitudes towards drugs and drug use 
counter balance more progressive approaches in debate 
• Stigma and discrimination perpetuate a reluctance to 
support initiatives aimed at improving the health of 
people who use drugs 
• Moral and religious arguments are used by both 
opponents and proponents of drug consumption rooms  
• Neighbourhood amenity is a driving factor in the push for 
change but there is no consensus in communities that 
DCRs are the solution 
6. The role of 
evidence 
• Disillusionment about the use of evidence and its ability 
to effect change 
• Evidence as persuasive or serving a protective function for 
services 
• The debate is not framed as revolving around the 
evidence of effectiveness but engages at a more visceral 
level 
• The ‘trial’ status of projects has been used to stall 
replication 
7.4 Theme 1: Problem definition and crisis 
The impact of ideational factors is explored through this theme as the perception of the 
problem of drugs and the impact of crisis on opportunities for policy change are considered. 
Those making the case for drug consumption rooms must identify both the ‘need’ that exists 
(or the problem being addressed) and then demonstrate how the proposed ‘solution’ 
addresses that need. For replication to be achieved, there are two inter-linked 
considerations: 1) that need continues to exist that is not being met by existing interventions; 
and 2) that the problem or need identified is matched by the proposed solution. Each case 
study site had its own issues, and to complicate matters, the factors did not remain static 
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over time. The sub-themes concerning how the problem of drug use was perceived and how 
the solution was ‘matched’ to it, and the role of crisis in accelerating action on DCRs, are 
discussed below. It should be noted that the following analysis is based on the perspectives 
of study participants and does not attempt to either quantify or qualify ‘need’ through the 
objective analysis of public health data from the case study sites. 
Identifying the problem 
Drug consumption rooms have been, by and large, conceived as a solution to open street-
based drug scenes where the visibility and associated problems of drug use such as overdose 
deaths and littering of paraphernalia are creating sufficient public issues that intervention is 
proposed. As such, they tend to be focused on a contained geographic area of activity. This 
is reinforced by the nature of the street drug market, which tends to cluster in certain areas. 
As many participants in the study observed, there is a strong tendency for people, having 
obtained drugs, to use them as soon as possible: 
“When you score your drugs, you want to use now. Because you've worked all morning 
picking bottles, breaking into cars, selling your body in order to score. You score, you're 
going to use as soon as you possibly can. If you happen to be close to the supervised 
injection site then you'll go use there... If you live three blocks, four blocks away, buy 
your drugs three or four blocks away, you're not going to go to the supervised injection 
site.” (Practitioner 2, Vancouver) 
In Melbourne, the local residents’ campaign for a service concentrated on the ‘factors’ that 
were present in the area around Richmond to build a case for the ‘need’ justifying the 
proposed solution.  
“I mean, I met with residents in the Richmond area in Melbourne and they have made 
some strong representations to government. There's been quite a strong grassroots 
local campaign about the need for an injecting facility there based on the number of 
occurrences of public injection, the number of discarded injecting material, the 
paraphernalia they're finding the streets, number of overdoses in that area. It all points 
to the need for a specific facility for people who are engaging in drug use, injecting 
drug use in particular.” (Policy Maker 5, Sydney) 
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Crisis 
Where there was an identified problem of street-based drug use, yet resistance to 
introducing supervised injection as a possible policy solution, participants explored the role 
of crisis as a driver for change. The perception of crisis was also identified through the case 
studies as a potential catalyst for policy change. For example, the HIV epidemic was identified 
in Vancouver as a factor that effectively shocked people into responding, due to the scale 
and severity of the situation: 
“The crisis then was defined as HIV infection as well as overdose and they were able 
to use a figure, there was a figure of an 80 per cent conversion rate to HIV per year 
around 1997 that was the highest in the Western hemisphere. So that was able to be 
used as something that people could get their head around: this is as bad as Haiti, this 
is as bad as sub-Saharan Africa and then people could say well, we need to do 
something about this. And then of course the overdose deaths in the alleys.” 
(Researcher 2, Vancouver) 
A participant from Toronto credited the current opioid crisis in Canada with having created 
“greater openness” in her city to the introduction of supervised injecting (Policy Maker 3, 
Toronto). A researcher from Sydney considered whether it was the scale of the problem 
which prompted action: 
“You need a crisis...So is it then, is the answer then scale, is scale then the answer to 
all of it which is you need a drug problem of such scale that people can't ignore it and 
therefore communities have to respond?” (Researcher 6, Sydney) 
Another participant recognised that the process of defining crisis was inherently political, and 
identified the importance of the act of framing a crisis and the use by activists of symbols to 
focus and distil arguments for change.  
“And I think the bigger issue is crisis. And sometimes crises are absolutely real and this 
one clearly is. But very often there's a politics to crisis about defining it, and building 
one, that definition and getting enough momentum behind the definition of 
something being a crisis versus something else…I mean it's about defining what is a 
problem, what is a crisis to be addressed and for whom and all that. But certainly 
people like Bud Osborn and VANDU and the other activists in the 1990s and the early 
2000s were able to really make the crisis visible through really clever things like the 
thousand crosses on Oppenheimer Park. So something very visible really brings it to 
mind.” (Researcher 2, Vancouver) 
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The perception of a crisis and the use of the language of crisis in the four case study sites has 
been linked to a concern with an escalation of a situation, whether it is increasing visibility of 
drug use and its effects, or increasing rates of overdose or blood borne viruses such as 
Hepatitis C and HIV. Some interviewees explored the idea of how these issues could be seen 
to affect parts of the community in different ways, resulting in varied motivations to act. One 
researcher in Melbourne observed how the arguments had changed over time, and that what 
once were issues that required a collective response were now seen to be more about 
individual risk. He saw a distancing and a narrowing of the focus on public drug use from 
previous times, suggesting a possible explanation for the lack of political will to introduce 
services in Melbourne: 
“We might argue that because that movement framed the issues as being relevant for 
everyone i.e. HIV/AIDS, public injecting on our streets, in your parks in your shopping 
areas, Hepatitis C: risk to everyone, Hepatitis B, it was more relevant for more of us. 
But it's different now. You know we don't hear talk about HIV or blood borne viruses 
now. We, with the exception of Richmond, don't hear talk about how public injecting 
is an issue that could affect you.” (Researcher 8, Melbourne) 
While the notion of crisis might prime policy makers for change, another participant 
identified the problems associated with making policy in response to crisis, rather than as a 
reaction to an immediate situation. In considering the current restriction in New South Wales 
(that a new service would require the passage of amended legislation), this participant 
argued: 
“But it would still be good here to have a change of legislation so that if a need did 
arise here, you wouldn't need to go through everything we had to go through. But 
getting reform, you know, when there's no crisis, from our point of view would be ideal 
because then you could really think it through. You know, we're not doing it all in the 
heat of the moment. But if you look historically at when the big changes happened, 
you know, reform-wise, it was almost always in response to a crisis. And yeah, it 
necessarily means you get this policy overreach or underreach, or you get this sort of 
politically expedient type of solutions, as with...you know not even decriminalising the 
provision of needles so that…30 years down the track we still have a very limited 
arrangement for needle syringe programs.” (Practitioner 7, Sydney) 
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Temporal factors 
The final sub-theme was the impact of time and change on the ‘problem’ that supervised 
injecting facilities seek to address, and therefore the implications for replicability. Drug 
markets are dynamic: types and composition of drugs can change; so too the patterns of use 
both demographically and geographically. The fixed model of a supervised injecting site that 
was trialled in both Canada and Australia may not be the best model as times change, or even 
the right solution as new problems emerge. This issue was raised in both Canada and 
Australia for very different reasons. In Canada, the arrival of fentanyl has had a devastating 
effect on users of all kinds of drugs and different modes of consumption, due to 
contamination of the drug supply (Belzak and Halverson, 2018). As one interviewee 
explained, the problem now being faced in Canada needed a more comprehensive response 
than just averting overdose deaths: 
“You know it's really tough. We've had a number of public health challenges related to 
drug use in this community including one of the worst epidemics of HIV seen in the 
western world. This thing scares me more than anything else because it's just the drugs 
that are in the supply are so, so strong. People will keep using it. I'm much more 
pessimistic than most people about the utility of a lot of overdose prevention 
interventions. … People are so desperate and in so much pain that they're not going to 
be like, "Oh there might be fentanyl in my drugs, I'd better not use today". … And so 
people keep rolling the dice and they keep dying. I think the solution is completely 
about rolling out those second, third, and fourth line opioid agonist treatments 
including injectable treatments. I mean injectable hydromorphone, injectable heroin; 
we need slow release oral morphine, we need more Suboxone, you need better 
methadone provision.” (Researcher 3, Vancouver) 
This concern was echoed by another participant who made the point that intervention on 
overdose was always a post hoc activity: 
“Are we serious about this or not? You know? And all of our interventions you have to 
wait until someone overdoses. Let's wait until somebody overdose to really do 
something about it. We'll give them naloxone; we'll catch them in their chair in the SIS. 
But, I don't know. It doesn't make a lot of sense.” (Practitioner 3, Toronto) 
The deadliness of fentanyl and the comprehensive contamination of the illicit drug market in 
Canada, a manifestly very real crisis, has spurred replication and innovation in service 
delivery. 
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While Australia could also face the prospect of the arrival of fentanyl (McGowan, 2018), at 
present street-based drug use has contracted. This is particularly apparent in Melbourne; the 
five ‘hot spots’ of the late 1990s no longer present the high profile and visible problem that 
launched drug use onto the political agenda at that time. Sydney too, has seen considerable 
changes to its street drug markets through a combination of factors such as gentrification, 
drug market diversification and changes to the acquisition and selling of drugs with the 
proliferation of mobile phones. Participants in Australia recognised that with the passage of 
time, these changes affected both the sense of crisis and the degree of political focus on 
street drug issues, with implications for the replication of policy. As one participant succinctly 
said in relation to the advent of supervised injecting in Australia: 
“Well, I mean it arose as a specific kind of policy problem in a particular context that 
doesn't exist anymore, you know, substantial street base injecting, huge volumes of 
public needle discards, and a sense of crisis.” (Advocate 4, Sydney) 
Participants stressed that it was not so much the case that ‘problem’ drug use had 
disappeared, but that the nature and perception of it had changed. As one interviewee 
recognised, reflecting on these changes, the policy solution being offered through supervised 
injecting may no longer be seen to fit the policy problem: 
“So you had both the reality of people dying literally in the streets of opiate overdose. 
And also the community experience of that and those two things each convince 
different groups probably, to different levels. But together that was what created the 
policy opportunity. And that doesn't exist and it's not going to exist again, partly 
because of that thing about there's a decline in street-based injecting, partly because 
you know opiate abuse is now primarily a phenomenon of pharmaceutical opiates 
rather than heroin. More people die of pharmaceutical opiate overdose than die of 
injected heroin. Sorry, pharmaceutical opiate overdose of which many cases would be 
oral opiates. Supervised injecting facilities are not going to address that, you know. 
Now we've got more people dying of pharmaceutical overdose than heroin overdose 
so it's like what you said really, we don't have the same policy problem that that's the 
neat solution for anymore.” (Policy Maker 6, Sydney) 
7.5 Theme 2: Interactions between different levels of 
government 
This theme explores the impact of structural and institutional impediments that arise from 
state-centred sources of policy change. It highlights the challenge of requiring political 
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support from three levels of government in order to initiate or sustain what is arguably a 
niche, local response to street-based drug use in a specific geographic location. The federal 
systems in Australia and Canada differ in terms of the division of powers, as the case studies 
above illustrate. Due to the criminalisation of drug use, both systems have required, to 
varying degrees, an alignment of support from governments at federal, state/provincial and 
local level. This has proved a significant challenge to the initial establishment of drug 
consumption rooms. Once the existence of DCRs has been accommodated through legislative 
means or exemption processes, the need for alignment has continued to vex attempts at 
replication. In addition, it is apparent that there is a tension regarding the need to debate 
drug consumption rooms at levels of government where there is a decreasing proximity from 
the immediate local area where services are proposed.  
Levels of government 
While not unique in policy making terms, the necessity that drug consumption rooms be 
considered by so many layers of government adds pressures in terms of timing and alignment 
of agendas. As one participant succinctly put it, “…in a country like Australia, and Canada, 
there’s so many levels of government that maybe that’s another kind of barrier because all 
those things need to line up in support” (Researcher 6, Sydney). Interview participants also 
recognised that political agendas at the national or state level may not be in alignment with 
local concerns. One Canadian practitioner in Vancouver explained how the federal 
government’s attention had been focused on prescription opioids as the driver of overdose 
deaths, rather than the street drugs which were driving fatalities locally (Practitioner 1, 
Vancouver). In Australia, this issue has played out at the state level, where broader 
government agendas were seen as undermining local concerns: 
“However as far as the Victorian state issue is concerned, you know, I'm convinced that 
the state government looks at the whole state in terms of the messaging across law 
and order issues…And I'm convinced they are quite prepared to throw the local 
member under the bus as long as they don't lose, you know, so many percentage 
points in polling state-wide in law and order.” (Advocate 6, Melbourne) 
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The need for coordination between levels of government to achieve policy change also 
introduced opportunities for higher of levels of government to resist pressure from local 
communities by arguing there was a lack of support elsewhere in the system. This was most 
apparent in Canada, where the federal government played such a prominent role to block 
local initiatives, first through its contesting of the court cases brought by local activists in 
Vancouver, and later through the introduction of the Respect for Communities 2015 
legislation. One Advocate felt this provided an opportunity for provincial governments in 
particular, with their responsibility for health funding, to delay making a commitment to local 
initiatives. 
“And that in fact has been a catch-22 that has delayed some of this and I think that 
speaks directly to the subject of your inquiry, particularly in a federal system where on 
one level the exemption from the drug laws that would enable you to run such a 
service without risk of prosecution comes from the federal government; in almost 
every circumstance any funding that you're going to be able to secure for such a service 
is going to come from the provincial and municipal level of government. It's become 
easy and we've seen that in several cases here in Canada including in Toronto and 
Ontario where there's this sort of buck passing between levels of governments. Not 
unknown in a federal system but certainly very much part of the dynamic that has 
played into delaying the scale up of these programs” (Advocate 3, Toronto). 
Proximity to the problem 
The necessity to engage in debate at both state/provincial and national level caused 
frustration for participants, particularly because the need arose on account of the 
criminalisation of drug use. In both Canada and Australia there were instances of local 
Councils keen to take action, but thwarted by their actions being ultra vires, making them 
reliant on higher level state authorities to determine whether or not they are permitted to 
act. This was the case in Melbourne where the Council of the City of Yarra was keen to 
proceed with a supervised injecting trial. An Advocate described their attempts to put up a 
proposal for an injecting facility in Richmond and North Yarra: 
“So we put that up and we put it to Council and we advocated to Council and we 
advocated to the state government and the state government were quite ambivalent 
about it. They weren't really interested. But the Council were very interested and they 
voted six to one in favour of trialling an injecting facility. And that was in May 2011. 
The state government said no.” (Advocate 6, Melbourne) 
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Similarly, a participant in Toronto described the frustration that arose from the lack of tools 
available at the local level to deal with the issues that affected their communities and their 
urban environments. In describing the local drug problems and the city’s inability to have an 
impact, he said: 
“And it got worse and worse and there were very little ways to deal with it because as 
long as it was within the criminal code, the city could do nothing because anything 
that's considered criminal, you can't regulate… except I worked awfully hard with the 
police and trying to find ways of dealing with it. But all I did was squeeze the rubber 
balloon, right? You apply the pressure at this end of the balloon and it goes away from 
those streets and just moves over two blocks, right? And then you squeeze there and 
then it comes back.” (Policy Maker 2, Toronto) 
These tensions led some participants to argue that supervised injecting should be 
determined at the local level. A participant from Sydney captured the conflict created by a 
higher political authority debating and making determinations on a problem from which they 
are removed, suggesting their lack of proximity to the location masks the need for action: 
“Which is why it should be a locally decided thing, I think, for a local, intense problem. 
Which is why it's silly for state governments to have to bother with this sort of thing, 
because of course, the Member for Yass or where ever is not going to have the 
appreciation of what it's like in Kings Cross, say. In the local area, all the politicians 
realised there was a problem that needed to be dealt with because it was on the 
doorstep and it was so palpable at the time. … But people in other areas are obviously 
not going to get that.” (Practitioner 7, Sydney) 
7.6 Theme 3: Policy conflict between public health and law 
enforcement approaches to drugs 
Drug consumption rooms are public health interventions aimed at reducing harms associated 
with drug use, yet both staff and clients are at risk of prosecution under drug laws in both 
Canada and Australia unless specific exemptions are issued. This requires governments to 
hold contradictory positions in relation to their own illicit drug policies. Interview participants 
saw this issue affecting replication in a number of ways, both in terms of the political debate 
and the potential conflict created within and between the law enforcement and public health 
arms of government. Through this theme, the issue is explored both in terms of the impact 
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of competing ideologies within drug policy and the challenge DCR policy presents for the 
bureaucratic institutions of government. 
Competing ideologies 
In order to justify changing laws or issuing exemptions, a strong political argument must be 
mounted, given the controversy attached to drug use in general and drug consumption 
rooms in particular. While the broader arguments and discourse employed are discussed 
under Theme 5 below, two particular challenges were identified by interview participants as 
being significant for Governments in considering change. First, Governments appeared to be 
reluctant to make concessions to their own laws when there was overt campaigning under a 
‘tough on crime’ banner, or when the position was generally seen to be antithetical to their 
ideological stance. Secondly, support for drug consumption rooms might be considered to be 
a ‘slippery slope’ for other drug policy reform that Governments were not prepared to 
address or embark upon.  
In Australia, participants felt that there had been a general shift towards more conservative, 
hard-line positions by political parties, driven by concerns with crime, probation and 
terrorism, and that such ‘tough on crime’ stances were inconsistent with embarking on 
controversial law reform in the area of drugs (Policy Maker 5, Sydney; Advocate 6, 
Melbourne; and Researcher 8, Melbourne). One Policy Maker supported this by reference to 
the increasing focus on law enforcement as the primary political lens through which drug 
issues were addressed, which was felt to contrast to an earlier period in Australia where drug 
policy was addressed as a more bipartisan issue: 
“…the best example I can give is in the Federal Parliament. If there's a question on 
drugs that's raised it would be the Federal Police or Justice Minister who gets up to 
answer that question. I haven't seen for quite a while a Health Minister get up and 
answer a question about drug use. And that shows a lot about where the emphasis is 
on government policy...” (Policy Maker 5, Sydney) 
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In Canada too, the demonstrable difference between the Harper and Trudeau Governments 
in their ideological positions on supervised injecting had a material impact on the prospects 
for replication of services. Canadian participants referred to the Harper Government’s 
antipathy towards the supervised injecting site in Vancouver, which according to one 
participant it fought “tooth and nail”, first through the courts and then through the onerous 
legislative regime of the Respect for Communities Act 2015, which had a “chilling effect” on 
any attempts at replication (Advocate 3, Toronto). While Governments might support harm 
reduction as one pillar of government policy on illicit drugs, support for these measures is 
vulnerable when ideological shifts are made as a result of a change in the ruling political party 
or as a general shift towards more conservative politics across the political spectrum.  
In addition, as a challenge to the dominant paradigm of prohibition, concessions for 
interventions such as supervised injecting are seen as a ‘slippery slope’ for Governments. As 
one participant argued: 
“And I think… one of these things that kind of casts a bit of a shadow over the debate 
is that, I think State Governments in particular, don't want to be seen as the one that 
made that decision which was the tipping point in terms of you other drug policy 
initiatives which we also need, like for example testing of drugs, heroin assisted 
treatment, needles and syringes in prison. So you kind of get sucked into that broader 
drug policy reform debate, even decriminalisation of drugs” (Advocate 6, Melbourne). 
 
Law enforcement 
The second aspect to this theme of policy conflict between law enforcement and public 
health approaches to drugs plays out in the agencies themselves or among their 
practitioners. The success of supervised injecting initiatives is dependent on the support and 
engagement of law enforcement. The effectiveness of both MSIC in Sydney and Insite in 
Vancouver demonstrates that partnerships can be forged that allow law enforcement and 
public health to work together on this issue. It also requires a cultural and managerial shift 
within law enforcement agencies to re-package or re-configure drug use as a health issue 
after years of addressing it as a criminal act. One interviewee, for example, described how 
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the successful working relationship between the Vancouver Police Department and Insite 
was achieved due to a shift in culture and practice in the early 2000s as they began to 
approach drug use and its implications from a health perspective: 
“All of our philosophy changed and it was a tough pill to swallow for a lot of cops who'd 
been working the beat for a long time and getting their bread and butter; it was, you 
know, possession charges or little street trafficking charges.” (Practitioner 2, 
Vancouver) 
In Australia, one participant discussed the challenge this posed within the police force: 
“Why can't we replicate this because it works? I think one of the things too is that 
people don't understand that the injecting centre is one small part of the overall health 
approach to drugs. And it should be a health approach. One of the terms I was using 
in the last couple of years in the police was we're after public health outcomes using 
law enforcement strategies and people look at you going, ‘What are you talking 
about?’. Except for people from outside the police who go, ‘He gets it’.” (Practitioner 
6, Sydney) 
The challenge for replication of drug consumption rooms is that these changes may not have 
permeated beyond the local command. There is a strong sense from participants that each 
new instance of a DCR starts with new, local negotiations that can be very arduous. For 
example, despite the police being key stakeholders and participants in the development of 
the City of Toronto’s broad drug strategy, access to the police by the needs and feasibility 
research team was difficult:  
“It took us over a year to get in to see the Police Chief, just to talk to him.” (Researcher 
4, Toronto)  
Public health imperatives 
Public health authorities also face challenges with their engagement in supervised injecting, 
particularly as the criminalisation of drug use complicates the pursuit of health objectives. 
The politicisation of the issue leads to, for some, an onerous requirement to consult and 
engage ‘community’, over and above what is normally expected for public health initiatives. 
For example, one Researcher expressed his frustration at the requirement to give police a 
‘seat at the table’ when discussing public health initiatives as he felt they did not have the 
required expertise. He argued: 
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“…I think the police and the enforcement community more broadly has had such a 
monopoly on drug policy for so long because we've criminalized the population that 
everybody thinks that they, somehow, have a really, really important voice in the 
design of public health interventions for drug users. And I think that's crap too. We 
don't tell them how to enforce people, enforce the laws. They shouldn't tell us how to 
deliver public health. Good luck going to a meeting about establishing a new, 
innovative service for drug users without cops there and without pandering to their 
concerns, without them sitting there and expressing their expert knowledge from their 
first-hand experience 'busting' people. They're suddenly experts on addiction.” 
(Researcher 3, Vancouver) 
Another participant from Vancouver echoed this concern but extended this frustration to the 
mandated need to also consult communities, which was captured in both the Supreme 
Court’s ruling and the subsequent federal legislation introduced by the Harper Government. 
She asked:  
“So if it's a health issue and if this is a health service then why are we required to 
consult with the police station and the communities?” (Advocate 2, Vancouver) 
The Supreme Court ruling’s recommendations on community consultation vexed another 
Canadian participant on the grounds that this created a standard that was not required of 
other health facilities, suggesting that a shift to treating the issue of drugs as a health issue 
had fallen short. 
“The expressions of community support or opposition is actually less defensible in my 
view and in some ways is the more objectionable…because really it is just a naked 
indulgence of stigma and discrimination against people who use drugs or at least it 
enables Governments and Health Ministers to play to that by putting it right there in 
the judgment as something that the Minister must have regard to. I think that's really 
problematic because you would not see that with respect to other health facilities for 
people with other health conditions. So it very much is a reflection I think of the Court's 
own underlying discomfort on some level with the notion that these things even if the 
judgment ultimately was certainly a win for Insite and overall a positive contribution 
to the jurisprudence.” (Advocate 3, Toronto) 
7.7 Theme 4: Politics and political leadership 
There was widespread agreement in the interviews in both Australia and Canada as to the 
centrality of politics in the deliberative processes surrounding drug consumption rooms, 
supported by statements like: 
“So, you know, I have very quickly learnt that it is the politics and the game playing 
that get things done in this area rather than anything else.” (Practitioner 4, Sydney) 
Opinions differed on the role of politics. For some the political arena was a genuine forum 
for mediating community concerns and views, while for others with a more cynical 
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perspective, the chasing of votes, and electoral and political cycles, overrode political will to 
act on controversial issues. Of critical importance to participants was the determining role 
played by political leadership in the process. These different factors all had an impact on the 
opportunities for replication to occur. 
Political debate 
Participants all agreed that drug consumption rooms specifically, and drug policy in general, 
are controversial for communities and therefore subject to considerable political debate. 
Interview participants reflected on the roles played by politicians in responding to 
community views. Strong arguments were put for the need for advocacy and active 
engagement in public discourse to shape those community views and provide politicians with 
a clear indication that there was support within the community for change. A supporter for 
increasing the number of drug consumption rooms in Sydney argued: 
“… there's so little leadership from within the political system, we need to demonstrate 
a constituency for change and also build power to apply pressure on politicians to 
make it easier for them to support the policies that we want than to maintain the 
status quo.” (Advocate 4, Sydney) 
The difficulties for politicians, however, were discussed by a Policy Maker who talked about 
the personal challenge of engaging in debate on drug policy “because of the strong and often 
diametrically opposed views of the community” (Policy Maker 6, Sydney). She went on to 
discuss the conflict created by advocating for a drug-related health service that is backed by 
strong evidence, but which does not appear to have the support of the local community: 
“But nonetheless I still found myself quite challenged by it and there were points 
where I thought am I really doing the right thing because the community who lived 
around it weren't very supportive of it and I could tell that there was a potential it 
would have a political impact on my future ability to hold my seat, and my seat was 
quite marginal.” (Policy Maker 6, Sydney) 
This quotation demonstrates the tension for politicians between their roles as 
representatives and their role in taking the lead to bring about change. The idea of 
representing a ‘community view’ is made more problematic by the question of how informed 
these views are (and indeed how informed they should be). This idea is explored further 
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below in the discussion on the role of evidence, but the political implications of this issue 
were drawn out by one Practitioner, reflecting on his own experience of initially approaching 
the question of drug consumption rooms with very little exposure to the issues: 
“Some people will object to these things just because they think that's what the 
community might want. And really the community quite often would be like some of 
the police, like I was, really if you don't understand it, it's very hard to have an informed 
decision about it” (Practitioner 6, Sydney).  
Political calculations and electoral politics 
While politicians and political parties are registering and responding to ‘the community’ in 
the process of deliberating policy, it is also apparent that decisions are being made based on 
calculations of their political capital and the risk of voter backlash – a factor that will be of 
greater or lesser significance depending on where a Government is in the electoral cycle. In 
New South Wales in particular, participants considering the successful establishment of MSIC 
thought it was significant that Premier Carr’s Government was in its second term: 
“But you know…sometimes these things are also hostage to the political cycle. I mean 
Bob Carr...if it had have been the Labor Government in 2007 even, after that election, 
probably, it might not have made such a decision because our political capital was so 
much lower. I mean it was almost at a perfect point in the political cycle to be able to 
do something that was bold because we'd won one election, we’d demonstrated that 
we could do that. And yet we were not so tired and old as a Government that our 
political stocks were really low.” (Policy Maker 6, Sydney) 
The issue of political capital was also raised in relation to the lack of support within the 
Parliamentary Labor Party in Victoria, when there were signs of strong support from so many 
other stakeholder groups (Advocate 6, Melbourne; Practitioner 4, Sydney). 
Another participant in Melbourne drew on the issue of proximity to the problem, as was 
raised in Theme 2 above, and discussed how electoral politics play out in marginal seats, 
removing decision making from the locus of the problem: 
“But I don't think that's how policy decisions get made...it's about single majority so I 
think what holds us back in the drug policy space is marginal electorates, swinging 
electorates and the swinging electorates are often in outer suburban areas. They've 
often got quite a conservative mix of people, a lot of them are actually faith based, so 
they can fall into a different sort of enthusiastic groups. And even if it's across the 
board 51 per cent in favour and 49, what really matters is where the swinging voters 
sit. And I think politicians get really swayed by the loudest voices in their local 
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community...there's not many people that argue for injecting facilities in Knox, but 
there's a lot of people in Knox that argue that the drug problem is too big and we need 
to wipe out the drug problem and those sort of things. Politicians put two and two 
together and think there's no votes for me in Knox if I support an injecting facility in 
Richmond. I think it's more grubby than just community sentiment more broadly. I 
think it's short term political calculations by politicians who are driven by electoral 
prospects.” (Practitioner 8, Melbourne) 
Political leadership 
In many ways, the sub-themes discussed under the broader theme of politics show a 
tendency to run counter to each other, juxtaposing a notion of the political process as a 
forum to mediate community views with a view of politicians cynically calibrating their 
decisions with vote maximisation depending on where in the political cycle they sit. There 
was surprisingly little discussion with participants on the ‘politics of conviction’. Where this 
did come through was in the recognition of the role of political leadership, a key ‘agency’ 
factor in the policy transfer process. The case studies in Chapters 5 and 6 illustrate occasions 
where political leadership appears to be decisive in breaking policy impasse on the issue of 
drug consumption rooms. These stories had a common thread, which was of a leader brought 
on a journey to realise the potential benefits of supervised injection. A Policy Maker from 
Toronto relayed one such story of the Mayor of Toronto, whose support was crucial in order 
to get the City of Toronto Council to adopt the recommendation of the TOSCA report to 
develop three supervised sites: 
“And John Tory while he is a conservative, he is a social conservative, and had been 
and we knew through his radio show, had talked about the issue of supervised 
injection services, how he originally thought it was crazy, but over time learning about 
it and talking to people who are knowledgeable about it, could see that it could be part 
of a solution.” (Policy Maker 3, Toronto) 
In the interviews, some participants speculated on the role of personal experience in 
influencing whether leaders were prepared to tackle difficult drug policy decisions. For 
example, a participant from Sydney reflected on the particular family circumstances of key 
figures in Australian politics and the influence of this in enabling leaders to relate to drug use 
and drug users and therefore progress policy: 
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“…but it's not a surprise, it's not a coincidence that Bob Hawke had a daughter who 
was a heroin user. I don't believe it's a coincidence that we have Bob Carr who had a 
brother who was known to have a heroin issue. Personal experience can help focus 
somebody's minds and help people understand the reality of what we're talking about 
and help break down that 'other'. You know whether you're talking about bloody anti-
Muslim sentiment or anti-drug user sentiment I mean we really need to break down 
the 'other'.” (Practitioner 4, Sydney) 
This level of personal experience sits at odds with the more mechanistic drivers identified 
above such as political cycles and swinging voters. For the overriding concern with 
understanding challenges for replication, the level of engagement of political leadership, 
however that is achieved, is clearly critical. 
7.8 Theme 5: Controversy and debate 
This theme is concerned with exploring the discourse, ideas and narratives that underlie 
debate in communities and the ongoing opposition to supervised injecting, even in places 
where successful trials have been conducted. Participants were asked to consider the nature 
of the controversy surrounding supervised injecting, and why they thought the policy 
continued to be contested. The sub-themes identified were often interlinked, but four 
dominant concerns emerged: attitudes towards illicit drugs; stigma and discrimination; 
religious and moral arguments; and neighbourhood amenity and community aspirations.  
Attitudes towards illicit drugs 
The first sub-theme of attitudes towards drugs captures the prevailing discourse that sees 
drugs as bad or, in even stronger language, as ‘evil’. It is through this framing of drug use as 
an undesirable act (confirmed by its illegality) that arguments are mounted against 
supporting an intervention which might be seen to be enabling or supporting further drug 
use. Participants in all four sites brought forth instances of this type of argumentation, 
acknowledging the challenge (noted in Theme 3) of the contradictory messages for the 
general public in simultaneously prohibiting and exempting use of the same substances.  
“I think it's very challenging. I think we forget that it is a very challenging idea for 
general public minds, the idea that there is somewhere where people can bring drugs 
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that they've obtained illegally, that they're probably committing a crime to pay for, 
and then they can go and use those drugs without any fear of repercussions or police 
intervention. And then they can move back out into the community drug affected. 
That's a very big leap for people to accept unless you work in this world where it's very 
normalised for us to think that that's completely fine.” (Researcher 6, Sydney) 
Some participants emphasised the act of enabling drug use by providing a place where the 
consumption of drugs could occur. The opposition to this was compounded, some 
participants felt, by the tendency for discourse around drug use to be against all drug use. 
This does not allow for a differentiation to be made between unproblematic drug use 
(whether alcohol and other drugs) and problematic drug use which would be the focus for 
an intervention such as a drug consumption room. A Policy Maker from Toronto captured 
these ideas when discussing what form opposition arguments took: 
“There's two related parts of it, of why people oppose interventions and that is 
because they think that drug use is bad - illicit drug use…It is against the law, and you 
are enabling an act. This notion of enabling is related. Somehow if you're encouraging 
people by having harm reduction services available even though evidence-wise flies in 
the face of that but, you know, ‘Why are you helping people to kill themselves?’, ‘Why 
are you helping people to commit illegal acts?’ And some people can't wrap their heads 
around that. And as long as drug use is criminalized that will continue. We cannot 
reduce the stigma that perpetuates that discriminatory viewpoint and get at the core 
of this which is, people use drugs for a whole host of reasons and most of which is non-
problematic but for folks for whom it is, we do need some extreme measures.” (Policy 
Maker 3, Toronto) 
The criticism that drug consumption rooms ‘send the wrong message’ and unjustifiably 
enable the continuation of drug use is tied in with arguments that people should ‘just stop 
taking drugs’ and that treatment is a preferable option or solution. The effectiveness of 
treatment, however, is contested. As one participant addressing these concerns 
demonstrates, there continues to be a wide range of views in the debates and discussion 
around ‘what works’, and what therefore would be a better solution to deal with the 
problems that arise from problematic drug use: 
“But there is still like a good chunk of naysayers, right, that hate them, always will hate 
them… And they're just perceived to be taking it too far. That's, you know, why are you 
doing that when really people should go to treatment? … And I don't think anybody 
really understands that actually treatment is not very effective. I think there's this idea 
like a hospital; we put you in the hospital and you come out fixed, but that's not how 
treatment works. And I don't think your average Joe understands that, even though 
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they probably have seen it in their family, either through drugs or alcohol or even 
tobacco. That it requires many quit attempts and most people fail…Drug use has been 
criminalized for so long, and even though there's more support in the media, there's 
still that hard core war on drugs even though that is starting to crumble a little bit as 
well. So it's just, it's too far.” (Researcher 4, Toronto) 
Stigma and discrimination 
The second sub-theme in this section is stigma and discrimination, which were identified by 
a number of interview participants as being instrumental in ongoing opposition to supervised 
injecting, therefore posing a challenge to the replication of services. For some interviewees, 
the stigmatisation of people who use drugs was seen to be at the heart of why more services 
were not provided. As one Advocate described, support for supervised injection entails an 
acceptance that you are not going to eradicate drug use and that is a position that was 
unacceptable for many people: 
“So why it would be so controversial I'm not sure, except in so far as you're even more 
explicitly, pragmatically accepting the reality of problematic drug use, which people 
don't want to do because it remains a stigmatized behaviour. So it's not something 
that should be encouraged. The more you're doing things that, quote, make it easy, 
for people to do the thing that we don't think that they should be doing, I guess the 
more discomfort and oppositional reaction you're likely to provoke.” (Advocate 3, 
Toronto) 
The criminalisation of drug use was linked to the ongoing existence of stigma with one 
participant making the comparison with the treatment of people with mental health 
conditions. He contended that where people suffering from mental health issues could 
access support, drug users were blamed for “not taking responsibility or making bad choices”, 
with their criminality compounding the situation (Policy Maker 5, Sydney). Such 
stigmatisation was also attributed to a lack of understanding of drug use issues which 
maintains a divide between ‘us and them’, with the ‘other’ often being seen to be unworthy 
of help. One Practitioner felt that there was a need to frame the debates in terms of a 
conversation about “who belongs and who doesn’t”. While recognising the impact of 
prejudice, which he described as “that giant, block structure in the middle of that road”, he 
also cautioned against being too judgemental, attributing such attitudes to a lack of exposure 
to the issues: 
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“I would never want to take on saying to an affluent community, which is full of good 
people, but they're as conditioned as anybody because I know how conditioned I am 
and I don't hold a different ruler to anyone else and I don't think I have any insight, it's 
just where I work and eventually you build up insight into the area you work in, that's 
all. It's as simple as that. And so you have to have that kind of standard when you find 
people who don't get it, right? They're not bad people. I would have been in the exact 
same shoes, years ago.” (Practitioner 1, Vancouver) 
Religion and morality 
The role played by religion and morality forms a third sub-theme. As the case studies in 
Chapters 5 and 6 illustrate, religious groups and stakeholders from religious organisations 
have both supported and opposed drug consumption rooms, illustrating a spectrum of beliefs 
from the conservative to the more radical. While some participants noted the role played by 
organised religion in trying to influence political decisions in relation to drug policy, they also 
acknowledged the significant role played by churches in service delivery as charities. This 
issue seemed particularly pertinent in the Australian case studies, although the tendency for 
religious identity to correlate with social conservatism was also noted in Canada (Researcher 
2, Vancouver). 
“I think there's a variety of views within religious organisations because so often 
they're the organisations that are providing these services who are on the front line of 
dealing with people with drug and alcohol problems and they know what is needed 
and they know how desperate people can often be and therefore what sort of 
responses are going to work. But I think if you know looking at the community more 
broadly you know can you correlate religion and people who are religious, whatever 
their brand of religion with more conservative thinking? Yeah probably. So in that 
sense in the broader community, yes, maybe electorates that have a higher portion of 
people who are religious would be less likely to support a medically supervised 
injecting centre.” (Policy Maker 6, Sydney) 
Moral arguments have underscored the debates on drug consumption rooms in Canada and 
Australia, in both political circles and at the community level. At the centre of these debates 
is the interpretation as to what constitutes a moral position in relation to drug use and people 
who use drugs. Opposition arguments have centred around an association of drug use with 
immorality and general social conservatism, while arguments supporting interventions for 
drug users have been linked with values that highlight compassion and care for the 
vulnerable and marginalised. One of the implications of the strong association of drug use 
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and questions of morality is that evidence and concerns with impact and effectiveness may 
be marginalised. Where arguments have been heavily based on a moral stance, it has been 
difficult to find common ground in order to progress policy development. 
The contested interpretations of these moral/religious positions were apparent from the 
interviews, with comments such as:  
“…I can’t even work out why as a religious person you’d be in opposition to saving 
lives.” (Advocate 6, Melbourne) 
“…how do we get this idea that we can just turn our backs on people who are suffering? 
That’s certainly not taught in any religion that I’ve been exposed to.” (Advocate 4, 
Toronto). 
Two participants raised the issue of love, and interpreting what it is to love, in relation to 
understanding how we care about people and can best support people in need. An Advocate 
from Toronto considered his own journey and engagement with harm reduction: 
“What is morality? It changes. It fluctuates. In my own life I've seen such changes. Most 
of which have been good, I think. You know as we become…better people our morality 
shifts and becomes more loving. The other thing is that I can't separate safe sites from 
harm reduction in general because it's a big piece of harm reduction but it's all about 
love. ...But when I talk to other people…I often get the comment, ‘This is why I started 
doing this work in the first place but I'd lost touch with’. The idea of love, the idea of 
we're here to make change. And it isn't just changing the person to fit the system, it's 
changing the system.” (Advocate 4, Toronto) 
Amenity and community aspirations 
The final sub-theme related to controversy and debate is neighbourhood amenity and 
community aspirations. Open drug scenes have a significant impact on public amenity 
through discarded injecting litter; fear of the criminality associated with drug use and drug 
dealing; anti-social behaviour; and the risk of people overdosing, sometimes fatally, in public 
places. One Advocate from Melbourne gave her impressions of the current situation in a local 
suburb, gained from her experience of walking through the area: 
“In Richmond, I mean the stories that the residents around there tell, it's just 
frightening. Yet at times I'll walk around there, and Fitzroy too, and you just see people 
in a huddle and then you walk a bit further and you've got to watch that you don't step 
on a needle and sometimes it's whole syringes. Other times it's just needles. And 
they're in the park, where there are children playing.” (Advocate 5, Melbourne) 
One Policy Maker in Toronto spoke of his interest in exploring the potential of drug 
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consumption rooms from the perspective of wanting to improve the amenity in his 
neighbourhood as it tried to come to terms with a growing open drug scene: 
“And so what I began to realise is that although there is a public health stream about 
the efficacy of dealing with the health concerns, there's also the neighbourhood health 
concerns and that's how I really got pulled into this. How do you help a neighbourhood 
cope? How do you make it safer for a neighbourhood? I'm not talking about getting rid 
of it, but how do you create a place where it's managed so that the neighbourhood 
isn't so negatively impacted by it. So that is where I ended up coming from.” (Policy 
Maker 2, Toronto) 
He was, however, confronted by opposition from local residents, who were not convinced 
that such services would improve the situation, but rather feared they would entrench 
problems that they were seeking to eradicate: 
“Neighbourhood associations were horribly opposed to the issue. ...No neighbourhood 
is going to say, ‘Thank you, we want it’ because they're sceptical about it being in any 
way ameliorating of the conditions in the neighbourhood. They just think it's going to 
be a magnet. It's just going to make it worse.” (Policy Maker 2, Toronto) 
Another participant felt opposition to drug consumption rooms stemmed from a reluctance 
to embrace a solution that required an acceptance that drug use is occurring and will 
continue to occur in a local community. He felt that the inherent acknowledgment of the 
presence of drug use would contradict more positive community aspirations: 
“I mean part of it's fear. Part of it’s just a concern about what kinds of commerce/ 
public goods/ public institutions you want to see in your community. And somehow, 
for some people the fact that there's a consumption site in their community is a sign 
of failure. Somehow, you know, the community isn't working right. So I think that's 
where the resistance comes from. Those kinds of sentiments.” (Researcher 1, 
Vancouver) 
This quotation captures the complexity of the issue for communities deliberating the 
appropriateness of DCRs. Questions of what kind of community people want, and how they 
solve their problems, are demonstrated here not to be simply answered with technocratic 
proposals.  
7.9 Theme 6: The role of evidence 
The study participants diverged most on the impact of evidence on the prospects for 
replication of the successful models of drug consumption rooms. Some argued that building 
the evidence base to demonstrate drug consumption rooms work was critical for the services 
208 
 
 
and the policy decision making processes. Others expressed palpable frustration at the lack 
of impact of evidence on policy reform and were sceptical about the prospects for creating 
evidence-based policy solutions to street-based drug use in new areas of need. Another set 
of participants was more sanguine, reflecting on the need to approach policy change from 
multiple angles, including appeals to emotion, in order to effect change in a contested policy 
landscape. 
The evidence base 
Both Insite in Vancouver and MSIC in Sydney were established as trials and subject to 
extensive evaluation, as described in the case study chapters above. At the time of their 
establishment, there were over 45 existing facilities operating in Europe, but according to 
Dolan et al., there were “few thorough impact evaluations” – although their assessment of 
the studies that did exist concluded findings were “encouraging” (Dolan et al., 2000 pp.340, 
344). Recalling the establishment of MSIC, a Practitioner reflected on the perceived benefits 
of proceeding as a trial: 
“… the wording also specified a trial in the original resolution. So that was a way, 
obviously, to reassure people that this was not cast in stone. It was also, I think, 
genuinely part of a commitment to evidence-based policy making that was very much 
the flavour of the Drug Summit. So at that stage, I thought that was both strategically 
a good idea and also would add to the evidence base, a great asset to have.” 
(Practitioner 7, Sydney) 
Many Canadian participants in the study were adamant that the intensive process of 
accumulating the body of evidence was critical to the survival of Insite in the face of the court 
cases, and therefore critical for the prospect of building future services. Commenting on the 
role of evidence, one Advocate said: 
“It's been central, I think. I think the evidence that was able to be marshalled on the 
record in the Insite challenge won the case. I think the legal arguments were important 
and, you know, needed to be the hooks on which to hang some conclusions and a 
remedy but if there hadn't been the solid evidentiary base it would not have happened, 
or it would have been far less likely to succeed, I think. And you see that and even the 
Court says in its decision, Insite saved lives, its benefits have been proven. You know 
that's the crux of the decision right there in those two sentences.” (Advocate 3, 
Toronto) 
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Aside from serving a purpose formally in the courts, others emphasised the persuasive nature 
of the evidence on public opinion and politicians. In Toronto, both Researcher 4 and Policy 
Maker 3 argued that the ‘hard data’ developed to assess the need for services in Toronto and 
Ottawa played a significant role in building a persuasive case that resonated with politicians. 
Impact on policy making 
In contrast to these arguments, other study participants were dismissive of the relevance of 
evidence in policy making processes, citing their own experience or observations about the 
nature of the debates that occurred and the seeming limited impact of evidence on the 
arguments that were put forth. A Policy Maker in Toronto was adamant that his engagement 
in the issue was not dependent on receiving the imprimatur of the scientific community, 
while acknowledging that for others the authority of the ‘scientific study’ was persuasive: 
“You know, from my perspective, I couldn't have cared less. Right? Do it. There's a 
need to figure out how to fix this. You've got to do it. And I don't need a scientist to 
tell me that, right? It is that people are dying and we need to find a way to fix this 
problem. But there are an awful lot of people who are on the other side of the fence 
who need to be convinced and they need that scientific study. So it is important but 
it's not important for all of us.” (Policy Maker 2, Toronto) 
In this debate over drug consumption rooms, evidence is contested. Is it persuasive? How 
much evidence is needed? Is the quality of the evidence sufficient? Is it transferable? One 
participant, reflecting on his engagement in the issue in Melbourne in the late 1990s, argued 
that even with a less robust evidence base than currently exists, there was strong enough 
evidence to mount a convincing case for supervised injecting: 
“I think the evidence was strong enough in the 1990s to run injecting facilities and I 
think the evidence is stronger now, but it was definitely convincing in the 1990s.” 
(Practitioner 8, Melbourne) 
The ongoing requirement or pattern for supervised injecting facilities to undergo continuous 
trial is an additional challenge that suggests there is a tactical use of evidence at work. A 
participant in Sydney acknowledged that there was a responsibility for researchers to make 
their research accessible to policy makers, but she admitted she was “exhausted” by the 
ongoing situation where she felt evidence was not being used: 
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“But it is very frustrating to think that, you know, in Melbourne for example, it is so 
obvious that they are now in a situation that we were in 15 years ago. And they could 
slide something in that would alleviate people's distress.” (Researcher 6, Sydney) 
There was also a notion that the controversy surrounding drug consumption rooms meant 
fairness was compromised, as the evidential requirements for supervised injecting went far 
beyond what might be ‘normal’ for a public health intervention, a factor that was attributed 
to the stigma attached to drug use and criminality. As one participant argued: 
“People don't listen to evidence and people aren't willing to listen to evidence. The 
studies are out there. Insite, again, evidence: like there isn't a more researched health 
experiment in the country, maybe even the world, than Insite. And yet we have one 
and we have to jump over Mt. Everest to get two. Evidence isn't the answer. They 
might want to see more evidence but they don't. They just want to see that it's not 
going to have an impact on their day-to-day life, that it's not going to increase crime 
or affect their feeling of safety because drugs are still a crime. They're not a health 
issue. If you had a clinic for diabetics that worked like a charm you'd have 60 clinics for 
diabetics that worked like a charm across the province. It's the criminality. It's the 
association with it being a crime that keeps this a dirty word, a dirty idea.” (Practitioner 
2, Vancouver) 
Alternative arguments 
In a final sub-theme under the issue of evidence, a number of participants referred to the 
visceral nature of the debate on drug consumption rooms and argued that to focus on 
evidence alone in making a case for offering services would be to miss an opportunity to 
engage with that debate directly. Researcher 2, for example, noted despite the rhetoric 
about evidence-based policy from influential drug reform groups in Canada, they too “know 
that that’s not enough because it’s always coupled with appeals to emotion, appeals to the 
humanity of the people who are using” (Researcher 2, Vancouver). A Practitioner in Sydney 
explained how she moved away from relying primarily on evidence to convince people, and 
engaged directly in questions of the ethics of not addressing preventable deaths: 
“And so I increasingly realized that. I was better off not using the evidence, the 
scientific evidence necessarily to argue the toss because that just sent people to sleep, 
but you know, arguing on that emotional level that was really what was fuelling them, 
so that then we were at least on the same page. So then I reframed, tried to reframe 
it as you know basically you people think it's alright to close the doors and have these 
people go back into the back streets …I would counter that to say well, you know, from 
a medical point of view that's unethical. You know we have to do everything we can to 
save life and I make no apology for that.” (Practitioner 7, Sydney) 
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This insight demonstrates the consideration given to the role of argumentation and framing 
within the debate, which is an effective counterpoint to approaches which seek to privilege 
evidence as the decisive factor in policy making. 
7.10 Conclusions 
The purpose of this chapter has been to contribute to our understanding of the challenges 
facing the replication of drug consumption room policy by analysing data from key informant 
interviews. Through the application of thematic analysis, the interviews have yielded critical 
insights into the complexity of the policy making process. Ideational elements have been 
prominent. Running across the themes are the impact of ideology, framing and narratives, 
demonstrating the importance of the discourse that influences policy debates. The analysis 
has identified the impact of attitudes towards drugs and drug use, and the role played by 
stigma and discrimination in discussions on these issues. Perceptions on the role played by 
evidence have been diverse. Overall, conflict, not consensus, runs across the themes. 
Participants have also drawn attention to their perceptions of the ‘workings’ of government 
and the importance of considering institutional factors that affect policy making. Electoral 
impact, the division of powers between levels of government and proximity to the problem 
have all been highlighted. The following chapter will now draw on these findings and those 
of the case studies to interrogate the research question regarding replication of drug 
consumption room policy through the policy transfer lens.  
 
 
 
 
 
 
 
 
 
 
 
Chapter eight      
Policy transfer: understanding  
success and failure 
• • • • • • • • 
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8.1 Introduction 
The preceding three chapters present the empirical findings of this thesis on the experience 
of policy change in relation to drug consumption rooms in four cities in Canada and Australia. 
The contested nature of the policy has been illustrated through the debates around, and 
resistance to, the introduction of this idea into the policy domain. As the technical feasibility 
of the interventions has been established, the central concern of this thesis has been to 
understand the factors that have limited the diffusion of the policy over the twenty-year 
period from the late 1990s. Following a long period of hiatus, Canada has now experienced 
a national scaling up of drug consumption rooms. In contrast, in Australia, the two DCRs in 
Sydney and Melbourne remain one-off interventions in each state. The purpose of this 
chapter, therefore, is to draw these findings together under a coherent theoretical 
framework as a means of interrogating the key constraining and facilitating factors in relation 
to the replication of drug consumption rooms.  
The review of the literature in Chapter Two identifies the limited application of policy transfer 
as a concept to explore change in the field of drug policy. Chapter Three presents the 
arguments for using the policy transfer framework to analyse the main findings of the case 
studies and the empirical findings from the thematic analysis of the interview data. I argue 
that the policy transfer framework offered an underutilised but appropriate means of 
addressing the challenges and barriers to the replication of drug consumption rooms, 
through its focus on multiple sources of policy change, multiple levels of governance and 
multiple agents interacting dialectically. Policy transfer is concerned with ideas and the 
sharing and transfer of knowledge; these are key factors in considering the question of why 
a demonstrably successful intervention struggles to be scaled up or more widely diffused.  
The chapter is divided into three main sections. Section 8.2 rigorously applies the findings of 
the three previous empirical chapters to the four components of Evans’ (2004) policy transfer 
framework, mapping the key case study findings and the outcomes of the thematic analysis. 
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The key constraining and facilitating factors are identified and analysed as to their 
significance. Section 8.3 then presents the outcome of a review of the empirical findings in 
order to identify any factors that do not appear to fit into the framework. It introduces the 
significant role played by civil disobedience as a driver for change in Canada: the site where 
policy diffusion eventually did occur, beginning in 2017. Acts of civil disobedience are 
compared across and within the case study sites, revealing that the actions of community 
activists have been important in bringing about this change in the context of a large-scale 
opioid overdose crisis. On the strengths of this analysis, I present the case in Section 8.4 for 
modifying the policy transfer framework to incorporate a fifth component that considers the 
broader role of civil society in the policy transfer process. 
8.2 The application of the policy transfer framework 
Evans’ (2004) policy transfer framework focuses on four sources of policy change (or stall):  
i) global/international structures;  
ii) state-centred forces;  
iii) policy oriented learning; and  
iv) policy transfer networks.  
This section analyses each of these in turn to assess which factors were significant in 
restricting and facilitating policy change in relation to the replication of drug consumption 
rooms in the case study sites. A summary of the key constraining and facilitating factors for 
each facet of the policy transfer framework is presented below in Table 8.1. The results of 
this analysis serve two key purposes. The first purpose is to provide a structured way to 
interrogate the specific question of the challenges of replicating drug consumption room 
policy. The second purpose of the analysis is to inform reflections on the applicability of the 
policy transfer framework to questions of drug policy.  
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Table 8.1 Key constraining and facilitating factors of policy change affecting replication 
Source of policy 
change 
Constraining factors Facilitating factors Links to 
Themes 
(findings) 
Assessment 
of impact 
1. Global, 
international 
and 
transnational 
sources 
 
Ideational 
• Ideology of 
prohibition  
 
Institutional 
• International 
narcotic control 
treaties and 
institutions  
Ideational 
• International 
harm reduction 
movement/ 
epistemic 
community 
Theme 3 
Policy conflict 
Weak 
2. State-centred 
sources 
 
  
Ideational 
• Ideology of 
prohibition 
• Conflicting 
policy agendas  
 
Institutional 
• Interactions of 
different levels 
of government 
• Role of 
parliament and 
legislation 
• Electoral cycles 
and politics 
Ideational 
• Ideological 
change 
 
Institutional 
• Systems change 
(electoral) 
• Role of courts 
 
Agency 
• Political 
leadership 
 
Theme 2 
Government 
interactions 
Theme 3 Policy 
conflict 
Theme 4 
Politics and 
political 
leadership 
Theme 6 Role 
of evidence 
 
Strong 
3. Policy-
oriented 
learning 
 
Ideational 
• Cognitive 
obstacles 
including policy 
conflict 
• Elite and public 
opinion 
• Persuasiveness 
of evidence 
• Stigma and 
discrimination 
 
  
Ideational 
• Evidence-base 
• Crisis framing 
• Problem 
recognition 
 
Theme 1 
Problem 
definition and 
crisis 
Theme 3 Policy 
conflict 
Theme 5 
Controversy 
and debate 
Theme 6 Role 
of evidence 
Strong 
4. Policy transfer 
networks 
 
Agents 
• Ineffective elite 
mobilisation 
 
  
Agents and 
ideational 
• Epistemic 
communities 
• Community 
consultation 
 
Theme 5 
Controversy 
and debate 
Theme 6 Role 
of evidence 
Medium  
5. Other 
(outside the 
framework) 
 Agents 
• Civil 
disobedience 
 Strong 
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8.2.1 Global, international and transnational sources of policy change 
This thesis has identified both ideational and institutional structures operating at an 
international and global level that can be shown to shape the behaviour of state and non-
state actors in relation to policy transfer in the case of drug consumption rooms in Australia 
and Canada. The impact of these factors, however, appear to be relatively weak in relation 
to both the constraint and facilitation of replication: these two aspects are considered in 
turn. 
Constraining factors 
At the global level, the key ideational factor impacting on the replication of drug consumption 
rooms is the internationally shared ideology of prohibition. As was demonstrated in the 
discussion on the theme of policy conflict in the findings of Chapter Seven, prohibition 
remains the fundamental basis of both Canada and Australia’s illicit drug policies. The 
operation of DCRs directly challenge the laws that support prohibition by requiring an 
exemption to protect staff and clients from prosecution. The conflict that this creates for 
Governments was a definite constraint on replication, as demonstrated by the restrictive 
regimes they put in place to provide these exemptions. This is discussed in more detail in the 
section on state-centred forces below.  
This international ideology finds institutional form through the international drug control 
conventions that are overseen by the International Narcotics Control Board. It was noted in 
the case studies of both Australia and Canada that the INCB monitored policy developments 
in both countries and made public statements condemning their actions (International 
Narcotics Control Board, 2000 and 2004). Under both Australia’s and Canada’s constitutions, 
there was provision for the federal government to intervene under its external affairs 
powers, should it determine the introduction of a drug consumption room would breach its 
international treaty obligations. The question of whether the interventions breached the 
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conventions remains contested due to treaty provisions which recognise the need for 
interventions to address the harms that arise from drug use (NSW Parliament, 1998; Totaro, 
2000; O’Neil, 2007). In the case of Australia, successive Federal Governments took no action 
in relation to New South Wales’ Medically Supervised Injection Centre or more recently 
Victoria’s Medically Supervised Injecting Room. In Canada, the Harper Government actively 
opposed Insite in Vancouver, first through the courts and then through legislative means. 
However, with the power to legislate on criminal matters pertaining to illicit substances 
sitting at the federal level of government, there was no need for external powers to be 
invoked. International sources of policy change can be concluded, therefore, to have had only 
a limited impact on the stalled replication of drug consumption rooms in both case study 
countries. This argument is consolidated by the fact that the INCB itself took no direct action 
against either country beyond noting its displeasure through statements in annual reports 
(as noted above). 
Facilitating factors 
The findings of this study confirm the international sharing of knowledge that enables the 
idea of drug consumption rooms to travel with the support of an epistemic community. For 
example, Vancouver’s four pillar strategy borrowed directly from European drug strategies. 
Toronto then drew on Vancouver’s four pillar approach in the development of its own drug 
strategy that recommended the city council explore the introduction of DCRs (MacPherson, 
2000; Toronto Drug Strategy Advisory Committee, 2005). In Australia, the extensive work 
undertaken by parliamentary and government-appointed expert committees, intent on 
scrutinising the appropriateness and viability of DCRs, drew on international research 
evidence (Parliament of New South Wales, 1998; Drug Policy Expert Committee, 2000). It is 
also possible to see the remarkable closeness in design of the MSIC and Insite facilities. 
McCann and Temenos’ (2015) study confirms the professional relationships between 
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practitioners at each site. While this evidence demonstrates the international sharing of 
knowledge and the circulation of ideas to facilitate the establishment of centres, the impact 
in relation to the subsequent continued diffusion of the idea at a sub-national level is scarce. 
The idea persists, as we see in the case of the continued advocacy for a supervised injecting 
facility in Melbourne after the initial failure to secure the proposed five sites, but the scaling 
up of facilities is not achieved at all in Australia, and delayed for many years in Canada. In 
conclusion, the existence of an international harm reduction movement can be 
demonstrated to contribute to the circulation of ideas, but we must turn to other factors to 
identify stronger drivers (or inhibitors) of change.  
8.2.2 State-centred sources of policy change 
State-centred forces provide another level of macro-analysis for identifying factors that 
affect policy transfer. This study identifies both ideational and institutional factors that work 
at a structural level to constrain and facilitate the replication of drug consumption rooms. 
The impact of these factors has been significant in all four case study sites. In particular, the 
roles played by parliaments, legislation and electoral politics can be shown to have been 
effective in constraining change in this area and curtailing efforts that would have allowed 
the policies to have diffused or become more normalised. These institutional constraints 
have been supported by ideational factors such as the dominant ideology of prohibition. 
Following a discussion of these constraining factors, the key drivers that have facilitated 
change at the level of the state are identified. These fall under the headings of ideational, 
institutional and agency factors, and encompass opportunities presented by ideological 
change, electoral change and the role of political leadership. 
Constraining factors 
One of the most readily identified constraints that has mitigated against a permeation of 
policy in this area has been the necessity for different levels of government to support a 
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common policy objective. In both Australia and Canada, different levels of government 
become engaged in this issue as a consequence of the division of powers in the federal 
systems, which has resulted in the separation of responsibilities for criminal justice, health 
and local government. As a drug policy issue with a public health orientation, drug 
consumption rooms have straddled both health and criminal justice policy portfolios and 
layers of government, placing a level of complication on the development and passage of 
policy initiatives. This issue is explored in detail under Theme 2 of the previous chapter, which 
looks at the tensions and challenges that arise from the requirement to coordinate and 
cooperate across political and governance boundaries.  
For the question of replication, of particular interest is the issue of the constraints placed on 
diffusion of the policy. In each case study country, at least one drug consumption room was 
able to be established, demonstrating their technical and legal feasibility. This study’s 
findings show that legislation has been used very specifically to constrain expansion of 
service. In Australia, this took the form of enabling legislation in the two States only making 
provision for one centre, requiring any expansion of services to go before the Parliament 
again to debate amended legislation. In Canada, the Harper Government introduced the 
Respect for Communities Act 2015 following the Supreme Court’s ruling in favour of the 
constitutionality of providing drug consumption rooms. This legislation deliberately set 
burdensome requirements that discouraged applications under the existing exemption 
process (Hayle, 2015). In each of the countries, Governments have used legislation to set 
tight and constraining boundaries, sending a strong message that drug consumption rooms 
are exceptional services that are not to be normalised. This is in keeping with Evans and 
Davies’ (1999) conjecture that policy ideas that do not align with the strategic concerns of 
the state are unlikely to be adopted – or in this case, scaled up.  
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The function of parliaments has also been critical, particularly in Australia, reflecting the 
important role played by institutions in resisting or blocking policy change. For example, 
despite the Bracks Government in Victoria campaigning on the introduction of supervised 
injecting facilities and gaining a mandate through its electoral victory, its Bill was defeated in 
a vote in the Upper House, where the Government of the day did not have a majority. Clearly, 
this is not out of keeping with the function of Parliament, but it reinforces that the policy 
process, particularly in contested policy areas, must be navigated. In seeking to understand 
outcomes, we must trace the institutional pathways along which policy travels (Lewis, 2005). 
The constraining role played by parliaments is also noted in the parliamentary committee 
process where bills are scrutinised prior to being taken to the floor for debate. As discussed 
in the case study of Melbourne, for example, despite the fact that 46 of the 49 submissions 
submitted to the 2017 Inquiry into Fiona Patten’s bill proposed a medically supervised 
injecting centre in North Richmond, the Committee did not recommend supporting the trial 
(Parliament of Victoria, 2017). Earlier in NSW too, a Joint Select Committee of Parliament 
recommended against supporting the recommendation in the Wood Royal Commission to 
established supervised injecting facilities (Parliament of New South Wales, 1998). In both of 
these cases, the Committee’s recommendations prevented legislation proceeding to debate 
on the floor of Parliament at that time. 
The findings of this thesis demonstrate that the ideology of prohibition, which provided the 
rationale for the criminalisation of drugs, created tensions for states contemplating change 
in this area. Theme three in the previous chapter explores in some detail the policy conflict 
between public health and law enforcement approaches to drugs, and how drug 
consumption rooms sit at the interface of these policy domains. While harm reduction 
policies existed in both Canada and Australia, providing the rationale and ideational ‘home’ 
for DCRs, this study exposed the reluctance of governments to embark upon change in favour 
of health oriented policies if it made them look ‘weak’, particularly if they were in a phase of 
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campaigning on law and order issues or were simply ideologically disposed towards being 
‘tough on crime’. Part of the explanation for their reluctance was explained by electoral 
concerns but also by the potential of the ‘slippery slope’ that reform in one area of drug 
policy opened up should the paradigm of prohibition be challenged (see Theme 3, Chapter 
Seven). Drug policy appears to be a ‘threshold’ policy issue where Governments hesitate. As 
will be discussed below in the case of Canada, significant ideological change is required to 
overcome this constraining factor or change will be very difficult to achieve. 
Facilitating factors 
Several key state-centred factors for facilitating policy diffusion are identified here. The first 
is ideational and discusses the role of ideological change in Canada; the second is 
institutional, looking at both systems change as a result of elections and the role of the 
courts; and the third is agency related, focusing on the role of political leadership. 
Drug consumption rooms in Canada began to be scaled up in the context of the overdose 
crisis as a result of the increase in fentanyl consumption, but prior to the extent of the crisis 
becoming apparent in late 2016, there had already been a shift in support at the federal level 
of government. The Trudeau Government won office in October 2015 and strongly signalled 
it would support the establishment of further DCRs. This encouraged organisations to submit 
or accelerate plans for applications for exemptions to run drug consumption rooms (Hayle, 
2017). The Dr Peter Centre became the second site to gain official status in 2016, bringing 
the number of sites to two. By November 2017, 23 additional drug consumption rooms had 
been approved (Health Canada, 2017). What is significant is that the Harper Government’s 
Respect for Communities Act 2015 remained in place until May 2017. This meant applications 
for exemptions to be considered by Health Canada had to fulfil the arduous requirements of 
the standing Act. The legislation was identified by a number of study participants as a major 
barrier to the scaling up of supervised injecting, yet under the new Government, 
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organisations were able to successfully meet the requirements of the old legislation and were 
granted exemptions to operate. This demonstrates that the ideological stance of the new 
Government facilitated change without actually removing what has been identified as a 
structural impediment. This is consistent with Evans’ (2004) argument that change can 
emanate from system change, which in this case introduced new ideological approaches as 
a result of electoral changes. 
This ideological change was facilitated in Canada due to systems change brought about by 
the electoral victory of Trudeau. The findings of this thesis are somewhat ambivalent around 
the impact of electoral concerns in relation to replication. While Trudeau’s win facilitated 
change occurring in Canada, as discussed above, the Bracks Government’s plan for five 
centres in Melbourne was contested as an electoral issue, yet the legislation was defeated in 
the Upper House of Parliament, a result which undermined the ability of the electoral 
outcome to facilitate policy change. The discussion on the theme of politics in Chapter Seven 
demonstrated concerns with the political capital of Governments at particular points in the 
electoral cycle, as well as the vulnerability felt by politicians in relation to issues they felt 
divided their electorate. In all case study sites, a consciousness of the impact of addressing 
controversial issues on electoral prospects was raised. This is consistent with MacGregor’s 
(2013) finding, in her study of British politicians’ views of drug issues, that messages sent 
about drugs can be linked to short term political gain, as well as signalling overall positions 
in regards to sets of interests or values.  
A key difference between the two countries has been the role played by the courts. In 
Australia, parliaments have proved to be the key fora for deliberation over the question of 
supervised injecting. In Canada, however, the finding of the Supreme Court that the denial 
of access to health services violated Charter rights emerged as a facilitating factor that 
provided a legal argument for the scaling up of services (Voell, 2012). According to Hyshka et 
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al., “Officials in several other cities have initiated or accelerated preparations for new 
facilities due to speculation that the ruling provides sufficient legal basis to expand 
supervised injection in Canada” (Hyshka et al., 2013 p.468). Whether this ruling did amount 
to an endorsement is contested on the grounds that the Supreme Court’s decision related so 
specifically to Insite and its effectiveness (Boyd, 2103). The Harper Government, however, 
felt sufficiently compelled to react to the Court’s ruling with the introduction of legislation 
designed to discourage service providers from seeking exemptions. That legislation proved 
to be short-lived and as discussed above, was not actually an impediment in a more politically 
supportive environment when the Trudeau Government came to power. No case was 
brought to test the constitutionality of the Respect for Communities Act 2015. The facilitating 
influence of the courts is perhaps best viewed in terms of the opportunities the long-running 
and high-profile court cases afforded to draw the general public’s attention to the aims and 
outcomes of Insite, thus potentially cultivating more general support, or at least tolerance, 
for the concept of supervised injecting. 
The final state-centred facilitating factor to be explored is political leadership. Through the 
case studies and the thematic analysis, acts of political leadership are identified as having 
been decisive in breaking impasses to allow policy change to occur. These acts of political 
leadership have often been captured as a ‘change of heart’. Example include the emergence 
of Premier Bob Carr’s support for supervised injecting at the end of the NSW Drug Summit, 
and the Mayor of Vancouver Philip Owen’s conversion from opponent to supporter of 
supervised injecting facilities (Humphries and Totaro, 1999; Campbell et al., 2009). These acts 
of political leadership in coming out in support of controversial policy change can be 
demonstrated to have impact in initial policy change but cannot be shown to have resulted 
in replication or a scaling up of policy. For example, despite Bob Carr’s engagement with the 
issue of supervised injecting having been decisive in bringing MSIC into existence, the 
legislative instrument that supported MSIC only made provision for one facility. In Victoria in 
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2017, Premier Andrews spoke publicly in support of supervised injecting and personally 
delivered the message as to the change in Government policy. Yet again, the legislation in 
allowing only one centre set strict limits, signalling the Government’s support was narrow 
and specific, not in-principle support of the broader concept (Wahlquist, 2017).  
In terms of policy transfer, it is useful to consider Hay’s (2002) discussion of the 
intersubjectivity of structure and agency when attempting to assess the impact that these 
political leaders have had as agents through their conduct on the structures or context in 
which they operate. There appears to be a tendency to act conservatively and limit change. 
This supports an interpretation that acts of political leadership have been about ‘strategic 
selection’, with the contexts (structures) in which the leaders were situated generally 
favouring certain, more conservative, strategies over others (Hay, 2002). In explaining why 
scaling up did occur in Canada, we need to look to the role of crisis in breaking these more 
general patterns of preserving institutional stability. As Hay says, “Agents acting in a routine 
manner will tend to reproduce existing structures and patterns of social and political relations 
over time, while actors rejecting norms and conventions will tend to transform existing 
institutions and practices” (Hay, 2002 p.166). He argues that perceived crisis provides greater 
opportunities for institutional and ideational change than at other times. The critical role of 
crisis is further considered in the section below in relation to opportunities for policy-
oriented learning. 
8.2.3 Policy oriented learning 
The third aspect of the policy transfer framework to be considered is the impact of policy-
oriented learning on the question of replication of drug consumption rooms. Evans identifies 
four different forms of policy-oriented learning that are associated with the transfer of policy: 
copying, emulation, hybridization and inspiration (Evans, 2004 pp.37-38). This thesis’ focus 
on the question of the replication of policy shifts the focus from the initial transfer of policy 
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to what facilitated or constrained the diffusion of the idea of supervised injecting. This allows 
an assessment to be made of significant policy learning issues beyond the other political and 
structural constraints and facilitating factors that have been identified above. The findings of 
the study identify a number of micro-level factors that have acted as barriers to the diffusion 
of the idea and the realisation of drug consumption rooms. They are i) cognitive obstacles, 
including the policy conflict between harm reduction approaches and prohibition; ii) 
ineffective mobilisation of elites; iii) the persuasiveness of evidence, and iv) stigma and 
discrimination. These are discussed before consideration is given to the facilitating factors 
that have appeared to support the process of replication in Canada: i) crisis framing and 
problem recognition; and ii) the use of the evidence base. 
Constraining factors 
Four key constraining factors affecting policy-oriented learning have been identified by the 
thesis. These are discussed separately below, but it should be noted that these constraints 
on the diffusion of policy are interlinked and reinforcing. The combination of factors 
strengthens resistance to the ‘new idea’ of drug consumption rooms, even in the face of 
evidence of the effectiveness of the interventions. These constraining factors include 
ideational and cognitive obstacles that affect the ability to mobilise the support of policy 
elites and affect the frames through which evidence is viewed. Ongoing stigma and 
discrimination towards drug use and drug users serve to reinforce an environment where the 
provision of services to drug users is viewed as enabling undesirable behaviour, rather than 
the dominant frame being one of providing care and compassion. 
The third theme presented in Chapter Seven is policy conflict in relation to public health and 
law enforcement approaches to drugs. As was explored, the existing criminal laws present 
an obstacle to the operational requirement of a drug consumption room to offer clients a 
safe and legal place to consume illicit drugs. Political support for sanctioned drug 
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consumption therefore requires Governments to hold effectively contradictory positions on 
illicit drugs, making them vulnerable to political attack. In Australia, the restrictive legislation 
that was passed in both case study locations reflects the acknowledgement that supervised 
injecting was an extreme measure that would be tolerated but not normalised. This reflects 
there was no underlying change to the values being reflected in the general political stance 
on drug issues, and in fact, as was argued in the previous chapter, support for public health 
approaches to drug issues was vulnerable in times when Governments were seen to be 
focused on being ‘tough on crime’. The ‘success’ of MSIC in Sydney could have resulted in 
policy learning that supported that knowledge being diffused to other places in New South 
Wales and nationally, but cognitive obstacles remained.  
Ineffective mobilisation of elites is one of the potential obstacles to policy transfer identified 
by Evans (2004). Linking to the discussion on political leadership above, the findings of the 
study show that many politicians were reluctant to put their full support behind drug 
consumption rooms given the ‘difficulties’ associated with perceptions of drug use and its 
associated criminality. This quotation from an Advocate in Melbourne who campaigned for 
years for an injecting centre in North Richmond demonstrates the obstacles campaigners 
confronted in attempting to sway government in the face of competing demands: 
“We started to get feedback from Government to say…more people within 
Government are starting to recognise the issue or the need for an injecting room but 
the party room is at that point where they just don't believe there's enough community 
support or there's too many factors which could impact negatively on the Government. 
And that became quite apparent when we started to ask, well, what is it about the 
campaign or what aspect of what we are saying is not resonating with the Government 
and…the feedback that we got was that the Government wants to run an agenda 
around law and order. They believe that that's where the Opposition feels that the 
Government is weak.” (Advocate 6, Melbourne) 
In effect, supervised injecting was seen as a ‘hard sell’ and given the technical feasibility of 
DCRs (as proven in Vancouver and Sydney) this reluctance to support expansion or adopt the 
idea across sub-national jurisdictions does appear to be have been affected by an inability to 
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mobilise sufficient elite support. For more on this issue, see the discussion on policy transfer 
networks in section 8.2.4 below. 
The findings in relation to the role of evidence are presented under Theme 6 in Chapter Seven 
and as argued there, study participants were divided as to whether evidence had a significant 
impact on the prospects for drug consumption rooms to be scaled up or the policy to become 
more diffused. The case studies in Chapters Five and Six also revealed instances of public 
figures being dismissive or disputing the findings of formal evaluations, perhaps the most 
notorious incident being Canadian Federal Minister Tony Clement calling into question 
Insite’s effectiveness on the basis of contrary ‘research’ that proved to be non-peer reviewed 
research commissioned by the Royal Canadian Mounted Policy (Paulsen, 2008). The thesis 
has found that in all case study sites, evidence has been used selectively in the course of 
parliamentary, council and community debates on the issue of supervised injecting. The 
evidence of the effectiveness of the centres as presented in the scientific literature and 
evaluation materials has not proven to be persuasive in a way that has removed the level of 
controversy or concerns about the acceptability of the services. The role played by evidence 
in relation to policy learning appears to be consistent with Sabatier’s notion that learning is 
a political process and the battle of ideas will be fought in accordance with core underlying 
beliefs. Sabatier maintains those core beliefs or values are difficult to change and therefore 
information that contradicts them will be resisted until a sufficient challenge arises that 
forced a revision of the belief system (Sabatier, 1988). 
The fourth and final micro-level factor to be found to constrain policy learning is the ongoing 
existence of stigma and discrimination towards drug use and drug users. Stigma and 
discrimination were identified as a factor driving continued opposition to supervised injecting 
by participants in all four sites, as discussed under Theme 5, Controversy and debate, in 
Chapter Seven. Opposition to drug consumption rooms based on a view of drug users as 
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being undeserving of help, or that DCRs ‘enabled’ undesirable and criminal acts, affected the 
opportunities for policy learning and potential scaling up. For policy makers, this reinforced 
a sense of risk in relation to supporting something that could be held to be at odds with what 
the community wanted. The ongoing stigmatisation of drug use, reinforced by the criminality 
associated with it, has the effect of blocking the normalisation of the provision of such 
services to drug users. While they remain controversial and contested, political risk remains 
attached to them and the debate is removed from questions of their technical 
implementation. Policy learning in a controversial area is aided by a shift in underlying values 
or beliefs; ongoing stigma and discrimination mitigate against that change. This is supported 
in the literature by the work of Schneider and Ingram who argue that “Knowledge…is used 
when risks to policy makers are low and when knowledge reinforces either benefits to those 
socially constructed as “advantaged” or burdens those socially constructed as “deviant”” 
(Frantz and Sato, 2005 p.187). These ideas were also explored in the literature review in 
Chapter Two through the focus on ‘deservedness’ in the works of MacGregor (2013) and 
Stevens (2011). Hudebine’s (2005) study of UK drug policy also captures these notions and 
he concludes that a duality emerges as the focus on social inclusion of a marginalised 
population sits at odds with the deviantisation that is achieved through repressive policies of 
prohibition. 
Facilitating factors 
The thesis identifies two key ideational factors that operated at the micro-level to facilitate 
the diffusion of policy: crisis framing and problem recognition; and the use of the evidence 
base. These are discussed below in relation to the scaling up of drug consumption rooms in 
Canada in 2017. 
There has been a strong association with a notion of ‘crisis’ and problem recognition in all 
four case study sites, as discussed under Theme 1 in Chapter Seven. The findings captured in 
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Table 7.1 show that crisis framing is required for political support for DCRs to emerge, and 
that a challenge exists to match the ‘problem’ of street-based drug use to the ‘solution’ of 
supervised injecting. As the thesis demonstrates, Australia has not experienced a scaling up 
of supervised injecting and 17 years lapsed between the establishment of Sydney’s MSIC in 
2001 and Australia’s second site in Melbourne. However, in 2017, the landscape changed 
considerably in Canada with the number of approved sites reaching 23, in addition to the 
emergence of multiple ‘overdose prevention sites’ operating outside the law (Health Canada, 
2018). Here I will argue that it was the particulars of the crisis framing concerning the opioid 
overdose situation that increased the receptivity of policy actors to recognise the policy 
problem and take action. While this is discussed as a key ideational factor that facilitated 
policy-oriented learning, I also argue that without civil disobedience, that crisis framing 
would not have been sufficient to achieve the scale of change. The role of civil disobedience 
is further discussed in Section 8.3.1 below. 
As was presented under Theme 1 of Chapter Seven, arguments to promote DCRs as a solution 
to street-based drug scenes have been concerned with issues of the visibility of the problem 
and associated amenity issues. There has also been a strong geographic factor linked to the 
nature of street drug markets and the fact that people will tend to use drugs in close 
proximity to the place of purchase (Reddon et al., 2013). As a high-profile facility, Insite in 
Vancouver was seen to be a solution to the specific and highly visible problems of street-
based drug use in the Downtown Eastside. In one sense, this represented a barrier to the 
transfer of the policy, as confirmed by participants in Toronto. They identified resistance to 
the adoption of the idea of supervised injecting as the case had been made that their local 
dispersed drug scene did not appear to match the concentrated conditions of the DTES, 
generating arguments against adopting the model of Insite (Researcher 4, Toronto; 
Practitioner 3, Toronto; Policy Maker 4, Toronto).  
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The current opioid crisis in Canada, associated with the arrival of fentanyl into the illicit drug 
market, has some significantly different characteristics from the earlier public health crisis 
that was declared in response to overdose deaths and HIV prevalence rates in the Downtown 
Eastside of Vancouver. First, the impact has been national in scale, in comparison to the 
bounded problem associated with the DTES or other specific but limited locations in Canadian 
cities with street-based drug scenes. Secondly, fentanyl has widely contaminated the drug 
market and the risks associated with it are not contained within a specific category of drug, 
such as heroin, or a specific method of consumption, such as injecting. Thirdly, this 
widespread contamination of the market has resulted in new populations of people, outside 
of more traditional street-based drug market locations, being affected by overdose. Opioid 
overdose deaths have become a suburban phenomenon rather than an issue associated with 
street scenes, drawing new populations into the crisis (Belzak and Halverson, 2018). The 
effect has spread to all drug-using populations, challenging stigmatised notions that there is 
such a thing as a ‘typical’ drug user. This demonstrably different crisis presents an 
opportunity for the framing to shift the more familiar boundaries of ‘us’ and ‘them’, 
challenging the constraint of stigma noted above. It is perhaps more akin to the generalised 
threat of HIV that presented opportunities for more radical options to be tabled in the 1990s. 
In terms of policy-based learning, this crisis framing has reduced some of the constraining 
barriers and allowed for more widespread recognition of the problem being faced, and 
therefore acceptability of the ‘solution’ being matched to it.  
As discussed above, the issue of the role of evidence remains ambiguous; this was included 
as a factor constraining policy-oriented learning. However, the case can also be made that 
evidence played a positive role in facilitating policy-oriented learning. As presented under 
Theme 6 in Chapter Seven, a number of Canadian participants argued strongly that the 
rigorous building of the evidence base of the effectiveness of Insite was critical for the 
prospect of building future services. In particular, the court cases concerning Insite, as 
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discussed in the Vancouver case study in Chapter Six, deliberated specifically on the effects 
of the intervention. The research evidence that was presented in the courts was crucial to 
the rulings that found in favour of right for people to receive this health care (or more 
specifically, that it would be a violation of Charter rights to be denied the service) on the 
grounds that the services provided at the centre were proved to reduce risk for injecting drug 
users (Small, 2012). The court cases were widely reported in the media and this contributed 
to a raised level of public awareness of the issue of supervised injecting and the strong 
arguments that could be made in support of the provision of such a service, thereby reducing 
cognitive obstacles to policy learning.  
8.2.4 Policy transfer networks 
The fourth component of the policy transfer framework is policy transfer networks. Evans 
defines policy transfer networks as “collaborative decision structures comprised of state and 
non-state actors that are set up with the deliberate intention of engineering policy change” 
(Evans, 2004 p.36). He argues that their significance lies in their ability to shape the policy 
outcomes that result from the transfer process. Under the policy transfer framework, 
emphasis is placed on the intentionality of the process of transfer – distinguishing it from 
policy convergence that may occur in an unintended way. The focus on the intentionality 
suggests agents play a key role in the process (Evans and Davies, 1999). Analysis of the 
networks is process-centred, but there are equally important ideational aspects with the 
focus on epistemic communities and the movement of ideas. 
The sharing of knowledge about drug consumption rooms along a number of policy transfer 
pathways (for example, international to national, national to national, and local to local) has 
been documented in the drug policy literature (McCann and Temenos, 2015; Mendes, 2002; 
Dolan et al., 2000). In particular, there is evidence of visitors from European centres sharing 
their knowledge in both Canada and Australia prior to the opening of the first centres, and 
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of politicians embarking on study tours to view the operation of facilities in order to bring 
first-hand experience to the policy debates (Campbell et al., 2009; Mendes, 2002; Interview, 
Researcher 8, Melbourne; Interview, Policy Maker 2, Toronto). For example, Premier Steve 
Bracks argued in the Victorian Parliament: 
“Overseas evidence is overwhelming. Anyone who has had the opportunity to travel 
and see some the facilities and talk to municipal officials, police and other 
organisations would bear that out…There has been a shift of drug use off the streets 
and away from public places, and the extent of public nuisance has been reduced. I 
saw some of the facilities in Switzerland, and to date no deaths have occurred in 
injecting facilities there.” (Quoted in Mendes, 2002 p.143) 
The findings of the case studies support the existence of policy transfer networks in all four 
case study sites. Table 8.2 gives examples of events, processes or fora in which these 
networks have operated and in which agents collaborated to pursue policy transfer in 
support of drug consumption rooms. While this demonstrates collaborative activity in pursuit 
of a policy agenda, the pertinent question in relation to this thesis’ concern with replication 
is what specific factors contributed to constrain or facilitate the diffusion of policy in this 
area. Can the stalling of policy diffusion in Australia, and earlier in Canada, be attributed to 
the failure of policy transfer networks? Conversely, how central were policy transfer 
networks to the success of the more recent replication of policy in Canada? These issues are 
considered in the sections below. 
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Table 8.2 Examples of policy knowledge sharing and work of epistemic communities in case 
study sites 
Location Event, process or forum Agents of policy 
transfer 
Sydney, Australia 
 
Expert presentations to the Drug Summit, Nov 1999 
Public forum for the 15th anniversary of the 
establishment of the ‘Tolerance Room’ organised by 
Unharm 2014 
Stakeholder consultation, Statutory Review of Part 2A 
of the Drug Misuse and Trafficking Act 1985, 2016 
Parliamentarians 
Bureaucrats 
Advocates 
Activists 
Researchers 
Public health 
practitioners 
Lawyers and 
court officials 
Coroners 
 
Melbourne, 
Australia 
 
Drug Policy Expert Committee, called to advise the 
Victorian State Government, 1999 
Community Forums, organised by the DPEC, addressed 
by experts, various locations, 1999 
Keynote address by Vancouver Mayor Larry Campbell 
to the International Conference on the Reduction of 
Drug Related Harm, Melbourne, April 2004 
Coroner Hawkins calls expert witnesses on supervised 
injecting to her inquest into a heroin related death, 
2017 
Vancouver, Canada 
 
International Forum on Drug Treatment and Crime 
Prevention, gathering of international experts, June 
1998 
International Harm Reduction Association’s conference 
hosted in Vancouver, 2006 
International Society for the Study of Drug Policy’s 
annual conference hosted in Vancouver, May 2018 
Toronto, Canada 
  
Toronto Residents’ Reference Panel on Supervised 
Injection Services, Final Report, July 2014 
10th Anniversary celebration of the City of Toronto 
Drug Strategy including a community forum addressed 
by drug policy experts (including former Vancouver 
Mayor Larry Campbell), November 2015 
Fourth International Law Enforcement and Public 
Health conference hosted in Toronto, September 2018 
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Constraining factors 
The most significant constraining factor on the actions of agents with the potential to 
influence policy outcomes appears to be ineffective or, at least, insufficient mobilisation of 
elites. There is extensive evidence of the existence of knowledge about drug consumption 
rooms in all four case study sites as documented in the case study chapters. With each 
attempt to introduce supervised injecting, there was intensive debate in the media, scrutiny 
by committees (whether the Boards of Health in Canada, or specifically convened 
parliamentary committees or expert panels in Australia), and feasibility studies such as the 
TOSCA report in Toronto or the Burnet Institute’s study of street-based injecting in North 
Richmond (Bayoumi et al., 2012; Dwyer et al., 2013). In addition, the formal evaluations of 
Insite and MSIC provided credible evidence as to the objectives and effectiveness of DCRs 
(Wood et al., 2006; KPMG, 2010).  
As was argued above in Section 8.2.3 on policy-oriented learning, this evidence did not prove 
to be persuasive enough to mobilise sufficient elite support beyond limited approval of single 
sites, until the recent changes experienced in Canada. Elites instead often made their 
decisions based on value judgements and in doing so, exercised considerable influence as to 
the ‘unacceptability’ of supervised injecting. This is illustrated by a speech in the NSW 
Parliament by MP Katrina Hodgkinson in 2010 on why she opposed legislation in support of 
the Medically Supervised Injecting Centre in Sydney. Ms Hodgkinson outlined her visit to 
MSIC and was fulsome in her praise for the staff and the service they provide to a client group 
with very specific needs, but then provided the following defence for her decision to oppose 
the legislation: 
“My primary focus must be on the message that I send to my electorate…I have 
outlined the many good things that are being done by the centre, but at the end of the 
day the message I must send back to my electorate is that it is never okay to start 
taking drugs. Drugs are bad. Drugs will do bad things to your body and to your mental 
health. It should never be okay to send children a positive message about drugs. It is 
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just not okay. Therefore, I will oppose the legislation.” (Parliament of NSW, Legislative 
Assembly Hansard, 2010, p.26391) 
Another example of the constraining role played by elites is the outcome of the 
parliamentary committee processes. Such committees play an important role in scrutinising 
potential legislation prior to it being debated in the Parliament, and their recommendations 
can determine whether draft legislation proceeds to debate or is withdrawn. An example of 
a lack of support from policy elites is illustrated by the outcomes of the Victorian Parliament’s 
Legal and Social Committee’s consideration of a draft bill to introduce a pilot drug 
consumption room in Melbourne in 2017 (see Chapter Five for further discussion). Despite 
46 of the 49 public submissions to the inquiry arguing in favour of supporting an injecting 
centre in North Richmond, the Committee did not support the legislation proceeding to 
debate in the Parliament (Parliament of Victoria, 2017). This example relates only to a 
potential first centre in the State of Victoria, but demonstrates the road blocks confronting 
any scaling up of services. Nearly twenty years earlier, a Joint Select Committee of the New 
South Wales Parliament sat to consider the same issue. The Committee produced a 300-page 
report considering the state of injecting drug use in NSW; overseas research and experience; 
and health, social, economic and legal arguments for and against supervised injecting. 
Ultimately a majority of Committee members did not recommend proceeding to a trial, 
despite the Chair noting in her Foreword that support for the trial had come from “public 
health officials, the NSW Law Society, the Australian Medical Association, the Bar Association, 
and parents who have suffered the death of a child” (Parliament of NSW, 1998, p.xiv). 
The introduction to this section posed the question as to whether the stalling of policy 
diffusion in Australia and earlier in Canada could be attributed to a failure of the policy 
transfer networks. The empirical findings of this study demonstrate the existence of 
concerted campaigns to bring about policy change in the case study sites, and equally 
demonstrate instances of the blockages presented by key political agents. In this simple 
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sense, those policy networks, or “advocacy coalitions” if conceptualised in Sabatier and 
Jenkin-Smith’s (1993) terms, have failed to dominate the battle of ideas or prove sufficiently 
persuasive. However, this failure needs to be analysed in conjunction with the other findings, 
identifying the limitations imposed by structural and institutional factors, that are discussed 
in the earlier section of this chapter. In this way, we can better understand how the context 
in which agents work has limited the opportunities for networks to succeed. 
Facilitating factors 
The facilitating role played by policy transfer networks was most evident in an epistemic 
community that continued to keep the idea of drug consumption rooms in circulation in 
Canada, where replication was eventually achieved. For example, a Policy Maker in Toronto 
highlighted the role played by proponents of harm reduction and acknowledged the 
influence of policy developments in Vancouver on the policy community in Toronto:  
“But also we have a very active and strong harm reduction community, and they're 
strong advocates. They've been talking about these issues for a long time, and they 
come to the Board of Health and they depute; and they come to city committees and 
they speak out, and they wanted to see more. I think certainly when Vancouver came 
forward with their drug strategy, and we started to talk at a different level about a new 
approach to the issue, it provided a good opportunity.” (Policy Maker 3, Toronto) 
Through research publications, conferences and the provision of expert advice, an active 
research community kept the idea of supervised injecting ‘alive’ even during the difficult 
political period of the Harper Government. As has been discussed, however, the evidence 
produced by this epistemic community continued to be disputed and used selectively, so the 
impact of the epistemic community on the more widespread implementation of supervised 
injecting that occurred in Canada can only be assessed as having a medium impact on 
facilitating replication.  
As the case study on Toronto concludes, the process in that city was bureaucratically driven 
through the work of the drug strategy task force and the actions of the Medical Officer of 
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Health, Dr David McKeown and his staff, in continuing to table the proposal for drug 
consumption rooms via the Board of Health. Through documentation such as submissions, 
reports and meeting minutes of the Toronto Drug Strategy Implementation Panel, the City of 
Toronto Council and the Board of Health, the work of a policy transfer network is the most 
transparent to trace of all the four case studies. The findings of that case study, however, are 
that progress was extremely protracted, with over twelve years lapsing between the initial 
tabling of the idea in the city’s drug strategy and approval for services being granted in 2017. 
Again, this supports the finding that networks could facilitate ideas remaining in circulation 
as potential policy options, but those networks had to contend with the significant 
constraints that operated at different levels of governance.  
Kingdon’s (2010) multiple streams approach to policy change provides insights to the 
limitations of the impact of policy transfer networks. Toronto’s experience appears to fit the 
argument that there was readiness in the policy stream but without sufficient momentum in 
the problem stream and the politics stream, the work of the policy transfer network was 
insufficient. For the problem stream, there was the question of whether supervised injection 
was an appropriate response or model for Toronto’s dispersed drug scene and the relatively 
limited use of injectable drugs (Toronto Drug Strategy Advisory Committee, 2005; Porter, 
2005). For the politics stream, the findings of the case study point to constraints emanating 
at the national level due to the Harper Government’s stance (up until 2015), and at the 
provincial level, where the Government did not lend its support to the TOSCA Report 
recommendations for three sites to open in Toronto (Dale, 2013).  
An additional facilitating factor in Toronto was the community engagement work undertaken 
by the policy transfer network. There is evidence of a sustained effort to work with 
communities at all stages of the development of the policy proposals, including through the 
research design of the TOSCA study, which included extensive surveying and community 
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forums. When the recommendations of the study were brought forward, they were couched 
in terms of their community acceptability, focusing on the feasibility objective of the study, 
rather than just the ‘needs’ component. Interview participants attributed the lack of 
apparent controversy within communities to this degree of engagement and consultation. 
For example, a Policy Maker from Toronto described the range of people and groups that 
came forward to publicly support the proposals being considered by the Board of Health: 
“At the time the Medical Officer of Health, when we came forward to the Board that 
was in July 2013, and as I say we had a sea of people. All different kinds of people, 
parents, faith leaders, community, lots of harm reduction folks, people who use drugs 
but scientists and treatment providers with a wealth of expertise and knowledge, from 
CAMH et cetera. They all deputed for it. The media was 95% I would say supportive. 
So there wasn't a huge backlash.” (Policy Maker 3, Toronto) 
In summary, policy transfer networks were able to act to facilitate policy replication, but they 
are assessed as only having a medium impact. They served to promote the idea of supervised 
injecting but relied ultimately on an engaged and mobilised policy elite and, specifically, the 
support of politicians, due to the legislative requirements needed to facilitate policy change. 
8.3 Alternative sources of policy change: the role of civil 
disobedience 
 “So it's confronting to think…you can have all the evidence in the world if you like but 
it doesn't always have the intended impact at the level of government decisions in this 
area.  
And so what does that mean? What do you do then as a policy response or as an 
academic who’s paid to develop good knowledge and intervene in public debates 
about important public policy issues? Does it mean that you just continue to develop 
the evidence and bang your head against that wall or does it mean that you start 
thinking about alternative options for influencing public opinion, for changing 
government policy processes? 
Do those options include civil disobedience?” (Researcher 8, Melbourne) 
The analysis above demonstrates the wide applicability and usefulness of the policy transfer 
framework for interrogating the factors which have been significant in constraining or 
facilitating policy change. Further implications of this will be discussed below, but one further 
piece of analysis was required to ensure a rigorous approach was taken to applying the policy 
transfer framework. Following the exercise of mapping the case study and thematic analysis 
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findings to the framework, care was taken to identify any theme or issue of significance that 
did not sit within the framework’s components. One key factor emerged from this 
assessment: the role of civil disobedience, and by broader implication, the role of community 
participation. The actions of those who defy the law are clearly acts of ‘agency’ which 
challenge legal and political structures. Within the framework, agents of policy transfer are 
identified as being part of policy transfer networks. Civil disobedience, with its disruptive 
tendency, does not sit consistently within this conceptualisation of the original framework, 
with its emphasis on collaborative decision structures “set up with the specific intention of 
engineering policy change” (Evans and Davies, 1999 p.376). As a result, modification of the 
policy transfer framework may be required to address this limitation. 
Acts of civil disobedience have been of a different scale and had a different impact in Canada 
than in Australia. Chapters Five and Six include discussions of civil disobedience in each case 
study site and the following summary recapitulates the findings. In Australia, there has been 
limited civil disobedience in relation to the provision of supervised injecting. In Melbourne, 
local groups set up a temporary public site in Collingwood in May 1999 (Mendes, 2002). The 
impact of this appears to be negligible as supervised injecting had the backing of a major 
political party, the Australian Labor Party, which campaigned on the issue during the 
Victorian state election that same year. In Sydney, an unsanctioned site was set up in the 
Wayside Chapel, also in 1999, as a deliberate act to draw attention to the issue in the lead 
up to the NSW Drug Summit (Wodak et al., 2003). This action was of higher profile, involving 
prominent people and engaging purposely with the media. While it can be concluded that it 
was an important action and served an agenda setting function, there have been no 
subsequent acts. Civil disobedience, therefore, has not played a key role in relation to policy 
replication or stall in Australia. The story in Canada, however, is significantly different.  
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Multiple cases of civil disobedience can be identified in Canada: the unsanctioned supervised 
injecting sites established by activists in Vancouver prior to the establishment of Insite; the 
Dr Peter Centre’s long running unsanctioned site; and, the overdose prevention sites initiated 
in Vancouver in 2016, but expanded nationally in response to the opioid overdose crisis. The 
contribution of activists in Vancouver to the establishment and survival of Insite is explored 
above in Section 6.2.2, where unsanctioned sites are discussed. Activism, including civil 
disobedience, is acknowledged as an essential part of the Vancouver story (Osborn and Small, 
2006; Small et al., 2006; Harati, 2015). The role played by activists was highly political and 
included participation in the formal structures of the body politic, such as holding 
membership positions on the Vancouver Board of Health (Campbell et al., 2009). The stalling 
of the scaling up of supervised injection during the 2000s, however, indicates that civil 
disobedience did not act as a facilitating factor to the further expansion of sites. 
This can also be said of the act of civil disobedience quietly undertaken for fourteen years by 
the Dr Peter Centre in Vancouver (discussed in Section 6.2.2). From 2002, the Dr Peter Centre, 
a private HIV/AIDS care facility, offered a dedicated space where their clients could inject 
under the supervision of a nurse. The Centre disputed that their service was an act of civil 
disobedience. They justified their actions as being within the scope of registered nursing 
practice, and argued that to not provide service might therefore place their nursing staff in 
breach of professional standards contained in British Columbia’s Nurses (Registered) Act 
RSBC 1996 (Davis, 2007). They operated with the knowledge of, but without interference 
from, health or law enforcement authorities. In 2016, they submitted a successful application 
for exemption from the Controlled Drugs and Substances Act 1996, becoming the second 
official DCR in Canada. The Dr Peter Centre’s claims to lawfulness were untested, therefore 
it cannot be said whether their model could have provided an alternative pathway to the 
scaling up of services by circumventing the arduous requirements of seeking Ministerial 
exemption. One article exploring the prospects for the scaling up of supervised injection in 
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Canada suggested organisations could consider working with their provincial nurses’ 
association “to define supervised injection within legally binding definition of scope of 
practice” (Hyshka et al., 2013 p.471), but no evidence was uncovered in the course of this 
research that this had occurred. It can be concluded, therefore, that this second form of civil 
disobedience had only a minimal impact on the replication of services in Canada. 
In 2016, a new wave of community activism did change the political landscape for the scaling 
up and replication of drug consumption rooms. The establishment of the unsanctioned 
overdose prevention sites – first in Vancouver in September 2016, but then in other locations 
across Canada, including Toronto – represented a significant turning point in the policy 
transfer process, and one that is not adequately captured by the policy transfer framework. 
Details of the actions of the Overdose Prevention Society are provided in Section 6.2.3, 
including the support the Society received from both local and provincial governments, 
despite operating in direct defiance of the requirements of the Controlled Drugs and 
Substances Act 1996. My analysis is that the establishment of overdose prevention sites 
proved to be a tipping point for the issue of supervised injection in Canada, triggering a 
paradigm shift in the approach towards drugs in Canadian politics.  
As this was not the first time that activists had engaged in civil disobedience, what factors 
were different in 2016-2017 that enabled acts of civil disobedience to contribute to the 
scaling up of drug consumption rooms? First, the spatiality and scale of the crisis was critical. 
Arguably, the national public health crisis declared in 1997 opened the way for consideration 
of supervised injecting; however, there was a sharp focus on the Downtown Eastside of 
Vancouver as the epicentre of the epidemic. While the Downtown Eastside experienced the 
initial impact of the opioid crisis in the last few years, the threat posed by fentanyl has not 
been contained in the DTES but has affected all provinces with rising overdose deaths being 
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recorded nationally. A recent synthesis of all publicly available opioid-related surveillance or 
epidemiological reports found that: 
 “This is not a problem restricted to persons who use illegal or street drugs; rather, this 
is national public health crisis that affects people in communities across Canada, across 
all ages and across all socioeconomic groups.” (Belzak and Halverson, 2018 p. 224)  
The impact of civil disobedience must be understood in terms of the specific crisis context in 
which it has occurred, rather than as an isolated factor. 
Secondly, while there has been a remarkable degree of tolerance of illegal sites in Canada 
over many years, as the case studies demonstrate, 2016 marked a turning point when 
government authorities at the local and provincial level provided direct material support to 
the unsanctioned overdose prevention sites, providing physical resources such as tents and 
supplies, and in the case of Vancouver, covering some salary costs (personal correspondence, 
Sarah Blyth, April 2017). In British Columbia, overdose prevention sites were endorsed 
through a Minister Order issued by the provincial health minister, Terry Lake. The province 
argued that overdose prevention sites did not supervise drug users, but only monitored use, 
and therefore would not be subject to the strictures placed on supervised injection sites such 
as Insite (Lupick, 2016b). This support came at a critical time. Although the new Federal 
Government had signalled its broad support for supervised injecting, the legislative 
architecture of the Harper Government remained in place, presenting a potential obstacle to 
the expansion of supervised services until 19 months into the Trudeau Government’s period 
of office (Woo, 2017). Terry Lake attributes his decision directly to the impact of activist Sarah 
Blyth, who co-founded Vancouver’s Overdose Prevention Society:  
“In the face of the crisis, she had such an impact on me that I thought, this is crazy: 
We’ve got someone out there by herself, you’re saving lives, and it’s our job to do that 
very thing.” (St Denis, 2018) 
The effect of this endorsement of activism by the provincial government was to break the 
impasse created by the previous requirement to coordinate support at three levels of 
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governance, while overturning the major structural obstacle presented by the existing 
legislation.  
Civil disobedience in Canada in 2016-2017 can be seen to have impacted the process of policy 
replication in four ways, making it a significant factor that must be accounted for in order to 
further understand policy change. Firstly, it contributed to the framing of the opioid crisis by 
drawing attention to the extent of the crisis and the desperation of people, particularly 
through the media profile of key activists such as Sarah Blyth. In this way, it served an agenda 
setting role. Secondly, it challenged politicians to justify the existing laws when the state did 
not appear to be inclined to enforce them. Ultimately it broke the impasse created by the 
‘buck passing’ observed between different levels of government. Thirdly, it served as a 
catalyst, speeding up the ‘slow wheels’ of government by demanding change and, in effect, 
shaming governments into providing services. Finally, the overdose prevention sites 
demonstrated the ease with which services could be delivered, demystifying the process of 
providing assistance for drug users made vulnerable by the increasingly unreliable drug 
supply. Through these impacts, civil disobedience served as a challenge to the state to reform 
its legal apparatus, a move aided by the increasing receptivity of policy elites to the ‘solution’ 
of supervised drug consumption in the face of a worsening public health crisis. 
8.4 Appraising the policy transfer framework 
It is a finding of this thesis that the policy transfer framework has proved to be a robust tool 
for interrogating the factors which both constrain and facilitate policy transfer. Its particular 
strength lies in its capacity to capture the complexities of the policy process, through its focus 
on multiple levels of governance and the roles of both structural and agency factors. By 
mapping the empirical findings of the case studies and the thematic analysis of the semi-
structured interviews to the framework, it was possible to identify the key facilitating and 
constraining factors that influenced opportunities for the replication of drug consumption 
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rooms in the cases under examination. State-centred factors were shown to have been 
particularly significant, confirming the need to examine structural and institutional factors in 
the process of policy change. The framework’s focus on policy-oriented learning is useful for 
examining the influence of ideational factors. What this analysis demonstrated is the 
interconnectedness of many factors; for example, the role of ideology in setting boundaries 
for policy ideas. It is evident from the findings that policy ideas have to travel institutional 
pathways and that there is a tendency towards conservatism. Where replication did not 
occur, this reflects limited change to the underlying values that dominated political decision 
making on the broad question of how to approach drugs, with prohibition remaining the 
dominant ideology. A factor that mitigates against this tendency towards conservatism is 
crisis or, more specifically, the framing of crisis. This study confirms Hay’s (2002) argument 
that crisis can serve to reveal the gap between the cognitive templates under which policy 
makers operate and the experience of the material world. When significant gaps emerge, 
‘new’ ideas – or as in this case, existing ideas that had not gained full acceptance (as 
demonstrated by the legislative constraints imposed on their execution) – are more fully 
embraced, allowing for diffusion.  
It is also, however, a finding of this thesis that there is a significant factor facilitating change 
that is not satisfactorily captured by the policy transfer framework. Civil disobedience has 
been identified as having been critical to the process of change in Canada, serving an agenda 
setting function in the context of crisis, as well as acting as a catalyst to the often slow 
processes of government. In addition, the acts of civil disobedience in setting up 
unsanctioned overdose prevention sites contributed to policy-oriented learning by 
demonstrating from pitched tents the simplicity with which services could be offered, serving 
to demystify the processes by which vulnerable drug users could be supported.  
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It is my contention that the policy transfer framework, as conceived by Evans and Davies 
(1999) and Evans (2004), does not adequately capture the role played by broader community 
participation in the process of policy transfer. The framework is weighted towards capturing 
top-down policy change. Its conception of policy transfer networks, acting with deliberation 
to engineer policy change, does not capture the more maverick actions of agents working to 
provide direct services – regardless of the policy environment. However, the impact of these 
agents on the more formal processes by which policy is developed and delivered through 
institutions has been found to be significant in the cases where there was successful policy 
diffusion (Vancouver and Toronto). I therefore propose that the policy transfer framework 
could be usefully augmented by the addition of a fifth component that identifies the role of 
civil society as a source of policy change or stall. This proposed new framework is presented 
in Figure 8.1. By focusing on both facilitating and constraining factors, the addition of the 
actions and participation of civil society lends more scope and depth to efforts to understand 
why some policy ideas are adopted and why some fail to progress. In particular, it would 
provide a vital lens for better coming to grips with the role played by opponents and not just 
by activists or advocates who support and promote policy reform. 
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Figure 8.1 Modified policy transfer framework: sources of policy change and stall 
 
8.5 Conclusions 
Utilising the policy transfer framework, this chapter has presented analysis identifying the 
factors that constrained or facilitated the diffusion of policy in relation to drug consumption 
rooms. This framework has proved to be a useful heuristic for interrogating and comparing 
the factors that affected policy change in the different sites. The analysis has enabled the 
identification of the factors or circumstances that, working in combination, facilitated policy 
replication in the case of the Canadian sites, and those factors that constrained policy 
replication in Australia. The patterns of the two countries’ experiences in relation to the slow 
uptake of drug consumption rooms were very similar until the changes that occurred in 
Canada from 2015 onwards.  
The major factors identified as working together to bring about significant change are a 
combination of state-centred factors and opportunities for policy learning to occur, which 
increased the receptivity to the idea of supervised injecting among policy elites. Those 
specific factors were ideological and systems changes brought about by the election of a new 
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Federal Government in Canada, and the combination of crisis and the community response 
through civil disobedience with the opening of unlawful overdose prevention sites. For the 
case study sites in Australia, where there has been no general diffusion of the policy, it has 
been shown that there has been very limited change at the structural and institutional level. 
This is reflected in the restrictive nature of the legislation that was introduced in both states. 
There has been a failure to mobilise policy elites to support the idea of supervised injecting, 
as it remains too firmly in conflict with the dominant ideology of prohibition. More 
generalised support for supervised injecting would have required a shift in the underlying 
values, which does not appear to have occurred amongst policy elites. Unlike in Canada, 
there has also been less persuasive crisis framing, reflecting the dynamics of the street-based 
drug market which has been evolving over the last decade. 
Evans’ (2004) policy transfer framework has been found to be very useful for exploring the 
question of policy replication in relation to drug consumption rooms. In particular, the 
framework’s focus on both structural and agency factors and the dialectic relationship 
between them has allowed this study to explore the multiple influences on the policy making 
process and make comparisons across sites. Analysis using this framework has confirmed the 
sometimes marginal role played by evidence in the policy deliberation process, while 
allowing for a range of key constraining and facilitating factors to be identified. As the 
literature review in Chapter Two identified, comparative studies are not common within drug 
policy scholarship. This thesis demonstrates the usefulness of applying concepts from policy 
transfer to explore comparative research in this field. A finding of my comparative analysis is 
that civil disobedience, in the context of crisis, is a major factor that has affected policy 
outcomes in relation to drug consumption rooms. This outcome has been significant as it has 
highlighted that the role of civil society and community participation has been underplayed 
in the current formulation of the policy transfer framework. This has led to the 
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recommendation of a modification to the framework to reflect the influence of agents acting 
outside the intentional, albeit ad hoc, policy networks conceived by Evans and Davies (1999).  
In the final chapter, I will reflect further on the question of civil society’s participation in 
policy making, and the applicability of policy transfer concepts to the field of drug policy, as 
I draw together the key contributions of this thesis and their implications for future research. 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter nine      
Conclusions 
• • • • • • • • • 
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9.1 Introduction 
This thesis aimed to identify the barriers, challenges and facilitating factors that impact the 
replication of drug consumption room policy in Australia and Canada. At the commencement 
of the research in 2015, both countries’ experiences of introducing drug consumption rooms 
were broadly similar: single government-sanctioned sites introduced in the early 2000s had 
not been replicated. This was despite the services having been formally evaluated as 
successfully meeting their objectives. The research was concerned with identifying 
challenges or barriers that had affected the replication of services, and sub-national transfer 
of policy to other regions where similar problems with street-based drug use might have 
made drug consumption rooms a potential policy solution. During the course of the study 
the policy paths of the two countries diverged as Canada embarked on a significant scaling 
up of services across the country in 2017. These circumstances led to a modification of the 
initial research question to focus on the stalling and diffusion of drug consumption room 
policy. 
Drug policy is multi-faceted, being concerned with criminal law, law enforcement, health and 
education. Drug consumption rooms are an intervention that seeks primarily to address the 
health and well-being of drug users, while reducing risks and exposure to the harms of drug 
use for the general public where open street-based drug markets exist. As discussed in the 
Introduction to this thesis, a considerable body of literature has focused on the evidence of 
the effectiveness of drug consumption rooms. The aim of this thesis has not been to assess 
the validity of these scientific claims. An underlying assumption of this research is that policy 
is the result of multiple influences. This position is a rejection of the privileging of evidence 
as would occur through the adoption of an evidence-based policy paradigm. To further our 
understanding of the policy making process, we must look beyond the production and 
weighing of evidence, and seek to understand the different sources of policy change and the 
relationship between them. From this standpoint, perceptions, regardless of the validity of 
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the information they are based on, can have a causal effect (Hay, 2002). For this reason, the 
research has focused on the interaction of these factors rather than the production of further 
evidence as to the effectiveness of DCRs. 
Chapter Two presented a review of the existing literature from a post-evidence-based policy 
perspective, focusing on ideational and social constructionist approaches to understanding 
drug policy. This review identified that while drug policy scholars have been drawing on 
theoretical frameworks from policy studies and political science, the literature on policy 
transfer had only been utilised in a limited way. This is despite its ability to accommodate 
comparative research and to interrogate the relationship between multiple levels of 
government and multiple sources of policy change. Through the adoption of a policy transfer 
framework (Evans, 2004), this research explains how the interactions of structural and 
ideational factors can either constrain or facilitate sub-national policy transfer processes, 
helping to increase our understanding of the challenges of replicating drug consumption 
room policy in Australia and Canada.  
The conclusions of this thesis are presented in four sections. Section 9.2 provides a summary 
of the main findings of the research. Drawing on the structural, ideational and agency factors 
that affect policy development, two scenarios are compared: policy stall, and policy diffusion 
which results in the scaling up of interventions. Section 9.3 considers the empirical and 
theoretical contributions of the research. The fourth section discusses the limitations of the 
research. This is followed by Section 9.5 which proposes future research directions. 
9.2 Summary of the main findings 
Scenario one: policy stall 
In both Australia and Canada, it was demonstrated that state-sanctioned supervised injecting 
facilities were technically and legally feasible. However, policy learning that would have 
supported the diffusion of the intervention was constrained, particularly by state-centred 
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structural sources of policy change and ideational factors. Structural factors, such as the 
division of powers under the federal systems in both states and the criminalisation of drug 
use, resulted in the engagement in policy development of multiple levels of government. 
Policy change required a high level of coordination and an alignment of goals which proved 
a challenge, particularly in Canada, through the initial period. A commitment to policy change 
was required at levels of government that were geographically removed from the areas 
experiencing the amenity issues arising from street-based drug use. Local community 
concerns had to compete with broader political agendas and the concerns of 
parliamentarians for whom drug policy reform was considered a risk with their electorates. 
In Australia, legislation was used deliberately to limit the provision of service to single sites, 
reinforcing the message that supervised injecting would be tolerated under specific 
conditions but not normalised or diffused. This use of legislation contradicted the emphasis 
on policy learning that was implied by framing of the interventions as trials and focusing on 
evaluations to ensure continuation was linked to evidence of effectiveness.  
The tendency towards conservatism, in relation to drug policy change that has been 
reinforced institutionally, has strong ideational elements. The four case studies all record that 
policy makers and stakeholders were exposed to ideas from overseas, initially through study 
tours and through inquiries, research reports, parliamentary debates and media reports. 
Once the initial services were established in Sydney and Vancouver, evidence arises of 
sharing of knowledge and experience across domestic jurisdictions. However, these ideas 
proved insufficiently compelling to result in the lasting structural change that would support 
ongoing policy diffusion. The research identifies two key ideational factors that contribute to 
this in cases of policy stall. The first is the policy contradiction that arises between the 
dominant paradigm of prohibition and the sanctioning of supervised injecting. The second is 
the ongoing existence of stigma and discrimination regarding drug use and drug users. In 
addition, the research confirms findings of other drug policy scholarship that evidence, while 
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important, is only one contributing factor in the policy development process (Stevens and 
Ritter, 2013; Stevens, 2007; Ritter, 2009; Lancaster, 2014; Lancaster and Ritter, 2014; 
MacGregor, 2013; Monaghan, 2011). 
Ultimately, where policy has stalled, it has been the consequence of politics and the actions 
of politicians. This conclusion is consistent with MacGregor’s (2013; 2017) findings of drug 
policy making in the United Kingdom. The cases in Australia demonstrate that the debate on 
supervised injecting has been dominated by parliamentary institutions and therefore would 
have relied on the mobilisation of policy elites to support more deeply embedded change. As 
such, there is no evidence of a change to the underlying values amongst those policy elites 
that continue to support a prohibitionist ideology. Supervised injecting has proved a 
‘threshold’ issue politically. Support waivers in the face of the competing, politically 
expedient agendas that arise periodically, under banners such as ‘tough on crime’. This is 
despite evidence that community support for supervised injecting may be high. Finally, in 
both countries, there has been a significant temporal element. In Australia, the changes to 
street drug market scenes in major cities have affected the nature of the issue, reducing the 
‘match’ between the policy problem and the policy solution. In Canada, as discussed below, 
the changing problem presented by its dynamic drug market has also required new policy 
solutions. In summary, the cases of policy stall show us that while the idea of supervised 
injection has continued to circulate, it cannot be said to have attained a level of acceptance 
which will see the interventions ‘normalised’ as a public health provision. The scenario below 
outlines what this research allows us to learn from the alternative scenario of policy diffusion 
and scaling up. 
Scenario two: scaling up 
The rapid scaling up of drug consumption rooms in Canada during the course of research for 
this thesis presented something of a natural experiment, introducing an unexpected 
254 
 
 
comparison to the previous stable, stalled states of supervised injecting policy in both Canada 
and Australia. Analysis of this occurrence identified three findings from the research that 
facilitated change in Canada.  
The first is crisis. The opioid overdose crisis ushered in by the arrival of fentanyl in the illicit 
drug market rapidly changed the scale and scope of the problem, requiring a policy response. 
Drug consumption rooms represented a (partial) solution with their capacity to reverse 
opioid overdoses through the administration of naloxone. Political resistance or objection to 
the idea of supervising drug use became less tenable in the face of increasing death rates and 
the exposure of the widespread nature of the problem. As fentanyl penetrated a range of 
drug markets, including the recreational drug market, the problem could no longer be framed 
as one that only affected marginalised communities such as those in the Downtown Eastside, 
mobilising broader political support. 
The second factor that facilitated change was structural and lay with the institutional change 
that occurred with the election of the new federal government in Canada in 2015. As 
explored in Chapter Six, national factors had a significant impact on the capacity of cities to 
provide supervised drug consumption and affected the capacity for sub-national policy 
transfer to occur. The systems change brought about by the election of the Trudeau 
Government worked to bring about a more supportive policy environment. Federal drug 
policy was re-framed to support harm reduction and the restrictive legislation of the Harper 
Government was rescinded. However, it was the ideological position of the new Government 
and the signalling of their intent that allowed drug consumption rooms to begin to scale up. 
This occurred prior to the formal change of legislation, demonstrating the power of the 
interaction between ideational and structural forces in achieving policy change. 
Finally, the third factor is the role played by civil disobedience. Despite the rigorous process 
of evaluating the effectiveness of Insite in Canada, evidence did not prove decisive in 
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persuading policy elites to expand supervised injecting beyond the initial site in Vancouver, 
limiting policy transfer. The persistence of activists, as evidenced in Vancouver, kept the idea 
of drug consumption rooms in circulation, demonstrating their potential through the 
unsanctioned provision of services and by continuing to keep the issue on the political 
agenda. In terms of replication, the advent of the overdose prevention sites in 2017 proved 
catalytic, forcing governments at local, provincial and national levels to acknowledge of the 
scale and severity of the problem.  Furthermore, the OPSs demonstrated the simplicity, in 
many ways, of the solution. Politicians and policy makers responded to the actions of 
community activists, first through material support and then through systemic policy change 
that supported the provision of more sustainable and regulated services. In Australia, the 
policy process was dominated by control that emanated from the top down, reflecting the 
embedded institutional interests of the elite. In Canada, the challenge to institutionalised 
power came from the bottom up, driven by a community’s response to crisis. 
9.3 Contributions of this research 
As the scoping review presented in Chapter Two demonstrates, drug policy scholarship is a 
vibrant field addressing complex issues in a contested policy landscape. This thesis has aimed 
to make distinct empirical and theoretical contributions to this body of scholarship. 
Specifically, it has addressed two gaps that were identified in the review of the literature: the 
dearth of comparative studies; and the limited application of policy transfer concepts to 
understanding policy change in the drug policy field. These are addressed in turn below. 
Despite the limitations set by the research question guiding the scoping review, it is 
nonetheless surprising that only four studies were identified that utilised a comparative 
methodology. This thesis, therefore, advances our understanding of policy making by the 
choice of case studies that have provided opportunities for comparative analysis at both 
national and sub-national levels. In doing so, this research makes a contribution to the body 
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of comparative drug policy literature. In addition, it provides an opportunity to interrogate 
the relationship between national policy and local policy and implementation: another gap 
identified by the scoping review. The choice of case studies at the outset was guided by a 
replication logic (Yin, 2014) based on a change/no change criterion where Sydney and 
Vancouver had initial services but no replication, and Melbourne and Toronto had no services 
despite attempts to develop policy in support of drug consumption rooms. The unfolding 
situation in Canada, which could not have been anticipated, provided contrasting 
comparative cases. The timing of the research enabled reflection on policy change in real 
time, but set against a backdrop of a twenty-year period lending the analysis depth and 
breadth. The inclusion of Australian case studies also makes a timely empirical contribution 
to drug policy literature. There has been very limited scholarship considering the cases of 
both Melbourne and Sydney and virtually no focus on the issue of policy diffusion or scaling 
up of services. This research therefore addresses this gap and contributes insights into 
evolving perceptions of the problems presented by street-based drug markets and their 
impact on local communities. It may also serve to inform future policy debates as to the need 
to develop new, more flexible models of service delivery in the Australian context. 
In terms of original theoretical contributions, this research can lay claim to three distinct 
advancements relating to the utilisation of the policy transfer framework. The first concerns 
the capacity of policy transfer to act as a bridge between divergent theoretical approaches 
being employed in drug policy scholarship. The second relates to the theoretical contribution 
to policy transfer scholarship through a proposed modification to the policy transfer 
framework. Lastly, the findings of this research on the critical role played by state-centred 
sources of policy change present a challenge to the claims within policy mobility literature 
(Temenos, 2017) that we have entered a post-political condition, strengthening the case for 
an ongoing need to look to structures and institutions in order to understand policy change. 
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This research was conducted on the underlying premise that in order to gain insight into 
policy change and development, we must look beyond the evidence-based policy paradigm 
to understand the dynamics of policy making. Within drug policy literature, there has been a 
divergence of approaches attempting to do this, which was explored through the focus on 
ideational and social constructionist approaches in Chapter Two. This research identified that 
the concept of policy transfer had been underutilised in the drug policy field, and therefore 
aimed to test out the utility of the policy transfer framework. Chapter Eight demonstrated 
the value of this conceptual approach in accounting for multiple sources of policy change and 
identifying both constraining and facilitating factors that impact policy replication and 
diffusion. This research has illustrated the value of exploring both structural and agency 
factors and the dialectic relationship between them. Importantly, it is the capacity of the 
policy transfer approach to appreciate the role played by structural and institutional forces, 
while accommodating constructionist concepts (narratives, problem construction, ideas) 
that adds value. This research has demonstrated the potential of policy transfer concepts to 
bridge the gap between the often divergent theoretical stances taken in drug policy 
literature, contributing the capacity to develop a fuller understanding of policy making in this 
contested domain. 
In addition to the contribution to drug policy scholarship, this research has engaged with the 
broader policy transfer literature by proposing a modification to Evans’ (2004) policy transfer 
framework. Through the rigorous process of mapping the empirical findings of the case 
studies and the themes identified from analysis of the interview data, a significant source of 
policy change emerged that was not satisfactorily captured by the framework. I contend that 
the framework is oriented to capturing top-down policy change. However, this research 
demonstrates the challenge posed to institutional power through the bottom-up actions of 
activists and community groups, including through acts of civil disobedience. As these actions 
of civil society have proved significant in explaining how policy change is catalysed, I have 
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proposed a fifth source of policy change, civil society, be added to the policy transfer 
framework to aid in the identification of facilitating or constraining factors for future studies 
of policy transfer. 
Finally, the conclusions reached in relation to the role played by state-centred sources of 
policy change pose a challenge to policy mobility scholars, such as Temenos (2017), who 
maintain that power lies with agents, not within institutions or structures. Chapter Three 
introduced the work of policy mobility scholars who were concerned with the circulation of 
knowledge and the movement of policy ideas and their adaptation in local contexts (McCann, 
2008; McCann and Temenos, 2013; Temenos, 2016; Temenos, 2017; Longhurst and McCann, 
2017). Their approach is consistent with a constructionist ontological position. The findings 
of this research reinforce that institutions must be studied in order to understand policy 
development. Structural forces are demonstrated through the exercise of power through 
institutions such as parliaments which have a tendency to constrain political possibilities 
through conservatism. Ideas matter, but they are mediated through institutional processes. 
This was apparent through the use of legislation to deliberately constrain change and 
opportunities for policy learning in the case studies of Sydney, Melbourne and Vancouver. As 
Hay (2002) argues, agents are also important, but the contexts in which they operate must 
be acknowledged. Such a position is at odds with Temenos, in particular, who argues that the 
capture of political structures by neoliberal forces requires we look elsewhere to understand 
change. While this research shares an interest with Temenos in the role of activists and civil 
society, and is arguing for the acknowledgment of civil society as a source of policy change, 
it does so while remaining deeply committed to understanding the structures or contexts in 
which such forces can catalyse systemic change. This point is also relevant for embarking on 
further dialogue within drug policy scholarship where constructionism is becoming 
increasingly influential (Lancaster, 2014; Lancaster, Duke and Ritter, 2015; Fraser and Moore, 
2011; Stevens, 2011).  
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9.4 Limitations 
Despite the consideration given to the framing of the research question and the research 
design, several limitations of this thesis are noted. 
First, the choice of case studies in Australia and Canada cannot be said to be representative 
of the experience of the diffusion of supervised injecting policy, noting the majority of DCRs 
are in Europe. This issue was examined in Chapter Four and an argument made for the 
appropriateness of these cases for this comparative study, including the ability to work in 
English and the broadly similar experience of both countries, at least at the outset of the 
research. Nonetheless, caution should be applied regarding the generalisability of the 
findings. The use of comparative methodology, however, has ensured rigour in terms of 
providing a counterpoint for the reflections on the findings of the research, noting that these 
conclusions apply specifically to Canada and Australia. 
A potential criticism of the study is the lack of systematic evidence to build a case that scaling 
up is warranted. This issue is addressed several times in the thesis by stating that the research 
question is concerned with the policy process and does not set out to resolve the question 
of scaling up from an epidemiological or public health standpoint. The framing of the research 
question did not close off the possibility of finding that sub-national and sub-regional policy 
transfer did not occur because there was insufficient demand for services. As the Australian 
case studies demonstrate, changes to drug markets over time have affected the nature of 
the problem of street-based drug use that DCRs have the potential to address. This research 
has drawn conclusions based on perceptions of stakeholders, as an underlying assumption 
of the research is that ideas, whether factually based or not, have causal power in relation to 
policy change. However, it is important to acknowledge that research that specifically 
addresses the need for services, particularly from a public health standpoint, is a valuable 
complement to the findings in this thesis. 
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Lastly, limitations related to the collection of data should be noted. Interviews were 
conducted in four field locations in two countries. Effort was made to approach a range of 
participants who had been engaged in the policy making process, as identified through the 
development of the case studies, documentary analysis and through contact with key 
informants. Despite attempts to include people who had specifically opposed drug 
consumption rooms, none agreed to participate. As a result, the interview data does not 
reflect as full a range of views as intended. To counteract this potential bias, specific attention 
was paid through the documentary analysis to public statements from opponents, 
particularly through media reports and parliamentary debates. Nevertheless, the lack of 
opponents’ views from the interview data does pose a limit to this research. While there was 
no opportunity to make return visits to the field sites in the course of the research, a future 
remedy would be to spend more time in developing suitable contacts and networks in 
advance of entering the field.  
9.5 Future research directions 
The contested nature of drug policy generates a host of questions that warrant ongoing 
research. Stemming directly from the findings of this thesis, four specific issues are identified 
that would merit further enquiry. 
The opposition to drug consumption rooms highlights that the idea of supervised drug 
consumption has failed to be persuasive for many people, resulting in ongoing political 
contestation and a lack of normalisation of the provision of such services. Yet, as Justice 
Wood argued in New South Wales in 1997, given the public provision of needles and syringes 
it seemed short sighted to waiver on providing sanitary conditions under which people could 
inject (Wood, 1997). A comparative study of attitudes towards, and the debate around, 
needle syringe programmes compared to DCRs would provide some valuable insights into 
what factors have contributed to the apparent public acceptance of needle syringe 
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programmes, to inform the framing of arguments for drug consumption rooms. Further, such 
research would provide an opportunity to delve more deeply into the nature of opposition 
to DCRs, thus addressing one of the identified limitations of this research. 
The second broad area of proposed future research relates to questions of the role of 
representation, public participation in policy making and deliberative democracy as 
considered through case studies of DCR policy making. This research identified that the 
political debates concerning DCRs saw politicians holding positions on the appropriateness 
or otherwise of DCRs that did not align with apparent community support for such services. 
While this thesis has identified a number of factors that have influenced politicians (such as 
perceived electoral backlash and proximity to the problem), there would be value in 
considering this issue in more depth, particularly through more extensive interviewing of 
politicians than was able to be undertaken for this thesis. Such research could further 
develop the work of Treloar and Fraser’s (2007) exploration of why positive community 
attitudes towards harm reduction and NSPs fail to translate to political action, and 
MacGregor’s (2011) work on the role of politicians in the development of drug policy. 
Empirical findings could contribute to theorising on participation in policy making, 
governance, the potential for deliberative democracy and the question of whose voice is 
heard – a pertinent concern in a domain where civil disobedience has proved influential 
(Ritter, 2015; Ritter et al., 2018; valentine, 2009; Houborg and Frank, 2014).  
The third proposed research area relates to the suggested modifications to the policy transfer 
framework that were outlined in Chapter Eight. The recommended adaptation of Evans’ 
(2004) model arose directly from the findings of the thesis in relation to policy transfer and 
policy replication. The idea of delineating civil society as a separate domain of policy change 
from the agents in a policy transfer network reflects a concern with re-balancing the policy 
transfer framework to better reflect both top-down and bottom-up change. This 
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modification also speaks to the concerns addressed in the paragraph above on 
representation and governance issues. It would be appropriate to now subject the modified 
framework to analysis and case studies beyond drug consumption rooms and drug policy to 
test the value of the proposed change. 
Lastly, to return to a concern regarding drug consumption rooms and policy transfer, it is 
proposed that there would be value in further interrogating the issue of specific models of 
DCRs (for example fixed, mobile and integrated) from the perspective of the ideational 
impact of ‘models’ as a fixed and potentially constraining idea in a dynamic environment. 
Data collected in the interviews suggests that some participants were concerned that the 
focus on setting up pilot sites with stringent evaluation requirements may have constrained 
the transfer of the idea to other sites that did not match the specific conditions; for example, 
of the Downtown Eastside in Vancouver. This idea warrants further exploration and could 
engage with McCann’s (2011) notion of exemplars from the policy mobility literature.  
9.6 Conclusions 
This thesis set out to understand the challenges and barriers which have constrained the 
scaling up of a life-saving public health intervention: drug consumption rooms. In the process, 
an opportunity arose to examine the conditions and factors that have facilitated the diffusion 
of policy. I have argued that evidence of the effectiveness of supervised drug consumption 
has not proved sufficiently compelling for the policy idea to become mainstream. It continues 
to compete with conflicting political agendas and dominant ideologies that support the 
architecture of drug prohibition, impeding policy transfer. In Canada, crisis has galvanised a 
community into acts of civil disobedience that have succeeded in bringing about change, both 
locally and at provincial and national levels. This thesis has demonstrated that the context or 
structures in which ideas emerge and circulate matter if change is to be effected. Ideas do, 
however, have a causal impact and can bring about change at the institutional level through 
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the actions of agents. Thus a dialectic relationship exists, both constraining and facilitating 
policy change. The tendency towards conservatism within institutional structures can slow 
the pace of change, which is an undesirable outcome in the face of preventable suffering and 
death. Where positive policy solutions exist, communities should be encouraged to continue 
to speak up and, if necessary, demonstrate through their actions the feasibility of providing 
life-saving community-based services. Such actions can serve to galvanise the courage of 
those with the power to provide sustaining institutional protection through the policy making 
process.  
 
 
 Appendix 1 Ideation, social construction and drug policy scoping review charted data, 2016 
Author, Year Journal/Book/Thesis Country Theoretical approach Drug policy/issue Method Data source 
Alexandrescu (2014) Crime, Media, Culture UK Narratives and frames Mephedrone, media and moral panic Discourse and media analysis Online published news items 
Amundson et al.  
(2015)  
Sociological Spectrum US Social construction of target 
populations 
Construction of welfare recipients as 
drug users 
Documentary discourse 
analysis  
Media, press releases and 
speeches 
Bewley-Taylor (2014) International Journal of Drug Policy Afghanistan Policy transfer Development of the Afghan national 
drug strategy 
Narrative policy analysis and 
historical reconstruction 
Documents and interviews 
Bright et al. (2008) Addiction Research and Theory Australia Discourse analysis Identification of dominant discourses 
on drugs 
Media analysis Newspaper articles and 
media 
Bright et al. (2013) International Journal of Drug Policy Australia Narratives and frames Kronic, dominant discourses, moral 
panic 
Media and discursive 
analysis 
Online published stories, 
google trends analysis and 
survey data 
Butler (2013) Drugs: Education, Prevention and 
Policy  
Ireland Policy transfer Drug courts in Ireland Case study Documents and interviews 
Clarke (2016) Critical Social Policy US Narratives (Narrative Policy 
Framework) 
Needle exchange programs in California Narrative analysis Documents, media, 
committee recordings and 
interviews 
Dingelstad et al. 
(1996)  
Social Science and Medicine Australia Social construction (problem 
construction) 
Drug debates and interest groups Case studies Interviews and research 
texts 
Dwyer and Moore 
(2013) 
International Journal of Drug Policy Australia Social construction, Science 
and Technology Studies 
Methamphetamine and public 
discourse 
Discourse analysis and 
ethnography 
Web content, media, policy 
documents, grey literature, 
research texts and 
ethnographic material 
Elliot and Chapman 
(2000)  
Drug and Alcohol Review Australia Social construction of target 
populations 
Construction of drug users and the ACT 
heroin trial 
Qualitative content analysis Newspaper articles 
Euchner et al. (2013) Journal of European Public Policy Germany 
and 
Netherlands 
Frames and frame shifting Morality framing of gambling and drug 
use in the Netherlands and Germany 
Case studies and 
documentary analysis 
Parliamentary and 
government documents 
Everett (1998) Book chapter US Social construction (problem 
construction and public 
arenas model) 
Sentencing of crack cocaine offences in 
the US 
Narrative reconstruction and 
media analysis 
Documents and media 
Fitzgerald (2013) Critical Public Health Australia Narratives (Narrative Policy 
Framework) and framing 
Safe injecting facilities in Australia Narrative analysis Interviews, policy 
documents, parliamentary 
records, research texts and 
ethnographic material 
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Fraser and Moore 
(2011) 
International Journal of Drug Policy Australia Social construction (problem 
construction) 
Amphetamine-type substances policy, 
representation, knowledge and 
evidence 
Policy analysis Policy documents 
Gunaratnum (2005) Report Australia Kingdon's multiple streams Safe injecting facilities in Australia Case studies Media, press releases, 
parliamentary records, 
reports and research texts 
Hallam (2006) PhD Thesis Australia Sabatier's Advocacy Coalition 
Framework 
Drug policy and harm reduction in 
Australia 
Case studies Media, press releases, 
parliamentary records, 
reports and research texts 
Houborg and Frank 
(2014) 
International Journal of Drug Policy Denmark Kingdon's multiple streams 
and Callon's 'framing' and 
'overflowing' 
Drug consumption rooms in Denmark Critical discourse analysis Media, legislation, 
government and NGO 
documentation 
Hudebine (2005) Addiction Research and Theory UK Policy paradigms and problem 
construction 
Harm reduction and drug policy in the 
UK and perceptions of drug users 
Cognitive policy analysis Policy documents, reports, 
research texts and interviews 
Hughes et al. (2011) International Journal of Drug Policy Australia Frames Australian news media reporting of 
illicit drug issues 
Media content analysis Newspaper articles 
Hughes et al. (2014) International Journal of Drug Policy Australia Policy theory (Kingdon and 
Sabatier) 
Legal thresholds for drug trafficking Critical legal and historical 
analysis 
Policy documents, 
legislation, parliamentary 
records, government 
inquiries, policy reports and 
research texts 
Kolind et al. (2016) Drugs: Education, Prevention and 
Policy 
Denmark Science and Technology 
Studies, 'enactments' and 
actor network theory 
Drugs in prisons Critical analysis Interviews and participant 
observations 
Kübler (2001) Journal of European Public Policy Switzerland Sabatier's Advocacy Coalition 
Framework 
Harm reduction policies in Switzerland Tests ACF's policy change 
hypothoses; case study 
Documents 
Lancaster et. al. (2011) Drug and Alcohol Review Australia Media/ communication 
theories 
Impact of media and effect on drug 
policy 
Models of media effects Research texts 
Lancaster (2014) International Journal of Drug Policy General Social construction (problem 
construction) 
The evidence-based drug policy 
endeavour 
Discursive analysis and 
commentary 
Research texts 
Lancaster and Ritter 
(2014) 
International Journal of Drug Policy Australia Social construction (problem 
construction and 
representation) 
Australia's national drug strategy 
documents 
Critical discourse analysis Documents 
Lancaster et al. (2014) Policy Studies Australia Kingdon's multiple streams Methamphetamine and public 
discourse 
Case study Research texts, summit 
papers, grey literature, 
government reports, policy 
announcements and media 
Lancaster et al. (2015) International Journal of Drug Policy UK and 
Australia  
Social construction (problem 
construction) 
Recovery agenda in the UK and 
Australia 
Comparative policy analysis Reports 
Lawrence et al. (2000) Aust & NZ Journal of Public Health Australia Frames Media coverage and the ACT Heroin 
Trail 
Media content analysis Newspaper articles 
266 
 
 
Lybeker et al. (2015) Policy and Internet US and 
Mexico 
Social construction of target 
populations and narratives 
(Narrative Policy Framework) 
New media and the portrayal of issues 
on the US-Mexico border 
Media analysis YouTube videos 
MacGregor (2013) Drugs: Education, Prevention and 
Policy 
UK Social construction (problem 
construction) and narratives 
and frames 
Political perspectives of drug issues in 
the UK 
Thematic analysis using 
grounded theory approach 
Government and policy 
documents, media, 
interviews and participant 
observation 
McCann (2008) Environment and Planning A Canada Policy transfer and urban 
policy mobilities  
Drug policy in Vancouver Case study Documents, media and 
interviews 
McCann and Temenos 
(2015) 
Health and Place International Policy mobilities Drug consumption rooms Case study Government and policy 
documents, research texts, 
reports and interviews 
Monaghan (2011) Book UK Sabatier's Advocacy Coalition 
Framework; models of 
evidence use and the 
'processual' model 
UK cannabis classification system and 
evidence 
Case study Government and policy 
documents, research texts, 
reports and interviews 
Monaghan (2010) Social Policy and Society UK Models of evidence use and 
the 'processual' model 
UK cannabis classification system and 
evidence 
Theory building Government and policy 
documents, research texts, 
reports and interviews 
Moore and Fraser 
(2013)  
Qualitative Health Research Australia Social construction (problem 
construction) 
Addiction treatment policy Case study Interviews 
Neill (2014) World Medical and Health Policy US Social construction of target 
populations 
Social construction of drug users and 
impact on drug policy in the US  
Historical narrative Research texts 
Ritter (2009) International Journal of Drug Policy Australia Evidence-based policy Use of evidence in drug policy making Empirical research Interviews 
Ritter and Bammer 
(2010)  
Drug and Alcohol Review Australia Policy making theories 
(multiple) 
Impact of research on drug policy 
making 
Descriptive and analytical Policy documents 
Roumeliotis (2014) Addiction Research and Theory Sweden Social construction (problem 
construction)  
Knowledge utilisation and ideology in 
Swedish drug policy 
Discourse analysis Public reports 
Small et al. (2006) International Journal of Drug Policy Canada Social construction (problem 
construction), narratives and 
cultural change  
Safe injecting facility in Canada Narrative account Research texts 
Sobeck (2003) Administration and Society US  Sabatier's Advocacy Coalition 
Framework, bureaucratic 
politics framework and the 
institutional analysis and 
development framework 
Group membership and participation in 
the drug policy making process in 
California 
Case study comparing 
different policy frameworks 
Meeting minutes, 
observations, reports, 
interviews and surveys 
Stevens (2007) Critical Social Policy UK Narratives and frames and 
'evolutionary' theory of 
evidence selection  
Bias in the use of evidence in policy 
development 
Theory building Policy documents 
267 
 
 
Stevens (2011) Book UK, US, 
Sweden and 
the 
Netherlands 
Narratives and frames, 
evidence and policy making 
Bias in the use of evidence in policy 
development; harmful consequences of 
drug policy 
Empirical research Government and policy 
documents, observations, 
and ethnography 
Stevens and Ritter 
(2013)  
Drugs: Education, Prevention and 
Policy 
General  Narratives Drug policy development and evidence 
utilisation 
Editorial to IJPD special 
edition 
Research texts 
Tammi (2005) International Journal of Drug Policy Finland Social construction and elite 
networks 
Drug policy development in Finland Discourse and network 
analysis, case study 
Policy documents, reports, 
proceedings, committee 
member notes, media and 
interviews 
Temenos (2016) Space and Polity International Policy mobilities Conferences, networks and drug policy 
reform 
Empirical research Documents, interviews and 
observations 
Tieberghien (2014) International Journal of Drug Policy Belgium Research utilisation and the 
media 
Drug policy debates in Belgium Discourse analysis Newspaper articles and 
policy documents 
van Tooren (2016) Evidence and Policy Australia Social construction (problem 
construction) and frames 
Compares role of evidence in drug 
policy and child protection 
Case studies and discourse 
analysis 
Policy documents 
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Appendix 2 Interview guides 
 
Drug consumption rooms case study (Sydney) - semi-structured interview guide 
1. Introductions; ensure the interviewee is aware of the purpose of the research.  Signing 
of the consent form. 
2. Establishing the role and experience of the interviewee regarding drug policy 
development and specifically, safe injecting facilities (SIFs) in Sydney. 
3. Overview of the nature of street-based drug use in Sydney and its consequences for 
public health and public security. 
- An assessment of the need for safe injecting services in Sydney, including beyond 
Kings Cross, and more broadly in NSW. 
4. Identification of the main stakeholder groups which played a significant role in policy 
debates about the setting up MSIC in Sydney and proposed new facilities. 
5. The role of evidence in the policy debate. 
- How evidence was introduced into and used in the debate. 
- What was the role of local evidence? International evidence? 
6. Perception of the primary arguments that were raised to oppose the introduction of a 
safe injection facility. 
7. Perception of the role and influence of the media in the debates in Sydney. 
8. What role was played by different levels of government? 
- Local/State/Federal 
9.  The role of legal and legislative processes in relation to the MSIC. 
- What impact did the attempt to challenge the MSIC in court have? 
- Why does the legislation only allow for one safe injecting facility? 
10. Identification of key factors that might account for there only being one safe injecting 
facility in New South Wales.  Have there been any critical events that have affected 
potential replication?  
11. Impact of the decision to design and manage the first safe injecting room as a scientific 
trial on further expansion of safe injection facilities in Australia. 
12. Exploration of the notion of ‘normalisation’ of safe injection services. 
- What factors might support normalisation; what factors might mitigate it? 
13. Identification of ongoing challenges. 
14. Any further reflections. 
Drug consumption rooms case study (Melbourne) - semi-structured interview guide 
1. Introductions; ensure the interviewee is aware of the purpose of the research.  Signing 
of the consent form. 
2. Establishing the role and experience of the interviewee regarding drug policy 
development and specifically, safe injecting facilities (SIFs) in Melbourne. 
3. Overview of the nature of street-based drug use in Melbourne and its consequences 
for public health and public security. 
- An assessment of the need for safe injecting services in Melbourne and more 
broadly in Victoria. 
4. Identification of the main stakeholder groups which played a significant role in policy 
debates about the setting up of safe injecting facilities in Melbourne. 
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5. The role of evidence in the policy debate. 
- How evidence was introduced into and used in the debate. 
- What was the role of local and national evidence? International evidence? 
6. Perception of the primary arguments that were raised to oppose the introduction of 
safe injection facilities. 
7. Perception of the role and influence of the media in the debates in Melbourne. 
8. What role was played by different levels of government? 
- Local/State/Federal 
9. The role of legal and legislative processes in relation to the MSIC. 
- Have proposed facilities been the subject of any legal action or threat of legal 
action? 
- What has been the impact of the recent Coroner’s verdict recommending a 
facility in Richmond? 
- Why was the original (failed) legislation not reintroduced? 
10. Identification of key factors that might account for there being no safe injection 
facilities in Melbourne? Have there been any critical events that have affected 
potential replication of Sydney’s MSIC?  
11. Impact of the decision to design and manage the first safe injecting room as a scientific 
trial on further expansion of safe injection facilities in Australia. 
12. Exploration of the notion of ‘normalisation’ of safe injection services. 
- What factors might support normalisation; what factors might mitigate it? 
13. Identification of ongoing challenges. 
14. Any further reflections. 
 
Drug consumption rooms case study (Vancouver) - semi-structured interview guide 
1. Introductions; ensure the interviewee is aware of the purpose of the research.  Signing 
of the consent form. 
2. Establishing the role and experience of the interviewee regarding drug policy 
development and specifically, safe injecting facilities (SIFs) in Vancouver. 
3. Overview of the nature of street-based drug use in Vancouver and its consequences 
for public health and public security. 
- An assessment of the need for safe injecting services in Vancouver, including 
beyond DTES. 
4. Identification of the main stakeholder groups which played a significant role in policy 
debates about the setting up of SIFs in Vancouver. 
5. The role of evidence in the policy debate. 
- How evidence was introduced into and used in the debate. 
- What was the role of local evidence? International evidence? 
6. Perception of the primary arguments that were raised to oppose the introduction of 
safe injection facilities. 
7. Perception of the role and influence of the media in the debates in Vancouver. 
8. The role of legal and/or legislative issues in relation to attempts to introduce SIFs in 
Vancouver. 
- What has been the impact of federal law on the province in this policy area? 
- How did the 2011 Supreme Court ruling influence the policy process locally? 
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9. What role was played by the province in relation to the City of Vancouver achieving its 
policy goals? 
10. Identification of key factors that might account for the gap in time between the 
opening of Insite in Vancouver and the extension of safe injection facilities elsewhere. 
- What were the critical moments that spurred action; what were the critical 
moments that stymied action? 
11. Impact of the decision to design and manage the first safe injecting room as a scientific 
trial on further expansion of safe injection facilities in Canada. 
12. Exploration of the notion of ‘normalisation’ of safe injection services. 
- What factors might support normalisation; what factors might mitigate it? 
13. Identification of ongoing challenges. 
14. Any further reflections. 
 
Drug consumption rooms case study (Toronto) - semi-structured interview guide 
1. Introductions; ensure the interviewee is aware of the purpose of the research.  Signing 
of the consent form. 
2. Establishing the role and experience of the interviewee regarding drug development 
policy and specifically, safe injecting facilities (SIFs) in Toronto. 
3. Overview of the nature of street-based drug use in Toronto and its consequences for 
public health and public security. 
- An assessment of the need for safe injecting services in Toronto. 
4. Identification of the main stakeholder groups which played a significant role in policy 
debates about the setting up of SIFs in Toronto. 
5. The role of evidence in the policy debate. 
- How evidence was introduced into and used in the debate. 
- What was the role of local evidence? 
6. Perception of the primary arguments that were raised to oppose the introduction of 
safe injection facilities. 
7. Perception of the role and influence of the media in the debates in Toronto. 
8. The role of legal and/or legislative issues in relation to attempts to introduce SIFs in 
Toronto. 
- How did the 2011 Supreme Court ruling influence the policy process locally? 
- What has been the impact of federal law on the province in this policy area? 
9. Identification of key factors that might account for the gap in time between the 
opening of Insite in Vancouver and the opening of similar services in Toronto. 
- What were the critical moments that spurred action; what were the critical 
moments that stymied action? 
10. Impact of the decision to design and manage the first safe injecting room as a scientific 
trial on further expansion of safe injection facilities in Canada. 
11. Identification of lessons learned from the national experience that are being applied to 
the development of services in Toronto. 
12. Exploration of the notion of ‘normalisation’ of safe injection services. 
- What factors might support normalisation; what factors might mitigate it? 
13. Identification of ongoing challenges. 
14. Any further reflections. 
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